Compound ID,Uniprot ID,Compound Name,Standard inchi key,Max Phase,Target Pref Name,Gene Names,Target Class,Wild type or mutant,Mutation information,PubMed ID,End Point Standard Type,End Point Standard Relation,End Point Standard Value,End Point Standard Units,Endpoint Mode of Action,Assay Format,Assay Type,Assay Sub Type,Inhibitor Type,Detection Technology,Compound concentration value,Compound concentration value units,Substrate type,Substrate Type Standard Relation,Substrate Type Standard Value,Substrate Type Standard Units,Assay cell line,Assay Description,Activity Comments,Title,Journal,Year,Volume,Issue,Authors,Annotation Comments,Assay ID,DTC Tid,DTC Activity ID,DTC Molregno,Record ID,DTC Document ID
CHEMBL1077203,P50281,,CNUCYIDHDPTDOD-SFHVURJKSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,20172725,KI,=,1196,NM,,,,,,,,,,,,,,Inhibition of MMP14,,Discovery and SAR of hydantoin TACE inhibitors.,Bioorg. Med. Chem. Lett.,2010,20,6,"Yu W, Guo Z, Orth P, Madison V, Chen L, Dai C, Feltz RJ, Girijavallabhan VM, Kim SH, Kozlowski JA, Lavey BJ, Li D, Lundell D, Niu X, Piwinski JJ, Popovici-Muller J, Rizvi R, Rosner KE, Shankar BB, Shih NY, Siddiqui MA, Sun J, Tong L, Umland S, Wong MK, Yang DY, Zhou G",,615269,DTCT0024091,3227042,DTCC00631173,1104573,38167
CHEMBL1078279,P50281,,AHXGZLJBINZPQZ-DYHNYNMBSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,21417219,IC50,=,19,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP14 after 60 mins by fluorescence plate reader,,"Discovery of (1S,2R,3R)-2,3-Dimethyl-2-phenyl-1-sulfamidocyclopropanecarboxylates: Novel and Highly Selective Aggrecanase Inhibitors.",J. Med. Chem.,2011,54,8,"Shiozaki M, Maeda K, Miura T, Kotoku M, Yamasaki T, Matsuda I, Aoki K, Yasue K, Imai H, Ubukata M, Suma A, Yokota M, Hotta T, Tanaka M, Hase Y, Haas J, Fryer AM, Laird ER, Littmann NM, Andrews SW, Josey JA, Mimura T, Shinozaki Y, Yoshiuchi H, Inaba T",,743597,DTCT0024091,5926792,DTCC00632904,1460948,44276
CHEMBL1078281,P50281,,GRSFKJZRDUZQPW-ONUMYQOESA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,21417219,IC50,=,3.4,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP14 after 60 mins by fluorescence plate reader,,"Discovery of (1S,2R,3R)-2,3-Dimethyl-2-phenyl-1-sulfamidocyclopropanecarboxylates: Novel and Highly Selective Aggrecanase Inhibitors.",J. Med. Chem.,2011,54,8,"Shiozaki M, Maeda K, Miura T, Kotoku M, Yamasaki T, Matsuda I, Aoki K, Yasue K, Imai H, Ubukata M, Suma A, Yokota M, Hotta T, Tanaka M, Hase Y, Haas J, Fryer AM, Laird ER, Littmann NM, Andrews SW, Josey JA, Mimura T, Shinozaki Y, Yoshiuchi H, Inaba T",,743597,DTCT0024091,5926788,DTCC00632907,1007708,44276
CHEMBL1078396,P50281,,PIEMRKVLYXWKFP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,20172725,KI,=,31910,NM,,,,,,,,,,,,,,Inhibition of MMP14,,Discovery and SAR of hydantoin TACE inhibitors.,Bioorg. Med. Chem. Lett.,2010,20,6,"Yu W, Guo Z, Orth P, Madison V, Chen L, Dai C, Feltz RJ, Girijavallabhan VM, Kim SH, Kozlowski JA, Lavey BJ, Li D, Lundell D, Niu X, Piwinski JJ, Popovici-Muller J, Rizvi R, Rosner KE, Shankar BB, Shih NY, Siddiqui MA, Sun J, Tong L, Umland S, Wong MK, Yang DY, Zhou G",,615269,DTCT0024091,3227041,DTCC00631942,1232705,38167
CHEMBL1082317,P50281,,QOWJHUFMPPFELP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,20529685,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibition of MMP14,,MMP-13 selective isonipecotamide alpha-sulfone hydroxamates.,Bioorg. Med. Chem. Lett.,2010,20,12,"Kolodziej SA, Hockerman SL, DeCrescenzo GA, McDonald JJ, Mischke DA, Munie GE, Fletcher TR, Stehle N, Swearingen C, Becker DP",,634124,DTCT0024091,3346218,DTCC00647799,780673,35540
CHEMBL1082318,P50281,,HWZVYNMATDDRGV-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,20529685,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibition of MMP14,,MMP-13 selective isonipecotamide alpha-sulfone hydroxamates.,Bioorg. Med. Chem. Lett.,2010,20,12,"Kolodziej SA, Hockerman SL, DeCrescenzo GA, McDonald JJ, Mischke DA, Munie GE, Fletcher TR, Stehle N, Swearingen C, Becker DP",,634124,DTCT0024091,3346219,DTCC00647800,2038151,35540
CHEMBL1082370,P50281,,XZDDXHHQKBWEQB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,20529684,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibition of MMP14,,"Orally bioavailable dual MMP-1/MMP-14 sparing, MMP-13 selective alpha-sulfone hydroxamates.",Bioorg. Med. Chem. Lett.,2010,20,12,"Kolodziej SA, Hockerman SL, Boehm TL, Carroll JN, DeCrescenzo GA, McDonald JJ, Mischke DA, Munie GE, Fletcher TR, Rico JG, Stehle NW, Swearingen C, Becker DP",,634108,DTCT0024091,3346065,DTCC00647469,954160,35532
CHEMBL1082371,P50281,,PYJCXRBSZSSHDD-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,20529684,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibition of MMP14,,"Orally bioavailable dual MMP-1/MMP-14 sparing, MMP-13 selective alpha-sulfone hydroxamates.",Bioorg. Med. Chem. Lett.,2010,20,12,"Kolodziej SA, Hockerman SL, Boehm TL, Carroll JN, DeCrescenzo GA, McDonald JJ, Mischke DA, Munie GE, Fletcher TR, Rico JG, Stehle NW, Swearingen C, Becker DP",,634108,DTCT0024091,3346066,DTCC00647470,2049561,35532
CHEMBL1082381,P50281,SC-276,WXNWNNKHEJMQOM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,20529684,IC50,=,19,NM,,,,,,,,,,,,,,Inhibition of MMP14,,"Orally bioavailable dual MMP-1/MMP-14 sparing, MMP-13 selective alpha-sulfone hydroxamates.",Bioorg. Med. Chem. Lett.,2010,20,12,"Kolodziej SA, Hockerman SL, Boehm TL, Carroll JN, DeCrescenzo GA, McDonald JJ, Mischke DA, Munie GE, Fletcher TR, Rico JG, Stehle NW, Swearingen C, Becker DP",,634108,DTCT0024091,3346109,DTCC00031197,792376,35532
CHEMBL1082381,P50281,SC-276,WXNWNNKHEJMQOM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,20726512,IC50,=,19.1,NM,,,,,,,,,,,,,,Inhibition of human MMP14 assessed as cleavage of fluorogenic peptide MCAPro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 by fluorometric assay,,"Orally active MMP-1 sparing a-tetrahydropyranyl and a-piperidinyl sulfone matrix metalloproteinase (MMP) inhibitors with efficacy in cancer, arthritis, and cardiovascular disease.",J. Med. Chem.,2010,53,18,"Becker DP, Barta TE, Bedell LJ, Boehm TL, Bond BR, Carroll J, Carron CP, Decrescenzo GA, Easton AM, Freskos JN, Funckes-Shippy CL, Heron M, Hockerman S, Howard CP, Kiefer JR, Li MH, Mathis KJ, McDonald JJ, Mehta PP, Munie GE, Sunyer T, Swearingen CA, Villamil CI, Welsch D, Williams JM, Yu Y, Yao J",,754465,DTCT0024091,6005738,DTCC00031197,781480,45214
CHEMBL1082381,P50281,SC-276,WXNWNNKHEJMQOM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,21493063,IC50,=,8,NM,,,,,,,,,,,,,,Inhibition of human MMP14,,MMP-13 selective alpha-sulfone hydroxamates: Identification of selective P1' amides.,Bioorg. Med. Chem. Lett.,2011,21,10,"Fobian YM, Freskos JN, Barta TE, Bedell LJ, Heintz R, Kassab DJ, Kiefer JR, Mischke BV, Molyneaux JM, Mullins P, Munie GE, Becker DP",,744874,DTCT0024091,5936698,DTCC00031197,799452,44425
CHEMBL1082966,P50281,,NHBOIMAIUCLQKQ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,20529684,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibition of MMP14,,"Orally bioavailable dual MMP-1/MMP-14 sparing, MMP-13 selective alpha-sulfone hydroxamates.",Bioorg. Med. Chem. Lett.,2010,20,12,"Kolodziej SA, Hockerman SL, Boehm TL, Carroll JN, DeCrescenzo GA, McDonald JJ, Mischke DA, Munie GE, Fletcher TR, Rico JG, Stehle NW, Swearingen C, Becker DP",,634108,DTCT0024091,3346054,DTCC00647118,1051282,35532
CHEMBL1083322,P50281,,FSVPEOOPDJVOOW-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,20529684,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibition of MMP14,,"Orally bioavailable dual MMP-1/MMP-14 sparing, MMP-13 selective alpha-sulfone hydroxamates.",Bioorg. Med. Chem. Lett.,2010,20,12,"Kolodziej SA, Hockerman SL, Boehm TL, Carroll JN, DeCrescenzo GA, McDonald JJ, Mischke DA, Munie GE, Fletcher TR, Rico JG, Stehle NW, Swearingen C, Becker DP",,634108,DTCT0024091,3346064,DTCC00647405,112725,35532
CHEMBL1083609,P50281,,KWMLNYHZDJEOKG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,20478708,INHIBITION,=,48,%,,,,,,,,,,,,,,Inhibition of MMP14 at 100 uM,,New hydroxypyrimidinone-containing sulfonamides as carbonic anhydrase inhibitors also acting as MMP inhibitors.,Bioorg. Med. Chem. Lett.,2010,20,12,"Esteves MA, Ortet O, Capelo A, Supuran CT, Marques SM, Santos MA",,635104,DTCT0024091,3350492,DTCC00647058,274642,39108
CHEMBL1083906,P50281,,HYKTXCHYRXFJMV-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,20529684,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibition of MMP14,,"Orally bioavailable dual MMP-1/MMP-14 sparing, MMP-13 selective alpha-sulfone hydroxamates.",Bioorg. Med. Chem. Lett.,2010,20,12,"Kolodziej SA, Hockerman SL, Boehm TL, Carroll JN, DeCrescenzo GA, McDonald JJ, Mischke DA, Munie GE, Fletcher TR, Rico JG, Stehle NW, Swearingen C, Becker DP",,634108,DTCT0024091,3346055,DTCC00647119,1665937,35532
CHEMBL1083907,P50281,,XFCISDUWYSMJOU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,20529684,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibition of MMP14,,"Orally bioavailable dual MMP-1/MMP-14 sparing, MMP-13 selective alpha-sulfone hydroxamates.",Bioorg. Med. Chem. Lett.,2010,20,12,"Kolodziej SA, Hockerman SL, Boehm TL, Carroll JN, DeCrescenzo GA, McDonald JJ, Mischke DA, Munie GE, Fletcher TR, Rico JG, Stehle NW, Swearingen C, Becker DP",,634108,DTCT0024091,3346056,DTCC00647120,534358,35532
CHEMBL1083918,P50281,,NBVVLRJKURZELV-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,20478708,INHIBITION,=,28,%,,,,,,,,,,,,,,Inhibition of MMP14 at 100 uM,,New hydroxypyrimidinone-containing sulfonamides as carbonic anhydrase inhibitors also acting as MMP inhibitors.,Bioorg. Med. Chem. Lett.,2010,20,12,"Esteves MA, Ortet O, Capelo A, Supuran CT, Marques SM, Santos MA",,635104,DTCT0024091,3350493,DTCC00647059,1277543,39108
CHEMBL1083931,P50281,,VGQUGXBRZGFKOH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,20529684,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibition of MMP14,,"Orally bioavailable dual MMP-1/MMP-14 sparing, MMP-13 selective alpha-sulfone hydroxamates.",Bioorg. Med. Chem. Lett.,2010,20,12,"Kolodziej SA, Hockerman SL, Boehm TL, Carroll JN, DeCrescenzo GA, McDonald JJ, Mischke DA, Munie GE, Fletcher TR, Rico JG, Stehle NW, Swearingen C, Becker DP",,634108,DTCT0024091,3346060,DTCC00647257,824921,35532
CHEMBL1083932,P50281,,BADHAWRYSSJDAG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,20529684,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibition of MMP14,,"Orally bioavailable dual MMP-1/MMP-14 sparing, MMP-13 selective alpha-sulfone hydroxamates.",Bioorg. Med. Chem. Lett.,2010,20,12,"Kolodziej SA, Hockerman SL, Boehm TL, Carroll JN, DeCrescenzo GA, McDonald JJ, Mischke DA, Munie GE, Fletcher TR, Rico JG, Stehle NW, Swearingen C, Becker DP",,634108,DTCT0024091,3346061,DTCC00647258,1472207,35532
CHEMBL1084206,P50281,,RMMYIAVIROFVLC-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,20529684,IC50,=,2860,NM,,,,,,,,,,,,,,Inhibition of MMP14,,"Orally bioavailable dual MMP-1/MMP-14 sparing, MMP-13 selective alpha-sulfone hydroxamates.",Bioorg. Med. Chem. Lett.,2010,20,12,"Kolodziej SA, Hockerman SL, Boehm TL, Carroll JN, DeCrescenzo GA, McDonald JJ, Mischke DA, Munie GE, Fletcher TR, Rico JG, Stehle NW, Swearingen C, Becker DP",,634108,DTCT0024091,3346057,DTCC00647201,1697970,35532
CHEMBL1084208,P50281,,QQPOIMHFFPBDQM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,20529684,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibition of MMP14,,"Orally bioavailable dual MMP-1/MMP-14 sparing, MMP-13 selective alpha-sulfone hydroxamates.",Bioorg. Med. Chem. Lett.,2010,20,12,"Kolodziej SA, Hockerman SL, Boehm TL, Carroll JN, DeCrescenzo GA, McDonald JJ, Mischke DA, Munie GE, Fletcher TR, Rico JG, Stehle NW, Swearingen C, Becker DP",,634108,DTCT0024091,3346058,DTCC00647203,1727327,35532
CHEMBL1084209,P50281,,HBPYDCJRDHWDAE-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,20529684,IC50,=,8220,NM,,,,,,,,,,,,,,Inhibition of MMP14,,"Orally bioavailable dual MMP-1/MMP-14 sparing, MMP-13 selective alpha-sulfone hydroxamates.",Bioorg. Med. Chem. Lett.,2010,20,12,"Kolodziej SA, Hockerman SL, Boehm TL, Carroll JN, DeCrescenzo GA, McDonald JJ, Mischke DA, Munie GE, Fletcher TR, Rico JG, Stehle NW, Swearingen C, Becker DP",,634108,DTCT0024091,3346059,DTCC00647204,1018809,35532
CHEMBL1084220,P50281,,DPDYQDPIBOABCX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,20529684,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibition of MMP14,,"Orally bioavailable dual MMP-1/MMP-14 sparing, MMP-13 selective alpha-sulfone hydroxamates.",Bioorg. Med. Chem. Lett.,2010,20,12,"Kolodziej SA, Hockerman SL, Boehm TL, Carroll JN, DeCrescenzo GA, McDonald JJ, Mischke DA, Munie GE, Fletcher TR, Rico JG, Stehle NW, Swearingen C, Becker DP",,634108,DTCT0024091,3346062,DTCC00647323,1886832,35532
CHEMBL1084221,P50281,,FNEPKOHTWFANAW-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,20529684,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibition of MMP14,,"Orally bioavailable dual MMP-1/MMP-14 sparing, MMP-13 selective alpha-sulfone hydroxamates.",Bioorg. Med. Chem. Lett.,2010,20,12,"Kolodziej SA, Hockerman SL, Boehm TL, Carroll JN, DeCrescenzo GA, McDonald JJ, Mischke DA, Munie GE, Fletcher TR, Rico JG, Stehle NW, Swearingen C, Becker DP",,634108,DTCT0024091,3346063,DTCC00647324,598800,35532
CHEMBL1084238,P50281,,UFKFLDDRYBWLPH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,20529684,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibition of MMP14,,"Orally bioavailable dual MMP-1/MMP-14 sparing, MMP-13 selective alpha-sulfone hydroxamates.",Bioorg. Med. Chem. Lett.,2010,20,12,"Kolodziej SA, Hockerman SL, Boehm TL, Carroll JN, DeCrescenzo GA, McDonald JJ, Mischke DA, Munie GE, Fletcher TR, Rico JG, Stehle NW, Swearingen C, Becker DP",,634108,DTCT0024091,3346106,DTCC00647546,80529,35532
CHEMBL1084509,P50281,,VCKIKUWRRCAZBI-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,20529684,IC50,=,5000,NM,,,,,,,,,,,,,,Inhibition of MMP14,,"Orally bioavailable dual MMP-1/MMP-14 sparing, MMP-13 selective alpha-sulfone hydroxamates.",Bioorg. Med. Chem. Lett.,2010,20,12,"Kolodziej SA, Hockerman SL, Boehm TL, Carroll JN, DeCrescenzo GA, McDonald JJ, Mischke DA, Munie GE, Fletcher TR, Rico JG, Stehle NW, Swearingen C, Becker DP",,634108,DTCT0024091,3346107,DTCC00647547,1601315,35532
CHEMBL1084510,P50281,,HMVRHAWMVBUIKM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,20529684,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibition of MMP14,,"Orally bioavailable dual MMP-1/MMP-14 sparing, MMP-13 selective alpha-sulfone hydroxamates.",Bioorg. Med. Chem. Lett.,2010,20,12,"Kolodziej SA, Hockerman SL, Boehm TL, Carroll JN, DeCrescenzo GA, McDonald JJ, Mischke DA, Munie GE, Fletcher TR, Rico JG, Stehle NW, Swearingen C, Becker DP",,634108,DTCT0024091,3346108,DTCC00647548,1375495,35532
CHEMBL108494,P50281,,MBSMJAHZPVXQCK-HIGJEIRPSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,11563922,KI,=,3070,NM,,,,,,,,,,,,,,In vitro inhibitory activity against the catalytic domain of human matrix metalloprotease-14,,"Structure-based design and synthesis of potent matrix metalloproteinase inhibitors derived from a 6H-1,3,4-thiadiazine scaffold.",J. Med. Chem.,2001,44,20,"Schröder J, Henke A, Wenzel H, Brandstetter H, Stammler HG, Stammler A, Pfeiffer WD, Tschesche H",,106783,DTCT0024091,1704496,DTCC00282283,1196752,16424
CHEMBL108494,P50281,,MBSMJAHZPVXQCK-HIGJEIRPSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,18790648,KI,=,3070,NM,,,,,,,,,,,,,,Inhibition of MMP14,,Specific targeting of metzincin family members with small-molecule inhibitors: progress toward a multifarious challenge.,Bioorg. Med. Chem.,2008,16,19,"Georgiadis D, Yiotakis A",,497410,DTCT0024091,2457383,DTCC00282283,1210750,32556
CHEMBL1085257,P50281,,WVNVANHURONWTG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,20529685,IC50,=,10000,NM,,,,,,,,,,,,,,Inhibition of MMP14,,MMP-13 selective isonipecotamide alpha-sulfone hydroxamates.,Bioorg. Med. Chem. Lett.,2010,20,12,"Kolodziej SA, Hockerman SL, DeCrescenzo GA, McDonald JJ, Mischke DA, Munie GE, Fletcher TR, Stehle N, Swearingen C, Becker DP",,634124,DTCT0024091,3346226,DTCC00647802,262531,35540
CHEMBL1085263,P50281,,JOMDWNBZLUPPTA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,20529684,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibition of MMP14,,"Orally bioavailable dual MMP-1/MMP-14 sparing, MMP-13 selective alpha-sulfone hydroxamates.",Bioorg. Med. Chem. Lett.,2010,20,12,"Kolodziej SA, Hockerman SL, Boehm TL, Carroll JN, DeCrescenzo GA, McDonald JJ, Mischke DA, Munie GE, Fletcher TR, Rico JG, Stehle NW, Swearingen C, Becker DP",,634108,DTCT0024091,3346067,DTCC00647471,1051285,35532
CHEMBL1085602,P50281,,XFIZGIIZTOASLY-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,20529684,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibition of MMP14,,"Orally bioavailable dual MMP-1/MMP-14 sparing, MMP-13 selective alpha-sulfone hydroxamates.",Bioorg. Med. Chem. Lett.,2010,20,12,"Kolodziej SA, Hockerman SL, Boehm TL, Carroll JN, DeCrescenzo GA, McDonald JJ, Mischke DA, Munie GE, Fletcher TR, Rico JG, Stehle NW, Swearingen C, Becker DP",,634108,DTCT0024091,3346053,DTCC00647043,1568775,35532
CHEMBL1085725,P50281,,ZAPMQYOCCLDIJN-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,20478708,INHIBITION,=,3,%,,,,,,,,,,,,,,Inhibition of MMP14 at 3 uM,,New hydroxypyrimidinone-containing sulfonamides as carbonic anhydrase inhibitors also acting as MMP inhibitors.,Bioorg. Med. Chem. Lett.,2010,20,12,"Esteves MA, Ortet O, Capelo A, Supuran CT, Marques SM, Santos MA",,635105,DTCT0024091,3350495,DTCC00647060,405782,39108
CHEMBL1085725,P50281,,ZAPMQYOCCLDIJN-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,20478708,INHIBITION,=,42,%,,,,,,,,,,,,,,Inhibition of MMP14 at 100 uM,,New hydroxypyrimidinone-containing sulfonamides as carbonic anhydrase inhibitors also acting as MMP inhibitors.,Bioorg. Med. Chem. Lett.,2010,20,12,"Esteves MA, Ortet O, Capelo A, Supuran CT, Marques SM, Santos MA",,635104,DTCT0024091,3350494,DTCC00647060,405782,39108
CHEMBL1088878,P50281,,WMJKIJLFVOMJDF-HSZRJFAPSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,20180536,IC50,=,29,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP14 by fluorometric assay,,Potent arylsulfonamide inhibitors of tumor necrosis factor-alpha converting enzyme able to reduce activated leukocyte cell adhesion molecule shedding in cancer cell models.,J. Med. Chem.,2010,53,6,"Nuti E, Casalini F, Avramova SI, Santamaria S, Fabbi M, Ferrini S, Marinelli L, La Pietra V, Limongelli V, Novellino E, Cercignani G, Orlandini E, Nencetti S, Rossello A",,624095,DTCT0024091,3287147,DTCC00635636,2081582,38228
CHEMBL1089842,P50281,,YAYGKNVDBLFWFW-HXUWFJFHSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,20180536,IC50,=,210,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP14 by fluorometric assay,,Potent arylsulfonamide inhibitors of tumor necrosis factor-alpha converting enzyme able to reduce activated leukocyte cell adhesion molecule shedding in cancer cell models.,J. Med. Chem.,2010,53,6,"Nuti E, Casalini F, Avramova SI, Santamaria S, Fabbi M, Ferrini S, Marinelli L, La Pietra V, Limongelli V, Novellino E, Cercignani G, Orlandini E, Nencetti S, Rossello A",,624095,DTCT0024091,3287135,DTCC00635634,1211870,38228
CHEMBL1089843,P50281,,MWMRJYLEVAWDDL-LJQANCHMSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,20180536,IC50,=,4.3,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP14 by fluorometric assay,,Potent arylsulfonamide inhibitors of tumor necrosis factor-alpha converting enzyme able to reduce activated leukocyte cell adhesion molecule shedding in cancer cell models.,J. Med. Chem.,2010,53,6,"Nuti E, Casalini F, Avramova SI, Santamaria S, Fabbi M, Ferrini S, Marinelli L, La Pietra V, Limongelli V, Novellino E, Cercignani G, Orlandini E, Nencetti S, Rossello A",,624095,DTCT0024091,3287141,DTCC00635635,1375373,38228
CHEMBL1090035,P50281,,BBUAWDNXWDAMGY-CQSZACIVSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,20180536,IC50,=,240,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP14 by fluorometric assay,,Potent arylsulfonamide inhibitors of tumor necrosis factor-alpha converting enzyme able to reduce activated leukocyte cell adhesion molecule shedding in cancer cell models.,J. Med. Chem.,2010,53,6,"Nuti E, Casalini F, Avramova SI, Santamaria S, Fabbi M, Ferrini S, Marinelli L, La Pietra V, Limongelli V, Novellino E, Cercignani G, Orlandini E, Nencetti S, Rossello A",,624095,DTCT0024091,3286031,DTCC00635487,566470,38228
CHEMBL1090283,P50281,,AKOBMMAQXVKOJR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,20180536,IC50,=,360,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP14 by fluorometric assay,,Potent arylsulfonamide inhibitors of tumor necrosis factor-alpha converting enzyme able to reduce activated leukocyte cell adhesion molecule shedding in cancer cell models.,J. Med. Chem.,2010,53,6,"Nuti E, Casalini F, Avramova SI, Santamaria S, Fabbi M, Ferrini S, Marinelli L, La Pietra V, Limongelli V, Novellino E, Cercignani G, Orlandini E, Nencetti S, Rossello A",,624095,DTCT0024091,3286025,DTCC00635486,760177,38228
CHEMBL1090284,P50281,,KLOYCYLPVRADHA-OAHLLOKOSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,20180536,IC50,=,16,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP14 by fluorometric assay,,Potent arylsulfonamide inhibitors of tumor necrosis factor-alpha converting enzyme able to reduce activated leukocyte cell adhesion molecule shedding in cancer cell models.,J. Med. Chem.,2010,53,6,"Nuti E, Casalini F, Avramova SI, Santamaria S, Fabbi M, Ferrini S, Marinelli L, La Pietra V, Limongelli V, Novellino E, Cercignani G, Orlandini E, Nencetti S, Rossello A",,624095,DTCT0024091,3286037,DTCC00635488,824786,38228
CHEMBL1090647,P50281,,RLHOCYLKSSHKMW-QGZVFWFLSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,20180536,IC50,=,34,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP14 by fluorometric assay,,Potent arylsulfonamide inhibitors of tumor necrosis factor-alpha converting enzyme able to reduce activated leukocyte cell adhesion molecule shedding in cancer cell models.,J. Med. Chem.,2010,53,6,"Nuti E, Casalini F, Avramova SI, Santamaria S, Fabbi M, Ferrini S, Marinelli L, La Pietra V, Limongelli V, Novellino E, Cercignani G, Orlandini E, Nencetti S, Rossello A",,624095,DTCT0024091,3286049,DTCC00635564,792230,38228
CHEMBL1092104,P50281,,MTDVSXPXWCWOED-OAHLLOKOSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,20180536,IC50,=,0.9,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP14 by fluorometric assay,,Potent arylsulfonamide inhibitors of tumor necrosis factor-alpha converting enzyme able to reduce activated leukocyte cell adhesion molecule shedding in cancer cell models.,J. Med. Chem.,2010,53,6,"Nuti E, Casalini F, Avramova SI, Santamaria S, Fabbi M, Ferrini S, Marinelli L, La Pietra V, Limongelli V, Novellino E, Cercignani G, Orlandini E, Nencetti S, Rossello A",,624095,DTCT0024091,3287129,DTCC00635567,1310213,38228
CHEMBL109214,P50281,,PDKBAEDNMKVROV-CQSZACIVSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,11563922,KI,=,150,NM,,,,,,,,,,,,,,In vitro inhibitory activity against the ectodomain of the human matrix metalloprotease-14,,"Structure-based design and synthesis of potent matrix metalloproteinase inhibitors derived from a 6H-1,3,4-thiadiazine scaffold.",J. Med. Chem.,2001,44,20,"Schröder J, Henke A, Wenzel H, Brandstetter H, Stammler HG, Stammler A, Pfeiffer WD, Tschesche H",,106784,DTCT0024091,1718170,DTCC00282259,422410,16424
CHEMBL109214,P50281,,PDKBAEDNMKVROV-CQSZACIVSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,11563922,KI,=,290,NM,,,,,,,,,,,,,,In vitro inhibitory activity against the catalytic domain of human matrix metalloprotease-14,,"Structure-based design and synthesis of potent matrix metalloproteinase inhibitors derived from a 6H-1,3,4-thiadiazine scaffold.",J. Med. Chem.,2001,44,20,"Schröder J, Henke A, Wenzel H, Brandstetter H, Stammler HG, Stammler A, Pfeiffer WD, Tschesche H",,106783,DTCT0024091,1718169,DTCC00282259,422410,16424
CHEMBL109353,P50281,,JXHAGXRDZALSLG-GFCCVEGCSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,11563922,KI,=,50,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-14,,"Structure-based design and synthesis of potent matrix metalloproteinase inhibitors derived from a 6H-1,3,4-thiadiazine scaffold.",J. Med. Chem.,2001,44,20,"Schröder J, Henke A, Wenzel H, Brandstetter H, Stammler HG, Stammler A, Pfeiffer WD, Tschesche H",,106786,DTCT0024091,1716619,DTCC00282683,357026,16424
CHEMBL109353,P50281,,JXHAGXRDZALSLG-GFCCVEGCSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,11563922,KI,=,210,NM,,,,,,,,,,,,,,In vitro inhibitory activity against the ectodomain of the human matrix metalloprotease-14,,"Structure-based design and synthesis of potent matrix metalloproteinase inhibitors derived from a 6H-1,3,4-thiadiazine scaffold.",J. Med. Chem.,2001,44,20,"Schröder J, Henke A, Wenzel H, Brandstetter H, Stammler HG, Stammler A, Pfeiffer WD, Tschesche H",,106784,DTCT0024091,1716621,DTCC00282683,357026,16424
CHEMBL1093689,P50281,,HOKBADYASDUFAM-OAQYLSRUSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,20180536,IC50,=,1800,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP14 by fluorometric assay,,Potent arylsulfonamide inhibitors of tumor necrosis factor-alpha converting enzyme able to reduce activated leukocyte cell adhesion molecule shedding in cancer cell models.,J. Med. Chem.,2010,53,6,"Nuti E, Casalini F, Avramova SI, Santamaria S, Fabbi M, Ferrini S, Marinelli L, La Pietra V, Limongelli V, Novellino E, Cercignani G, Orlandini E, Nencetti S, Rossello A",,624095,DTCT0024091,3287117,DTCC00635565,177119,38228
CHEMBL1093690,P50281,,XXZNXULRAJJTRV-LLVKDONJSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,20180536,IC50,=,300,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP14 by fluorometric assay,,Potent arylsulfonamide inhibitors of tumor necrosis factor-alpha converting enzyme able to reduce activated leukocyte cell adhesion molecule shedding in cancer cell models.,J. Med. Chem.,2010,53,6,"Nuti E, Casalini F, Avramova SI, Santamaria S, Fabbi M, Ferrini S, Marinelli L, La Pietra V, Limongelli V, Novellino E, Cercignani G, Orlandini E, Nencetti S, Rossello A",,624095,DTCT0024091,3287123,DTCC00635566,340097,38228
CHEMBL109579,P50281,,LEDMBBYIVRLZAS-LBPRGKRZSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,11563922,KI,=,440,NM,,,,,,,,,,,,,,In vitro inhibitory activity against the catalytic domain of human matrix metalloprotease-14,,"Structure-based design and synthesis of potent matrix metalloproteinase inhibitors derived from a 6H-1,3,4-thiadiazine scaffold.",J. Med. Chem.,2001,44,20,"Schröder J, Henke A, Wenzel H, Brandstetter H, Stammler HG, Stammler A, Pfeiffer WD, Tschesche H",,106783,DTCT0024091,1713955,DTCC00282314,258563,16424
CHEMBL109603,P50281,,JOKZNFFZUNYVMR-SFHVURJKSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,11563922,KI,=,740,NM,,,,,,,,,,,,,,In vitro inhibitory activity against the catalytic domain of human matrix metalloprotease-14,,"Structure-based design and synthesis of potent matrix metalloproteinase inhibitors derived from a 6H-1,3,4-thiadiazine scaffold.",J. Med. Chem.,2001,44,20,"Schröder J, Henke A, Wenzel H, Brandstetter H, Stammler HG, Stammler A, Pfeiffer WD, Tschesche H",,106783,DTCT0024091,1693276,DTCC00281761,2034295,16424
CHEMBL109655,P50281,,PDKBAEDNMKVROV-AWEZNQCLSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,11563922,KI,=,380,NM,,,,,,,,,,,,,,In vitro inhibitory activity against the catalytic domain of human matrix metalloprotease-14,,"Structure-based design and synthesis of potent matrix metalloproteinase inhibitors derived from a 6H-1,3,4-thiadiazine scaffold.",J. Med. Chem.,2001,44,20,"Schröder J, Henke A, Wenzel H, Brandstetter H, Stammler HG, Stammler A, Pfeiffer WD, Tschesche H",,106783,DTCT0024091,1689452,DTCC00281762,2066041,16424
CHEMBL109770,P50281,,MYFWCGILTGDUAM-LBPRGKRZSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,11563922,KI,=,390,NM,,,,,,,,,,,,,,In vitro inhibitory activity against the ectodomain of the human matrix metalloprotease-14,,"Structure-based design and synthesis of potent matrix metalloproteinase inhibitors derived from a 6H-1,3,4-thiadiazine scaffold.",J. Med. Chem.,2001,44,20,"Schröder J, Henke A, Wenzel H, Brandstetter H, Stammler HG, Stammler A, Pfeiffer WD, Tschesche H",,106784,DTCT0024091,1685585,DTCC00282704,1553370,16424
CHEMBL109770,P50281,,MYFWCGILTGDUAM-LBPRGKRZSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,11563922,KI,=,580,NM,,,,,,,,,,,,,,In vitro inhibitory activity against the catalytic domain of human matrix metalloprotease-14,,"Structure-based design and synthesis of potent matrix metalloproteinase inhibitors derived from a 6H-1,3,4-thiadiazine scaffold.",J. Med. Chem.,2001,44,20,"Schröder J, Henke A, Wenzel H, Brandstetter H, Stammler HG, Stammler A, Pfeiffer WD, Tschesche H",,106783,DTCT0024091,1685584,DTCC00282704,1553370,16424
CHEMBL109806,P50281,,JJTWETADXAELLS-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,11563922,KI,=,110,NM,,,,,,,,,,,,,,In vitro inhibitory activity against the ectodomain of the human matrix metalloprotease-14,,"Structure-based design and synthesis of potent matrix metalloproteinase inhibitors derived from a 6H-1,3,4-thiadiazine scaffold.",J. Med. Chem.,2001,44,20,"Schröder J, Henke A, Wenzel H, Brandstetter H, Stammler HG, Stammler A, Pfeiffer WD, Tschesche H",,106784,DTCT0024091,1709914,DTCC00281760,1871211,16424
CHEMBL109806,P50281,,JJTWETADXAELLS-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,11563922,KI,=,150,NM,,,,,,,,,,,,,,In vitro inhibitory activity against the catalytic domain of human matrix metalloprotease-14,,"Structure-based design and synthesis of potent matrix metalloproteinase inhibitors derived from a 6H-1,3,4-thiadiazine scaffold.",J. Med. Chem.,2001,44,20,"Schröder J, Henke A, Wenzel H, Brandstetter H, Stammler HG, Stammler A, Pfeiffer WD, Tschesche H",,106783,DTCT0024091,1709913,DTCC00281760,1871211,16424
CHEMBL109861,P50281,,BTMGFNYLYGWAKT-JTQLQIEISA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,11563922,KI,=,250,NM,,,,,,,,,,,,,,In vitro inhibitory activity against the catalytic domain of human matrix metalloprotease-14,,"Structure-based design and synthesis of potent matrix metalloproteinase inhibitors derived from a 6H-1,3,4-thiadiazine scaffold.",J. Med. Chem.,2001,44,20,"Schröder J, Henke A, Wenzel H, Brandstetter H, Stammler HG, Stammler A, Pfeiffer WD, Tschesche H",,106783,DTCT0024091,1703227,DTCC00282336,1003340,16424
CHEMBL110750,P50281,,WOIMZSMDPIJLFO-LBPRGKRZSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,11563922,KI,=,340,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-14,,"Structure-based design and synthesis of potent matrix metalloproteinase inhibitors derived from a 6H-1,3,4-thiadiazine scaffold.",J. Med. Chem.,2001,44,20,"Schröder J, Henke A, Wenzel H, Brandstetter H, Stammler HG, Stammler A, Pfeiffer WD, Tschesche H",,106786,DTCT0024091,1683061,DTCC00281785,518969,16424
CHEMBL110970,P50281,,WOIMZSMDPIJLFO-GFCCVEGCSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,11563922,KI,=,180,NM,,,,,,,,,,,,,,In vitro inhibitory activity against the ectodomain of the human matrix metalloprotease-14,,"Structure-based design and synthesis of potent matrix metalloproteinase inhibitors derived from a 6H-1,3,4-thiadiazine scaffold.",J. Med. Chem.,2001,44,20,"Schröder J, Henke A, Wenzel H, Brandstetter H, Stammler HG, Stammler A, Pfeiffer WD, Tschesche H",,106784,DTCT0024091,1713948,DTCC00281754,1035753,16424
CHEMBL110970,P50281,,WOIMZSMDPIJLFO-GFCCVEGCSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,11563922,KI,=,200,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-14,,"Structure-based design and synthesis of potent matrix metalloproteinase inhibitors derived from a 6H-1,3,4-thiadiazine scaffold.",J. Med. Chem.,2001,44,20,"Schröder J, Henke A, Wenzel H, Brandstetter H, Stammler HG, Stammler A, Pfeiffer WD, Tschesche H",,106786,DTCT0024091,1713947,DTCC00281754,1035753,16424
CHEMBL111179,P50281,,GINBTQGVSPUJLE-ZDUSSCGKSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,11563922,KI,=,180,NM,,,,,,,,,,,,,,In vitro inhibitory activity against the ectodomain of the human matrix metalloprotease-14,,"Structure-based design and synthesis of potent matrix metalloproteinase inhibitors derived from a 6H-1,3,4-thiadiazine scaffold.",J. Med. Chem.,2001,44,20,"Schröder J, Henke A, Wenzel H, Brandstetter H, Stammler HG, Stammler A, Pfeiffer WD, Tschesche H",,106784,DTCT0024091,1715095,DTCC00282652,389663,16424
CHEMBL111179,P50281,,GINBTQGVSPUJLE-ZDUSSCGKSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,11563922,KI,=,190,NM,,,,,,,,,,,,,,In vitro inhibitory activity against the catalytic domain of human matrix metalloprotease-14,,"Structure-based design and synthesis of potent matrix metalloproteinase inhibitors derived from a 6H-1,3,4-thiadiazine scaffold.",J. Med. Chem.,2001,44,20,"Schröder J, Henke A, Wenzel H, Brandstetter H, Stammler HG, Stammler A, Pfeiffer WD, Tschesche H",,106783,DTCT0024091,1715094,DTCC00282652,389663,16424
CHEMBL111257,P50281,,JXHAGXRDZALSLG-LBPRGKRZSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,11563922,KI,=,100,NM,,,,,,,,,,,,,,In vitro inhibitory activity against the catalytic domain of human matrix metalloprotease-14,,"Structure-based design and synthesis of potent matrix metalloproteinase inhibitors derived from a 6H-1,3,4-thiadiazine scaffold.",J. Med. Chem.,2001,44,20,"Schröder J, Henke A, Wenzel H, Brandstetter H, Stammler HG, Stammler A, Pfeiffer WD, Tschesche H",,106783,DTCT0024091,1696862,DTCC00282583,809139,16424
CHEMBL111257,P50281,,JXHAGXRDZALSLG-LBPRGKRZSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,11563922,KI,=,210,NM,,,,,,,,,,,,,,In vitro inhibitory activity against the ectodomain of the human matrix metalloprotease-14,,"Structure-based design and synthesis of potent matrix metalloproteinase inhibitors derived from a 6H-1,3,4-thiadiazine scaffold.",J. Med. Chem.,2001,44,20,"Schröder J, Henke A, Wenzel H, Brandstetter H, Stammler HG, Stammler A, Pfeiffer WD, Tschesche H",,106784,DTCT0024091,1696863,DTCC00282583,809139,16424
CHEMBL111450,P50281,,IIABJCHWKFZJBK-CYBMUJFWSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,11563922,KI,=,240,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-14,,"Structure-based design and synthesis of potent matrix metalloproteinase inhibitors derived from a 6H-1,3,4-thiadiazine scaffold.",J. Med. Chem.,2001,44,20,"Schröder J, Henke A, Wenzel H, Brandstetter H, Stammler HG, Stammler A, Pfeiffer WD, Tschesche H",,106786,DTCT0024091,1701969,DTCC00282684,291838,16424
CHEMBL111450,P50281,,IIABJCHWKFZJBK-CYBMUJFWSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,11563922,KI,=,400,NM,,,,,,,,,,,,,,In vitro inhibitory activity against the ectodomain of the human matrix metalloprotease-14,,"Structure-based design and synthesis of potent matrix metalloproteinase inhibitors derived from a 6H-1,3,4-thiadiazine scaffold.",J. Med. Chem.,2001,44,20,"Schröder J, Henke A, Wenzel H, Brandstetter H, Stammler HG, Stammler A, Pfeiffer WD, Tschesche H",,106784,DTCT0024091,1701970,DTCC00282684,291838,16424
CHEMBL111678,P50281,,WJWOJAKOSRCFKB-JTQLQIEISA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,11563922,KI,=,200,NM,,,,,,,,,,,,,,In vitro inhibitory activity against the ectodomain of the human matrix metalloprotease-14,,"Structure-based design and synthesis of potent matrix metalloproteinase inhibitors derived from a 6H-1,3,4-thiadiazine scaffold.",J. Med. Chem.,2001,44,20,"Schröder J, Henke A, Wenzel H, Brandstetter H, Stammler HG, Stammler A, Pfeiffer WD, Tschesche H",,106784,DTCT0024091,1688181,DTCC00282653,809140,16424
CHEMBL111678,P50281,,WJWOJAKOSRCFKB-JTQLQIEISA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,11563922,KI,=,320,NM,,,,,,,,,,,,,,In vitro inhibitory activity against the catalytic domain of human matrix metalloprotease-14,,"Structure-based design and synthesis of potent matrix metalloproteinase inhibitors derived from a 6H-1,3,4-thiadiazine scaffold.",J. Med. Chem.,2001,44,20,"Schröder J, Henke A, Wenzel H, Brandstetter H, Stammler HG, Stammler A, Pfeiffer WD, Tschesche H",,106783,DTCT0024091,1688180,DTCC00282653,809140,16424
CHEMBL111856,P50281,,ZBRHTUMWSDPCMI-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,15177439,IC50,=,7.4,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-14,,Pyran-containing sulfonamide hydroxamic acids: potent MMP inhibitors that spare MMP-1.,Bioorg. Med. Chem. Lett.,2004,14,13,"Reiter LA, Robinson RP, McClure KF, Jones CS, Reese MR, Mitchell PG, Otterness IG, Bliven ML, Liras J, Cortina SR, Donahue KM, Eskra JD, Griffiths RJ, Lame ME, Lopez-Anaya A, Martinelli GJ, McGahee SM, Yocum SA, Lopresti-Morrow LL, Tobiassen LM, Vaughn-Bowser ML",,106790,DTCT0024091,1496221,DTCC00287961,76527,6475
CHEMBL114878,P50281,,LCWWOMJWYGNKJF-IARZGTGTSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,11585440,KI,>,2000,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-14,,"Discovery of macrocyclic hydroxamic acids containing biphenylmethyl derivatives at P1', a series of selective TNF-alpha converting enzyme inhibitors with potent cellular activity in the inhibition of TNF-alpha release.",J. Med. Chem.,2001,44,21,"Xue CB, He X, Corbett RL, Roderick J, Wasserman ZR, Liu RQ, Jaffee BD, Covington MB, Qian M, Trzaskos JM, Newton RC, Magolda RL, Wexler RR, Decicco CP",,106787,DTCT0024091,1322680,DTCC00286952,724080,16439
CHEMBL115263,P50281,,SOPDPCOBVSOXIM-ZDXQCDESSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,11585440,KI,>,2000,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-14,,"Discovery of macrocyclic hydroxamic acids containing biphenylmethyl derivatives at P1', a series of selective TNF-alpha converting enzyme inhibitors with potent cellular activity in the inhibition of TNF-alpha release.",J. Med. Chem.,2001,44,21,"Xue CB, He X, Corbett RL, Roderick J, Wasserman ZR, Liu RQ, Jaffee BD, Covington MB, Qian M, Trzaskos JM, Newton RC, Magolda RL, Wexler RR, Decicco CP",,106787,DTCT0024091,1309697,DTCC00287904,433861,16439
CHEMBL115460,P50281,,FOOIUOKCYUZPDW-YCLCTBJKSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,12877590,IC50,=,66900,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-14,,"A potent, selective inhibitor of matrix metalloproteinase-3 for the topical treatment of chronic dermal ulcers.",J. Med. Chem.,2003,46,16,"Fray MJ, Dickinson RP, Huggins JP, Occleston NL",,106775,DTCT0024091,1548445,DTCC00293174,1871336,17445
CHEMBL115653,P50281,CIPEMASTAT,GFUITADOEPNRML-SJORKVTESA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,19422229,IC50,=,23,NM,,,,,,,,,,,,,,Inhibition of MMP14,,"Discovery of potent, selective, and orally active carboxylic acid based inhibitors of matrix metalloproteinase-13.",J. Med. Chem.,2009,52,11,"Monovich LG, Tommasi RA, Fujimoto RA, Blancuzzi V, Clark K, Cornell WD, Doti R, Doughty J, Fang J, Farley D, Fitt J, Ganu V, Goldberg R, Goldstein R, Lavoie S, Kulathila R, Macchia W, Parker DT, Melton R, O'Byrne E, Pastor G, Pellas T, Quadros E, Reel N, Roland DM, Sakane Y, Singh H, Skiles J, Somers J, Toscano K, Wigg A, Zhou S, Zhu L, Shieh WC, Xue S, McQuire LW",,500586,DTCT0024091,2824188,DTCC00288838,1841984,33635
CHEMBL115774,P50281,,YQEMFOGNUTYMTJ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,14711305,KI,=,105,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-14,,Evaluation of P1'-diversified phosphinic peptides leads to the development of highly selective inhibitors of MMP-11.,J. Med. Chem.,2004,47,2,"Matziari M, Beau F, Cuniasse P, Dive V, Yiotakis A",,106780,DTCT0024091,1264834,DTCC00287265,336153,17924
CHEMBL115774,P50281,,YQEMFOGNUTYMTJ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,16392792,KI,=,105,NM,,,,,,,,,,,,,,Binding affinity to MMP14,,Matrix metalloproteinase target family landscape: a chemometrical approach to ligand selectivity based on protein binding site analysis.,J. Med. Chem.,2006,49,1,"Pirard B, Matter H",,329828,DTCT0024091,1880226,DTCC00287265,325923,20214
CHEMBL117225,P50281,UK-356618,JJHRUUKMPWUYIB-HVOSOHGQSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,11229774,IC50,=,1900,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-14,,Discovery of potent and selective succinyl hydroxamate inhibitors of matrix metalloprotease-3 (stromelysin-1).,Bioorg. Med. Chem. Lett.,2001,11,4,"Fray MJ, Dickinson RP",,106774,DTCT0024091,573967,DTCC01742560,174043,4692
CHEMBL117225,P50281,UK-356618,JJHRUUKMPWUYIB-HVOSOHGQSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,12877590,IC50,=,1900,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-14,,"A potent, selective inhibitor of matrix metalloproteinase-3 for the topical treatment of chronic dermal ulcers.",J. Med. Chem.,2003,46,16,"Fray MJ, Dickinson RP, Huggins JP, Occleston NL",,106775,DTCT0024091,1551210,DTCC01742560,162203,17445
CHEMBL117225,P50281,UK-356618,JJHRUUKMPWUYIB-HVOSOHGQSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,18790648,IC50,=,1900,NM,,,,,,,,,,,,,,Inhibition of MMP14,,Specific targeting of metzincin family members with small-molecule inhibitors: progress toward a multifarious challenge.,Bioorg. Med. Chem.,2008,16,19,"Georgiadis D, Yiotakis A",,497410,DTCT0024091,2457459,DTCC01742560,176034,32556
CHEMBL1222867,P50281,,XMSHNXONZBWQTA-DEOSSOPVSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,20663669,INH,=,25,NM,,,,,,,,,,,,,,Inhibition of MMP14,,Biaryl substituted hydantoin compounds as TACE inhibitors.,Bioorg. Med. Chem. Lett.,2010,20,17,"Yu W, Tong L, Kim SH, Wong MK, Chen L, Yang DY, Shankar BB, Lavey BJ, Zhou G, Kosinski A, Rizvi R, Li D, Feltz RJ, Piwinski JJ, Rosner KE, Shih NY, Siddiqui MA, Guo Z, Orth P, Shah H, Sun J, Umland S, Lundell DJ, Niu X, Kozlowski JA",,651602,DTCT0024091,3456522,DTCC00691619,307666,40340
CHEMBL1223007,P50281,,JHADKVOWWKZBNS-QHCPKHFHSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,20663669,INH,=,19,NM,,,,,,,,,,,,,,Inhibition of MMP14,,Biaryl substituted hydantoin compounds as TACE inhibitors.,Bioorg. Med. Chem. Lett.,2010,20,17,"Yu W, Tong L, Kim SH, Wong MK, Chen L, Yang DY, Shankar BB, Lavey BJ, Zhou G, Kosinski A, Rizvi R, Li D, Feltz RJ, Piwinski JJ, Rosner KE, Shih NY, Siddiqui MA, Guo Z, Orth P, Shah H, Sun J, Umland S, Lundell DJ, Niu X, Kozlowski JA",,651602,DTCT0024091,3456548,DTCC00691756,1310511,40340
CHEMBL1223075,P50281,,HGPPYGXNQCWPLJ-VWLOTQADSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,20663669,INH,=,36,NM,,,,,,,,,,,,,,Inhibition of MMP14,,Biaryl substituted hydantoin compounds as TACE inhibitors.,Bioorg. Med. Chem. Lett.,2010,20,17,"Yu W, Tong L, Kim SH, Wong MK, Chen L, Yang DY, Shankar BB, Lavey BJ, Zhou G, Kosinski A, Rizvi R, Li D, Feltz RJ, Piwinski JJ, Rosner KE, Shih NY, Siddiqui MA, Guo Z, Orth P, Shah H, Sun J, Umland S, Lundell DJ, Niu X, Kozlowski JA",,651602,DTCT0024091,3456565,DTCC00691820,922026,40340
CHEMBL1229516,P50281,,,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,26871660,IC50,=,88,NM,,,,,,,,,,,,,,Inhibition of recombinant human MMP-14 using Mca-Lys-Pro-Leu-Gly-Leu-Dap(Dnp)-Ala-Arg-NH2 as substrate after 3 hrs by fluorometric assay,,Discovery of a new selective inhibitor of A Disintegrin And Metalloprotease 10 (ADAM-10) able to reduce the shedding of NKG2D ligands in Hodgkin's lymphoma cell models.,Eur. J. Med. Chem.,2016,111,,"Camodeca C, Nuti E, Tepshi L, Boero S, Tuccinardi T, Stura EA, Poggi A, Zocchi MR, Rossello A.",,1559051,DTCT0024091,101502,DTCC00046206,581272,66304
CHEMBL1229868,P50281,SC-77774,FOSWRYKPHVPIDJ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,20726512,IC50,=,64,NM,,,,,,,,,,,,,,Inhibition of human MMP14 assessed as cleavage of fluorogenic peptide MCAPro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 by fluorometric assay,,"Orally active MMP-1 sparing a-tetrahydropyranyl and a-piperidinyl sulfone matrix metalloproteinase (MMP) inhibitors with efficacy in cancer, arthritis, and cardiovascular disease.",J. Med. Chem.,2010,53,18,"Becker DP, Barta TE, Bedell LJ, Boehm TL, Bond BR, Carroll J, Carron CP, Decrescenzo GA, Easton AM, Freskos JN, Funckes-Shippy CL, Heron M, Hockerman S, Howard CP, Kiefer JR, Li MH, Mathis KJ, McDonald JJ, Mehta PP, Munie GE, Sunyer T, Swearingen CA, Villamil CI, Welsch D, Williams JM, Yu Y, Yao J",,754465,DTCT0024091,6005770,DTCC00032045,781475,45214
CHEMBL1232487,P50281,,KOVQMCGGWATESY-VXKWHMMOSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,248089,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535033,DTCT0024091,173655,DTCC00694177,1422152,64498
CHEMBL1232489,P50281,,LIIRZRQVACDFBI-HOTGVXAUSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,248100,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535033,DTCT0024091,177971,DTCC00694178,484290,64498
CHEMBL1232492,P50281,,MMIHYNVQXYWTFM-GOTSBHOMSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,248180,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535033,DTCT0024091,180299,DTCC00694179,1680179,64498
CHEMBL1232492,P50281,,MMIHYNVQXYWTFM-GOTSBHOMSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,,KI,>,10000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,248181,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535033,DTCT0024091,180038,DTCC00694179,1680179,64498
CHEMBL1241348,P50281,FALDAPREVIR,LLGDPTDZOVKFDU-XUHJSTDZSA-N,3,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,20823284,INHIBITION,=,3,%,,,,,,,,,,,,,,Inhibition of human MMP-14 at 10 uM,,"Preclinical characterization of BI 201335, a C-terminal carboxylic acid inhibitor of the hepatitis C virus NS3-NS4A protease.",Antimicrob. Agents Chemother.,2010,54,11,"White PW, Llinàs-Brunet M, Amad M, Bethell RC, Bolger G, Cordingley MG, Duan J, Garneau M, Lagacé L, Thibeault D, Kukolj G",,724367,DTCT0024091,5125907,DTCC00126282,118904,43507
CHEMBL1269994,P50281,,RCTYLDJWEDNGIO-LJQANCHMSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,22342144,KI,>,50000,NM,,,,,,,,,,,,,,Inhibition of MMP-14 using OmniMMP as substrate,,Antidotes to anthrax lethal factor intoxication. Part 3: Evaluation of core structures and further modifications to the C2-side chain.,Bioorg. Med. Chem. Lett.,2012,22,6,"Jiao GS, Kim S, Moayeri M, Crown D, Thai A, Cregar-Hernandez L, McKasson L, Sankaran B, Lehrer A, Wong T, Johns L, Margosiak SA, Leppla SH, Johnson AT",,811341,DTCT0024091,10427369,DTCC00703250,1719078,47718
CHEMBL1303599,P50281,,GXZTYQUEABMZSU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,,IC50,=,31600,NM,,,,,,,,,,,,,,PubChem BioAssay. Dose Response confirmation of uHTS hits for a small molecule inhibitors of MT1-MMP activation in a fluorescence assay set 1. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,954361,DTCT0024091,12209101,DTCC00714686,1636915,33038
CHEMBL1308971,P50281,,NQYVRHPJMXWFED-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,,IC50,=,60800,NM,,,,,,,,,,,,,,PubChem BioAssay. Dose Response confirmation of uHTS hits for a small molecule inhibitors of MT1-MMP activation in a fluorescence assay set 2. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,954348,DTCT0024091,12216207,DTCC00719566,1180932,33038
CHEMBL1310297,P50281,,QVELRKGNIMJGHK-QBLKWEPVSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,,IC50,>,80000,NM,,,,,,,,,,,,,,PubChem BioAssay. Dose Response confirmation of uHTS hits for a small molecule inhibitors of MT1-MMP activation in a fluorescence assay set 1. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,954361,DTCT0024091,12209099,DTCC00720781,178256,33038
CHEMBL1311826,P50281,,CLRFQYDSYIRYQC-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,,IC50,=,23800,NM,,,,,,,,,,,,,,PubChem BioAssay. Dose Response confirmation of uHTS hits for a small molecule inhibitors of MT1-MMP activation in a fluorescence assay set 1. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,954361,DTCT0024091,12209105,DTCC00722161,1728456,33038
CHEMBL1312953,P50281,,WTMMPFWZPRLMLK-UHFFFAOYSA-M,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,,IC50,>,80000,NM,,,,,,,,,,,,,,PubChem BioAssay. Dose Response confirmation of uHTS hits for a small molecule inhibitors of MT1-MMP activation in a fluorescence assay set 1. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,954361,DTCT0024091,12209116,DTCC00723183,1537761,33038
CHEMBL1337347,P50281,,CUSKSQFMQKVELA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,,IC50,>,80000,NM,,,,,,,,,,,,,,PubChem BioAssay. Dose Response confirmation of uHTS hits for a small molecule inhibitors of MT1-MMP activation in a fluorescence assay set 2. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,954348,DTCT0024091,12216201,DTCC00746212,1537773,33038
CHEMBL1350,P50281,TILUDRONIC ACID,DKJJVAGXPKPDRL-UHFFFAOYSA-N,4,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,24071448,IC50,=,30500,NM,,,,,,,,,,,,,,Inhibition of MMP14 catalytic domain (unknown origin) using Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 as substrate incubated for 30 mins prior to substrate addition measured after 2 to 4 hrs by fluorometric assay,,Arylamino methylene bisphosphonate derivatives as bone seeking matrix metalloproteinase inhibitors.,Bioorg. Med. Chem.,2013,21,21,"Tauro M, Laghezza A, Loiodice F, Agamennone M, Campestre C, Tortorella P",,990167,DTCT0024091,12628994,DTCC00380285,609949,56259
CHEMBL1354299,P50281,,DEKTZASXOSRDDT-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,,IC50,=,46500,NM,,,,,,,,,,,,,,PubChem BioAssay. Dose Response confirmation of uHTS hits for a small molecule inhibitors of MT1-MMP activation in a fluorescence assay set 1. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,954361,DTCT0024091,12209103,DTCC00761660,1670534,33038
CHEMBL1366948,P50281,,VZFAJIKCBHJIEG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,,IC50,>,80000,NM,,,,,,,,,,,,,,PubChem BioAssay. Dose Response confirmation of uHTS hits for a small molecule inhibitors of MT1-MMP activation in a fluorescence assay set 1. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,954361,DTCT0024091,12209097,DTCC00773665,278012,33038
CHEMBL1371684,P50281,,SEZPRMPVJMVCBV-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,22018790,ACTIVITY,=,100.1,%,,,,,,,,,,,,,,Inhibition of MMP14 assessed as residual activity using Knight SSP as substrate at 100 uM after 1.5 to 4 hrs by spectrofluorometric analysis relative to control,,"Identification of novel, exosite-binding matrix metalloproteinase-13 inhibitor scaffolds.",Bioorg. Med. Chem. Lett.,2011,21,23,"Roth J, Minond D, Darout E, Liu Q, Lauer J, Hodder P, Fields GB, Roush WR",,799335,DTCT0024091,7597021,DTCC00778134,283182,47025
CHEMBL1371684,P50281,,SEZPRMPVJMVCBV-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,22018790,INHIBITION,=,20,%,,,,,,,,,,,,,,Inhibition of MMP14 using triple-helical fTHP-15 as substrate at 40 uM after 4 hrs by FRET assay,,"Identification of novel, exosite-binding matrix metalloproteinase-13 inhibitor scaffolds.",Bioorg. Med. Chem. Lett.,2011,21,23,"Roth J, Minond D, Darout E, Liu Q, Lauer J, Hodder P, Fields GB, Roush WR",,799266,DTCT0024091,7596116,DTCC00778134,283182,47025
CHEMBL1374970,P50281,,FPDGNJGNQFUCDJ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,,IC50,=,28000,NM,,,,,,,,,,,,,,PubChem BioAssay. Dose Response confirmation of uHTS hits for a small molecule inhibitors of MT1-MMP activation in a fluorescence assay set 2. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,954348,DTCT0024091,12216213,DTCC00781251,1634823,33038
CHEMBL1376183,P50281,,PSELFROHQVYFMG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,,IC50,=,27700,NM,,,,,,,,,,,,,,PubChem BioAssay. Dose Response confirmation of uHTS hits for a small molecule inhibitors of MT1-MMP activation in a fluorescence assay set 1. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,954361,DTCT0024091,12209071,DTCC00782380,2018839,33038
CHEMBL1379195,P50281,,BVJQSCJFZZKOAF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,,IC50,>,80000,NM,,,,,,,,,,,,,,PubChem BioAssay. Dose Response confirmation of uHTS hits for a small molecule inhibitors of MT1-MMP activation in a fluorescence assay set 1. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,954361,DTCT0024091,12209072,DTCC00785161,2052971,33038
CHEMBL1385494,P50281,,FAKAXIALGWLNKW-UGAWPWHASA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,,IC50,=,18500,NM,,,,,,,,,,,,,,PubChem BioAssay. Dose Response confirmation of uHTS hits for a small molecule inhibitors of MT1-MMP activation in a fluorescence assay set 1. (Class of assay: confirmatory) ,active,PUBCHEM BIOASSAY DATA SET,,,,,,,954361,DTCT0024091,12209118,DTCC00790872,635963,33038
CHEMBL1392507,P50281,,DTVQDPXRPMARHH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,,IC50,=,26700,NM,,,,,,,,,,,,,,PubChem BioAssay. Dose Response confirmation of uHTS hits for a small molecule inhibitors of MT1-MMP activation in a fluorescence assay set 1. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,954361,DTCT0024091,12209112,DTCC00797210,1761491,33038
CHEMBL1392507,P50281,,DTVQDPXRPMARHH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,,IC50,=,29100,NM,,,,,,,,,,,,,,PubChem BioAssay. SAR confirmation of uHTS hits for a small molecule inhibitors of MT1-MMP activation in a fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,954324,DTCT0024091,12304815,DTCC00797210,1768378,33038
CHEMBL1398645,P50281,,RORIJCSRDCVUQX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,,IC50,=,14500,NM,,,,,,,,,,,,,,PubChem BioAssay. Dose Response confirmation of uHTS hits for a small molecule inhibitors of MT1-MMP activation in a fluorescence assay set 1. (Class of assay: confirmatory) ,active,PUBCHEM BIOASSAY DATA SET,,,,,,,954361,DTCT0024091,12209108,DTCC00803103,1312854,33038
CHEMBL1403206,P50281,,FLSAYDXYMINGNG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,,IC50,=,2030,NM,,,,,,,,,,,,,,PubChem BioAssay. Dose Response confirmation of uHTS hits for a small molecule inhibitors of MT1-MMP activation in a fluorescence assay set 1. (Class of assay: confirmatory) ,active,PUBCHEM BIOASSAY DATA SET,,,,,,,954361,DTCT0024091,12209117,DTCC00807356,1666862,33038
CHEMBL1405895,P50281,,KCOBQGBIGCVBCR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,,IC50,>,80000,NM,,,,,,,,,,,,,,PubChem BioAssay. Dose Response confirmation of uHTS hits for a small molecule inhibitors of MT1-MMP activation in a fluorescence assay set 1. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,954361,DTCT0024091,12209090,DTCC00809858,1791067,33038
CHEMBL1415172,P50281,,NZZKHBAIOKVFPR-QGOAFFKASA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,,IC50,>,80000,NM,,,,,,,,,,,,,,PubChem BioAssay. Dose Response confirmation of uHTS hits for a small molecule inhibitors of MT1-MMP activation in a fluorescence assay set 1. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,954361,DTCT0024091,12209115,DTCC00818652,761632,33038
CHEMBL1423709,P50281,,LBIKHEQYPNHVFY-ZROIWOOFSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,,IC50,=,55300,NM,,,,,,,,,,,,,,PubChem BioAssay. Dose Response confirmation of uHTS hits for a small molecule inhibitors of MT1-MMP activation in a fluorescence assay set 2. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,954348,DTCT0024091,12216215,DTCC00826484,699302,33038
CHEMBL1427458,P50281,,KUELMQAVLKNHFA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,21669521,IC50,>,100000,NM,,,,,,,,,,,,,,Inhibition of MMP14,,Selective non zinc binding inhibitors of MMP13.,Bioorg. Med. Chem. Lett.,2011,21,14,"De Savi C, Morley AD, Ting A, Nash I, Karabelas K, Wood CM, James M, Norris SJ, Karoutchi G, Rankine N, Hamlin G, Macfaul PA, Ryan D, Baker SV, Hargreaves D, Gerhardt S",,754265,DTCT0024091,5996235,DTCC00829882,605884,45042
CHEMBL1446779,P50281,,WZUHUXBSVHVWKK-MFOYZWKCSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,,IC50,=,23700,NM,,,,,,,,,,,,,,PubChem BioAssay. Dose Response confirmation of uHTS hits for a small molecule inhibitors of MT1-MMP activation in a fluorescence assay set 2. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,954348,DTCT0024091,12216216,DTCC00847974,859265,33038
CHEMBL1446779,P50281,,WZUHUXBSVHVWKK-MFOYZWKCSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,,IC50,=,66500,NM,,,,,,,,,,,,,,PubChem BioAssay. SAR confirmation of uHTS hits for a small molecule inhibitors of MT1-MMP activation in a fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,954324,DTCT0024091,12304818,DTCC00847974,868569,33038
CHEMBL1455567,P50281,,LIBSJLLOCATOHR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,,IC50,=,23300,NM,,,,,,,,,,,,,,PubChem BioAssay. Dose Response confirmation of uHTS hits for a small molecule inhibitors of MT1-MMP activation in a fluorescence assay set 2. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,954348,DTCT0024091,12216200,DTCC00856332,210442,33038
CHEMBL1461176,P50281,,XEULJPQFOBUHGA-AATRIKPKSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,,IC50,=,26200,NM,,,,,,,,,,,,,,PubChem BioAssay. Dose Response confirmation of uHTS hits for a small molecule inhibitors of MT1-MMP activation in a fluorescence assay set 2. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,954348,DTCT0024091,12216209,DTCC00861480,599601,33038
CHEMBL146289,P50281,,NOENPCOHNDAVLW-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,14684295,IC50,=,1102,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-14 (MMP-14),,Tetrahydroisoquinoline based sulfonamide hydroxamates as potent matrix metalloproteinase inhibitors.,Bioorg. Med. Chem. Lett.,2004,14,1,"Ma D, Wu W, Yang G, Li J, Li J, Ye Q",,106791,DTCT0024091,891478,DTCC00334082,1371999,6330
CHEMBL1464312,P50281,,FUEGUVHMUOHCNU-VOTSOKGWSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,,IC50,=,56800,NM,,,,,,,,,,,,,,PubChem BioAssay. Dose Response confirmation of uHTS hits for a small molecule inhibitors of MT1-MMP activation in a fluorescence assay set 1. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,954361,DTCT0024091,12209119,DTCC00864335,1117204,33038
CHEMBL1467123,P50281,,PXNNPGGYHAWDJW-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,,IC50,=,19500,NM,,,,,,,,,,,,,,PubChem BioAssay. Dose Response confirmation of uHTS hits for a small molecule inhibitors of MT1-MMP activation in a fluorescence assay set 1. (Class of assay: confirmatory) ,active,PUBCHEM BIOASSAY DATA SET,,,,,,,954361,DTCT0024091,12209087,DTCC00866894,1440794,33038
CHEMBL146718,P50281,,RILFWDKQYPJIOQ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,14684295,IC50,=,62,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-14 (MMP-14),,Tetrahydroisoquinoline based sulfonamide hydroxamates as potent matrix metalloproteinase inhibitors.,Bioorg. Med. Chem. Lett.,2004,14,1,"Ma D, Wu W, Yang G, Li J, Li J, Ye Q",,106791,DTCT0024091,886403,DTCC00333495,173918,6330
CHEMBL1470466,P50281,,FPYXSDBIWANOQF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,,IC50,=,17400,NM,,,,,,,,,,,,,,PubChem BioAssay. Dose Response confirmation of uHTS hits for a small molecule inhibitors of MT1-MMP activation in a fluorescence assay set 1. (Class of assay: confirmatory) ,active,PUBCHEM BIOASSAY DATA SET,,,,,,,954361,DTCT0024091,12209107,DTCC00869926,471067,33038
CHEMBL147489,P50281,,YVJXBWDNNWDVMN-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,14684295,IC50,=,521,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-14 (MMP-14),,Tetrahydroisoquinoline based sulfonamide hydroxamates as potent matrix metalloproteinase inhibitors.,Bioorg. Med. Chem. Lett.,2004,14,1,"Ma D, Wu W, Yang G, Li J, Li J, Ye Q",,106791,DTCT0024091,881345,DTCC00333722,886509,6330
CHEMBL147604,P50281,,XLTGYQNRFLYPNU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,14684295,IC50,=,20820,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-14 (MMP-14),,Tetrahydroisoquinoline based sulfonamide hydroxamates as potent matrix metalloproteinase inhibitors.,Bioorg. Med. Chem. Lett.,2004,14,1,"Ma D, Wu W, Yang G, Li J, Li J, Ye Q",,106791,DTCT0024091,885132,DTCC00334132,1436341,6330
CHEMBL147881,P50281,,YVCCTHCWKOIESX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,14684295,IC50,=,39,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-14 (MMP-14),,Tetrahydroisoquinoline based sulfonamide hydroxamates as potent matrix metalloproteinase inhibitors.,Bioorg. Med. Chem. Lett.,2004,14,1,"Ma D, Wu W, Yang G, Li J, Li J, Ye Q",,106791,DTCT0024091,878657,DTCC00333744,1339403,6330
CHEMBL147882,P50281,,PFIFGQWOKBQYID-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,14684295,IC50,=,52,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-14 (MMP-14),,Tetrahydroisoquinoline based sulfonamide hydroxamates as potent matrix metalloproteinase inhibitors.,Bioorg. Med. Chem. Lett.,2004,14,1,"Ma D, Wu W, Yang G, Li J, Li J, Ye Q",,106791,DTCT0024091,874876,DTCC00333745,1113042,6330
CHEMBL148169,P50281,IK-682,YDMIPBHQKFOFQW-NSYGIPOTSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,12408705,KI,=,15872,NM,,,,,,,,,,,,,,Affinity for Matrix metalloprotease-14 (MMP-14),,"Discovery of gamma-lactam hydroxamic acids as selective inhibitors of tumor necrosis factor alpha converting enzyme: design, synthesis, and structure-activity relationships.",J. Med. Chem.,2002,45,23,"Duan JJ, Chen L, Wasserman ZR, Lu Z, Liu RQ, Covington MB, Qian M, Hardman KD, Magolda RL, Newton RC, Christ DD, Wexler RR, Decicco CP",,106781,DTCT0024091,697263,DTCC01743557,205947,17028
CHEMBL148169,P50281,IK-682,YDMIPBHQKFOFQW-NSYGIPOTSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,18790648,KI,=,15872,NM,,,,,,,,,,,,,,Inhibition of MMP14,,Specific targeting of metzincin family members with small-molecule inhibitors: progress toward a multifarious challenge.,Bioorg. Med. Chem.,2008,16,19,"Georgiadis D, Yiotakis A",,497410,DTCT0024091,2457291,DTCC01743557,208203,32556
CHEMBL148171,P50281,,JOGYGVFUVCZABB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,14684295,IC50,=,867,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-14 (MMP-14),,Tetrahydroisoquinoline based sulfonamide hydroxamates as potent matrix metalloproteinase inhibitors.,Bioorg. Med. Chem. Lett.,2004,14,1,"Ma D, Wu W, Yang G, Li J, Li J, Ye Q",,106791,DTCT0024091,877395,DTCC00334131,1851209,6330
CHEMBL148214,P50281,,AYFCYVLVRYQGME-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,14684295,IC50,=,68,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-14 (MMP-14),,Tetrahydroisoquinoline based sulfonamide hydroxamates as potent matrix metalloproteinase inhibitors.,Bioorg. Med. Chem. Lett.,2004,14,1,"Ma D, Wu W, Yang G, Li J, Li J, Ye Q",,106791,DTCT0024091,878666,DTCC00334130,1501033,6330
CHEMBL148406,P50281,,VVZFBVIPGIVQRI-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,14684295,IC50,=,835,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-14 (MMP-14),,Tetrahydroisoquinoline based sulfonamide hydroxamates as potent matrix metalloproteinase inhibitors.,Bioorg. Med. Chem. Lett.,2004,14,1,"Ma D, Wu W, Yang G, Li J, Li J, Ye Q",,106791,DTCT0024091,870997,DTCC00333693,1754320,6330
CHEMBL1485159,P50281,,KCNZELNVICFCHO-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,,IC50,=,10500,NM,,,,,,,,,,,,,,PubChem BioAssay. Dose Response confirmation of uHTS hits for a small molecule inhibitors of MT1-MMP activation in a fluorescence assay set 2. (Class of assay: confirmatory) ,active,PUBCHEM BIOASSAY DATA SET,,,,,,,954348,DTCT0024091,12216212,DTCC00883749,2021876,33038
CHEMBL1487570,P50281,,YVNYQVSPOQFAEG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,,IC50,=,22100,NM,,,,,,,,,,,,,,PubChem BioAssay. Dose Response confirmation of uHTS hits for a small molecule inhibitors of MT1-MMP activation in a fluorescence assay set 1. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,954361,DTCT0024091,12209075,DTCC00886023,1085342,33038
CHEMBL1487570,P50281,,YVNYQVSPOQFAEG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,,IC50,>,80000,NM,,,,,,,,,,,,,,PubChem BioAssay. SAR confirmation of uHTS hits for a small molecule inhibitors of MT1-MMP activation in a fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,954324,DTCT0024091,12304819,DTCC00886023,1094891,33038
CHEMBL1491255,P50281,,CWMIMOPIOOXSEA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,,IC50,=,54200,NM,,,,,,,,,,,,,,PubChem BioAssay. Dose Response confirmation of uHTS hits for a small molecule inhibitors of MT1-MMP activation in a fluorescence assay set 1. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,954361,DTCT0024091,12209100,DTCC00889521,1378052,33038
CHEMBL1495714,P50281,,ISTFTATZQQNYEU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,,IC50,=,36800,NM,,,,,,,,,,,,,,PubChem BioAssay. Dose Response confirmation of uHTS hits for a small molecule inhibitors of MT1-MMP activation in a fluorescence assay set 2. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,954348,DTCT0024091,12216204,DTCC00893700,113908,33038
CHEMBL1497459,P50281,,YTUVMXHPTVLRKU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,,IC50,=,17200,NM,,,,,,,,,,,,,,PubChem BioAssay. Dose Response confirmation of uHTS hits for a small molecule inhibitors of MT1-MMP activation in a fluorescence assay set 1. (Class of assay: confirmatory) ,active,PUBCHEM BIOASSAY DATA SET,,,,,,,954361,DTCT0024091,12209076,DTCC00895302,1505094,33038
CHEMBL1497797,P50281,,QXOKSTGXTNUTRX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,,IC50,>,80000,NM,,,,,,,,,,,,,,PubChem BioAssay. Dose Response confirmation of uHTS hits for a small molecule inhibitors of MT1-MMP activation in a fluorescence assay set 1. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,954361,DTCT0024091,12209077,DTCC00895615,1378737,33038
CHEMBL1497838,P50281,,CGKNQKTUUZILFY-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,,IC50,=,14000,NM,,,,,,,,,,,,,,PubChem BioAssay. Dose Response confirmation of uHTS hits for a small molecule inhibitors of MT1-MMP activation in a fluorescence assay set 1. (Class of assay: confirmatory) ,active,PUBCHEM BIOASSAY DATA SET,,,,,,,954361,DTCT0024091,12209078,DTCC00895654,2086018,33038
CHEMBL1499843,P50281,,ROFCASCKNJMJDO-OKOHOLKASA-M,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,,IC50,=,24100,NM,,,,,,,,,,,,,,PubChem BioAssay. Dose Response confirmation of uHTS hits for a small molecule inhibitors of MT1-MMP activation in a fluorescence assay set 1. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,954361,DTCT0024091,12209088,DTCC00897474,1181201,33038
CHEMBL1507667,P50281,,WCXNWVCBDHKRMD-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,,IC50,=,13900,NM,,,,,,,,,,,,,,PubChem BioAssay. Dose Response confirmation of uHTS hits for a small molecule inhibitors of MT1-MMP activation in a fluorescence assay set 1. (Class of assay: confirmatory) ,active,PUBCHEM BIOASSAY DATA SET,,,,,,,954361,DTCT0024091,12209094,DTCC00904617,1280948,33038
CHEMBL1515648,P50281,,XDOXZFXJIASILF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,22018790,ACTIVITY,=,104,%,,,,,,,,,,,,,,Inhibition of MMP14 assessed as residual activity using Knight SSP as substrate at 100 uM after 1.5 to 4 hrs by spectrofluorometric analysis relative to control,,"Identification of novel, exosite-binding matrix metalloproteinase-13 inhibitor scaffolds.",Bioorg. Med. Chem. Lett.,2011,21,23,"Roth J, Minond D, Darout E, Liu Q, Lauer J, Hodder P, Fields GB, Roush WR",,799335,DTCT0024091,7597022,DTCC00912100,185710,47025
CHEMBL1515648,P50281,,XDOXZFXJIASILF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,22018790,INHIBITION,=,31,%,,,,,,,,,,,,,,Inhibition of MMP14 using triple-helical fTHP-15 as substrate at 40 uM after 4 hrs by FRET assay,,"Identification of novel, exosite-binding matrix metalloproteinase-13 inhibitor scaffolds.",Bioorg. Med. Chem. Lett.,2011,21,23,"Roth J, Minond D, Darout E, Liu Q, Lauer J, Hodder P, Fields GB, Roush WR",,799266,DTCT0024091,7596117,DTCC00912100,185710,47025
CHEMBL1524286,P50281,,XEHLDSAKZSXOFK-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,,IC50,>,80000,NM,,,,,,,,,,,,,,PubChem BioAssay. Dose Response confirmation of uHTS hits for a small molecule inhibitors of MT1-MMP activation in a fluorescence assay set 2. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,954348,DTCT0024091,12216211,DTCC00920208,343556,33038
CHEMBL1529511,P50281,,DRFYKMQMGSHPPW-XYNPZBRDSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,,IC50,=,23300,NM,,,,,,,,,,,,,,PubChem BioAssay. Dose Response confirmation of uHTS hits for a small molecule inhibitors of MT1-MMP activation in a fluorescence assay set 1. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,954361,DTCT0024091,12209086,DTCC00925131,1603445,33038
CHEMBL1539579,P50281,,BQCLRUKYDJSGRQ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,,IC50,=,37600,NM,,,,,,,,,,,,,,PubChem BioAssay. Dose Response confirmation of uHTS hits for a small molecule inhibitors of MT1-MMP activation in a fluorescence assay set 2. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,954348,DTCT0024091,12216208,DTCC00934451,2018705,33038
CHEMBL1544901,P50281,,WPLQCARIFVAYOT-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,,IC50,=,32300,NM,,,,,,,,,,,,,,PubChem BioAssay. Dose Response confirmation of uHTS hits for a small molecule inhibitors of MT1-MMP activation in a fluorescence assay set 1. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,954361,DTCT0024091,12209081,DTCC00939292,1248617,33038
CHEMBL1545873,P50281,,XFCCKOHKVLGFGL-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,,IC50,=,24400,NM,,,,,,,,,,,,,,PubChem BioAssay. Dose Response confirmation of uHTS hits for a small molecule inhibitors of MT1-MMP activation in a fluorescence assay set 1. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,954361,DTCT0024091,12209089,DTCC00940189,2018690,33038
CHEMBL1548704,P50281,,DPBQSCCTZVVUPC-WJDWOHSUSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,,IC50,=,32800,NM,,,,,,,,,,,,,,PubChem BioAssay. Dose Response confirmation of uHTS hits for a small molecule inhibitors of MT1-MMP activation in a fluorescence assay set 1. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,954361,DTCT0024091,12209104,DTCC00942736,731497,33038
CHEMBL1562029,P50281,,RGHCQLWSFGREJY-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,,IC50,>,80000,NM,,,,,,,,,,,,,,PubChem BioAssay. Dose Response confirmation of uHTS hits for a small molecule inhibitors of MT1-MMP activation in a fluorescence assay set 2. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,954348,DTCT0024091,12216206,DTCC00955289,1729275,33038
CHEMBL1563898,P50281,,ZULBKXYQNMBEJG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,,IC50,=,17900,NM,,,,,,,,,,,,,,PubChem BioAssay. Dose Response confirmation of uHTS hits for a small molecule inhibitors of MT1-MMP activation in a fluorescence assay set 2. (Class of assay: confirmatory) ,active,PUBCHEM BIOASSAY DATA SET,,,,,,,954348,DTCT0024091,12216214,DTCC00957023,1638246,33038
CHEMBL1564105,P50281,,MCMIIAYTZSTANM-VURMDHGXSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,,IC50,=,13300,NM,,,,,,,,,,,,,,PubChem BioAssay. Dose Response confirmation of uHTS hits for a small molecule inhibitors of MT1-MMP activation in a fluorescence assay set 1. (Class of assay: confirmatory) ,active,PUBCHEM BIOASSAY DATA SET,,,,,,,954361,DTCT0024091,12209106,DTCC00957215,1212755,33038
CHEMBL1565846,P50281,,MHMKWRMLSVEIRZ-YPKPFQOOSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,,IC50,>,80000,NM,,,,,,,,,,,,,,PubChem BioAssay. Dose Response confirmation of uHTS hits for a small molecule inhibitors of MT1-MMP activation in a fluorescence assay set 2. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,954348,DTCT0024091,12216199,DTCC00958859,825425,33038
CHEMBL1570005,P50281,,KVWDCSJFVIPRLD-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,,IC50,=,69000,NM,,,,,,,,,,,,,,PubChem BioAssay. Dose Response confirmation of uHTS hits for a small molecule inhibitors of MT1-MMP activation in a fluorescence assay set 1. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,954361,DTCT0024091,12209096,DTCC00962811,340841,33038
CHEMBL1571597,P50281,,FNTSHBHJZQRXCT-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,,IC50,=,18500,NM,,,,,,,,,,,,,,PubChem BioAssay. Dose Response confirmation of uHTS hits for a small molecule inhibitors of MT1-MMP activation in a fluorescence assay set 1. (Class of assay: confirmatory) ,active,PUBCHEM BIOASSAY DATA SET,,,,,,,954361,DTCT0024091,12209114,DTCC00964308,242944,33038
CHEMBL1573799,P50281,,JFCBOYPTHCVHSN-CCEZHUSRSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,,IC50,=,30600,NM,,,,,,,,,,,,,,PubChem BioAssay. Dose Response confirmation of uHTS hits for a small molecule inhibitors of MT1-MMP activation in a fluorescence assay set 1. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,954361,DTCT0024091,12209082,DTCC00966377,113390,33038
CHEMBL158521,P50281,,XGTBMCGGGJLOPS-IFMALSPDSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,19524436,IC50,=,15600,NM,,,,,,,,,,,,,,Inhibition of human recombinant MT1-MMP expressed in Escherichia coli by fluorogenic peptide cleavage assay,,Regioselective synthesis of methylated epigallocatechin gallate via nitrobenzenesulfonyl (Ns) protecting group.,Bioorg. Med. Chem. Lett.,2009,19,15,"Aihara Y, Yoshida A, Furuta T, Wakimoto T, Akizawa T, Konishi M, Kan T",,579664,DTCT0024091,2894223,DTCC00354992,37673,35073
CHEMBL1588368,P50281,,HTUJYEJCFSALEG-CCEZHUSRSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,,IC50,=,29700,NM,,,,,,,,,,,,,,PubChem BioAssay. Dose Response confirmation of uHTS hits for a small molecule inhibitors of MT1-MMP activation in a fluorescence assay set 1. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,954361,DTCT0024091,12209113,DTCC00979624,989634,33038
CHEMBL1588557,P50281,,VFCMIQSRZVLDRW-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,,IC50,=,22800,NM,,,,,,,,,,,,,,PubChem BioAssay. Dose Response confirmation of uHTS hits for a small molecule inhibitors of MT1-MMP activation in a fluorescence assay set 2. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,954348,DTCT0024091,12216217,DTCC00979796,858920,33038
CHEMBL1592668,P50281,,DHDGFXGBPRUTOT-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,,IC50,=,5570,NM,,,,,,,,,,,,,,PubChem BioAssay. Dose Response confirmation of uHTS hits for a small molecule inhibitors of MT1-MMP activation in a fluorescence assay set 1. (Class of assay: confirmatory) ,active,PUBCHEM BIOASSAY DATA SET,,,,,,,954361,DTCT0024091,12209095,DTCC00983730,1794654,33038
CHEMBL159433,P50281,,BXDRTHBTGNNTEW-NHCUHLMSSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,19524436,IC50,=,3700,NM,,,,,,,,,,,,,,Inhibition of human recombinant MT1-MMP expressed in Escherichia coli by fluorogenic peptide cleavage assay,,Regioselective synthesis of methylated epigallocatechin gallate via nitrobenzenesulfonyl (Ns) protecting group.,Bioorg. Med. Chem. Lett.,2009,19,15,"Aihara Y, Yoshida A, Furuta T, Wakimoto T, Akizawa T, Konishi M, Kan T",,579664,DTCT0024091,2894227,DTCC00354503,1535995,35073
CHEMBL1597345,P50281,,HVSCGGBMKWCYSY-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,,IC50,=,8320,NM,,,,,,,,,,,,,,PubChem BioAssay. Dose Response confirmation of uHTS hits for a small molecule inhibitors of MT1-MMP activation in a fluorescence assay set 1. (Class of assay: confirmatory) ,active,PUBCHEM BIOASSAY DATA SET,,,,,,,954361,DTCT0024091,12209102,DTCC00988160,1669087,33038
CHEMBL1598011,P50281,,BBOIFOBVWJBYCF-PLOBCEGZSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,,IC50,>,80000,NM,,,,,,,,,,,,,,PubChem BioAssay. Dose Response confirmation of uHTS hits for a small molecule inhibitors of MT1-MMP activation in a fluorescence assay set 1. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,954361,DTCT0024091,12209109,DTCC00988778,2052736,33038
CHEMBL1598101,P50281,,QAEAFNVULNJJSX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,,IC50,=,31300,NM,,,,,,,,,,,,,,PubChem BioAssay. Dose Response confirmation of uHTS hits for a small molecule inhibitors of MT1-MMP activation in a fluorescence assay set 1. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,954361,DTCT0024091,12209110,DTCC00988856,1441006,33038
CHEMBL1615186,P50281,,YSYXAGMNRKARQB-HJPURHCSSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,21300546,IC50,=,430,NM,,,,,,,,,,,,,,Inhibition of recombinant human MMP14 assessed as substrate cleavage by measuring increase in fluorescence after 16 hrs,,The design and synthesis of novel N-hydroxyformamide inhibitors of ADAM-TS4 for the treatment of osteoarthritis.,Bioorg. Med. Chem. Lett.,2011,21,5,"De Savi C, Pape A, Cumming JG, Ting A, Smith PD, Burrows JN, Mills M, Davies C, Lamont S, Milne D, Cook C, Moore P, Sawyer Y, Gerhardt S",,728837,DTCT0024091,5145512,DTCC01003608,975118,43649
CHEMBL1615187,P50281,,UAGAABCJKYADIR-HJPURHCSSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,21300546,IC50,>,8900,NM,,,,,,,,,,,,,,Inhibition of recombinant human MMP14 assessed as substrate cleavage by measuring increase in fluorescence after 16 hrs,,The design and synthesis of novel N-hydroxyformamide inhibitors of ADAM-TS4 for the treatment of osteoarthritis.,Bioorg. Med. Chem. Lett.,2011,21,5,"De Savi C, Pape A, Cumming JG, Ting A, Smith PD, Burrows JN, Mills M, Davies C, Lamont S, Milne D, Cook C, Moore P, Sawyer Y, Gerhardt S",,728837,DTCT0024091,5145588,DTCC01003609,1940035,43649
CHEMBL1651842,P50281,,IEHSRERHOYOHOA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,,KI,=,145,NM,,,,,,,,,,,,,,Competitive inhibition of human MMP14 using fluorogenic substrate by Dixon plot analysis,,,ACS Med. Chem. Lett.,2012,3,6,,,831080,DTCT0024091,10566551,DTCC01024067,543746,48923
CHEMBL1651842,P50281,,IEHSRERHOYOHOA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,,KI,=,150,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP14 catalytic domain by substrate hydrolysis based fluorescence spectrophotometry,,,ACS Med. Chem. Lett.,2011,2,2,,,702136,DTCT0024091,5066090,DTCC01024067,523282,42713
CHEMBL1651843,P50281,,KPYDTDKHTIUCAB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,,ACTIVITY,=,2.5,10'-3/M/S,,,,,,,,,,,,,,Inhibition of human recombinant MMP14 catalytic domain assessed as association rate constant by substrate hydrolysis based fluorescence spectrophotometry,,,ACS Med. Chem. Lett.,2011,2,2,,,702120,DTCT0024091,5066021,DTCC01024068,328820,42713
CHEMBL1651843,P50281,,KPYDTDKHTIUCAB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,,ACTIVITY,=,9,10'-3/M/S,,,,,,,,,,,,,,Inhibition of human recombinant MMP14 catalytic domain assessed as dissociation rate constant by substrate hydrolysis based fluorescence spectrophotometry,,,ACS Med. Chem. Lett.,2011,2,2,,,702130,DTCT0024091,5066051,DTCC01024068,328820,42713
CHEMBL1651843,P50281,,KPYDTDKHTIUCAB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,,KI,=,360,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP14 catalytic domain by substrate hydrolysis based fluorescence spectrophotometry,,,ACS Med. Chem. Lett.,2011,2,2,,,702136,DTCT0024091,5066091,DTCC01024068,328820,42713
CHEMBL1651844,P50281,,GODQVOUTCHZIOJ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,,ACTIVITY,=,1.8,10'-3/M/S,,,,,,,,,,,,,,Inhibition of human recombinant MMP14 catalytic domain assessed as dissociation rate constant by substrate hydrolysis based fluorescence spectrophotometry,,,ACS Med. Chem. Lett.,2011,2,2,,,702130,DTCT0024091,5066052,DTCC01024069,1364047,42713
CHEMBL1651844,P50281,,GODQVOUTCHZIOJ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,,ACTIVITY,=,7.6,10'-3/M/S,,,,,,,,,,,,,,Inhibition of human recombinant MMP14 catalytic domain assessed as association rate constant by substrate hydrolysis based fluorescence spectrophotometry,,,ACS Med. Chem. Lett.,2011,2,2,,,702120,DTCT0024091,5066022,DTCC01024069,1364047,42713
CHEMBL1651844,P50281,,GODQVOUTCHZIOJ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,,KI,=,240,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP14 catalytic domain by substrate hydrolysis based fluorescence spectrophotometry,,,ACS Med. Chem. Lett.,2011,2,2,,,702136,DTCT0024091,5066092,DTCC01024069,1364047,42713
CHEMBL1651845,P50281,,IQVPMSHPSMKSIK-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,,ACTIVITY,=,2,10'-3/M/S,,,,,,,,,,,,,,Inhibition of human recombinant MMP14 catalytic domain assessed as dissociation rate constant by substrate hydrolysis based fluorescence spectrophotometry,,,ACS Med. Chem. Lett.,2011,2,2,,,702130,DTCT0024091,5066053,DTCC01024070,846384,42713
CHEMBL1651845,P50281,,IQVPMSHPSMKSIK-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,,ACTIVITY,=,2.5,10'-3/M/S,,,,,,,,,,,,,,Inhibition of human recombinant MMP14 catalytic domain assessed as association rate constant by substrate hydrolysis based fluorescence spectrophotometry,,,ACS Med. Chem. Lett.,2011,2,2,,,702120,DTCT0024091,5066023,DTCC01024070,846384,42713
CHEMBL1651845,P50281,,IQVPMSHPSMKSIK-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,,KI,=,790,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP14 catalytic domain by substrate hydrolysis based fluorescence spectrophotometry,,,ACS Med. Chem. Lett.,2011,2,2,,,702136,DTCT0024091,5066093,DTCC01024070,846384,42713
CHEMBL1651846,P50281,,LWHDLJDNHJFUSI-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,,ACTIVITY,=,0.2,10'-3/M/S,,,,,,,,,,,,,,Inhibition of human recombinant MMP14 catalytic domain assessed as dissociation rate constant by substrate hydrolysis based fluorescence spectrophotometry,,,ACS Med. Chem. Lett.,2011,2,2,,,702130,DTCT0024091,5066054,DTCC01024071,716794,42713
CHEMBL1651846,P50281,,LWHDLJDNHJFUSI-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,,ACTIVITY,=,0.42,10'-3/M/S,,,,,,,,,,,,,,Inhibition of human recombinant MMP14 catalytic domain assessed as association rate constant by substrate hydrolysis based fluorescence spectrophotometry,,,ACS Med. Chem. Lett.,2011,2,2,,,702120,DTCT0024091,5066024,DTCC01024071,716794,42713
CHEMBL1651846,P50281,,LWHDLJDNHJFUSI-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,,KI,=,480,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP14 catalytic domain by substrate hydrolysis based fluorescence spectrophotometry,,,ACS Med. Chem. Lett.,2011,2,2,,,702136,DTCT0024091,5066094,DTCC01024071,716794,42713
CHEMBL1651847,P50281,,BXWKQAHPQICDHI-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,,ACTIVITY,=,0.15,10'-3/M/S,,,,,,,,,,,,,,Inhibition of human recombinant MMP14 catalytic domain assessed as association rate constant by substrate hydrolysis based fluorescence spectrophotometry,,,ACS Med. Chem. Lett.,2011,2,2,,,702120,DTCT0024091,5066025,DTCC01024072,198194,42713
CHEMBL1651847,P50281,,BXWKQAHPQICDHI-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,,ACTIVITY,=,1.6,10'-3/M/S,,,,,,,,,,,,,,Inhibition of human recombinant MMP14 catalytic domain assessed as dissociation rate constant by substrate hydrolysis based fluorescence spectrophotometry,,,ACS Med. Chem. Lett.,2011,2,2,,,702130,DTCT0024091,5066056,DTCC01024072,198194,42713
CHEMBL1651847,P50281,,BXWKQAHPQICDHI-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,,KI,=,11000,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP14 catalytic domain by substrate hydrolysis based fluorescence spectrophotometry,,,ACS Med. Chem. Lett.,2011,2,2,,,702136,DTCT0024091,5066095,DTCC01024072,198194,42713
CHEMBL1651848,P50281,,FDPYTWXXVNVJLZ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,,ACTIVITY,=,0.047,10'-3/M/S,,,,,,,,,,,,,,Inhibition of human recombinant MMP14 catalytic domain assessed as association rate constant by substrate hydrolysis based fluorescence spectrophotometry,,,ACS Med. Chem. Lett.,2011,2,2,,,702120,DTCT0024091,5066026,DTCC01024073,1137429,42713
CHEMBL1651848,P50281,,FDPYTWXXVNVJLZ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,,ACTIVITY,=,1.5,10'-3/M/S,,,,,,,,,,,,,,Inhibition of human recombinant MMP14 catalytic domain assessed as dissociation rate constant by substrate hydrolysis based fluorescence spectrophotometry,,,ACS Med. Chem. Lett.,2011,2,2,,,702130,DTCT0024091,5066057,DTCC01024073,1137429,42713
CHEMBL1651848,P50281,,FDPYTWXXVNVJLZ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,,KI,=,32000,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP14 catalytic domain by substrate hydrolysis based fluorescence spectrophotometry,,,ACS Med. Chem. Lett.,2011,2,2,,,702136,DTCT0024091,5066096,DTCC01024073,1137429,42713
CHEMBL1651849,P50281,,NMRGHYQXKHANMB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,,ACTIVITY,=,0.086,10'-3/M/S,,,,,,,,,,,,,,Inhibition of human recombinant MMP14 catalytic domain assessed as association rate constant by substrate hydrolysis based fluorescence spectrophotometry,,,ACS Med. Chem. Lett.,2011,2,2,,,702120,DTCT0024091,5066027,DTCC01024074,198195,42713
CHEMBL1651849,P50281,,NMRGHYQXKHANMB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,,ACTIVITY,=,1.7,10'-3/M/S,,,,,,,,,,,,,,Inhibition of human recombinant MMP14 catalytic domain assessed as dissociation rate constant by substrate hydrolysis based fluorescence spectrophotometry,,,ACS Med. Chem. Lett.,2011,2,2,,,702130,DTCT0024091,5066058,DTCC01024074,198195,42713
CHEMBL1651849,P50281,,NMRGHYQXKHANMB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,,KI,=,20000,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP14 catalytic domain by substrate hydrolysis based fluorescence spectrophotometry,,,ACS Med. Chem. Lett.,2011,2,2,,,702136,DTCT0024091,5066097,DTCC01024074,198195,42713
CHEMBL16520,P50281,RO-319790,QRXOZHSEEGNRFC-ZYHUDNBSSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,9548812,IC50,=,1.9,NM,,,,,,,,,,,,,,Activity against deletion mutant of MT1-MMP lacking the transmembrane domain (deltaMT1),,Inhibition of membrane-type 1 matrix metalloproteinase by hydroxamate inhibitors: an examination of the subsite pocket.,J. Med. Chem.,1998,41,8,"Yamamoto M, Tsujishita H, Hori N, Ohishi Y, Inoue S, Ikeda S, Okada Y",,217867,DTCT0024091,1000671,DTCC00147200,984635,15116
CHEMBL1668126,P50281,,GZVYRVDFHLLJPP-IDRUGXTQSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,21130662,ACTIVITY,,,,,,,,,,,,,,,,,Activity at MMP14,Not Active,Functional in vivo imaging of cysteine cathepsin activity in murine model of inflammation.,Bioorg. Med. Chem.,2011,19,3,"Caglic D, Globisch A, Kindermann M, Lim NH, Jeske V, Juretschke HP, Bartnik E, Weithmann KU, Nagase H, Turk B, Wendt KU",,717560,DTCT0024091,5112234,DTCC01024969,1122449,43232
CHEMBL1683443,P50281,,KLCHUAUMSZUJEX-KXBFYZLASA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,21300546,IC50,=,11,NM,,,,,,,,,,,,,,Inhibition of recombinant human MMP14 assessed as substrate cleavage by measuring increase in fluorescence after 16 hrs,,The design and synthesis of novel N-hydroxyformamide inhibitors of ADAM-TS4 for the treatment of osteoarthritis.,Bioorg. Med. Chem. Lett.,2011,21,5,"De Savi C, Pape A, Cumming JG, Ting A, Smith PD, Burrows JN, Mills M, Davies C, Lamont S, Milne D, Cook C, Moore P, Sawyer Y, Gerhardt S",,728837,DTCT0024091,5145472,DTCC01029429,2038633,43649
CHEMBL1683444,P50281,,BGUXTVRZPYKBBN-KXBFYZLASA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,21300546,IC50,=,180,NM,,,,,,,,,,,,,,Inhibition of recombinant human MMP14 assessed as substrate cleavage by measuring increase in fluorescence after 16 hrs,,The design and synthesis of novel N-hydroxyformamide inhibitors of ADAM-TS4 for the treatment of osteoarthritis.,Bioorg. Med. Chem. Lett.,2011,21,5,"De Savi C, Pape A, Cumming JG, Ting A, Smith PD, Burrows JN, Mills M, Davies C, Lamont S, Milne D, Cook C, Moore P, Sawyer Y, Gerhardt S",,728837,DTCT0024091,5145498,DTCC01029430,813528,43649
CHEMBL1683445,P50281,,MEGFCBVTRXVKDO-KKSFZXQISA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,21300546,IC50,=,7.6,NM,,,,,,,,,,,,,,Inhibition of recombinant human MMP14 assessed as substrate cleavage by measuring increase in fluorescence after 16 hrs,,The design and synthesis of novel N-hydroxyformamide inhibitors of ADAM-TS4 for the treatment of osteoarthritis.,Bioorg. Med. Chem. Lett.,2011,21,5,"De Savi C, Pape A, Cumming JG, Ting A, Smith PD, Burrows JN, Mills M, Davies C, Lamont S, Milne D, Cook C, Moore P, Sawyer Y, Gerhardt S",,728837,DTCT0024091,5145466,DTCC01029431,943053,43649
CHEMBL1683449,P50281,,KFGJNQLPIZMSFB-XDHUDOTRSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,21300546,IC50,=,900,NM,,,,,,,,,,,,,,Inhibition of recombinant human MMP14 assessed as substrate cleavage by measuring increase in fluorescence after 16 hrs,,The design and synthesis of novel N-hydroxyformamide inhibitors of ADAM-TS4 for the treatment of osteoarthritis.,Bioorg. Med. Chem. Lett.,2011,21,5,"De Savi C, Pape A, Cumming JG, Ting A, Smith PD, Burrows JN, Mills M, Davies C, Lamont S, Milne D, Cook C, Moore P, Sawyer Y, Gerhardt S",,728837,DTCT0024091,5145517,DTCC01029435,69400,43649
CHEMBL1683450,P50281,,UDTXDKDGZMYOBK-DFBJGRDBSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,21300546,IC50,=,360,NM,,,,,,,,,,,,,,Inhibition of recombinant human MMP14 assessed as substrate cleavage by measuring increase in fluorescence after 16 hrs,,The design and synthesis of novel N-hydroxyformamide inhibitors of ADAM-TS4 for the treatment of osteoarthritis.,Bioorg. Med. Chem. Lett.,2011,21,5,"De Savi C, Pape A, Cumming JG, Ting A, Smith PD, Burrows JN, Mills M, Davies C, Lamont S, Milne D, Cook C, Moore P, Sawyer Y, Gerhardt S",,728837,DTCT0024091,5145507,DTCC01029436,1137499,43649
CHEMBL1683451,P50281,,AFXZHRNVMMQHOL-XDHUDOTRSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,21300546,IC50,=,390,NM,,,,,,,,,,,,,,Inhibition of recombinant human MMP14 assessed as substrate cleavage by measuring increase in fluorescence after 16 hrs,,The design and synthesis of novel N-hydroxyformamide inhibitors of ADAM-TS4 for the treatment of osteoarthritis.,Bioorg. Med. Chem. Lett.,2011,21,5,"De Savi C, Pape A, Cumming JG, Ting A, Smith PD, Burrows JN, Mills M, Davies C, Lamont S, Milne D, Cook C, Moore P, Sawyer Y, Gerhardt S",,728837,DTCT0024091,5145509,DTCC01029437,1233395,43649
CHEMBL1683452,P50281,,JAPLGNWCNXCEJT-XDHUDOTRSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,21300546,IC50,=,56,NM,,,,,,,,,,,,,,Inhibition of recombinant human MMP14 assessed as substrate cleavage by measuring increase in fluorescence after 16 hrs,,The design and synthesis of novel N-hydroxyformamide inhibitors of ADAM-TS4 for the treatment of osteoarthritis.,Bioorg. Med. Chem. Lett.,2011,21,5,"De Savi C, Pape A, Cumming JG, Ting A, Smith PD, Burrows JN, Mills M, Davies C, Lamont S, Milne D, Cook C, Moore P, Sawyer Y, Gerhardt S",,728837,DTCT0024091,5145490,DTCC01029438,652502,43649
CHEMBL1683453,P50281,,JGAIDLBSMBNOAG-XDHUDOTRSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,21300546,IC50,=,3600,NM,,,,,,,,,,,,,,Inhibition of recombinant human MMP14 assessed as substrate cleavage by measuring increase in fluorescence after 16 hrs,,The design and synthesis of novel N-hydroxyformamide inhibitors of ADAM-TS4 for the treatment of osteoarthritis.,Bioorg. Med. Chem. Lett.,2011,21,5,"De Savi C, Pape A, Cumming JG, Ting A, Smith PD, Burrows JN, Mills M, Davies C, Lamont S, Milne D, Cook C, Moore P, Sawyer Y, Gerhardt S",,728837,DTCT0024091,5145535,DTCC01029439,619987,43649
CHEMBL1683454,P50281,,IXKRFERDVUXQLW-DFBJGRDBSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,21300546,IC50,=,160,NM,,,,,,,,,,,,,,Inhibition of recombinant human MMP14 assessed as substrate cleavage by measuring increase in fluorescence after 16 hrs,,The design and synthesis of novel N-hydroxyformamide inhibitors of ADAM-TS4 for the treatment of osteoarthritis.,Bioorg. Med. Chem. Lett.,2011,21,5,"De Savi C, Pape A, Cumming JG, Ting A, Smith PD, Burrows JN, Mills M, Davies C, Lamont S, Milne D, Cook C, Moore P, Sawyer Y, Gerhardt S",,728837,DTCT0024091,5145495,DTCC01029440,1557705,43649
CHEMBL1683455,P50281,,AYZCFZMCYDMFMY-DFBJGRDBSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,21300546,IC50,=,4600,NM,,,,,,,,,,,,,,Inhibition of recombinant human MMP14 assessed as substrate cleavage by measuring increase in fluorescence after 16 hrs,,The design and synthesis of novel N-hydroxyformamide inhibitors of ADAM-TS4 for the treatment of osteoarthritis.,Bioorg. Med. Chem. Lett.,2011,21,5,"De Savi C, Pape A, Cumming JG, Ting A, Smith PD, Burrows JN, Mills M, Davies C, Lamont S, Milne D, Cook C, Moore P, Sawyer Y, Gerhardt S",,728837,DTCT0024091,5145539,DTCC01029441,16131,43649
CHEMBL1683456,P50281,,HUWMGZNULSXXSW-PPHZAIPVSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,21300546,IC50,=,18000,NM,,,,,,,,,,,,,,Inhibition of recombinant human MMP14 assessed as substrate cleavage by measuring increase in fluorescence after 16 hrs,,The design and synthesis of novel N-hydroxyformamide inhibitors of ADAM-TS4 for the treatment of osteoarthritis.,Bioorg. Med. Chem. Lett.,2011,21,5,"De Savi C, Pape A, Cumming JG, Ting A, Smith PD, Burrows JN, Mills M, Davies C, Lamont S, Milne D, Cook C, Moore P, Sawyer Y, Gerhardt S",,728837,DTCT0024091,5145550,DTCC01029442,846445,43649
CHEMBL1683457,P50281,,NYJKRUFCTNREQN-LVXARBLLSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,21300546,IC50,=,4200,NM,,,,,,,,,,,,,,Inhibition of recombinant human MMP14 assessed as substrate cleavage by measuring increase in fluorescence after 16 hrs,,The design and synthesis of novel N-hydroxyformamide inhibitors of ADAM-TS4 for the treatment of osteoarthritis.,Bioorg. Med. Chem. Lett.,2011,21,5,"De Savi C, Pape A, Cumming JG, Ting A, Smith PD, Burrows JN, Mills M, Davies C, Lamont S, Milne D, Cook C, Moore P, Sawyer Y, Gerhardt S",,728837,DTCT0024091,5145536,DTCC01029443,1525647,43649
CHEMBL1683458,P50281,,SOTNGZPOQMJOPI-BVZFJXPGSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,21300546,IC50,=,17000,NM,,,,,,,,,,,,,,Inhibition of recombinant human MMP14 assessed as substrate cleavage by measuring increase in fluorescence after 16 hrs,,The design and synthesis of novel N-hydroxyformamide inhibitors of ADAM-TS4 for the treatment of osteoarthritis.,Bioorg. Med. Chem. Lett.,2011,21,5,"De Savi C, Pape A, Cumming JG, Ting A, Smith PD, Burrows JN, Mills M, Davies C, Lamont S, Milne D, Cook C, Moore P, Sawyer Y, Gerhardt S",,728837,DTCT0024091,5145549,DTCC01029444,101600,43649
CHEMBL1683459,P50281,,PQEGPXRQOCZFEH-DFBJGRDBSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,21300546,IC50,>,8000,NM,,,,,,,,,,,,,,Inhibition of recombinant human MMP14 assessed as substrate cleavage by measuring increase in fluorescence after 16 hrs,,The design and synthesis of novel N-hydroxyformamide inhibitors of ADAM-TS4 for the treatment of osteoarthritis.,Bioorg. Med. Chem. Lett.,2011,21,5,"De Savi C, Pape A, Cumming JG, Ting A, Smith PD, Burrows JN, Mills M, Davies C, Lamont S, Milne D, Cook C, Moore P, Sawyer Y, Gerhardt S",,728837,DTCT0024091,5145584,DTCC01029445,1746789,43649
CHEMBL1683460,P50281,,YAQNYFRHXMKRGE-HJPURHCSSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,21300546,IC50,=,2600,NM,,,,,,,,,,,,,,Inhibition of recombinant human MMP14 assessed as substrate cleavage by measuring increase in fluorescence after 16 hrs,,The design and synthesis of novel N-hydroxyformamide inhibitors of ADAM-TS4 for the treatment of osteoarthritis.,Bioorg. Med. Chem. Lett.,2011,21,5,"De Savi C, Pape A, Cumming JG, Ting A, Smith PD, Burrows JN, Mills M, Davies C, Lamont S, Milne D, Cook C, Moore P, Sawyer Y, Gerhardt S",,728837,DTCT0024091,5145528,DTCC01029446,684536,43649
CHEMBL1683461,P50281,,ICCQWMPCYVXIPA-DFBJGRDBSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,21300546,IC50,>,3700,NM,,,,,,,,,,,,,,Inhibition of recombinant human MMP14 assessed as substrate cleavage by measuring increase in fluorescence after 16 hrs,,The design and synthesis of novel N-hydroxyformamide inhibitors of ADAM-TS4 for the treatment of osteoarthritis.,Bioorg. Med. Chem. Lett.,2011,21,5,"De Savi C, Pape A, Cumming JG, Ting A, Smith PD, Burrows JN, Mills M, Davies C, Lamont S, Milne D, Cook C, Moore P, Sawyer Y, Gerhardt S",,728837,DTCT0024091,5145576,DTCC01029447,328882,43649
CHEMBL1683462,P50281,,WTIUPHRWVGHPRH-HJPURHCSSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,21300546,IC50,>,18000,NM,,,,,,,,,,,,,,Inhibition of recombinant human MMP14 assessed as substrate cleavage by measuring increase in fluorescence after 16 hrs,,The design and synthesis of novel N-hydroxyformamide inhibitors of ADAM-TS4 for the treatment of osteoarthritis.,Bioorg. Med. Chem. Lett.,2011,21,5,"De Savi C, Pape A, Cumming JG, Ting A, Smith PD, Burrows JN, Mills M, Davies C, Lamont S, Milne D, Cook C, Moore P, Sawyer Y, Gerhardt S",,728837,DTCT0024091,5145573,DTCC01029448,491087,43649
CHEMBL1683463,P50281,,SVXOKXGEZUGFFS-UUOWRZLLSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,21300546,IC50,=,40000,NM,,,,,,,,,,,,,,Inhibition of recombinant human MMP14 assessed as substrate cleavage by measuring increase in fluorescence after 16 hrs,,The design and synthesis of novel N-hydroxyformamide inhibitors of ADAM-TS4 for the treatment of osteoarthritis.,Bioorg. Med. Chem. Lett.,2011,21,5,"De Savi C, Pape A, Cumming JG, Ting A, Smith PD, Burrows JN, Mills M, Davies C, Lamont S, Milne D, Cook C, Moore P, Sawyer Y, Gerhardt S",,728837,DTCT0024091,5145558,DTCC01029449,69401,43649
CHEMBL1683464,P50281,,BWHNAQMOABQLDB-BVZFJXPGSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,21300546,IC50,>,3600,NM,,,,,,,,,,,,,,Inhibition of recombinant human MMP14 assessed as substrate cleavage by measuring increase in fluorescence after 16 hrs,,The design and synthesis of novel N-hydroxyformamide inhibitors of ADAM-TS4 for the treatment of osteoarthritis.,Bioorg. Med. Chem. Lett.,2011,21,5,"De Savi C, Pape A, Cumming JG, Ting A, Smith PD, Burrows JN, Mills M, Davies C, Lamont S, Milne D, Cook C, Moore P, Sawyer Y, Gerhardt S",,728837,DTCT0024091,5145575,DTCC01029450,911513,43649
CHEMBL1683465,P50281,,PDHFGTGPEOIGCF-SBUREZEXSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,21300546,IC50,=,29000,NM,,,,,,,,,,,,,,Inhibition of recombinant human MMP14 assessed as substrate cleavage by measuring increase in fluorescence after 16 hrs,,The design and synthesis of novel N-hydroxyformamide inhibitors of ADAM-TS4 for the treatment of osteoarthritis.,Bioorg. Med. Chem. Lett.,2011,21,5,"De Savi C, Pape A, Cumming JG, Ting A, Smith PD, Burrows JN, Mills M, Davies C, Lamont S, Milne D, Cook C, Moore P, Sawyer Y, Gerhardt S",,728837,DTCT0024091,5145556,DTCC01029451,1718370,43649
CHEMBL1698845,P50281,,JVICFMRAVNKDOE-UHFFFAOYSA-M,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,,IC50,>,80000,NM,,,,,,,,,,,,,,PubChem BioAssay. Dose Response confirmation of uHTS hits for a small molecule inhibitors of MT1-MMP activation in a fluorescence assay set 1. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,954361,DTCT0024091,12209074,DTCC01033793,1218750,33038
CHEMBL1700270,P50281,,OTKYOGBGHUUFPC-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,,IC50,=,1410,NM,,,,,,,,,,,,,,PubChem BioAssay. Dose Response confirmation of uHTS hits for a small molecule inhibitors of MT1-MMP activation in a fluorescence assay set 1. (Class of assay: confirmatory) ,active,PUBCHEM BIOASSAY DATA SET,,,,,,,954361,DTCT0024091,12209079,DTCC01035171,1608223,33038
CHEMBL170103,P50281,,BNPMWDDIMRPKMZ-JTSKRJEESA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,11958997,INHIBITION,=,74,%,,,,,,,,,,,,,,Percent remaining enzyme activity (RA) in catalytic domains of the membrane type MT1-MMP (matrix metalloprotease-14),,Oxal hydroxamic acid derivatives with inhibitory activity against matrix metalloproteinases.,Bioorg. Med. Chem. Lett.,2002,12,6,"Krumme D, Tschesche H",,106778,DTCT0024091,1129975,DTCC00371438,777871,5419
CHEMBL170346,P50281,,BNFQSPBDDPIXCF-VIFPVBQESA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,11958997,INHIBITION,=,80,%,,,,,,,,,,,,,,Percent remaining enzyme activity (RA) in catalytic domains of the membrane type MT1-MMP (matrix metalloprotease-14),,Oxal hydroxamic acid derivatives with inhibitory activity against matrix metalloproteinases.,Bioorg. Med. Chem. Lett.,2002,12,6,"Krumme D, Tschesche H",,106778,DTCT0024091,1126113,DTCC00371364,584245,5419
CHEMBL1704883,P50281,,YEJHAAXJCOITDT-NJNXFGOHSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,,IC50,=,14000,NM,,,,,,,,,,,,,,PubChem BioAssay. Dose Response confirmation of uHTS hits for a small molecule inhibitors of MT1-MMP activation in a fluorescence assay set 1. (Class of assay: confirmatory) ,active,PUBCHEM BIOASSAY DATA SET,,,,,,,954361,DTCT0024091,12209085,DTCC01039656,1123091,33038
CHEMBL170625,P50281,,AEAOFBYNIYSJQK-HNNXBMFYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,11958997,INHIBITION,=,23,%,,,,,,,,,,,,,,Percent remaining enzyme activity (RA) in catalytic domains of the membrane type MT1-MMP (matrix metalloprotease-14),,Oxal hydroxamic acid derivatives with inhibitory activity against matrix metalloproteinases.,Bioorg. Med. Chem. Lett.,2002,12,6,"Krumme D, Tschesche H",,106778,DTCT0024091,1111701,DTCC00371444,1036734,5419
CHEMBL1708493,P50281,,ZDFMCUHFIYMYTO-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,,IC50,=,38000,NM,,,,,,,,,,,,,,PubChem BioAssay. Dose Response confirmation of uHTS hits for a small molecule inhibitors of MT1-MMP activation in a fluorescence assay set 1. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,954361,DTCT0024091,12209093,DTCC01043143,1575706,33038
CHEMBL1714335,P50281,,USTZDWIBEMKHEZ-NXRKLTDKSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,,IC50,=,22700,NM,,,,,,,,,,,,,,PubChem BioAssay. Dose Response confirmation of uHTS hits for a small molecule inhibitors of MT1-MMP activation in a fluorescence assay set 1. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,954361,DTCT0024091,12209111,DTCC01048778,864724,33038
CHEMBL171466,P50281,,XVXXOYBXUAACNT-YWZLYKJASA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,11958997,KI,=,29000,NM,,,,,,,,,,,,,,Inhibition of membrane type MT1-MMP (Matrix metalloprotease-14)catalytic domain,,Oxal hydroxamic acid derivatives with inhibitory activity against matrix metalloproteinases.,Bioorg. Med. Chem. Lett.,2002,12,6,"Krumme D, Tschesche H",,106788,DTCT0024091,1123505,DTCC00371065,843002,5419
CHEMBL1717912,P50281,,FLSBHQJVJRJLRN-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,,IC50,=,18900,NM,,,,,,,,,,,,,,PubChem BioAssay. Dose Response confirmation of uHTS hits for a small molecule inhibitors of MT1-MMP activation in a fluorescence assay set 2. (Class of assay: confirmatory) ,active,PUBCHEM BIOASSAY DATA SET,,,,,,,954348,DTCT0024091,12216198,DTCC01052248,670050,33038
CHEMBL171949,P50281,,HRMFOWHCPWWSTB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,11958997,INHIBITION,=,48,%,,,,,,,,,,,,,,Percent remaining enzyme activity (RA) in catalytic domains of the membrane type MT1-MMP (matrix metalloprotease-14),,Oxal hydroxamic acid derivatives with inhibitory activity against matrix metalloproteinases.,Bioorg. Med. Chem. Lett.,2002,12,6,"Krumme D, Tschesche H",,106778,DTCT0024091,1133853,DTCC00373680,1230017,5419
CHEMBL1721330,P50281,,DOARKRWMRODJNP-UHFFFAOYSA-M,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,,IC50,>,80000,NM,,,,,,,,,,,,,,PubChem BioAssay. Dose Response confirmation of uHTS hits for a small molecule inhibitors of MT1-MMP activation in a fluorescence assay set 1. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,954361,DTCT0024091,12209080,DTCC01055548,1640628,33038
CHEMBL172180,P50281,,WKWHTFBYSLLKLG-YWZLYKJASA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,11958997,INHIBITION,=,37,%,,,,,,,,,,,,,,Percent remaining enzyme activity (RA) in catalytic domains of the membrane type MT1-MMP (matrix metalloprotease-14),,Oxal hydroxamic acid derivatives with inhibitory activity against matrix metalloproteinases.,Bioorg. Med. Chem. Lett.,2002,12,6,"Krumme D, Tschesche H",,106778,DTCT0024091,1103407,DTCC00371752,1490105,5419
CHEMBL172251,P50281,,FRRIILVFUOBZCJ-MBABXSBOSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,11958997,INHIBITION,=,42,%,,,,,,,,,,,,,,Percent remaining enzyme activity (RA) in catalytic domains of the membrane type MT1-MMP (matrix metalloprotease-14),,Oxal hydroxamic acid derivatives with inhibitory activity against matrix metalloproteinases.,Bioorg. Med. Chem. Lett.,2002,12,6,"Krumme D, Tschesche H",,106778,DTCT0024091,1110248,DTCC00371594,1619276,5419
CHEMBL1727678,P50281,,OTUQBJVZQSQBAC-UHFFFAOYSA-M,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,,IC50,=,14600,NM,,,,,,,,,,,,,,PubChem BioAssay. Dose Response confirmation of uHTS hits for a small molecule inhibitors of MT1-MMP activation in a fluorescence assay set 1. (Class of assay: confirmatory) ,active,PUBCHEM BIOASSAY DATA SET,,,,,,,954361,DTCT0024091,12209091,DTCC01061721,897077,33038
CHEMBL172874,P50281,,QXLUKDZXPBRJKE-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,11958997,INHIBITION,=,14,%,,,,,,,,,,,,,,Percent remaining enzyme activity (RA) in catalytic domains of the membrane type MT1-MMP (matrix metalloprotease-14),,Oxal hydroxamic acid derivatives with inhibitory activity against matrix metalloproteinases.,Bioorg. Med. Chem. Lett.,2002,12,6,"Krumme D, Tschesche H",,106778,DTCT0024091,1124719,DTCC00370663,1715183,5419
CHEMBL172874,P50281,,QXLUKDZXPBRJKE-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,11958997,KI,=,9000,NM,,,,,,,,,,,,,,Inhibition of membrane type MT1-MMP (Matrix metalloprotease-14)catalytic domain,,Oxal hydroxamic acid derivatives with inhibitory activity against matrix metalloproteinases.,Bioorg. Med. Chem. Lett.,2002,12,6,"Krumme D, Tschesche H",,106788,DTCT0024091,1124718,DTCC00370663,1715183,5419
CHEMBL173284,P50281,,IHNYAHCZDRILEC-YPMHNXCESA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,11958997,INHIBITION,=,79,%,,,,,,,,,,,,,,Percent remaining enzyme activity (RA) in catalytic domains of the membrane type MT1-MMP (matrix metalloprotease-14),,Oxal hydroxamic acid derivatives with inhibitory activity against matrix metalloproteinases.,Bioorg. Med. Chem. Lett.,2002,12,6,"Krumme D, Tschesche H",,106778,DTCT0024091,1119536,DTCC00370419,1904589,5419
CHEMBL173382,P50281,,HCKYIMJMJTUVAP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,11958997,INHIBITION,=,35,%,,,,,,,,,,,,,,Percent remaining enzyme activity (RA) in catalytic domains of the membrane type MT1-MMP (matrix metalloprotease-14),,Oxal hydroxamic acid derivatives with inhibitory activity against matrix metalloproteinases.,Bioorg. Med. Chem. Lett.,2002,12,6,"Krumme D, Tschesche H",,106778,DTCT0024091,1119541,DTCC00370756,1586614,5419
CHEMBL173382,P50281,,HCKYIMJMJTUVAP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,11958997,KI,=,35000,NM,,,,,,,,,,,,,,Inhibition of membrane type MT1-MMP (Matrix metalloprotease-14)catalytic domain,,Oxal hydroxamic acid derivatives with inhibitory activity against matrix metalloproteinases.,Bioorg. Med. Chem. Lett.,2002,12,6,"Krumme D, Tschesche H",,106788,DTCT0024091,1119540,DTCC00370756,1586614,5419
CHEMBL173533,P50281,,ODZPYMWQRDBEPD-LOSJGSFVSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,11958997,INHIBITION,=,5,%,,,,,,,,,,,,,,Percent remaining enzyme activity (RA) in catalytic domains of the membrane type MT1-MMP (matrix metalloprotease-14),,Oxal hydroxamic acid derivatives with inhibitory activity against matrix metalloproteinases.,Bioorg. Med. Chem. Lett.,2002,12,6,"Krumme D, Tschesche H",,106778,DTCT0024091,1100876,DTCC00372545,971793,5419
CHEMBL173533,P50281,,ODZPYMWQRDBEPD-LOSJGSFVSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,11958997,KI,=,1400,NM,,,,,,,,,,,,,,Inhibition of membrane type MT1-MMP (Matrix metalloprotease-14)catalytic domain,,Oxal hydroxamic acid derivatives with inhibitory activity against matrix metalloproteinases.,Bioorg. Med. Chem. Lett.,2002,12,6,"Krumme D, Tschesche H",,106788,DTCT0024091,1100874,DTCC00372545,971793,5419
CHEMBL173544,P50281,,VLUPODOOTLRMGI-NSHDSACASA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,11958997,INHIBITION,=,41,%,,,,,,,,,,,,,,Percent remaining enzyme activity (RA) in catalytic domains of the membrane type MT1-MMP (matrix metalloprotease-14),,Oxal hydroxamic acid derivatives with inhibitory activity against matrix metalloproteinases.,Bioorg. Med. Chem. Lett.,2002,12,6,"Krumme D, Tschesche H",,106778,DTCT0024091,1095529,DTCC00371020,358059,5419
CHEMBL1735454,P50281,,JQBUVPRAKRZKRZ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,,IC50,=,20500,NM,,,,,,,,,,,,,,PubChem BioAssay. Dose Response confirmation of uHTS hits for a small molecule inhibitors of MT1-MMP activation in a fluorescence assay set 2. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,954348,DTCT0024091,12216218,DTCC01069254,734968,33038
CHEMBL173818,P50281,,KKZUWROSSZALIB-ZETCQYMHSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,11958997,INHIBITION,=,61,%,,,,,,,,,,,,,,Percent remaining enzyme activity (RA) in catalytic domains of the membrane type MT1-MMP (matrix metalloprotease-14),,Oxal hydroxamic acid derivatives with inhibitory activity against matrix metalloproteinases.,Bioorg. Med. Chem. Lett.,2002,12,6,"Krumme D, Tschesche H",,106778,DTCT0024091,1122327,DTCC00370650,259623,5419
CHEMBL174084,P50281,,RJZVOLUHBQERAD-AWEZNQCLSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,11958997,INHIBITION,=,26,%,,,,,,,,,,,,,,Percent remaining enzyme activity (RA) in catalytic domains of the membrane type MT1-MMP (matrix metalloprotease-14),,Oxal hydroxamic acid derivatives with inhibitory activity against matrix metalloproteinases.,Bioorg. Med. Chem. Lett.,2002,12,6,"Krumme D, Tschesche H",,106778,DTCT0024091,1104965,DTCC00371209,1743527,5419
CHEMBL174373,P50281,,AIDZFVBIMNVQQY-LBPRGKRZSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,11958997,INHIBITION,=,33,%,,,,,,,,,,,,,,Percent remaining enzyme activity (RA) in catalytic domains of the membrane type MT1-MMP (matrix metalloprotease-14),,Oxal hydroxamic acid derivatives with inhibitory activity against matrix metalloproteinases.,Bioorg. Med. Chem. Lett.,2002,12,6,"Krumme D, Tschesche H",,106778,DTCT0024091,1096963,DTCC00371066,584244,5419
CHEMBL174373,P50281,,AIDZFVBIMNVQQY-LBPRGKRZSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,11958997,KI,=,15000,NM,,,,,,,,,,,,,,Inhibition of membrane type MT1-MMP (Matrix metalloprotease-14)catalytic domain,,Oxal hydroxamic acid derivatives with inhibitory activity against matrix metalloproteinases.,Bioorg. Med. Chem. Lett.,2002,12,6,"Krumme D, Tschesche H",,106788,DTCT0024091,1096962,DTCC00371066,584244,5419
CHEMBL174422,P50281,,LQPUQCAPJTUCIA-YOEHRIQHSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,11958997,INHIBITION,=,19,%,,,,,,,,,,,,,,Percent remaining enzyme activity (RA) in catalytic domains of the membrane type MT1-MMP (matrix metalloprotease-14),,Oxal hydroxamic acid derivatives with inhibitory activity against matrix metalloproteinases.,Bioorg. Med. Chem. Lett.,2002,12,6,"Krumme D, Tschesche H",,106778,DTCT0024091,1114186,DTCC00371013,745783,5419
CHEMBL174422,P50281,,LQPUQCAPJTUCIA-YOEHRIQHSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,11958997,KI,=,11000,NM,,,,,,,,,,,,,,Inhibition of membrane type MT1-MMP (Matrix metalloprotease-14)catalytic domain,,Oxal hydroxamic acid derivatives with inhibitory activity against matrix metalloproteinases.,Bioorg. Med. Chem. Lett.,2002,12,6,"Krumme D, Tschesche H",,106788,DTCT0024091,1114185,DTCC00371013,745783,5419
CHEMBL174865,P50281,,MKXCYCNTSAOKDX-LRDDRELGSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,11958997,INHIBITION,=,54,%,,,,,,,,,,,,,,Percent remaining enzyme activity (RA) in catalytic domains of the membrane type MT1-MMP (matrix metalloprotease-14),,Oxal hydroxamic acid derivatives with inhibitory activity against matrix metalloproteinases.,Bioorg. Med. Chem. Lett.,2002,12,6,"Krumme D, Tschesche H",,106778,DTCT0024091,1123510,DTCC00372935,520000,5419
CHEMBL174993,P50281,,WFYLXIFCLIAISI-KRWDZBQOSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,11958997,INHIBITION,=,37,%,,,,,,,,,,,,,,Percent remaining enzyme activity (RA) in catalytic domains of the membrane type MT1-MMP (matrix metalloprotease-14),,Oxal hydroxamic acid derivatives with inhibitory activity against matrix metalloproteinases.,Bioorg. Med. Chem. Lett.,2002,12,6,"Krumme D, Tschesche H",,106778,DTCT0024091,1121068,DTCC00373042,745782,5419
CHEMBL175009,P50281,,JQVKKTYOFNLOIP-MBSDFSHPSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,11958997,INHIBITION,=,69,%,,,,,,,,,,,,,,Percent remaining enzyme activity (RA) in catalytic domains of the membrane type MT1-MMP (matrix metalloprotease-14),,Oxal hydroxamic acid derivatives with inhibitory activity against matrix metalloproteinases.,Bioorg. Med. Chem. Lett.,2002,12,6,"Krumme D, Tschesche H",,106778,DTCT0024091,1135124,DTCC00372934,713481,5419
CHEMBL1760318,P50281,,SZPWYHRMRFNOHH-GHTZIAJQSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,22342144,KI,>,50000,NM,,,,,,,,,,,,,,Inhibition of MMP-14 using OmniMMP as substrate,,Antidotes to anthrax lethal factor intoxication. Part 3: Evaluation of core structures and further modifications to the C2-side chain.,Bioorg. Med. Chem. Lett.,2012,22,6,"Jiao GS, Kim S, Moayeri M, Crown D, Thai A, Cregar-Hernandez L, McKasson L, Sankaran B, Lehrer A, Wong T, Johns L, Margosiak SA, Leppla SH, Johnson AT",,811341,DTCT0024091,10427363,DTCC01075303,1687706,47718
CHEMBL1760322,P50281,,DUBRLRRJAJGWMU-LJQANCHMSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,22342144,KI,>,50000,NM,,,,,,,,,,,,,,Inhibition of MMP-14 using OmniMMP as substrate,,Antidotes to anthrax lethal factor intoxication. Part 3: Evaluation of core structures and further modifications to the C2-side chain.,Bioorg. Med. Chem. Lett.,2012,22,6,"Jiao GS, Kim S, Moayeri M, Crown D, Thai A, Cregar-Hernandez L, McKasson L, Sankaran B, Lehrer A, Wong T, Johns L, Margosiak SA, Leppla SH, Johnson AT",,811341,DTCT0024091,10427365,DTCC01075307,1201801,47718
CHEMBL1760324,P50281,,PVPXSRWESCVIBD-IBGZPJMESA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,22342144,KI,>,50000,NM,,,,,,,,,,,,,,Inhibition of MMP-14 using OmniMMP as substrate,,Antidotes to anthrax lethal factor intoxication. Part 3: Evaluation of core structures and further modifications to the C2-side chain.,Bioorg. Med. Chem. Lett.,2012,22,6,"Jiao GS, Kim S, Moayeri M, Crown D, Thai A, Cregar-Hernandez L, McKasson L, Sankaran B, Lehrer A, Wong T, Johns L, Margosiak SA, Leppla SH, Johnson AT",,811341,DTCT0024091,10427367,DTCC01075309,976029,47718
CHEMBL1766898,P50281,,KXRILFPUNAVTKU-FXHACXQTSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,21417219,IC50,,,,,,,,,,,,,,,,,Inhibition of human recombinant MMP14 after 60 mins by fluorescence plate reader,Not Determined,"Discovery of (1S,2R,3R)-2,3-Dimethyl-2-phenyl-1-sulfamidocyclopropanecarboxylates: Novel and Highly Selective Aggrecanase Inhibitors.",J. Med. Chem.,2011,54,8,"Shiozaki M, Maeda K, Miura T, Kotoku M, Yamasaki T, Matsuda I, Aoki K, Yasue K, Imai H, Ubukata M, Suma A, Yokota M, Hotta T, Tanaka M, Hase Y, Haas J, Fryer AM, Laird ER, Littmann NM, Andrews SW, Josey JA, Mimura T, Shinozaki Y, Yoshiuchi H, Inaba T",,743597,DTCT0024091,5926789,DTCC01079419,1105316,44276
CHEMBL1766899,P50281,,DSLRBIQFKOUGKT-LLSQANQASA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,21417219,IC50,=,1.3,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP14 after 60 mins by fluorescence plate reader,,"Discovery of (1S,2R,3R)-2,3-Dimethyl-2-phenyl-1-sulfamidocyclopropanecarboxylates: Novel and Highly Selective Aggrecanase Inhibitors.",J. Med. Chem.,2011,54,8,"Shiozaki M, Maeda K, Miura T, Kotoku M, Yamasaki T, Matsuda I, Aoki K, Yasue K, Imai H, Ubukata M, Suma A, Yokota M, Hotta T, Tanaka M, Hase Y, Haas J, Fryer AM, Laird ER, Littmann NM, Andrews SW, Josey JA, Mimura T, Shinozaki Y, Yoshiuchi H, Inaba T",,743597,DTCT0024091,5926790,DTCC01079420,1201084,44276
CHEMBL1766900,P50281,,OJPRZTDTKMGAMY-XVSDVWIESA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,21417219,IC50,=,1.2,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP14 after 60 mins by fluorescence plate reader,,"Discovery of (1S,2R,3R)-2,3-Dimethyl-2-phenyl-1-sulfamidocyclopropanecarboxylates: Novel and Highly Selective Aggrecanase Inhibitors.",J. Med. Chem.,2011,54,8,"Shiozaki M, Maeda K, Miura T, Kotoku M, Yamasaki T, Matsuda I, Aoki K, Yasue K, Imai H, Ubukata M, Suma A, Yokota M, Hotta T, Tanaka M, Hase Y, Haas J, Fryer AM, Laird ER, Littmann NM, Andrews SW, Josey JA, Mimura T, Shinozaki Y, Yoshiuchi H, Inaba T",,743597,DTCT0024091,5926791,DTCC01079421,781243,44276
CHEMBL1766901,P50281,,KFOJCCXBEQXGOL-JSZUHDFRSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,21417219,IC50,=,100,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP14 after 60 mins by fluorescence plate reader,,"Discovery of (1S,2R,3R)-2,3-Dimethyl-2-phenyl-1-sulfamidocyclopropanecarboxylates: Novel and Highly Selective Aggrecanase Inhibitors.",J. Med. Chem.,2011,54,8,"Shiozaki M, Maeda K, Miura T, Kotoku M, Yamasaki T, Matsuda I, Aoki K, Yasue K, Imai H, Ubukata M, Suma A, Yokota M, Hotta T, Tanaka M, Hase Y, Haas J, Fryer AM, Laird ER, Littmann NM, Andrews SW, Josey JA, Mimura T, Shinozaki Y, Yoshiuchi H, Inaba T",,743597,DTCT0024091,5926793,DTCC01079422,523428,44276
CHEMBL1766902,P50281,,QVFLVOHFXMNIFB-JSZUHDFRSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,21417219,IC50,=,100,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP14 after 60 mins by fluorescence plate reader,,"Discovery of (1S,2R,3R)-2,3-Dimethyl-2-phenyl-1-sulfamidocyclopropanecarboxylates: Novel and Highly Selective Aggrecanase Inhibitors.",J. Med. Chem.,2011,54,8,"Shiozaki M, Maeda K, Miura T, Kotoku M, Yamasaki T, Matsuda I, Aoki K, Yasue K, Imai H, Ubukata M, Suma A, Yokota M, Hotta T, Tanaka M, Hase Y, Haas J, Fryer AM, Laird ER, Littmann NM, Andrews SW, Josey JA, Mimura T, Shinozaki Y, Yoshiuchi H, Inaba T",,743597,DTCT0024091,5926794,DTCC01079423,230802,44276
CHEMBL1766903,P50281,,DNSIVPJNRUSHDP-USVHUCMKSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,21417219,IC50,=,17,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP14 after 60 mins by fluorescence plate reader,,"Discovery of (1S,2R,3R)-2,3-Dimethyl-2-phenyl-1-sulfamidocyclopropanecarboxylates: Novel and Highly Selective Aggrecanase Inhibitors.",J. Med. Chem.,2011,54,8,"Shiozaki M, Maeda K, Miura T, Kotoku M, Yamasaki T, Matsuda I, Aoki K, Yasue K, Imai H, Ubukata M, Suma A, Yokota M, Hotta T, Tanaka M, Hase Y, Haas J, Fryer AM, Laird ER, Littmann NM, Andrews SW, Josey JA, Mimura T, Shinozaki Y, Yoshiuchi H, Inaba T",,743597,DTCT0024091,5926795,DTCC01079424,1590116,44276
CHEMBL1766904,P50281,,PENUDEJHXUSMIL-USVHUCMKSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,21417219,IC50,=,8,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP14 after 60 mins by fluorescence plate reader,,"Discovery of (1S,2R,3R)-2,3-Dimethyl-2-phenyl-1-sulfamidocyclopropanecarboxylates: Novel and Highly Selective Aggrecanase Inhibitors.",J. Med. Chem.,2011,54,8,"Shiozaki M, Maeda K, Miura T, Kotoku M, Yamasaki T, Matsuda I, Aoki K, Yasue K, Imai H, Ubukata M, Suma A, Yokota M, Hotta T, Tanaka M, Hase Y, Haas J, Fryer AM, Laird ER, Littmann NM, Andrews SW, Josey JA, Mimura T, Shinozaki Y, Yoshiuchi H, Inaba T",,743597,DTCT0024091,5926796,DTCC01079425,781244,44276
CHEMBL1766905,P50281,,FTPFWQRREQUXLQ-USVHUCMKSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,21417219,IC50,=,25,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP14 after 60 mins by fluorescence plate reader,,"Discovery of (1S,2R,3R)-2,3-Dimethyl-2-phenyl-1-sulfamidocyclopropanecarboxylates: Novel and Highly Selective Aggrecanase Inhibitors.",J. Med. Chem.,2011,54,8,"Shiozaki M, Maeda K, Miura T, Kotoku M, Yamasaki T, Matsuda I, Aoki K, Yasue K, Imai H, Ubukata M, Suma A, Yokota M, Hotta T, Tanaka M, Hase Y, Haas J, Fryer AM, Laird ER, Littmann NM, Andrews SW, Josey JA, Mimura T, Shinozaki Y, Yoshiuchi H, Inaba T",,743597,DTCT0024091,5926797,DTCC01079426,1364221,44276
CHEMBL1766906,P50281,,GCYXMFHUCWJAKI-VMRPVKRXSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,21417219,IC50,=,450,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP14 after 60 mins by fluorescence plate reader,,"Discovery of (1S,2R,3R)-2,3-Dimethyl-2-phenyl-1-sulfamidocyclopropanecarboxylates: Novel and Highly Selective Aggrecanase Inhibitors.",J. Med. Chem.,2011,54,8,"Shiozaki M, Maeda K, Miura T, Kotoku M, Yamasaki T, Matsuda I, Aoki K, Yasue K, Imai H, Ubukata M, Suma A, Yokota M, Hotta T, Tanaka M, Hase Y, Haas J, Fryer AM, Laird ER, Littmann NM, Andrews SW, Josey JA, Mimura T, Shinozaki Y, Yoshiuchi H, Inaba T",,743597,DTCT0024091,5926798,DTCC01079427,1746905,44276
CHEMBL1766907,P50281,,XWUCDOCUSPAHFU-QPJICYPMSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,21417219,IC50,=,300,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP14 after 60 mins by fluorescence plate reader,,"Discovery of (1S,2R,3R)-2,3-Dimethyl-2-phenyl-1-sulfamidocyclopropanecarboxylates: Novel and Highly Selective Aggrecanase Inhibitors.",J. Med. Chem.,2011,54,8,"Shiozaki M, Maeda K, Miura T, Kotoku M, Yamasaki T, Matsuda I, Aoki K, Yasue K, Imai H, Ubukata M, Suma A, Yokota M, Hotta T, Tanaka M, Hase Y, Haas J, Fryer AM, Laird ER, Littmann NM, Andrews SW, Josey JA, Mimura T, Shinozaki Y, Yoshiuchi H, Inaba T",,743597,DTCT0024091,5926799,DTCC01079428,846545,44276
CHEMBL1766908,P50281,,STTHHFYKRNBSEX-AJYGTSELSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,21417219,IC50,=,2100,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP14 after 60 mins by fluorescence plate reader,,"Discovery of (1S,2R,3R)-2,3-Dimethyl-2-phenyl-1-sulfamidocyclopropanecarboxylates: Novel and Highly Selective Aggrecanase Inhibitors.",J. Med. Chem.,2011,54,8,"Shiozaki M, Maeda K, Miura T, Kotoku M, Yamasaki T, Matsuda I, Aoki K, Yasue K, Imai H, Ubukata M, Suma A, Yokota M, Hotta T, Tanaka M, Hase Y, Haas J, Fryer AM, Laird ER, Littmann NM, Andrews SW, Josey JA, Mimura T, Shinozaki Y, Yoshiuchi H, Inaba T",,743597,DTCT0024091,5926800,DTCC01079429,1168806,44276
CHEMBL1766909,P50281,,STTHHFYKRNBSEX-LZWBKRQXSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,21417219,IC50,=,2500,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP14 after 60 mins by fluorescence plate reader,,"Discovery of (1S,2R,3R)-2,3-Dimethyl-2-phenyl-1-sulfamidocyclopropanecarboxylates: Novel and Highly Selective Aggrecanase Inhibitors.",J. Med. Chem.,2011,54,8,"Shiozaki M, Maeda K, Miura T, Kotoku M, Yamasaki T, Matsuda I, Aoki K, Yasue K, Imai H, Ubukata M, Suma A, Yokota M, Hotta T, Tanaka M, Hase Y, Haas J, Fryer AM, Laird ER, Littmann NM, Andrews SW, Josey JA, Mimura T, Shinozaki Y, Yoshiuchi H, Inaba T",,743597,DTCT0024091,5926801,DTCC01079430,813623,44276
CHEMBL1766910,P50281,,BJACWSRNAORLEC-OOQGRHGZSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,21417219,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP14 after 60 mins by fluorescence plate reader,,"Discovery of (1S,2R,3R)-2,3-Dimethyl-2-phenyl-1-sulfamidocyclopropanecarboxylates: Novel and Highly Selective Aggrecanase Inhibitors.",J. Med. Chem.,2011,54,8,"Shiozaki M, Maeda K, Miura T, Kotoku M, Yamasaki T, Matsuda I, Aoki K, Yasue K, Imai H, Ubukata M, Suma A, Yokota M, Hotta T, Tanaka M, Hase Y, Haas J, Fryer AM, Laird ER, Littmann NM, Andrews SW, Josey JA, Mimura T, Shinozaki Y, Yoshiuchi H, Inaba T",,743597,DTCT0024091,5926802,DTCC01079431,716964,44276
CHEMBL1766911,P50281,,GQZOGEGQMATKMX-LQNXUBFPSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,21417219,IC50,=,2900,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP14 after 60 mins by fluorescence plate reader,,"Discovery of (1S,2R,3R)-2,3-Dimethyl-2-phenyl-1-sulfamidocyclopropanecarboxylates: Novel and Highly Selective Aggrecanase Inhibitors.",J. Med. Chem.,2011,54,8,"Shiozaki M, Maeda K, Miura T, Kotoku M, Yamasaki T, Matsuda I, Aoki K, Yasue K, Imai H, Ubukata M, Suma A, Yokota M, Hotta T, Tanaka M, Hase Y, Haas J, Fryer AM, Laird ER, Littmann NM, Andrews SW, Josey JA, Mimura T, Shinozaki Y, Yoshiuchi H, Inaba T",,743597,DTCT0024091,5926803,DTCC01079432,1493441,44276
CHEMBL1766912,P50281,,PHSMGENFLLYXOS-TWFUEQBQSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,21417219,IC50,=,6100,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP14 after 60 mins by fluorescence plate reader,,"Discovery of (1S,2R,3R)-2,3-Dimethyl-2-phenyl-1-sulfamidocyclopropanecarboxylates: Novel and Highly Selective Aggrecanase Inhibitors.",J. Med. Chem.,2011,54,8,"Shiozaki M, Maeda K, Miura T, Kotoku M, Yamasaki T, Matsuda I, Aoki K, Yasue K, Imai H, Ubukata M, Suma A, Yokota M, Hotta T, Tanaka M, Hase Y, Haas J, Fryer AM, Laird ER, Littmann NM, Andrews SW, Josey JA, Mimura T, Shinozaki Y, Yoshiuchi H, Inaba T",,743597,DTCT0024091,5926804,DTCC01079433,781245,44276
CHEMBL1766913,P50281,,GDLNLDAXSYMNKX-AJYGTSELSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,21417219,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP14 after 60 mins by fluorescence plate reader,,"Discovery of (1S,2R,3R)-2,3-Dimethyl-2-phenyl-1-sulfamidocyclopropanecarboxylates: Novel and Highly Selective Aggrecanase Inhibitors.",J. Med. Chem.,2011,54,8,"Shiozaki M, Maeda K, Miura T, Kotoku M, Yamasaki T, Matsuda I, Aoki K, Yasue K, Imai H, Ubukata M, Suma A, Yokota M, Hotta T, Tanaka M, Hase Y, Haas J, Fryer AM, Laird ER, Littmann NM, Andrews SW, Josey JA, Mimura T, Shinozaki Y, Yoshiuchi H, Inaba T",,743597,DTCT0024091,5926805,DTCC01079434,1746906,44276
CHEMBL1766915,P50281,,POBFTZWPMIMUSM-HLBGSYOWSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,21417219,IC50,=,6000,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP14 after 60 mins by fluorescence plate reader,,"Discovery of (1S,2R,3R)-2,3-Dimethyl-2-phenyl-1-sulfamidocyclopropanecarboxylates: Novel and Highly Selective Aggrecanase Inhibitors.",J. Med. Chem.,2011,54,8,"Shiozaki M, Maeda K, Miura T, Kotoku M, Yamasaki T, Matsuda I, Aoki K, Yasue K, Imai H, Ubukata M, Suma A, Yokota M, Hotta T, Tanaka M, Hase Y, Haas J, Fryer AM, Laird ER, Littmann NM, Andrews SW, Josey JA, Mimura T, Shinozaki Y, Yoshiuchi H, Inaba T",,743597,DTCT0024091,5926807,DTCC01079436,1908006,44276
CHEMBL1766916,P50281,,CZQXANJDCCAOHA-KGIZBLLCSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,21417219,IC50,=,5400,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP14 after 60 mins by fluorescence plate reader,,"Discovery of (1S,2R,3R)-2,3-Dimethyl-2-phenyl-1-sulfamidocyclopropanecarboxylates: Novel and Highly Selective Aggrecanase Inhibitors.",J. Med. Chem.,2011,54,8,"Shiozaki M, Maeda K, Miura T, Kotoku M, Yamasaki T, Matsuda I, Aoki K, Yasue K, Imai H, Ubukata M, Suma A, Yokota M, Hotta T, Tanaka M, Hase Y, Haas J, Fryer AM, Laird ER, Littmann NM, Andrews SW, Josey JA, Mimura T, Shinozaki Y, Yoshiuchi H, Inaba T",,743597,DTCT0024091,5926808,DTCC01079437,328991,44276
CHEMBL1766917,P50281,,WQDCDSSZTJOWCF-PHAJSTNCSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,21417219,IC50,=,1100,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP14 after 60 mins by fluorescence plate reader,,"Discovery of (1S,2R,3R)-2,3-Dimethyl-2-phenyl-1-sulfamidocyclopropanecarboxylates: Novel and Highly Selective Aggrecanase Inhibitors.",J. Med. Chem.,2011,54,8,"Shiozaki M, Maeda K, Miura T, Kotoku M, Yamasaki T, Matsuda I, Aoki K, Yasue K, Imai H, Ubukata M, Suma A, Yokota M, Hotta T, Tanaka M, Hase Y, Haas J, Fryer AM, Laird ER, Littmann NM, Andrews SW, Josey JA, Mimura T, Shinozaki Y, Yoshiuchi H, Inaba T",,743597,DTCT0024091,5926809,DTCC01079438,1396630,44276
CHEMBL1766918,P50281,,IUIQYGWNHACUOZ-HLBGSYOWSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,21417219,IC50,=,1400,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP14 after 60 mins by fluorescence plate reader,,"Discovery of (1S,2R,3R)-2,3-Dimethyl-2-phenyl-1-sulfamidocyclopropanecarboxylates: Novel and Highly Selective Aggrecanase Inhibitors.",J. Med. Chem.,2011,54,8,"Shiozaki M, Maeda K, Miura T, Kotoku M, Yamasaki T, Matsuda I, Aoki K, Yasue K, Imai H, Ubukata M, Suma A, Yokota M, Hotta T, Tanaka M, Hase Y, Haas J, Fryer AM, Laird ER, Littmann NM, Andrews SW, Josey JA, Mimura T, Shinozaki Y, Yoshiuchi H, Inaba T",,743597,DTCT0024091,5926810,DTCC01079439,230803,44276
CHEMBL1766919,P50281,,NVERRANKYVTEPN-ZFGLAFRWSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,21417219,IC50,=,420,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP14 after 60 mins by fluorescence plate reader,,"Discovery of (1S,2R,3R)-2,3-Dimethyl-2-phenyl-1-sulfamidocyclopropanecarboxylates: Novel and Highly Selective Aggrecanase Inhibitors.",J. Med. Chem.,2011,54,8,"Shiozaki M, Maeda K, Miura T, Kotoku M, Yamasaki T, Matsuda I, Aoki K, Yasue K, Imai H, Ubukata M, Suma A, Yokota M, Hotta T, Tanaka M, Hase Y, Haas J, Fryer AM, Laird ER, Littmann NM, Andrews SW, Josey JA, Mimura T, Shinozaki Y, Yoshiuchi H, Inaba T",,743597,DTCT0024091,5926811,DTCC01079440,523429,44276
CHEMBL1766920,P50281,,CBZOKXRPUYLLBY-DYHNYNMBSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,21417219,IC50,=,610,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP14 after 60 mins by fluorescence plate reader,,"Discovery of (1S,2R,3R)-2,3-Dimethyl-2-phenyl-1-sulfamidocyclopropanecarboxylates: Novel and Highly Selective Aggrecanase Inhibitors.",J. Med. Chem.,2011,54,8,"Shiozaki M, Maeda K, Miura T, Kotoku M, Yamasaki T, Matsuda I, Aoki K, Yasue K, Imai H, Ubukata M, Suma A, Yokota M, Hotta T, Tanaka M, Hase Y, Haas J, Fryer AM, Laird ER, Littmann NM, Andrews SW, Josey JA, Mimura T, Shinozaki Y, Yoshiuchi H, Inaba T",,743597,DTCT0024091,5926812,DTCC01079441,813624,44276
CHEMBL1766921,P50281,,OTCWHHBFFQOWCU-DYHNYNMBSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,21417219,IC50,=,270,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP14 after 60 mins by fluorescence plate reader,,"Discovery of (1S,2R,3R)-2,3-Dimethyl-2-phenyl-1-sulfamidocyclopropanecarboxylates: Novel and Highly Selective Aggrecanase Inhibitors.",J. Med. Chem.,2011,54,8,"Shiozaki M, Maeda K, Miura T, Kotoku M, Yamasaki T, Matsuda I, Aoki K, Yasue K, Imai H, Ubukata M, Suma A, Yokota M, Hotta T, Tanaka M, Hase Y, Haas J, Fryer AM, Laird ER, Littmann NM, Andrews SW, Josey JA, Mimura T, Shinozaki Y, Yoshiuchi H, Inaba T",,743597,DTCT0024091,5926813,DTCC01079442,1105317,44276
CHEMBL1766922,P50281,,UWKSANSSQRUVAR-XSXHMXBXSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,21417219,IC50,=,2300,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP14 after 60 mins by fluorescence plate reader,,"Discovery of (1S,2R,3R)-2,3-Dimethyl-2-phenyl-1-sulfamidocyclopropanecarboxylates: Novel and Highly Selective Aggrecanase Inhibitors.",J. Med. Chem.,2011,54,8,"Shiozaki M, Maeda K, Miura T, Kotoku M, Yamasaki T, Matsuda I, Aoki K, Yasue K, Imai H, Ubukata M, Suma A, Yokota M, Hotta T, Tanaka M, Hase Y, Haas J, Fryer AM, Laird ER, Littmann NM, Andrews SW, Josey JA, Mimura T, Shinozaki Y, Yoshiuchi H, Inaba T",,743597,DTCT0024091,5926814,DTCC01079443,2005989,44276
CHEMBL1767003,P50281,,CPYCKLJBTHKVRT-LIUKBUMOSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,21417219,IC50,=,280,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP14 after 60 mins by fluorescence plate reader,,"Discovery of (1S,2R,3R)-2,3-Dimethyl-2-phenyl-1-sulfamidocyclopropanecarboxylates: Novel and Highly Selective Aggrecanase Inhibitors.",J. Med. Chem.,2011,54,8,"Shiozaki M, Maeda K, Miura T, Kotoku M, Yamasaki T, Matsuda I, Aoki K, Yasue K, Imai H, Ubukata M, Suma A, Yokota M, Hotta T, Tanaka M, Hase Y, Haas J, Fryer AM, Laird ER, Littmann NM, Andrews SW, Josey JA, Mimura T, Shinozaki Y, Yoshiuchi H, Inaba T",,743597,DTCT0024091,5926815,DTCC01079525,1072576,44276
CHEMBL1767004,P50281,,OGCHVEMYHSXDJE-MMACOIQUSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,21417219,IC50,=,2200,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP14 after 60 mins by fluorescence plate reader,,"Discovery of (1S,2R,3R)-2,3-Dimethyl-2-phenyl-1-sulfamidocyclopropanecarboxylates: Novel and Highly Selective Aggrecanase Inhibitors.",J. Med. Chem.,2011,54,8,"Shiozaki M, Maeda K, Miura T, Kotoku M, Yamasaki T, Matsuda I, Aoki K, Yasue K, Imai H, Ubukata M, Suma A, Yokota M, Hotta T, Tanaka M, Hase Y, Haas J, Fryer AM, Laird ER, Littmann NM, Andrews SW, Josey JA, Mimura T, Shinozaki Y, Yoshiuchi H, Inaba T",,743597,DTCT0024091,5926816,DTCC01079526,587714,44276
CHEMBL1767005,P50281,,SHSGVWNTSAKSFC-DYHNYNMBSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,21417219,IC50,=,1100,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP14 after 60 mins by fluorescence plate reader,,"Discovery of (1S,2R,3R)-2,3-Dimethyl-2-phenyl-1-sulfamidocyclopropanecarboxylates: Novel and Highly Selective Aggrecanase Inhibitors.",J. Med. Chem.,2011,54,8,"Shiozaki M, Maeda K, Miura T, Kotoku M, Yamasaki T, Matsuda I, Aoki K, Yasue K, Imai H, Ubukata M, Suma A, Yokota M, Hotta T, Tanaka M, Hase Y, Haas J, Fryer AM, Laird ER, Littmann NM, Andrews SW, Josey JA, Mimura T, Shinozaki Y, Yoshiuchi H, Inaba T",,743597,DTCT0024091,5926817,DTCC01079527,523433,44276
CHEMBL1767006,P50281,,HTBWAVKWLNLFGD-DYHNYNMBSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,21417219,IC50,=,240,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP14 after 60 mins by fluorescence plate reader,,"Discovery of (1S,2R,3R)-2,3-Dimethyl-2-phenyl-1-sulfamidocyclopropanecarboxylates: Novel and Highly Selective Aggrecanase Inhibitors.",J. Med. Chem.,2011,54,8,"Shiozaki M, Maeda K, Miura T, Kotoku M, Yamasaki T, Matsuda I, Aoki K, Yasue K, Imai H, Ubukata M, Suma A, Yokota M, Hotta T, Tanaka M, Hase Y, Haas J, Fryer AM, Laird ER, Littmann NM, Andrews SW, Josey JA, Mimura T, Shinozaki Y, Yoshiuchi H, Inaba T",,743597,DTCT0024091,5926818,DTCC01079528,16658,44276
CHEMBL1767007,P50281,,HVPBZXDEMBWXRX-ZFGLAFRWSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,21417219,IC50,=,4900,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP14 after 60 mins by fluorescence plate reader,,"Discovery of (1S,2R,3R)-2,3-Dimethyl-2-phenyl-1-sulfamidocyclopropanecarboxylates: Novel and Highly Selective Aggrecanase Inhibitors.",J. Med. Chem.,2011,54,8,"Shiozaki M, Maeda K, Miura T, Kotoku M, Yamasaki T, Matsuda I, Aoki K, Yasue K, Imai H, Ubukata M, Suma A, Yokota M, Hotta T, Tanaka M, Hase Y, Haas J, Fryer AM, Laird ER, Littmann NM, Andrews SW, Josey JA, Mimura T, Shinozaki Y, Yoshiuchi H, Inaba T",,743597,DTCT0024091,5926819,DTCC01079529,69502,44276
CHEMBL1767008,P50281,,LSRFXDADRHAGGZ-QPJICYPMSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,21417219,IC50,=,900,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP14 after 60 mins by fluorescence plate reader,,"Discovery of (1S,2R,3R)-2,3-Dimethyl-2-phenyl-1-sulfamidocyclopropanecarboxylates: Novel and Highly Selective Aggrecanase Inhibitors.",J. Med. Chem.,2011,54,8,"Shiozaki M, Maeda K, Miura T, Kotoku M, Yamasaki T, Matsuda I, Aoki K, Yasue K, Imai H, Ubukata M, Suma A, Yokota M, Hotta T, Tanaka M, Hase Y, Haas J, Fryer AM, Laird ER, Littmann NM, Andrews SW, Josey JA, Mimura T, Shinozaki Y, Yoshiuchi H, Inaba T",,743597,DTCT0024091,5926820,DTCC01079530,1201087,44276
CHEMBL1767009,P50281,,WNPVOXQIWJVANA-ZFGLAFRWSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,21417219,IC50,=,4300,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP14 after 60 mins by fluorescence plate reader,,"Discovery of (1S,2R,3R)-2,3-Dimethyl-2-phenyl-1-sulfamidocyclopropanecarboxylates: Novel and Highly Selective Aggrecanase Inhibitors.",J. Med. Chem.,2011,54,8,"Shiozaki M, Maeda K, Miura T, Kotoku M, Yamasaki T, Matsuda I, Aoki K, Yasue K, Imai H, Ubukata M, Suma A, Yokota M, Hotta T, Tanaka M, Hase Y, Haas J, Fryer AM, Laird ER, Littmann NM, Andrews SW, Josey JA, Mimura T, Shinozaki Y, Yoshiuchi H, Inaba T",,743597,DTCT0024091,5926821,DTCC01079531,846547,44276
CHEMBL1767010,P50281,,HKMCNRZPOCVMKL-DYHNYNMBSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,21417219,IC50,=,2100,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP14 after 60 mins by fluorescence plate reader,,"Discovery of (1S,2R,3R)-2,3-Dimethyl-2-phenyl-1-sulfamidocyclopropanecarboxylates: Novel and Highly Selective Aggrecanase Inhibitors.",J. Med. Chem.,2011,54,8,"Shiozaki M, Maeda K, Miura T, Kotoku M, Yamasaki T, Matsuda I, Aoki K, Yasue K, Imai H, Ubukata M, Suma A, Yokota M, Hotta T, Tanaka M, Hase Y, Haas J, Fryer AM, Laird ER, Littmann NM, Andrews SW, Josey JA, Mimura T, Shinozaki Y, Yoshiuchi H, Inaba T",,743597,DTCT0024091,5926822,DTCC01079532,1493444,44276
CHEMBL1767011,P50281,,KIMAXDZENSBFAC-DYHNYNMBSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,21417219,IC50,=,140,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP14 after 60 mins by fluorescence plate reader,,"Discovery of (1S,2R,3R)-2,3-Dimethyl-2-phenyl-1-sulfamidocyclopropanecarboxylates: Novel and Highly Selective Aggrecanase Inhibitors.",J. Med. Chem.,2011,54,8,"Shiozaki M, Maeda K, Miura T, Kotoku M, Yamasaki T, Matsuda I, Aoki K, Yasue K, Imai H, Ubukata M, Suma A, Yokota M, Hotta T, Tanaka M, Hase Y, Haas J, Fryer AM, Laird ER, Littmann NM, Andrews SW, Josey JA, Mimura T, Shinozaki Y, Yoshiuchi H, Inaba T",,743597,DTCT0024091,5926823,DTCC01079533,911624,44276
CHEMBL1767012,P50281,,VFXFWORULVVRDM-YIKPVDIZSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,21417219,IC50,=,98,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP14 after 60 mins by fluorescence plate reader,,"Discovery of (1S,2R,3R)-2,3-Dimethyl-2-phenyl-1-sulfamidocyclopropanecarboxylates: Novel and Highly Selective Aggrecanase Inhibitors.",J. Med. Chem.,2011,54,8,"Shiozaki M, Maeda K, Miura T, Kotoku M, Yamasaki T, Matsuda I, Aoki K, Yasue K, Imai H, Ubukata M, Suma A, Yokota M, Hotta T, Tanaka M, Hase Y, Haas J, Fryer AM, Laird ER, Littmann NM, Andrews SW, Josey JA, Mimura T, Shinozaki Y, Yoshiuchi H, Inaba T",,743597,DTCT0024091,5926824,DTCC01079534,1973317,44276
CHEMBL1767013,P50281,,COXUXHHGASUMFC-KHIBUBOWSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,21417219,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP14 after 60 mins by fluorescence plate reader,,"Discovery of (1S,2R,3R)-2,3-Dimethyl-2-phenyl-1-sulfamidocyclopropanecarboxylates: Novel and Highly Selective Aggrecanase Inhibitors.",J. Med. Chem.,2011,54,8,"Shiozaki M, Maeda K, Miura T, Kotoku M, Yamasaki T, Matsuda I, Aoki K, Yasue K, Imai H, Ubukata M, Suma A, Yokota M, Hotta T, Tanaka M, Hase Y, Haas J, Fryer AM, Laird ER, Littmann NM, Andrews SW, Josey JA, Mimura T, Shinozaki Y, Yoshiuchi H, Inaba T",,743597,DTCT0024091,5926825,DTCC01079535,523434,44276
CHEMBL1767014,P50281,,RDRCRROFSMSFED-KHIBUBOWSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,21417219,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP14 after 60 mins by fluorescence plate reader,,"Discovery of (1S,2R,3R)-2,3-Dimethyl-2-phenyl-1-sulfamidocyclopropanecarboxylates: Novel and Highly Selective Aggrecanase Inhibitors.",J. Med. Chem.,2011,54,8,"Shiozaki M, Maeda K, Miura T, Kotoku M, Yamasaki T, Matsuda I, Aoki K, Yasue K, Imai H, Ubukata M, Suma A, Yokota M, Hotta T, Tanaka M, Hase Y, Haas J, Fryer AM, Laird ER, Littmann NM, Andrews SW, Josey JA, Mimura T, Shinozaki Y, Yoshiuchi H, Inaba T",,743597,DTCT0024091,5926826,DTCC01079536,2005992,44276
CHEMBL1767015,P50281,,LVVFVQDWLWATBO-KHIBUBOWSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,21417219,IC50,=,2100,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP14 after 60 mins by fluorescence plate reader,,"Discovery of (1S,2R,3R)-2,3-Dimethyl-2-phenyl-1-sulfamidocyclopropanecarboxylates: Novel and Highly Selective Aggrecanase Inhibitors.",J. Med. Chem.,2011,54,8,"Shiozaki M, Maeda K, Miura T, Kotoku M, Yamasaki T, Matsuda I, Aoki K, Yasue K, Imai H, Ubukata M, Suma A, Yokota M, Hotta T, Tanaka M, Hase Y, Haas J, Fryer AM, Laird ER, Littmann NM, Andrews SW, Josey JA, Mimura T, Shinozaki Y, Yoshiuchi H, Inaba T",,743597,DTCT0024091,5926827,DTCC01079537,491213,44276
CHEMBL1767016,P50281,,HOFOGNHCTQAGAM-AHWCRGGASA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,21417219,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP14 after 60 mins by fluorescence plate reader,,"Discovery of (1S,2R,3R)-2,3-Dimethyl-2-phenyl-1-sulfamidocyclopropanecarboxylates: Novel and Highly Selective Aggrecanase Inhibitors.",J. Med. Chem.,2011,54,8,"Shiozaki M, Maeda K, Miura T, Kotoku M, Yamasaki T, Matsuda I, Aoki K, Yasue K, Imai H, Ubukata M, Suma A, Yokota M, Hotta T, Tanaka M, Hase Y, Haas J, Fryer AM, Laird ER, Littmann NM, Andrews SW, Josey JA, Mimura T, Shinozaki Y, Yoshiuchi H, Inaba T",,743597,DTCT0024091,5926828,DTCC01079538,1654938,44276
CHEMBL1767017,P50281,,IMBIYJRGLQMLSC-VMHCRYLRSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,21417219,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP14 after 60 mins by fluorescence plate reader,,"Discovery of (1S,2R,3R)-2,3-Dimethyl-2-phenyl-1-sulfamidocyclopropanecarboxylates: Novel and Highly Selective Aggrecanase Inhibitors.",J. Med. Chem.,2011,54,8,"Shiozaki M, Maeda K, Miura T, Kotoku M, Yamasaki T, Matsuda I, Aoki K, Yasue K, Imai H, Ubukata M, Suma A, Yokota M, Hotta T, Tanaka M, Hase Y, Haas J, Fryer AM, Laird ER, Littmann NM, Andrews SW, Josey JA, Mimura T, Shinozaki Y, Yoshiuchi H, Inaba T",,743597,DTCT0024091,5926829,DTCC01079539,101720,44276
CHEMBL176993,P50281,,VMVSKQSBVKMLRK-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,11958997,INHIBITION,=,20,%,,,,,,,,,,,,,,Percent remaining enzyme activity (RA) in catalytic domains of the membrane type MT1-MMP (matrix metalloprotease-14),,Oxal hydroxamic acid derivatives with inhibitory activity against matrix metalloproteinases.,Bioorg. Med. Chem. Lett.,2002,12,6,"Krumme D, Tschesche H",,106778,DTCT0024091,1103417,DTCC00109233,1490104,5419
CHEMBL177048,P50281,,IFKOWFBQQCCFPQ-AWEZNQCLSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,11958997,INHIBITION,=,30,%,,,,,,,,,,,,,,Percent remaining enzyme activity (RA) in catalytic domains of the membrane type MT1-MMP (matrix metalloprotease-14),,Oxal hydroxamic acid derivatives with inhibitory activity against matrix metalloproteinases.,Bioorg. Med. Chem. Lett.,2002,12,6,"Krumme D, Tschesche H",,106778,DTCT0024091,1122331,DTCC00373478,1262886,5419
CHEMBL1770629,P50281,,IIBLNMYMPDUKOQ-HKDUHGGJSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,20638281,KI,=,1100,NM,,,,,,,,,,,,,,Inhibition of MMP14,,Structure and activity relationships of tartrate-based TACE inhibitors.,Bioorg. Med. Chem. Lett.,2010,20,16,"Li D, Popovici-Muller J, Belanger DB, Caldwell J, Dai C, David M, Girijavallabhan VM, Lavey BJ, Lee JF, Liu Z, Mazzola R, Rizvi R, Rosner KE, Shankar B, Spitler J, Ting PC, Vaccaro H, Yu W, Zhou G, Zhu Z, Niu X, Sun J, Guo Z, Orth P, Chen S, Kozlowski JA, Lundell DJ, Madison V, McKittrick B, Piwinski JJ, Shih NY, Shipps GW, Siddiqui MA, Strickland CO",,748393,DTCT0024091,5959021,DTCC01080384,652661,44590
CHEMBL1770629,P50281,,IIBLNMYMPDUKOQ-HKDUHGGJSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,21458257,KI,=,1148,NM,,,,,,,,,,,,,,Inhibition of MMP14,,"2-(2-Aminothiazol-4-yl)pyrrolidine-based tartrate diamides as potent, selective and orally bioavailable TACE inhibitors.",Bioorg. Med. Chem. Lett.,2011,21,10,"Dai C, Li D, Popovici-Muller J, Zhao L, Girijavallabhan VM, Rosner KE, Lavey BJ, Rizvi R, Shankar BB, Wong MK, Guo Z, Orth P, Strickland CO, Sun J, Niu X, Chen S, Kozlowski JA, Lundell DJ, Piwinski JJ, Shih NY, Siddiqui MA",,744289,DTCT0024091,5930526,DTCC01080384,652615,44403
CHEMBL1770649,P50281,,PRUCBZGVKSTGBL-FPHUIIFBSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,21458257,KI,>,40000,NM,,,,,,,,,,,,,,Inhibition of MMP14,,"2-(2-Aminothiazol-4-yl)pyrrolidine-based tartrate diamides as potent, selective and orally bioavailable TACE inhibitors.",Bioorg. Med. Chem. Lett.,2011,21,10,"Dai C, Li D, Popovici-Muller J, Zhao L, Girijavallabhan VM, Rosner KE, Lavey BJ, Rizvi R, Shankar BB, Wong MK, Guo Z, Orth P, Strickland CO, Sun J, Niu X, Chen S, Kozlowski JA, Lundell DJ, Piwinski JJ, Shih NY, Siddiqui MA",,744289,DTCT0024091,5930527,DTCC01080402,1266399,44403
CHEMBL1770700,P50281,,MASDJPGVHCTFLM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,21507637,KI,>,10000,NM,,,,,,,,,,,,,,Inhibition of human MMP-14,,MMP-13 selective a-sulfone hydroxamates: A survey of P1' heterocyclic amide isosteres.,Bioorg. Med. Chem. Lett.,2011,21,10,"Barta TE, Becker DP, Bedell LJ, Easton AM, Hockerman SL, Kiefer J, Munie GE, Mathis KJ, Li MH, Rico JG, Villamil CI, Williams JM",,744956,DTCT0024091,5930605,DTCC01080452,1040141,44430
CHEMBL1770826,P50281,,LOTUNSOIIWVNBG-JUJUEEDWSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,21458257,KI,=,16400,NM,,,,,,,,,,,,,,Inhibition of MMP14,,"2-(2-Aminothiazol-4-yl)pyrrolidine-based tartrate diamides as potent, selective and orally bioavailable TACE inhibitors.",Bioorg. Med. Chem. Lett.,2011,21,10,"Dai C, Li D, Popovici-Muller J, Zhao L, Girijavallabhan VM, Rosner KE, Lavey BJ, Rizvi R, Shankar BB, Wong MK, Guo Z, Orth P, Strickland CO, Sun J, Niu X, Chen S, Kozlowski JA, Lundell DJ, Piwinski JJ, Shih NY, Siddiqui MA",,744289,DTCT0024091,5930528,DTCC01080561,749314,44403
CHEMBL1771212,P50281,SD-2590,NXUHVWMBPOFLMA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,20726512,IC50,=,13,NM,,,,,,,,,,,,,,Inhibition of human MMP14 assessed as cleavage of fluorogenic peptide MCAPro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 by fluorometric assay,,"Orally active MMP-1 sparing a-tetrahydropyranyl and a-piperidinyl sulfone matrix metalloproteinase (MMP) inhibitors with efficacy in cancer, arthritis, and cardiovascular disease.",J. Med. Chem.,2010,53,18,"Becker DP, Barta TE, Bedell LJ, Boehm TL, Bond BR, Carroll J, Carron CP, Decrescenzo GA, Easton AM, Freskos JN, Funckes-Shippy CL, Heron M, Hockerman S, Howard CP, Kiefer JR, Li MH, Mathis KJ, McDonald JJ, Mehta PP, Munie GE, Sunyer T, Swearingen CA, Villamil CI, Welsch D, Williams JM, Yu Y, Yao J",,754465,DTCT0024091,6005747,DTCC00033985,1557982,45214
CHEMBL1771212,P50281,SD-2590,NXUHVWMBPOFLMA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,21507637,KI,=,14,NM,,,,,,,,,,,,,,Inhibition of human MMP-14,,MMP-13 selective a-sulfone hydroxamates: A survey of P1' heterocyclic amide isosteres.,Bioorg. Med. Chem. Lett.,2011,21,10,"Barta TE, Becker DP, Bedell LJ, Easton AM, Hockerman SL, Kiefer J, Munie GE, Mathis KJ, Li MH, Rico JG, Villamil CI, Williams JM",,744956,DTCT0024091,5930603,DTCC00033985,1557806,44430
CHEMBL1771213,P50281,,QCRPOQONCVCBFI-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,21507637,KI,>,10000,NM,,,,,,,,,,,,,,Inhibition of human MMP-14,,MMP-13 selective a-sulfone hydroxamates: A survey of P1' heterocyclic amide isosteres.,Bioorg. Med. Chem. Lett.,2011,21,10,"Barta TE, Becker DP, Bedell LJ, Easton AM, Hockerman SL, Kiefer J, Munie GE, Mathis KJ, Li MH, Rico JG, Villamil CI, Williams JM",,744956,DTCT0024091,5930604,DTCC01080938,1040140,44430
CHEMBL1771214,P50281,,UIGGXLFLAQCMAY-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,21507637,KI,>,10000,NM,,,,,,,,,,,,,,Inhibition of human MMP-14,,MMP-13 selective a-sulfone hydroxamates: A survey of P1' heterocyclic amide isosteres.,Bioorg. Med. Chem. Lett.,2011,21,10,"Barta TE, Becker DP, Bedell LJ, Easton AM, Hockerman SL, Kiefer J, Munie GE, Mathis KJ, Li MH, Rico JG, Villamil CI, Williams JM",,744956,DTCT0024091,5930606,DTCC01080939,134084,44430
CHEMBL1771215,P50281,,BNPWNBBKUMLEJM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,21507637,KI,>,10000,NM,,,,,,,,,,,,,,Inhibition of human MMP-14,,MMP-13 selective a-sulfone hydroxamates: A survey of P1' heterocyclic amide isosteres.,Bioorg. Med. Chem. Lett.,2011,21,10,"Barta TE, Becker DP, Bedell LJ, Easton AM, Hockerman SL, Kiefer J, Munie GE, Mathis KJ, Li MH, Rico JG, Villamil CI, Williams JM",,744956,DTCT0024091,5930607,DTCC01080940,361645,44430
CHEMBL1771216,P50281,,MTRATHZFTCSGDT-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,21507637,KI,>,10000,NM,,,,,,,,,,,,,,Inhibition of human MMP-14,,MMP-13 selective a-sulfone hydroxamates: A survey of P1' heterocyclic amide isosteres.,Bioorg. Med. Chem. Lett.,2011,21,10,"Barta TE, Becker DP, Bedell LJ, Easton AM, Hockerman SL, Kiefer J, Munie GE, Mathis KJ, Li MH, Rico JG, Villamil CI, Williams JM",,744956,DTCT0024091,5930608,DTCC01080941,1233526,44430
CHEMBL1771217,P50281,,MMCUCOOPEAHRPL-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,21507637,KI,>,10000,NM,,,,,,,,,,,,,,Inhibition of human MMP-14,,MMP-13 selective a-sulfone hydroxamates: A survey of P1' heterocyclic amide isosteres.,Bioorg. Med. Chem. Lett.,2011,21,10,"Barta TE, Becker DP, Bedell LJ, Easton AM, Hockerman SL, Kiefer J, Munie GE, Mathis KJ, Li MH, Rico JG, Villamil CI, Williams JM",,744956,DTCT0024091,5930609,DTCC01080942,1040142,44430
CHEMBL1771218,P50281,,LIQFLIXIOKMDTJ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,21507637,KI,>,10000,NM,,,,,,,,,,,,,,Inhibition of human MMP-14,,MMP-13 selective a-sulfone hydroxamates: A survey of P1' heterocyclic amide isosteres.,Bioorg. Med. Chem. Lett.,2011,21,10,"Barta TE, Becker DP, Bedell LJ, Easton AM, Hockerman SL, Kiefer J, Munie GE, Mathis KJ, Li MH, Rico JG, Villamil CI, Williams JM",,744956,DTCT0024091,5930610,DTCC01080943,1908020,44430
CHEMBL1771219,P50281,,VCIBNYPUVKINDS-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,21507637,KI,>,10000,NM,,,,,,,,,,,,,,Inhibition of human MMP-14,,MMP-13 selective a-sulfone hydroxamates: A survey of P1' heterocyclic amide isosteres.,Bioorg. Med. Chem. Lett.,2011,21,10,"Barta TE, Becker DP, Bedell LJ, Easton AM, Hockerman SL, Kiefer J, Munie GE, Mathis KJ, Li MH, Rico JG, Villamil CI, Williams JM",,744956,DTCT0024091,5930611,DTCC01080944,975250,44430
CHEMBL1771220,P50281,,NVQGQIYFJRAZLX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,21507637,KI,>,10000,NM,,,,,,,,,,,,,,Inhibition of human MMP-14,,MMP-13 selective a-sulfone hydroxamates: A survey of P1' heterocyclic amide isosteres.,Bioorg. Med. Chem. Lett.,2011,21,10,"Barta TE, Becker DP, Bedell LJ, Easton AM, Hockerman SL, Kiefer J, Munie GE, Mathis KJ, Li MH, Rico JG, Villamil CI, Williams JM",,744956,DTCT0024091,5930612,DTCC01080945,1590129,44430
CHEMBL1771221,P50281,,JRPLACGAMSWTCU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,21507637,KI,>,10000,NM,,,,,,,,,,,,,,Inhibition of human MMP-14,,MMP-13 selective a-sulfone hydroxamates: A survey of P1' heterocyclic amide isosteres.,Bioorg. Med. Chem. Lett.,2011,21,10,"Barta TE, Becker DP, Bedell LJ, Easton AM, Hockerman SL, Kiefer J, Munie GE, Mathis KJ, Li MH, Rico JG, Villamil CI, Williams JM",,744956,DTCT0024091,5930613,DTCC01080946,230822,44430
CHEMBL1771222,P50281,,FVPQYGSYGOKFLW-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,21507637,KI,>,10000,NM,,,,,,,,,,,,,,Inhibition of human MMP-14,,MMP-13 selective a-sulfone hydroxamates: A survey of P1' heterocyclic amide isosteres.,Bioorg. Med. Chem. Lett.,2011,21,10,"Barta TE, Becker DP, Bedell LJ, Easton AM, Hockerman SL, Kiefer J, Munie GE, Mathis KJ, Li MH, Rico JG, Villamil CI, Williams JM",,744956,DTCT0024091,5930614,DTCC01080947,1105335,44430
CHEMBL1771223,P50281,,UAFRGDNTZQMZFA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,21507637,KI,>,10000,NM,,,,,,,,,,,,,,Inhibition of human MMP-14,,MMP-13 selective a-sulfone hydroxamates: A survey of P1' heterocyclic amide isosteres.,Bioorg. Med. Chem. Lett.,2011,21,10,"Barta TE, Becker DP, Bedell LJ, Easton AM, Hockerman SL, Kiefer J, Munie GE, Mathis KJ, Li MH, Rico JG, Villamil CI, Williams JM",,744956,DTCT0024091,5930615,DTCC01080948,587727,44430
CHEMBL1779630,P50281,,BXLWVAKSQMYQKF-HRUVVLKGSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,20638281,KI,=,120,NM,,,,,,,,,,,,,,Inhibition of MMP14,,Structure and activity relationships of tartrate-based TACE inhibitors.,Bioorg. Med. Chem. Lett.,2010,20,16,"Li D, Popovici-Muller J, Belanger DB, Caldwell J, Dai C, David M, Girijavallabhan VM, Lavey BJ, Lee JF, Liu Z, Mazzola R, Rizvi R, Rosner KE, Shankar B, Spitler J, Ting PC, Vaccaro H, Yu W, Zhou G, Zhu Z, Niu X, Sun J, Guo Z, Orth P, Chen S, Kozlowski JA, Lundell DJ, Madison V, McKittrick B, Piwinski JJ, Shih NY, Shipps GW, Siddiqui MA, Strickland CO",,748393,DTCT0024091,5959058,DTCC01085211,1875737,44590
CHEMBL1784338,P50281,,FUEVUWZQRYWTIH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,21536437,IC50,>,100000,NM,,,,,,,,,,,,,,Inhibition of recombinant human MMP-14 assessed as substrate cleavage after 20 hrs by fluorescence assay,,Orally active achiral N-hydroxyformamide inhibitors of ADAM-TS4 (aggrecanase-1) and ADAM-TS5 (aggrecanase-2) for the treatment of osteoarthritis.,Bioorg. Med. Chem. Lett.,2011,21,11,"De Savi C, Pape A, Sawyer Y, Milne D, Davies C, Cumming JG, Ting A, Lamont S, Smith PD, Tart J, Page K, Moore P",,751103,DTCT0024091,5969341,DTCC01087874,1991668,44768
CHEMBL1784339,P50281,,NYSZVCQWENKRKM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,21536437,IC50,=,3100,NM,,,,,,,,,,,,,,Inhibition of recombinant human MMP-14 assessed as substrate cleavage after 20 hrs by fluorescence assay,,Orally active achiral N-hydroxyformamide inhibitors of ADAM-TS4 (aggrecanase-1) and ADAM-TS5 (aggrecanase-2) for the treatment of osteoarthritis.,Bioorg. Med. Chem. Lett.,2011,21,11,"De Savi C, Pape A, Sawyer Y, Milne D, Davies C, Cumming JG, Ting A, Lamont S, Smith PD, Tart J, Page K, Moore P",,751103,DTCT0024091,5969342,DTCC01087875,1219147,44768
CHEMBL1784340,P50281,,ISHINUUQDKDNHQ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,21536437,IC50,>,23000,NM,,,,,,,,,,,,,,Inhibition of recombinant human MMP-14 assessed as substrate cleavage after 20 hrs by fluorescence assay,,Orally active achiral N-hydroxyformamide inhibitors of ADAM-TS4 (aggrecanase-1) and ADAM-TS5 (aggrecanase-2) for the treatment of osteoarthritis.,Bioorg. Med. Chem. Lett.,2011,21,11,"De Savi C, Pape A, Sawyer Y, Milne D, Davies C, Cumming JG, Ting A, Lamont S, Smith PD, Tart J, Page K, Moore P",,751103,DTCT0024091,5969343,DTCC01087876,314584,44768
CHEMBL1784341,P50281,,DDRRRYMVRWYNKI-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,21536437,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibition of recombinant human MMP-14 assessed as substrate cleavage after 20 hrs by fluorescence assay,,Orally active achiral N-hydroxyformamide inhibitors of ADAM-TS4 (aggrecanase-1) and ADAM-TS5 (aggrecanase-2) for the treatment of osteoarthritis.,Bioorg. Med. Chem. Lett.,2011,21,11,"De Savi C, Pape A, Sawyer Y, Milne D, Davies C, Cumming JG, Ting A, Lamont S, Smith PD, Tart J, Page K, Moore P",,751103,DTCT0024091,5970336,DTCC01087877,248843,44768
CHEMBL1784342,P50281,,OGDMRINQXHOSNB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,21536437,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibition of recombinant human MMP-14 assessed as substrate cleavage after 20 hrs by fluorescence assay,,Orally active achiral N-hydroxyformamide inhibitors of ADAM-TS4 (aggrecanase-1) and ADAM-TS5 (aggrecanase-2) for the treatment of osteoarthritis.,Bioorg. Med. Chem. Lett.,2011,21,11,"De Savi C, Pape A, Sawyer Y, Milne D, Davies C, Cumming JG, Ting A, Lamont S, Smith PD, Tart J, Page K, Moore P",,751103,DTCT0024091,5970337,DTCC01087878,1991670,44768
CHEMBL1784343,P50281,,XRFARLVFDBABAU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,21536437,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibition of recombinant human MMP-14 assessed as substrate cleavage after 20 hrs by fluorescence assay,,Orally active achiral N-hydroxyformamide inhibitors of ADAM-TS4 (aggrecanase-1) and ADAM-TS5 (aggrecanase-2) for the treatment of osteoarthritis.,Bioorg. Med. Chem. Lett.,2011,21,11,"De Savi C, Pape A, Sawyer Y, Milne D, Davies C, Cumming JG, Ting A, Lamont S, Smith PD, Tart J, Page K, Moore P",,751103,DTCT0024091,5970338,DTCC01087879,767362,44768
CHEMBL1784344,P50281,,DTSDNCVLJXFMRH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,21536437,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibition of recombinant human MMP-14 assessed as substrate cleavage after 20 hrs by fluorescence assay,,Orally active achiral N-hydroxyformamide inhibitors of ADAM-TS4 (aggrecanase-1) and ADAM-TS5 (aggrecanase-2) for the treatment of osteoarthritis.,Bioorg. Med. Chem. Lett.,2011,21,11,"De Savi C, Pape A, Sawyer Y, Milne D, Davies C, Cumming JG, Ting A, Lamont S, Smith PD, Tart J, Page K, Moore P",,751103,DTCT0024091,5970339,DTCC01087880,1732985,44768
CHEMBL1784345,P50281,,IIJIMCYNCLMHHL-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,21536437,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibition of recombinant human MMP-14 assessed as substrate cleavage after 20 hrs by fluorescence assay,,Orally active achiral N-hydroxyformamide inhibitors of ADAM-TS4 (aggrecanase-1) and ADAM-TS5 (aggrecanase-2) for the treatment of osteoarthritis.,Bioorg. Med. Chem. Lett.,2011,21,11,"De Savi C, Pape A, Sawyer Y, Milne D, Davies C, Cumming JG, Ting A, Lamont S, Smith PD, Tart J, Page K, Moore P",,751103,DTCT0024091,5970340,DTCC01087881,184445,44768
CHEMBL1784346,P50281,,OUTUIYKUSHWASL-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,21536437,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibition of recombinant human MMP-14 assessed as substrate cleavage after 20 hrs by fluorescence assay,,Orally active achiral N-hydroxyformamide inhibitors of ADAM-TS4 (aggrecanase-1) and ADAM-TS5 (aggrecanase-2) for the treatment of osteoarthritis.,Bioorg. Med. Chem. Lett.,2011,21,11,"De Savi C, Pape A, Sawyer Y, Milne D, Davies C, Cumming JG, Ting A, Lamont S, Smith PD, Tart J, Page K, Moore P",,751103,DTCT0024091,5970341,DTCC01087882,1252217,44768
CHEMBL1784347,P50281,,IWRJDNKXMJBFEA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,21536437,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibition of recombinant human MMP-14 assessed as substrate cleavage after 20 hrs by fluorescence assay,,Orally active achiral N-hydroxyformamide inhibitors of ADAM-TS4 (aggrecanase-1) and ADAM-TS5 (aggrecanase-2) for the treatment of osteoarthritis.,Bioorg. Med. Chem. Lett.,2011,21,11,"De Savi C, Pape A, Sawyer Y, Milne D, Davies C, Cumming JG, Ting A, Lamont S, Smith PD, Tart J, Page K, Moore P",,751103,DTCT0024091,5970342,DTCC01087883,897249,44768
CHEMBL1784348,P50281,,JHWOJEJVRYYQFM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,21536437,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibition of recombinant human MMP-14 assessed as substrate cleavage after 20 hrs by fluorescence assay,,Orally active achiral N-hydroxyformamide inhibitors of ADAM-TS4 (aggrecanase-1) and ADAM-TS5 (aggrecanase-2) for the treatment of osteoarthritis.,Bioorg. Med. Chem. Lett.,2011,21,11,"De Savi C, Pape A, Sawyer Y, Milne D, Davies C, Cumming JG, Ting A, Lamont S, Smith PD, Tart J, Page K, Moore P",,751103,DTCT0024091,5970343,DTCC01087884,541502,44768
CHEMBL1784349,P50281,,CCTJPVSDIZDFJW-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,21536437,IC50,=,8000,NM,,,,,,,,,,,,,,Inhibition of recombinant human MMP-14 assessed as substrate cleavage after 20 hrs by fluorescence assay,,Orally active achiral N-hydroxyformamide inhibitors of ADAM-TS4 (aggrecanase-1) and ADAM-TS5 (aggrecanase-2) for the treatment of osteoarthritis.,Bioorg. Med. Chem. Lett.,2011,21,11,"De Savi C, Pape A, Sawyer Y, Milne D, Davies C, Cumming JG, Ting A, Lamont S, Smith PD, Tart J, Page K, Moore P",,751103,DTCT0024091,5969337,DTCC01087885,1284804,44768
CHEMBL1784350,P50281,,PSAIRTKPKUWNNP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,21536437,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibition of recombinant human MMP-14 assessed as substrate cleavage after 20 hrs by fluorescence assay,,Orally active achiral N-hydroxyformamide inhibitors of ADAM-TS4 (aggrecanase-1) and ADAM-TS5 (aggrecanase-2) for the treatment of osteoarthritis.,Bioorg. Med. Chem. Lett.,2011,21,11,"De Savi C, Pape A, Sawyer Y, Milne D, Davies C, Cumming JG, Ting A, Lamont S, Smith PD, Tart J, Page K, Moore P",,751103,DTCT0024091,5970344,DTCC01087886,1284805,44768
CHEMBL1784351,P50281,,IHEWXNWFNBGUFE-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,21536437,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibition of recombinant human MMP-14 assessed as substrate cleavage after 20 hrs by fluorescence assay,,Orally active achiral N-hydroxyformamide inhibitors of ADAM-TS4 (aggrecanase-1) and ADAM-TS5 (aggrecanase-2) for the treatment of osteoarthritis.,Bioorg. Med. Chem. Lett.,2011,21,11,"De Savi C, Pape A, Sawyer Y, Milne D, Davies C, Cumming JG, Ting A, Lamont S, Smith PD, Tart J, Page K, Moore P",,751103,DTCT0024091,5970345,DTCC01087887,1350068,44768
CHEMBL1784352,P50281,,YIKZSHOVCXXIBY-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,21536437,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibition of recombinant human MMP-14 assessed as substrate cleavage after 20 hrs by fluorescence assay,,Orally active achiral N-hydroxyformamide inhibitors of ADAM-TS4 (aggrecanase-1) and ADAM-TS5 (aggrecanase-2) for the treatment of osteoarthritis.,Bioorg. Med. Chem. Lett.,2011,21,11,"De Savi C, Pape A, Sawyer Y, Milne D, Davies C, Cumming JG, Ting A, Lamont S, Smith PD, Tart J, Page K, Moore P",,751103,DTCT0024091,5970346,DTCC01087888,1704803,44768
CHEMBL1784353,P50281,,CAFLLFZUWQCIHM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,21536437,IC50,>,7500,NM,,,,,,,,,,,,,,Inhibition of recombinant human MMP-14 assessed as substrate cleavage after 20 hrs by fluorescence assay,,Orally active achiral N-hydroxyformamide inhibitors of ADAM-TS4 (aggrecanase-1) and ADAM-TS5 (aggrecanase-2) for the treatment of osteoarthritis.,Bioorg. Med. Chem. Lett.,2011,21,11,"De Savi C, Pape A, Sawyer Y, Milne D, Davies C, Cumming JG, Ting A, Lamont S, Smith PD, Tart J, Page K, Moore P",,751103,DTCT0024091,5970347,DTCC01087889,735158,44768
CHEMBL1784354,P50281,,JKTGELXOMXEKJI-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,21536437,IC50,=,1400,NM,,,,,,,,,,,,,,Inhibition of recombinant human MMP-14 assessed as substrate cleavage after 20 hrs by fluorescence assay,,Orally active achiral N-hydroxyformamide inhibitors of ADAM-TS4 (aggrecanase-1) and ADAM-TS5 (aggrecanase-2) for the treatment of osteoarthritis.,Bioorg. Med. Chem. Lett.,2011,21,11,"De Savi C, Pape A, Sawyer Y, Milne D, Davies C, Cumming JG, Ting A, Lamont S, Smith PD, Tart J, Page K, Moore P",,751103,DTCT0024091,5970414,DTCC01087890,1058279,44768
CHEMBL1784355,P50281,,OGLLJVIOQHNPQC-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,21536437,IC50,,,,,,,,,,,,,,,,,Inhibition of recombinant human MMP-14 assessed as substrate cleavage after 20 hrs by fluorescence assay,Not Determined,Orally active achiral N-hydroxyformamide inhibitors of ADAM-TS4 (aggrecanase-1) and ADAM-TS5 (aggrecanase-2) for the treatment of osteoarthritis.,Bioorg. Med. Chem. Lett.,2011,21,11,"De Savi C, Pape A, Sawyer Y, Milne D, Davies C, Cumming JG, Ting A, Lamont S, Smith PD, Tart J, Page K, Moore P",,751103,DTCT0024091,5970418,DTCC01087891,1284806,44768
CHEMBL1784356,P50281,,HECFJRXDSZZJLW-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,21536437,IC50,=,2900,NM,,,,,,,,,,,,,,Inhibition of recombinant human MMP-14 assessed as substrate cleavage after 20 hrs by fluorescence assay,,Orally active achiral N-hydroxyformamide inhibitors of ADAM-TS4 (aggrecanase-1) and ADAM-TS5 (aggrecanase-2) for the treatment of osteoarthritis.,Bioorg. Med. Chem. Lett.,2011,21,11,"De Savi C, Pape A, Sawyer Y, Milne D, Davies C, Cumming JG, Ting A, Lamont S, Smith PD, Tart J, Page K, Moore P",,751103,DTCT0024091,5970423,DTCC01087892,443570,44768
CHEMBL1784357,P50281,,XAXGZPUPBCYAIE-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,21536437,IC50,,,,,,,,,,,,,,,,,Inhibition of recombinant human MMP-14 assessed as substrate cleavage after 20 hrs by fluorescence assay,Not Determined,Orally active achiral N-hydroxyformamide inhibitors of ADAM-TS4 (aggrecanase-1) and ADAM-TS5 (aggrecanase-2) for the treatment of osteoarthritis.,Bioorg. Med. Chem. Lett.,2011,21,11,"De Savi C, Pape A, Sawyer Y, Milne D, Davies C, Cumming JG, Ting A, Lamont S, Smith PD, Tart J, Page K, Moore P",,751103,DTCT0024091,5970427,DTCC01087893,1575892,44768
CHEMBL1784358,P50281,,VLNVWKDSFQRXHZ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,21536437,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibition of recombinant human MMP-14 assessed as substrate cleavage after 20 hrs by fluorescence assay,,Orally active achiral N-hydroxyformamide inhibitors of ADAM-TS4 (aggrecanase-1) and ADAM-TS5 (aggrecanase-2) for the treatment of osteoarthritis.,Bioorg. Med. Chem. Lett.,2011,21,11,"De Savi C, Pape A, Sawyer Y, Milne D, Davies C, Cumming JG, Ting A, Lamont S, Smith PD, Tart J, Page K, Moore P",,751103,DTCT0024091,5969330,DTCC01087894,1543800,44768
CHEMBL1784359,P50281,,BZUGNOPIQMYMFU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,21536437,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibition of recombinant human MMP-14 assessed as substrate cleavage after 20 hrs by fluorescence assay,,Orally active achiral N-hydroxyformamide inhibitors of ADAM-TS4 (aggrecanase-1) and ADAM-TS5 (aggrecanase-2) for the treatment of osteoarthritis.,Bioorg. Med. Chem. Lett.,2011,21,11,"De Savi C, Pape A, Sawyer Y, Milne D, Davies C, Cumming JG, Ting A, Lamont S, Smith PD, Tart J, Page K, Moore P",,751103,DTCT0024091,5969331,DTCC01087895,184446,44768
CHEMBL1784360,P50281,,VYEJHVQIVKCLHC-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,21536437,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibition of recombinant human MMP-14 assessed as substrate cleavage after 20 hrs by fluorescence assay,,Orally active achiral N-hydroxyformamide inhibitors of ADAM-TS4 (aggrecanase-1) and ADAM-TS5 (aggrecanase-2) for the treatment of osteoarthritis.,Bioorg. Med. Chem. Lett.,2011,21,11,"De Savi C, Pape A, Sawyer Y, Milne D, Davies C, Cumming JG, Ting A, Lamont S, Smith PD, Tart J, Page K, Moore P",,751103,DTCT0024091,5969332,DTCC01087896,509332,44768
CHEMBL1784361,P50281,,STVUCRKRBAWCPC-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,21536437,IC50,>,7200,NM,,,,,,,,,,,,,,Inhibition of recombinant human MMP-14 assessed as substrate cleavage after 20 hrs by fluorescence assay,,Orally active achiral N-hydroxyformamide inhibitors of ADAM-TS4 (aggrecanase-1) and ADAM-TS5 (aggrecanase-2) for the treatment of osteoarthritis.,Bioorg. Med. Chem. Lett.,2011,21,11,"De Savi C, Pape A, Sawyer Y, Milne D, Davies C, Cumming JG, Ting A, Lamont S, Smith PD, Tart J, Page K, Moore P",,751103,DTCT0024091,5969333,DTCC01087897,1186951,44768
CHEMBL1784362,P50281,,AWLKOGZBGNQOBA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,21536437,IC50,=,1200,NM,,,,,,,,,,,,,,Inhibition of recombinant human MMP-14 assessed as substrate cleavage after 20 hrs by fluorescence assay,,Orally active achiral N-hydroxyformamide inhibitors of ADAM-TS4 (aggrecanase-1) and ADAM-TS5 (aggrecanase-2) for the treatment of osteoarthritis.,Bioorg. Med. Chem. Lett.,2011,21,11,"De Savi C, Pape A, Sawyer Y, Milne D, Davies C, Cumming JG, Ting A, Lamont S, Smith PD, Tart J, Page K, Moore P",,751103,DTCT0024091,5969334,DTCC01087898,1025922,44768
CHEMBL1784363,P50281,,DVWZDEQXQWWQOU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,21536437,IC50,>,770,NM,,,,,,,,,,,,,,Inhibition of recombinant human MMP-14 assessed as substrate cleavage after 20 hrs by fluorescence assay,,Orally active achiral N-hydroxyformamide inhibitors of ADAM-TS4 (aggrecanase-1) and ADAM-TS5 (aggrecanase-2) for the treatment of osteoarthritis.,Bioorg. Med. Chem. Lett.,2011,21,11,"De Savi C, Pape A, Sawyer Y, Milne D, Davies C, Cumming JG, Ting A, Lamont S, Smith PD, Tart J, Page K, Moore P",,751103,DTCT0024091,5969335,DTCC01087899,184447,44768
CHEMBL1784364,P50281,,IBSGSCYXBWXQDW-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,21536437,IC50,=,2900,NM,,,,,,,,,,,,,,Inhibition of recombinant human MMP-14 assessed as substrate cleavage after 20 hrs by fluorescence assay,,Orally active achiral N-hydroxyformamide inhibitors of ADAM-TS4 (aggrecanase-1) and ADAM-TS5 (aggrecanase-2) for the treatment of osteoarthritis.,Bioorg. Med. Chem. Lett.,2011,21,11,"De Savi C, Pape A, Sawyer Y, Milne D, Davies C, Cumming JG, Ting A, Lamont S, Smith PD, Tart J, Page K, Moore P",,751103,DTCT0024091,5969336,DTCC01087900,2024514,44768
CHEMBL1784365,P50281,,OFQBKLDPHHFEPJ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,21536437,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibition of recombinant human MMP-14 assessed as substrate cleavage after 20 hrs by fluorescence assay,,Orally active achiral N-hydroxyformamide inhibitors of ADAM-TS4 (aggrecanase-1) and ADAM-TS5 (aggrecanase-2) for the treatment of osteoarthritis.,Bioorg. Med. Chem. Lett.,2011,21,11,"De Savi C, Pape A, Sawyer Y, Milne D, Davies C, Cumming JG, Ting A, Lamont S, Smith PD, Tart J, Page K, Moore P",,751103,DTCT0024091,5969338,DTCC01087901,1861581,44768
CHEMBL1784366,P50281,,BTKROMQYNIJXLC-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,21536437,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibition of recombinant human MMP-14 assessed as substrate cleavage after 20 hrs by fluorescence assay,,Orally active achiral N-hydroxyformamide inhibitors of ADAM-TS4 (aggrecanase-1) and ADAM-TS5 (aggrecanase-2) for the treatment of osteoarthritis.,Bioorg. Med. Chem. Lett.,2011,21,11,"De Savi C, Pape A, Sawyer Y, Milne D, Davies C, Cumming JG, Ting A, Lamont S, Smith PD, Tart J, Page K, Moore P",,751103,DTCT0024091,5969339,DTCC01087902,1317331,44768
CHEMBL1784367,P50281,,QVHFARCMIMVLSZ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,21536437,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibition of recombinant human MMP-14 assessed as substrate cleavage after 20 hrs by fluorescence assay,,Orally active achiral N-hydroxyformamide inhibitors of ADAM-TS4 (aggrecanase-1) and ADAM-TS5 (aggrecanase-2) for the treatment of osteoarthritis.,Bioorg. Med. Chem. Lett.,2011,21,11,"De Savi C, Pape A, Sawyer Y, Milne D, Davies C, Cumming JG, Ting A, Lamont S, Smith PD, Tart J, Page K, Moore P",,751103,DTCT0024091,5969340,DTCC01087903,1446758,44768
CHEMBL1784368,P50281,,MESQXIKYNYUZRV-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,21536437,IC50,=,226,NM,,,,,,,,,,,,,,Inhibition of recombinant human MMP-14 assessed as substrate cleavage after 20 hrs by fluorescence assay,,Orally active achiral N-hydroxyformamide inhibitors of ADAM-TS4 (aggrecanase-1) and ADAM-TS5 (aggrecanase-2) for the treatment of osteoarthritis.,Bioorg. Med. Chem. Lett.,2011,21,11,"De Savi C, Pape A, Sawyer Y, Milne D, Davies C, Cumming JG, Ting A, Lamont S, Smith PD, Tart J, Page K, Moore P",,751103,DTCT0024091,5970409,DTCC01087904,928980,44768
CHEMBL179288,P50281,,DGZZVIWCMGVHGV-LJQANCHMSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,15713379,IC50,=,9.8,NM,,,,,,,,,,,,,,Inhibition of human matrix metalloprotease-14,,N-i-Propoxy-N-biphenylsulfonylaminobutylhydroxamic acids as potent and selective inhibitors of MMP-2 and MT1-MMP.,Bioorg. Med. Chem. Lett.,2005,15,5,"Rossello A, Nuti E, Carelli P, Orlandini E, Macchia M, Nencetti S, Zandomeneghi M, Balzano F, Uccello Barretta G, Albini A, Benelli R, Cercignani G, Murphy G, Balsamo A",,305766,DTCT0024091,1747877,DTCC00381940,1069270,18841
CHEMBL179288,P50281,,DGZZVIWCMGVHGV-LJQANCHMSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,19775099,IC50,=,9.8,NM,,,,,,,,,,,,,,Inhibition of human recombinant pro-MMP14 catalytic domain after 4 hrs by fluorimetry,,"Design, synthesis, biological evaluation, and NMR studies of a new series of arylsulfones as selective and potent matrix metalloproteinase-12 inhibitors.",J. Med. Chem.,2009,52,20,"Nuti E, Panelli L, Casalini F, Avramova SI, Orlandini E, Santamaria S, Nencetti S, Tuccinardi T, Martinelli A, Cercignani G, D'Amelio N, Maiocchi A, Uggeri F, Rossello A",,591605,DTCT0024091,3044919,DTCC00381940,1071500,35647
CHEMBL1795351,P50281,,YZKJTNXYLZWHHJ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,21514700,IC50,=,700,NM,,,,,,,,,,,,,,Inhibition of human MMP14 by fluorometric assay,,Synthesis and biological evaluation in U87MG glioma cells of (ethynylthiophene)sulfonamido-based hydroxamates as matrix metalloproteinase inhibitors.,Eur. J. Med. Chem.,2011,46,7,"Nuti E, Casalini F, Santamaria S, Gabelloni P, Bendinelli S, Da Pozzo E, Costa B, Marinelli L, La Pietra V, Novellino E, Margarida Bernardo M, Fridman R, Da Settimo F, Martini C, Rossello A",,753771,DTCT0024091,6000212,DTCC01091696,1893893,44948
CHEMBL1795857,P50281,,VZNWQFCLBMVARX-SSEXGKCCSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,21514700,IC50,=,2100,NM,,,,,,,,,,,,,,Inhibition of human MMP14 by fluorometric assay,,Synthesis and biological evaluation in U87MG glioma cells of (ethynylthiophene)sulfonamido-based hydroxamates as matrix metalloproteinase inhibitors.,Eur. J. Med. Chem.,2011,46,7,"Nuti E, Casalini F, Santamaria S, Gabelloni P, Bendinelli S, Da Pozzo E, Costa B, Marinelli L, La Pietra V, Novellino E, Margarida Bernardo M, Fridman R, Da Settimo F, Martini C, Rossello A",,753771,DTCT0024091,6000219,DTCC01091697,1673074,44948
CHEMBL1795858,P50281,,ABUCHUKPMIVSQV-GDLZYMKVSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,21514700,IC50,=,6600,NM,,,,,,,,,,,,,,Inhibition of human MMP14 by fluorometric assay,,Synthesis and biological evaluation in U87MG glioma cells of (ethynylthiophene)sulfonamido-based hydroxamates as matrix metalloproteinase inhibitors.,Eur. J. Med. Chem.,2011,46,7,"Nuti E, Casalini F, Santamaria S, Gabelloni P, Bendinelli S, Da Pozzo E, Costa B, Marinelli L, La Pietra V, Novellino E, Margarida Bernardo M, Fridman R, Da Settimo F, Martini C, Rossello A",,753771,DTCT0024091,6000226,DTCC01091698,638553,44948
CHEMBL1795859,P50281,,RSAGFYGPXOAVNX-RUZDIDTESA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,21514700,IC50,=,1700,NM,,,,,,,,,,,,,,Inhibition of human MMP14 by fluorometric assay,,Synthesis and biological evaluation in U87MG glioma cells of (ethynylthiophene)sulfonamido-based hydroxamates as matrix metalloproteinase inhibitors.,Eur. J. Med. Chem.,2011,46,7,"Nuti E, Casalini F, Santamaria S, Gabelloni P, Bendinelli S, Da Pozzo E, Costa B, Marinelli L, La Pietra V, Novellino E, Margarida Bernardo M, Fridman R, Da Settimo F, Martini C, Rossello A",,753771,DTCT0024091,6000233,DTCC01091699,119860,44948
CHEMBL1795860,P50281,,YPLZYOZJLNQLST-XMMPIXPASA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,21514700,IC50,=,23000,NM,,,,,,,,,,,,,,Inhibition of human MMP14 by fluorometric assay,,Synthesis and biological evaluation in U87MG glioma cells of (ethynylthiophene)sulfonamido-based hydroxamates as matrix metalloproteinase inhibitors.,Eur. J. Med. Chem.,2011,46,7,"Nuti E, Casalini F, Santamaria S, Gabelloni P, Bendinelli S, Da Pozzo E, Costa B, Marinelli L, La Pietra V, Novellino E, Margarida Bernardo M, Fridman R, Da Settimo F, Martini C, Rossello A",,753771,DTCT0024091,6000240,DTCC01091700,1640794,44948
CHEMBL1795861,P50281,,KGOHHLONXFWMRE-SFHVURJKSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,21514700,IC50,=,1600,NM,,,,,,,,,,,,,,Inhibition of human MMP14 by fluorometric assay,,Synthesis and biological evaluation in U87MG glioma cells of (ethynylthiophene)sulfonamido-based hydroxamates as matrix metalloproteinase inhibitors.,Eur. J. Med. Chem.,2011,46,7,"Nuti E, Casalini F, Santamaria S, Gabelloni P, Bendinelli S, Da Pozzo E, Costa B, Marinelli L, La Pietra V, Novellino E, Margarida Bernardo M, Fridman R, Da Settimo F, Martini C, Rossello A",,753771,DTCT0024091,6000247,DTCC01091701,1861595,44948
CHEMBL1795862,P50281,,OTEWYJZEFZRZKI-XMMPIXPASA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,21514700,IC50,=,112,NM,,,,,,,,,,,,,,Inhibition of human MMP14 by fluorometric assay,,Synthesis and biological evaluation in U87MG glioma cells of (ethynylthiophene)sulfonamido-based hydroxamates as matrix metalloproteinase inhibitors.,Eur. J. Med. Chem.,2011,46,7,"Nuti E, Casalini F, Santamaria S, Gabelloni P, Bendinelli S, Da Pozzo E, Costa B, Marinelli L, La Pietra V, Novellino E, Margarida Bernardo M, Fridman R, Da Settimo F, Martini C, Rossello A",,753771,DTCT0024091,6000255,DTCC01091702,767378,44948
CHEMBL1796298,P50281,,YNSKBMXZDCLQIV-MHZLTWQESA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,22153941,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibition of MMP14 using Mca-Pro-cyclohexyl-Ala-Gly-Nva-His-Ala- Dap(Dnp)-NH2 as substrate by fluorometric analysis,,Lead optimisation of selective non-zinc binding inhibitors of MMP13. Part 2.,Bioorg. Med. Chem. Lett.,2012,22,1,"De Savi C, Morley AD, Nash I, Karoutchi G, Page K, Ting A, Gerhardt S",,798835,DTCT0024091,7601055,DTCC01092132,1927204,47049
CHEMBL179984,P50281,,RDCLFTKMELYUEI-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,15780611,IC50,=,6700,NM,,,,,,,,,,,,,,Inhibitory concentration against matrix metalloprotease 14,,Potent pyrimidinetrione-based inhibitors of MMP-13 with enhanced selectivity over MMP-14.,Bioorg. Med. Chem. Lett.,2005,15,7,"Blagg JA, Noe MC, Wolf-Gouveia LA, Reiter LA, Laird ER, Chang SP, Danley DE, Downs JT, Elliott NC, Eskra JD, Griffiths RJ, Hardink JR, Haugeto AI, Jones CS, Liras JL, Lopresti-Morrow LL, Mitchell PG, Pandit J, Robinson RP, Subramanyam C, Vaughn-Bowser ML, Yocum SA",,305128,DTCT0024091,1753719,DTCC00384592,1307385,18917
CHEMBL1800089,P50281,,VMWGPLRCSWOQJR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,20726512,IC50,=,7.4,NM,,,,,,,,,,,,,,Inhibition of human MMP14 assessed as cleavage of fluorogenic peptide MCAPro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 by fluorometric assay,,"Orally active MMP-1 sparing a-tetrahydropyranyl and a-piperidinyl sulfone matrix metalloproteinase (MMP) inhibitors with efficacy in cancer, arthritis, and cardiovascular disease.",J. Med. Chem.,2010,53,18,"Becker DP, Barta TE, Bedell LJ, Boehm TL, Bond BR, Carroll J, Carron CP, Decrescenzo GA, Easton AM, Freskos JN, Funckes-Shippy CL, Heron M, Hockerman S, Howard CP, Kiefer JR, Li MH, Mathis KJ, McDonald JJ, Mehta PP, Munie GE, Sunyer T, Swearingen CA, Villamil CI, Welsch D, Williams JM, Yu Y, Yao J",,754465,DTCT0024091,6005752,DTCC01095116,1622971,45214
CHEMBL1801045,P50281,,KOPIIXVBCHXDHO-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,20726512,IC50,=,4.5,NM,,,,,,,,,,,,,,Inhibition of human MMP14 assessed as cleavage of fluorogenic peptide MCAPro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 by fluorometric assay,,"Orally active MMP-1 sparing a-tetrahydropyranyl and a-piperidinyl sulfone matrix metalloproteinase (MMP) inhibitors with efficacy in cancer, arthritis, and cardiovascular disease.",J. Med. Chem.,2010,53,18,"Becker DP, Barta TE, Bedell LJ, Boehm TL, Bond BR, Carroll J, Carron CP, Decrescenzo GA, Easton AM, Freskos JN, Funckes-Shippy CL, Heron M, Hockerman S, Howard CP, Kiefer JR, Li MH, Mathis KJ, McDonald JJ, Mehta PP, Munie GE, Sunyer T, Swearingen CA, Villamil CI, Welsch D, Williams JM, Yu Y, Yao J",,754465,DTCT0024091,6005777,DTCC01094746,1747121,45214
CHEMBL1801046,P50281,,HBYRXCFAHCMHAA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,20726512,IC50,=,5.6,NM,,,,,,,,,,,,,,Inhibition of human MMP14 assessed as cleavage of fluorogenic peptide MCAPro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 by fluorometric assay,,"Orally active MMP-1 sparing a-tetrahydropyranyl and a-piperidinyl sulfone matrix metalloproteinase (MMP) inhibitors with efficacy in cancer, arthritis, and cardiovascular disease.",J. Med. Chem.,2010,53,18,"Becker DP, Barta TE, Bedell LJ, Boehm TL, Bond BR, Carroll J, Carron CP, Decrescenzo GA, Easton AM, Freskos JN, Funckes-Shippy CL, Heron M, Hockerman S, Howard CP, Kiefer JR, Li MH, Mathis KJ, McDonald JJ, Mehta PP, Munie GE, Sunyer T, Swearingen CA, Villamil CI, Welsch D, Williams JM, Yu Y, Yao J",,754465,DTCT0024091,6005776,DTCC01094747,1364426,45214
CHEMBL1801047,P50281,,RDFQXFRQTOWZEQ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,20726512,IC50,=,47,NM,,,,,,,,,,,,,,Inhibition of human MMP14 assessed as cleavage of fluorogenic peptide MCAPro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 by fluorometric assay,,"Orally active MMP-1 sparing a-tetrahydropyranyl and a-piperidinyl sulfone matrix metalloproteinase (MMP) inhibitors with efficacy in cancer, arthritis, and cardiovascular disease.",J. Med. Chem.,2010,53,18,"Becker DP, Barta TE, Bedell LJ, Boehm TL, Bond BR, Carroll J, Carron CP, Decrescenzo GA, Easton AM, Freskos JN, Funckes-Shippy CL, Heron M, Hockerman S, Howard CP, Kiefer JR, Li MH, Mathis KJ, McDonald JJ, Mehta PP, Munie GE, Sunyer T, Swearingen CA, Villamil CI, Welsch D, Williams JM, Yu Y, Yao J",,754465,DTCT0024091,6005775,DTCC01094748,1525962,45214
CHEMBL1801048,P50281,,PKAAOTCIUWGSDS-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,20726512,IC50,=,1.71,NM,,,,,,,,,,,,,,Inhibition of human MMP14 assessed as cleavage of fluorogenic peptide MCAPro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 by fluorometric assay,,"Orally active MMP-1 sparing a-tetrahydropyranyl and a-piperidinyl sulfone matrix metalloproteinase (MMP) inhibitors with efficacy in cancer, arthritis, and cardiovascular disease.",J. Med. Chem.,2010,53,18,"Becker DP, Barta TE, Bedell LJ, Boehm TL, Bond BR, Carroll J, Carron CP, Decrescenzo GA, Easton AM, Freskos JN, Funckes-Shippy CL, Heron M, Hockerman S, Howard CP, Kiefer JR, Li MH, Mathis KJ, McDonald JJ, Mehta PP, Munie GE, Sunyer T, Swearingen CA, Villamil CI, Welsch D, Williams JM, Yu Y, Yao J",,754465,DTCT0024091,6005774,DTCC01094749,1590328,45214
CHEMBL1801049,P50281,,NUTUARVYQWFZAA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,20726512,IC50,=,10.5,NM,,,,,,,,,,,,,,Inhibition of human MMP14 assessed as cleavage of fluorogenic peptide MCAPro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 by fluorometric assay,,"Orally active MMP-1 sparing a-tetrahydropyranyl and a-piperidinyl sulfone matrix metalloproteinase (MMP) inhibitors with efficacy in cancer, arthritis, and cardiovascular disease.",J. Med. Chem.,2010,53,18,"Becker DP, Barta TE, Bedell LJ, Boehm TL, Bond BR, Carroll J, Carron CP, Decrescenzo GA, Easton AM, Freskos JN, Funckes-Shippy CL, Heron M, Hockerman S, Howard CP, Kiefer JR, Li MH, Mathis KJ, McDonald JJ, Mehta PP, Munie GE, Sunyer T, Swearingen CA, Villamil CI, Welsch D, Williams JM, Yu Y, Yao J",,754465,DTCT0024091,6005773,DTCC01094750,1429088,45214
CHEMBL1801050,P50281,,SPEYRVQKGFNUCY-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,20726512,IC50,=,20,NM,,,,,,,,,,,,,,Inhibition of human MMP14 assessed as cleavage of fluorogenic peptide MCAPro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 by fluorometric assay,,"Orally active MMP-1 sparing a-tetrahydropyranyl and a-piperidinyl sulfone matrix metalloproteinase (MMP) inhibitors with efficacy in cancer, arthritis, and cardiovascular disease.",J. Med. Chem.,2010,53,18,"Becker DP, Barta TE, Bedell LJ, Boehm TL, Bond BR, Carroll J, Carron CP, Decrescenzo GA, Easton AM, Freskos JN, Funckes-Shippy CL, Heron M, Hockerman S, Howard CP, Kiefer JR, Li MH, Mathis KJ, McDonald JJ, Mehta PP, Munie GE, Sunyer T, Swearingen CA, Villamil CI, Welsch D, Williams JM, Yu Y, Yao J",,754465,DTCT0024091,6005772,DTCC01094751,2070708,45214
CHEMBL1801051,P50281,,VFDSDRZNXLFCFF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,20726512,IC50,=,24,NM,,,,,,,,,,,,,,Inhibition of human MMP14 assessed as cleavage of fluorogenic peptide MCAPro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 by fluorometric assay,,"Orally active MMP-1 sparing a-tetrahydropyranyl and a-piperidinyl sulfone matrix metalloproteinase (MMP) inhibitors with efficacy in cancer, arthritis, and cardiovascular disease.",J. Med. Chem.,2010,53,18,"Becker DP, Barta TE, Bedell LJ, Boehm TL, Bond BR, Carroll J, Carron CP, Decrescenzo GA, Easton AM, Freskos JN, Funckes-Shippy CL, Heron M, Hockerman S, Howard CP, Kiefer JR, Li MH, Mathis KJ, McDonald JJ, Mehta PP, Munie GE, Sunyer T, Swearingen CA, Villamil CI, Welsch D, Williams JM, Yu Y, Yao J",,754465,DTCT0024091,6005771,DTCC01094752,1811467,45214
CHEMBL1801052,P50281,,QLTNWLFWQKKDEO-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,20726512,IC50,=,10.6,NM,,,,,,,,,,,,,,Inhibition of human MMP14 assessed as cleavage of fluorogenic peptide MCAPro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 by fluorometric assay,,"Orally active MMP-1 sparing a-tetrahydropyranyl and a-piperidinyl sulfone matrix metalloproteinase (MMP) inhibitors with efficacy in cancer, arthritis, and cardiovascular disease.",J. Med. Chem.,2010,53,18,"Becker DP, Barta TE, Bedell LJ, Boehm TL, Bond BR, Carroll J, Carron CP, Decrescenzo GA, Easton AM, Freskos JN, Funckes-Shippy CL, Heron M, Hockerman S, Howard CP, Kiefer JR, Li MH, Mathis KJ, McDonald JJ, Mehta PP, Munie GE, Sunyer T, Swearingen CA, Villamil CI, Welsch D, Williams JM, Yu Y, Yao J",,754465,DTCT0024091,6005769,DTCC01094753,1105534,45214
CHEMBL1801053,P50281,,UZMULMICABXSNQ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,20726512,IC50,=,3.63,NM,,,,,,,,,,,,,,Inhibition of human MMP14 assessed as cleavage of fluorogenic peptide MCAPro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 by fluorometric assay,,"Orally active MMP-1 sparing a-tetrahydropyranyl and a-piperidinyl sulfone matrix metalloproteinase (MMP) inhibitors with efficacy in cancer, arthritis, and cardiovascular disease.",J. Med. Chem.,2010,53,18,"Becker DP, Barta TE, Bedell LJ, Boehm TL, Bond BR, Carroll J, Carron CP, Decrescenzo GA, Easton AM, Freskos JN, Funckes-Shippy CL, Heron M, Hockerman S, Howard CP, Kiefer JR, Li MH, Mathis KJ, McDonald JJ, Mehta PP, Munie GE, Sunyer T, Swearingen CA, Villamil CI, Welsch D, Williams JM, Yu Y, Yao J",,754465,DTCT0024091,6005768,DTCC01094754,1779150,45214
CHEMBL1801054,P50281,,PGEMRSCSFPLCBF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,20726512,IC50,=,200,NM,,,,,,,,,,,,,,Inhibition of human MMP14 assessed as cleavage of fluorogenic peptide MCAPro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 by fluorometric assay,,"Orally active MMP-1 sparing a-tetrahydropyranyl and a-piperidinyl sulfone matrix metalloproteinase (MMP) inhibitors with efficacy in cancer, arthritis, and cardiovascular disease.",J. Med. Chem.,2010,53,18,"Becker DP, Barta TE, Bedell LJ, Boehm TL, Bond BR, Carroll J, Carron CP, Decrescenzo GA, Easton AM, Freskos JN, Funckes-Shippy CL, Heron M, Hockerman S, Howard CP, Kiefer JR, Li MH, Mathis KJ, McDonald JJ, Mehta PP, Munie GE, Sunyer T, Swearingen CA, Villamil CI, Welsch D, Williams JM, Yu Y, Yao J",,754465,DTCT0024091,6005767,DTCC01094755,1940371,45214
CHEMBL1801057,P50281,,QJNGNVJSSUXWBO-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,20726512,IC50,=,3.1,NM,,,,,,,,,,,,,,Inhibition of human MMP14 assessed as cleavage of fluorogenic peptide MCAPro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 by fluorometric assay,,"Orally active MMP-1 sparing a-tetrahydropyranyl and a-piperidinyl sulfone matrix metalloproteinase (MMP) inhibitors with efficacy in cancer, arthritis, and cardiovascular disease.",J. Med. Chem.,2010,53,18,"Becker DP, Barta TE, Bedell LJ, Boehm TL, Bond BR, Carroll J, Carron CP, Decrescenzo GA, Easton AM, Freskos JN, Funckes-Shippy CL, Heron M, Hockerman S, Howard CP, Kiefer JR, Li MH, Mathis KJ, McDonald JJ, Mehta PP, Munie GE, Sunyer T, Swearingen CA, Villamil CI, Welsch D, Williams JM, Yu Y, Yao J",,754465,DTCT0024091,6005766,DTCC01094758,1687244,45214
CHEMBL1801393,P50281,,JATUSZYMCBLDQS-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,20726512,IC50,=,3.7,NM,,,,,,,,,,,,,,Inhibition of human MMP14 assessed as cleavage of fluorogenic peptide MCAPro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 by fluorometric assay,,"Orally active MMP-1 sparing a-tetrahydropyranyl and a-piperidinyl sulfone matrix metalloproteinase (MMP) inhibitors with efficacy in cancer, arthritis, and cardiovascular disease.",J. Med. Chem.,2010,53,18,"Becker DP, Barta TE, Bedell LJ, Boehm TL, Bond BR, Carroll J, Carron CP, Decrescenzo GA, Easton AM, Freskos JN, Funckes-Shippy CL, Heron M, Hockerman S, Howard CP, Kiefer JR, Li MH, Mathis KJ, McDonald JJ, Mehta PP, Munie GE, Sunyer T, Swearingen CA, Villamil CI, Welsch D, Williams JM, Yu Y, Yao J",,754465,DTCT0024091,6005744,DTCC01095085,1622970,45214
CHEMBL1801394,P50281,,OTKHAYOLIGHFRB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,20726512,IC50,=,9.5,NM,,,,,,,,,,,,,,Inhibition of human MMP14 assessed as cleavage of fluorogenic peptide MCAPro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 by fluorometric assay,,"Orally active MMP-1 sparing a-tetrahydropyranyl and a-piperidinyl sulfone matrix metalloproteinase (MMP) inhibitors with efficacy in cancer, arthritis, and cardiovascular disease.",J. Med. Chem.,2010,53,18,"Becker DP, Barta TE, Bedell LJ, Boehm TL, Bond BR, Carroll J, Carron CP, Decrescenzo GA, Easton AM, Freskos JN, Funckes-Shippy CL, Heron M, Hockerman S, Howard CP, Kiefer JR, Li MH, Mathis KJ, McDonald JJ, Mehta PP, Munie GE, Sunyer T, Swearingen CA, Villamil CI, Welsch D, Williams JM, Yu Y, Yao J",,754465,DTCT0024091,6005743,DTCC01095086,1557980,45214
CHEMBL1801396,P50281,,QDGVTWBFTFHWOG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,20726512,IC50,=,9,NM,,,,,,,,,,,,,,Inhibition of human MMP14 assessed as cleavage of fluorogenic peptide MCAPro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 by fluorometric assay,,"Orally active MMP-1 sparing a-tetrahydropyranyl and a-piperidinyl sulfone matrix metalloproteinase (MMP) inhibitors with efficacy in cancer, arthritis, and cardiovascular disease.",J. Med. Chem.,2010,53,18,"Becker DP, Barta TE, Bedell LJ, Boehm TL, Bond BR, Carroll J, Carron CP, Decrescenzo GA, Easton AM, Freskos JN, Funckes-Shippy CL, Heron M, Hockerman S, Howard CP, Kiefer JR, Li MH, Mathis KJ, McDonald JJ, Mehta PP, Munie GE, Sunyer T, Swearingen CA, Villamil CI, Welsch D, Williams JM, Yu Y, Yao J",,754465,DTCT0024091,6005742,DTCC01095088,1072789,45214
CHEMBL1801397,P50281,,WVUXCTUJEGJKKV-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,20726512,IC50,=,1.33,NM,,,,,,,,,,,,,,Inhibition of human MMP14 assessed as cleavage of fluorogenic peptide MCAPro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 by fluorometric assay,,"Orally active MMP-1 sparing a-tetrahydropyranyl and a-piperidinyl sulfone matrix metalloproteinase (MMP) inhibitors with efficacy in cancer, arthritis, and cardiovascular disease.",J. Med. Chem.,2010,53,18,"Becker DP, Barta TE, Bedell LJ, Boehm TL, Bond BR, Carroll J, Carron CP, Decrescenzo GA, Easton AM, Freskos JN, Funckes-Shippy CL, Heron M, Hockerman S, Howard CP, Kiefer JR, Li MH, Mathis KJ, McDonald JJ, Mehta PP, Munie GE, Sunyer T, Swearingen CA, Villamil CI, Welsch D, Williams JM, Yu Y, Yao J",,754465,DTCT0024091,6005741,DTCC01095089,1299069,45214
CHEMBL1801398,P50281,,QURZZKPWFKUXBF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,20726512,IC50,=,24.9,NM,,,,,,,,,,,,,,Inhibition of human MMP14 assessed as cleavage of fluorogenic peptide MCAPro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 by fluorometric assay,,"Orally active MMP-1 sparing a-tetrahydropyranyl and a-piperidinyl sulfone matrix metalloproteinase (MMP) inhibitors with efficacy in cancer, arthritis, and cardiovascular disease.",J. Med. Chem.,2010,53,18,"Becker DP, Barta TE, Bedell LJ, Boehm TL, Bond BR, Carroll J, Carron CP, Decrescenzo GA, Easton AM, Freskos JN, Funckes-Shippy CL, Heron M, Hockerman S, Howard CP, Kiefer JR, Li MH, Mathis KJ, McDonald JJ, Mehta PP, Munie GE, Sunyer T, Swearingen CA, Villamil CI, Welsch D, Williams JM, Yu Y, Yao J",,754465,DTCT0024091,6005740,DTCC01095090,555801,45214
CHEMBL1801399,P50281,,HYIVZTPHVNIXFU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,20726512,IC50,=,7.1,NM,,,,,,,,,,,,,,Inhibition of human MMP14 assessed as cleavage of fluorogenic peptide MCAPro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 by fluorometric assay,,"Orally active MMP-1 sparing a-tetrahydropyranyl and a-piperidinyl sulfone matrix metalloproteinase (MMP) inhibitors with efficacy in cancer, arthritis, and cardiovascular disease.",J. Med. Chem.,2010,53,18,"Becker DP, Barta TE, Bedell LJ, Boehm TL, Bond BR, Carroll J, Carron CP, Decrescenzo GA, Easton AM, Freskos JN, Funckes-Shippy CL, Heron M, Hockerman S, Howard CP, Kiefer JR, Li MH, Mathis KJ, McDonald JJ, Mehta PP, Munie GE, Sunyer T, Swearingen CA, Villamil CI, Welsch D, Williams JM, Yu Y, Yao J",,754465,DTCT0024091,6005739,DTCC01095091,1266628,45214
CHEMBL1801412,P50281,,ASZIRMQBBYBMMU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,20726512,IC50,=,6.8,NM,,,,,,,,,,,,,,Inhibition of human MMP14 assessed as cleavage of fluorogenic peptide MCAPro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 by fluorometric assay,,"Orally active MMP-1 sparing a-tetrahydropyranyl and a-piperidinyl sulfone matrix metalloproteinase (MMP) inhibitors with efficacy in cancer, arthritis, and cardiovascular disease.",J. Med. Chem.,2010,53,18,"Becker DP, Barta TE, Bedell LJ, Boehm TL, Bond BR, Carroll J, Carron CP, Decrescenzo GA, Easton AM, Freskos JN, Funckes-Shippy CL, Heron M, Hockerman S, Howard CP, Kiefer JR, Li MH, Mathis KJ, McDonald JJ, Mehta PP, Munie GE, Sunyer T, Swearingen CA, Villamil CI, Welsch D, Williams JM, Yu Y, Yao J",,754465,DTCT0024091,6005765,DTCC01095102,523654,45214
CHEMBL1801413,P50281,,SIEIWCDBNIGNIG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,20726512,IC50,=,53.9,NM,,,,,,,,,,,,,,Inhibition of human MMP14 assessed as cleavage of fluorogenic peptide MCAPro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 by fluorometric assay,,"Orally active MMP-1 sparing a-tetrahydropyranyl and a-piperidinyl sulfone matrix metalloproteinase (MMP) inhibitors with efficacy in cancer, arthritis, and cardiovascular disease.",J. Med. Chem.,2010,53,18,"Becker DP, Barta TE, Bedell LJ, Boehm TL, Bond BR, Carroll J, Carron CP, Decrescenzo GA, Easton AM, Freskos JN, Funckes-Shippy CL, Heron M, Hockerman S, Howard CP, Kiefer JR, Li MH, Mathis KJ, McDonald JJ, Mehta PP, Munie GE, Sunyer T, Swearingen CA, Villamil CI, Welsch D, Williams JM, Yu Y, Yao J",,754465,DTCT0024091,6005764,DTCC01095103,846766,45214
CHEMBL1801415,P50281,,SXSIQUOYBXOPSS-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,20726512,IC50,=,159,NM,,,,,,,,,,,,,,Inhibition of human MMP14 assessed as cleavage of fluorogenic peptide MCAPro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 by fluorometric assay,,"Orally active MMP-1 sparing a-tetrahydropyranyl and a-piperidinyl sulfone matrix metalloproteinase (MMP) inhibitors with efficacy in cancer, arthritis, and cardiovascular disease.",J. Med. Chem.,2010,53,18,"Becker DP, Barta TE, Bedell LJ, Boehm TL, Bond BR, Carroll J, Carron CP, Decrescenzo GA, Easton AM, Freskos JN, Funckes-Shippy CL, Heron M, Hockerman S, Howard CP, Kiefer JR, Li MH, Mathis KJ, McDonald JJ, Mehta PP, Munie GE, Sunyer T, Swearingen CA, Villamil CI, Welsch D, Williams JM, Yu Y, Yao J",,754465,DTCT0024091,6005763,DTCC01095105,1396864,45214
CHEMBL1801416,P50281,,PFIVDCYVKKFLEU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,20726512,IC50,=,25.8,NM,,,,,,,,,,,,,,Inhibition of human MMP14 assessed as cleavage of fluorogenic peptide MCAPro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 by fluorometric assay,,"Orally active MMP-1 sparing a-tetrahydropyranyl and a-piperidinyl sulfone matrix metalloproteinase (MMP) inhibitors with efficacy in cancer, arthritis, and cardiovascular disease.",J. Med. Chem.,2010,53,18,"Becker DP, Barta TE, Bedell LJ, Boehm TL, Bond BR, Carroll J, Carron CP, Decrescenzo GA, Easton AM, Freskos JN, Funckes-Shippy CL, Heron M, Hockerman S, Howard CP, Kiefer JR, Li MH, Mathis KJ, McDonald JJ, Mehta PP, Munie GE, Sunyer T, Swearingen CA, Villamil CI, Welsch D, Williams JM, Yu Y, Yao J",,754465,DTCT0024091,6005762,DTCC01095106,394582,45214
CHEMBL1801417,P50281,,SFEPJGMZSMIONR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,20726512,IC50,=,13.3,NM,,,,,,,,,,,,,,Inhibition of human MMP14 assessed as cleavage of fluorogenic peptide MCAPro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 by fluorometric assay,,"Orally active MMP-1 sparing a-tetrahydropyranyl and a-piperidinyl sulfone matrix metalloproteinase (MMP) inhibitors with efficacy in cancer, arthritis, and cardiovascular disease.",J. Med. Chem.,2010,53,18,"Becker DP, Barta TE, Bedell LJ, Boehm TL, Bond BR, Carroll J, Carron CP, Decrescenzo GA, Easton AM, Freskos JN, Funckes-Shippy CL, Heron M, Hockerman S, Howard CP, Kiefer JR, Li MH, Mathis KJ, McDonald JJ, Mehta PP, Munie GE, Sunyer T, Swearingen CA, Villamil CI, Welsch D, Williams JM, Yu Y, Yao J",,754465,DTCT0024091,6005761,DTCC01095107,263382,45214
CHEMBL1801418,P50281,,JNCKLKQBIMZPBF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,20726512,IC50,=,3486,NM,,,,,,,,,,,,,,Inhibition of human MMP14 assessed as cleavage of fluorogenic peptide MCAPro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 by fluorometric assay,,"Orally active MMP-1 sparing a-tetrahydropyranyl and a-piperidinyl sulfone matrix metalloproteinase (MMP) inhibitors with efficacy in cancer, arthritis, and cardiovascular disease.",J. Med. Chem.,2010,53,18,"Becker DP, Barta TE, Bedell LJ, Boehm TL, Bond BR, Carroll J, Carron CP, Decrescenzo GA, Easton AM, Freskos JN, Funckes-Shippy CL, Heron M, Hockerman S, Howard CP, Kiefer JR, Li MH, Mathis KJ, McDonald JJ, Mehta PP, Munie GE, Sunyer T, Swearingen CA, Villamil CI, Welsch D, Williams JM, Yu Y, Yao J",,754465,DTCT0024091,6005760,DTCC01095108,1525968,45214
CHEMBL1801419,P50281,,SYYRIPAKWJBIOW-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,20726512,IC50,=,83,NM,,,,,,,,,,,,,,Inhibition of human MMP14 assessed as cleavage of fluorogenic peptide MCAPro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 by fluorometric assay,,"Orally active MMP-1 sparing a-tetrahydropyranyl and a-piperidinyl sulfone matrix metalloproteinase (MMP) inhibitors with efficacy in cancer, arthritis, and cardiovascular disease.",J. Med. Chem.,2010,53,18,"Becker DP, Barta TE, Bedell LJ, Boehm TL, Bond BR, Carroll J, Carron CP, Decrescenzo GA, Easton AM, Freskos JN, Funckes-Shippy CL, Heron M, Hockerman S, Howard CP, Kiefer JR, Li MH, Mathis KJ, McDonald JJ, Mehta PP, Munie GE, Sunyer T, Swearingen CA, Villamil CI, Welsch D, Williams JM, Yu Y, Yao J",,754465,DTCT0024091,6005759,DTCC01095109,1072790,45214
CHEMBL1801420,P50281,,LMIHEFSBOIGKDH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,20726512,IC50,=,14.9,NM,,,,,,,,,,,,,,Inhibition of human MMP14 assessed as cleavage of fluorogenic peptide MCAPro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 by fluorometric assay,,"Orally active MMP-1 sparing a-tetrahydropyranyl and a-piperidinyl sulfone matrix metalloproteinase (MMP) inhibitors with efficacy in cancer, arthritis, and cardiovascular disease.",J. Med. Chem.,2010,53,18,"Becker DP, Barta TE, Bedell LJ, Boehm TL, Bond BR, Carroll J, Carron CP, Decrescenzo GA, Easton AM, Freskos JN, Funckes-Shippy CL, Heron M, Hockerman S, Howard CP, Kiefer JR, Li MH, Mathis KJ, McDonald JJ, Mehta PP, Munie GE, Sunyer T, Swearingen CA, Villamil CI, Welsch D, Williams JM, Yu Y, Yao J",,754465,DTCT0024091,6005758,DTCC01095110,879231,45214
CHEMBL1801421,P50281,,BDONYXHHXNTUSW-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,20726512,IC50,=,4,NM,,,,,,,,,,,,,,Inhibition of human MMP14 assessed as cleavage of fluorogenic peptide MCAPro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 by fluorometric assay,,"Orally active MMP-1 sparing a-tetrahydropyranyl and a-piperidinyl sulfone matrix metalloproteinase (MMP) inhibitors with efficacy in cancer, arthritis, and cardiovascular disease.",J. Med. Chem.,2010,53,18,"Becker DP, Barta TE, Bedell LJ, Boehm TL, Bond BR, Carroll J, Carron CP, Decrescenzo GA, Easton AM, Freskos JN, Funckes-Shippy CL, Heron M, Hockerman S, Howard CP, Kiefer JR, Li MH, Mathis KJ, McDonald JJ, Mehta PP, Munie GE, Sunyer T, Swearingen CA, Villamil CI, Welsch D, Williams JM, Yu Y, Yao J",,754465,DTCT0024091,6005757,DTCC01095111,1557981,45214
CHEMBL1801422,P50281,,ZHIRJJYNGRGHQQ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,20726512,IC50,=,0.73,NM,,,,,,,,,,,,,,Inhibition of human MMP14 assessed as cleavage of fluorogenic peptide MCAPro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 by fluorometric assay,,"Orally active MMP-1 sparing a-tetrahydropyranyl and a-piperidinyl sulfone matrix metalloproteinase (MMP) inhibitors with efficacy in cancer, arthritis, and cardiovascular disease.",J. Med. Chem.,2010,53,18,"Becker DP, Barta TE, Bedell LJ, Boehm TL, Bond BR, Carroll J, Carron CP, Decrescenzo GA, Easton AM, Freskos JN, Funckes-Shippy CL, Heron M, Hockerman S, Howard CP, Kiefer JR, Li MH, Mathis KJ, McDonald JJ, Mehta PP, Munie GE, Sunyer T, Swearingen CA, Villamil CI, Welsch D, Williams JM, Yu Y, Yao J",,754465,DTCT0024091,6005756,DTCC01095112,1718593,45214
CHEMBL1801423,P50281,,XFBRPTYLOIFAQR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,20726512,IC50,=,49.4,NM,,,,,,,,,,,,,,Inhibition of human MMP14 assessed as cleavage of fluorogenic peptide MCAPro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 by fluorometric assay,,"Orally active MMP-1 sparing a-tetrahydropyranyl and a-piperidinyl sulfone matrix metalloproteinase (MMP) inhibitors with efficacy in cancer, arthritis, and cardiovascular disease.",J. Med. Chem.,2010,53,18,"Becker DP, Barta TE, Bedell LJ, Boehm TL, Bond BR, Carroll J, Carron CP, Decrescenzo GA, Easton AM, Freskos JN, Funckes-Shippy CL, Heron M, Hockerman S, Howard CP, Kiefer JR, Li MH, Mathis KJ, McDonald JJ, Mehta PP, Munie GE, Sunyer T, Swearingen CA, Villamil CI, Welsch D, Williams JM, Yu Y, Yao J",,754465,DTCT0024091,6005755,DTCC01095113,1429093,45214
CHEMBL1801424,P50281,,AOPZFYOXZYZEAC-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,20726512,IC50,=,500,NM,,,,,,,,,,,,,,Inhibition of human MMP14 assessed as cleavage of fluorogenic peptide MCAPro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 by fluorometric assay,,"Orally active MMP-1 sparing a-tetrahydropyranyl and a-piperidinyl sulfone matrix metalloproteinase (MMP) inhibitors with efficacy in cancer, arthritis, and cardiovascular disease.",J. Med. Chem.,2010,53,18,"Becker DP, Barta TE, Bedell LJ, Boehm TL, Bond BR, Carroll J, Carron CP, Decrescenzo GA, Easton AM, Freskos JN, Funckes-Shippy CL, Heron M, Hockerman S, Howard CP, Kiefer JR, Li MH, Mathis KJ, McDonald JJ, Mehta PP, Munie GE, Sunyer T, Swearingen CA, Villamil CI, Welsch D, Williams JM, Yu Y, Yao J",,754465,DTCT0024091,6005754,DTCC01095114,101933,45214
CHEMBL1801425,P50281,,DZCGIZPIPKWUIX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,20726512,IC50,=,160,NM,,,,,,,,,,,,,,Inhibition of human MMP14 assessed as cleavage of fluorogenic peptide MCAPro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 by fluorometric assay,,"Orally active MMP-1 sparing a-tetrahydropyranyl and a-piperidinyl sulfone matrix metalloproteinase (MMP) inhibitors with efficacy in cancer, arthritis, and cardiovascular disease.",J. Med. Chem.,2010,53,18,"Becker DP, Barta TE, Bedell LJ, Boehm TL, Bond BR, Carroll J, Carron CP, Decrescenzo GA, Easton AM, Freskos JN, Funckes-Shippy CL, Heron M, Hockerman S, Howard CP, Kiefer JR, Li MH, Mathis KJ, McDonald JJ, Mehta PP, Munie GE, Sunyer T, Swearingen CA, Villamil CI, Welsch D, Williams JM, Yu Y, Yao J",,754465,DTCT0024091,6005753,DTCC01095115,1779153,45214
CHEMBL1801426,P50281,,LTCNKRUYOJZZJO-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,20726512,IC50,=,58.6,NM,,,,,,,,,,,,,,Inhibition of human MMP14 assessed as cleavage of fluorogenic peptide MCAPro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 by fluorometric assay,,"Orally active MMP-1 sparing a-tetrahydropyranyl and a-piperidinyl sulfone matrix metalloproteinase (MMP) inhibitors with efficacy in cancer, arthritis, and cardiovascular disease.",J. Med. Chem.,2010,53,18,"Becker DP, Barta TE, Bedell LJ, Boehm TL, Bond BR, Carroll J, Carron CP, Decrescenzo GA, Easton AM, Freskos JN, Funckes-Shippy CL, Heron M, Hockerman S, Howard CP, Kiefer JR, Li MH, Mathis KJ, McDonald JJ, Mehta PP, Munie GE, Sunyer T, Swearingen CA, Villamil CI, Welsch D, Williams JM, Yu Y, Yao J",,754465,DTCT0024091,6005751,DTCC01095117,1843781,45214
CHEMBL1801427,P50281,,JKRVXAWKSWVVCV-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,20726512,IC50,=,100.5,NM,,,,,,,,,,,,,,Inhibition of human MMP14 assessed as cleavage of fluorogenic peptide MCAPro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 by fluorometric assay,,"Orally active MMP-1 sparing a-tetrahydropyranyl and a-piperidinyl sulfone matrix metalloproteinase (MMP) inhibitors with efficacy in cancer, arthritis, and cardiovascular disease.",J. Med. Chem.,2010,53,18,"Becker DP, Barta TE, Bedell LJ, Boehm TL, Bond BR, Carroll J, Carron CP, Decrescenzo GA, Easton AM, Freskos JN, Funckes-Shippy CL, Heron M, Hockerman S, Howard CP, Kiefer JR, Li MH, Mathis KJ, McDonald JJ, Mehta PP, Munie GE, Sunyer T, Swearingen CA, Villamil CI, Welsch D, Williams JM, Yu Y, Yao J",,754465,DTCT0024091,6005750,DTCC01095118,1169008,45214
CHEMBL1801428,P50281,,ORSWNUGKUNQTLF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,20726512,IC50,=,108,NM,,,,,,,,,,,,,,Inhibition of human MMP14 assessed as cleavage of fluorogenic peptide MCAPro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 by fluorometric assay,,"Orally active MMP-1 sparing a-tetrahydropyranyl and a-piperidinyl sulfone matrix metalloproteinase (MMP) inhibitors with efficacy in cancer, arthritis, and cardiovascular disease.",J. Med. Chem.,2010,53,18,"Becker DP, Barta TE, Bedell LJ, Boehm TL, Bond BR, Carroll J, Carron CP, Decrescenzo GA, Easton AM, Freskos JN, Funckes-Shippy CL, Heron M, Hockerman S, Howard CP, Kiefer JR, Li MH, Mathis KJ, McDonald JJ, Mehta PP, Munie GE, Sunyer T, Swearingen CA, Villamil CI, Welsch D, Williams JM, Yu Y, Yao J",,754465,DTCT0024091,6005749,DTCC01095119,1687248,45214
CHEMBL1801429,P50281,,LCYYUMHWMVOGPC-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,20726512,IC50,=,53.3,NM,,,,,,,,,,,,,,Inhibition of human MMP14 assessed as cleavage of fluorogenic peptide MCAPro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 by fluorometric assay,,"Orally active MMP-1 sparing a-tetrahydropyranyl and a-piperidinyl sulfone matrix metalloproteinase (MMP) inhibitors with efficacy in cancer, arthritis, and cardiovascular disease.",J. Med. Chem.,2010,53,18,"Becker DP, Barta TE, Bedell LJ, Boehm TL, Bond BR, Carroll J, Carron CP, Decrescenzo GA, Easton AM, Freskos JN, Funckes-Shippy CL, Heron M, Hockerman S, Howard CP, Kiefer JR, Li MH, Mathis KJ, McDonald JJ, Mehta PP, Munie GE, Sunyer T, Swearingen CA, Villamil CI, Welsch D, Williams JM, Yu Y, Yao J",,754465,DTCT0024091,6005748,DTCC01095120,717206,45214
CHEMBL1801430,P50281,SC-77964,NBRBWZJMBITNBC-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,20726512,IC50,=,4.6,NM,,,,,,,,,,,,,,Inhibition of human MMP14 assessed as cleavage of fluorogenic peptide MCAPro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 by fluorometric assay,,"Orally active MMP-1 sparing a-tetrahydropyranyl and a-piperidinyl sulfone matrix metalloproteinase (MMP) inhibitors with efficacy in cancer, arthritis, and cardiovascular disease.",J. Med. Chem.,2010,53,18,"Becker DP, Barta TE, Bedell LJ, Boehm TL, Bond BR, Carroll J, Carron CP, Decrescenzo GA, Easton AM, Freskos JN, Funckes-Shippy CL, Heron M, Hockerman S, Howard CP, Kiefer JR, Li MH, Mathis KJ, McDonald JJ, Mehta PP, Munie GE, Sunyer T, Swearingen CA, Villamil CI, Welsch D, Williams JM, Yu Y, Yao J",,754465,DTCT0024091,6005746,DTCC00034383,620315,45214
CHEMBL1801431,P50281,,IXVDOEAUVAJHER-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,20726512,IC50,=,4.1,NM,,,,,,,,,,,,,,Inhibition of human MMP14 assessed as cleavage of fluorogenic peptide MCAPro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 by fluorometric assay,,"Orally active MMP-1 sparing a-tetrahydropyranyl and a-piperidinyl sulfone matrix metalloproteinase (MMP) inhibitors with efficacy in cancer, arthritis, and cardiovascular disease.",J. Med. Chem.,2010,53,18,"Becker DP, Barta TE, Bedell LJ, Boehm TL, Bond BR, Carroll J, Carron CP, Decrescenzo GA, Easton AM, Freskos JN, Funckes-Shippy CL, Heron M, Hockerman S, Howard CP, Kiefer JR, Li MH, Mathis KJ, McDonald JJ, Mehta PP, Munie GE, Sunyer T, Swearingen CA, Villamil CI, Welsch D, Williams JM, Yu Y, Yao J",,754465,DTCT0024091,6005745,DTCC01095121,263383,45214
CHEMBL180900,P50281,,LZYKHUZBVFGWCA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,15780611,IC50,=,260,NM,,,,,,,,,,,,,,Inhibitory concentration against matrix metalloprotease 14,,Potent pyrimidinetrione-based inhibitors of MMP-13 with enhanced selectivity over MMP-14.,Bioorg. Med. Chem. Lett.,2005,15,7,"Blagg JA, Noe MC, Wolf-Gouveia LA, Reiter LA, Laird ER, Chang SP, Danley DE, Downs JT, Elliott NC, Eskra JD, Griffiths RJ, Hardink JR, Haugeto AI, Jones CS, Liras JL, Lopresti-Morrow LL, Mitchell PG, Pandit J, Robinson RP, Subramanyam C, Vaughn-Bowser ML, Yocum SA",,305128,DTCT0024091,1752537,DTCC00384556,1436929,18917
CHEMBL181244,P50281,,PHGLPDURIUEELR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,15713379,IC50,>,833,NM,,,,,,,,,,,,,,Inhibition of human matrix metalloprotease-14,,N-i-Propoxy-N-biphenylsulfonylaminobutylhydroxamic acids as potent and selective inhibitors of MMP-2 and MT1-MMP.,Bioorg. Med. Chem. Lett.,2005,15,5,"Rossello A, Nuti E, Carelli P, Orlandini E, Macchia M, Nencetti S, Zandomeneghi M, Balzano F, Uccello Barretta G, Albini A, Benelli R, Cercignani G, Murphy G, Balsamo A",,305766,DTCT0024091,1747760,DTCC00381891,1586743,18841
CHEMBL181244,P50281,,PHGLPDURIUEELR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,15713379,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibition of human matrix metalloprotease-14,,N-i-Propoxy-N-biphenylsulfonylaminobutylhydroxamic acids as potent and selective inhibitors of MMP-2 and MT1-MMP.,Bioorg. Med. Chem. Lett.,2005,15,5,"Rossello A, Nuti E, Carelli P, Orlandini E, Macchia M, Nencetti S, Zandomeneghi M, Balzano F, Uccello Barretta G, Albini A, Benelli R, Cercignani G, Murphy G, Balsamo A",,305766,DTCT0024091,1747759,DTCC00381891,1586743,18841
CHEMBL181244,P50281,,PHGLPDURIUEELR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,19606871,IC50,=,2300,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP14,,"N-O-isopropyl sulfonamido-based hydroxamates: design, synthesis and biological evaluation of selective matrix metalloproteinase-13 inhibitors as potential therapeutic agents for osteoarthritis.",J. Med. Chem.,2009,52,15,"Nuti E, Casalini F, Avramova SI, Santamaria S, Cercignani G, Marinelli L, La Pietra V, Novellino E, Orlandini E, Nencetti S, Tuccinardi T, Martinelli A, Lim NH, Visse R, Nagase H, Rossello A",,571087,DTCT0024091,2859503,DTCC00381891,1588877,34421
CHEMBL181244,P50281,,PHGLPDURIUEELR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,20180536,IC50,=,2300,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP14 by fluorometric assay,,Potent arylsulfonamide inhibitors of tumor necrosis factor-alpha converting enzyme able to reduce activated leukocyte cell adhesion molecule shedding in cancer cell models.,J. Med. Chem.,2010,53,6,"Nuti E, Casalini F, Avramova SI, Santamaria S, Fabbi M, Ferrini S, Marinelli L, La Pietra V, Limongelli V, Novellino E, Cercignani G, Orlandini E, Nencetti S, Rossello A",,624095,DTCT0024091,3285988,DTCC00381891,1601174,38228
CHEMBL181819,P50281,,FSSPDFKSDKXWQO-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,15780611,IC50,=,22,NM,,,,,,,,,,,,,,Inhibitory concentration against matrix metalloprotease 14,,Potent pyrimidinetrione-based inhibitors of MMP-13 with enhanced selectivity over MMP-14.,Bioorg. Med. Chem. Lett.,2005,15,7,"Blagg JA, Noe MC, Wolf-Gouveia LA, Reiter LA, Laird ER, Chang SP, Danley DE, Downs JT, Elliott NC, Eskra JD, Griffiths RJ, Hardink JR, Haugeto AI, Jones CS, Liras JL, Lopresti-Morrow LL, Mitchell PG, Pandit J, Robinson RP, Subramanyam C, Vaughn-Bowser ML, Yocum SA",,305128,DTCT0024091,1754266,DTCC00384593,2014497,18917
CHEMBL181905,P50281,,OJGIWNSVHKBBDS-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,15780611,IC50,=,60,NM,,,,,,,,,,,,,,Inhibitory concentration against matrix metalloprotease 14,,Potent pyrimidinetrione-based inhibitors of MMP-13 with enhanced selectivity over MMP-14.,Bioorg. Med. Chem. Lett.,2005,15,7,"Blagg JA, Noe MC, Wolf-Gouveia LA, Reiter LA, Laird ER, Chang SP, Danley DE, Downs JT, Elliott NC, Eskra JD, Griffiths RJ, Hardink JR, Haugeto AI, Jones CS, Liras JL, Lopresti-Morrow LL, Mitchell PG, Pandit J, Robinson RP, Subramanyam C, Vaughn-Bowser ML, Yocum SA",,305128,DTCT0024091,1753192,DTCC00384547,2046716,18917
CHEMBL182344,P50281,,HYDHEJPXRHGPLP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,15780611,IC50,=,120,NM,,,,,,,,,,,,,,Inhibitory concentration against matrix metalloprotease 14,,Potent pyrimidinetrione-based inhibitors of MMP-13 with enhanced selectivity over MMP-14.,Bioorg. Med. Chem. Lett.,2005,15,7,"Blagg JA, Noe MC, Wolf-Gouveia LA, Reiter LA, Laird ER, Chang SP, Danley DE, Downs JT, Elliott NC, Eskra JD, Griffiths RJ, Hardink JR, Haugeto AI, Jones CS, Liras JL, Lopresti-Morrow LL, Mitchell PG, Pandit J, Robinson RP, Subramanyam C, Vaughn-Bowser ML, Yocum SA",,305128,DTCT0024091,1753599,DTCC00384445,1630746,18917
CHEMBL182534,P50281,,HMJIPPQTLJLPNE-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,15780611,IC50,=,620,NM,,,,,,,,,,,,,,Inhibitory concentration against matrix metalloprotease 14,,Potent pyrimidinetrione-based inhibitors of MMP-13 with enhanced selectivity over MMP-14.,Bioorg. Med. Chem. Lett.,2005,15,7,"Blagg JA, Noe MC, Wolf-Gouveia LA, Reiter LA, Laird ER, Chang SP, Danley DE, Downs JT, Elliott NC, Eskra JD, Griffiths RJ, Hardink JR, Haugeto AI, Jones CS, Liras JL, Lopresti-Morrow LL, Mitchell PG, Pandit J, Robinson RP, Subramanyam C, Vaughn-Bowser ML, Yocum SA",,305128,DTCT0024091,1754131,DTCC00384409,337345,18917
CHEMBL182582,P50281,,RBXJTRGTMYPRKK-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,15780611,IC50,=,36,NM,,,,,,,,,,,,,,Inhibitory concentration against matrix metalloprotease 14,,Potent pyrimidinetrione-based inhibitors of MMP-13 with enhanced selectivity over MMP-14.,Bioorg. Med. Chem. Lett.,2005,15,7,"Blagg JA, Noe MC, Wolf-Gouveia LA, Reiter LA, Laird ER, Chang SP, Danley DE, Downs JT, Elliott NC, Eskra JD, Griffiths RJ, Hardink JR, Haugeto AI, Jones CS, Liras JL, Lopresti-Morrow LL, Mitchell PG, Pandit J, Robinson RP, Subramanyam C, Vaughn-Bowser ML, Yocum SA",,305128,DTCT0024091,1753722,DTCC00384615,1981650,18917
CHEMBL182841,P50281,,WBRQJRYOZZQHQI-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,15780611,IC50,=,220,NM,,,,,,,,,,,,,,Inhibitory concentration against matrix metalloprotease 14,,Potent pyrimidinetrione-based inhibitors of MMP-13 with enhanced selectivity over MMP-14.,Bioorg. Med. Chem. Lett.,2005,15,7,"Blagg JA, Noe MC, Wolf-Gouveia LA, Reiter LA, Laird ER, Chang SP, Danley DE, Downs JT, Elliott NC, Eskra JD, Griffiths RJ, Hardink JR, Haugeto AI, Jones CS, Liras JL, Lopresti-Morrow LL, Mitchell PG, Pandit J, Robinson RP, Subramanyam C, Vaughn-Bowser ML, Yocum SA",,305128,DTCT0024091,1753725,DTCC00384630,304710,18917
CHEMBL182879,P50281,,GNDJOJQVOFQQBM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,15582436,IC50,,,,,,,,,,,,,,,,,Inhibitory concentration against matrix metalloprotease-14 in Escherichia coli was determined; NA:Not active,Not Active,"N-hydroxy-2-(naphthalene-2-ylsulfanyl)-acetamide, a novel hydroxamic acid-based inhibitor of aminopeptidase N and its anti-angiogenic activity.",Bioorg. Med. Chem. Lett.,2005,15,1,"Lee J, Shim JS, Jung SA, Lee ST, Kwon HJ",,306450,DTCT0024091,1757709,DTCC00385215,757396,18428
CHEMBL182894,P50281,,PLCRCZGBQOTIFV-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,15780611,IC50,=,19,NM,,,,,,,,,,,,,,Inhibitory concentration against matrix metalloprotease 14,,Potent pyrimidinetrione-based inhibitors of MMP-13 with enhanced selectivity over MMP-14.,Bioorg. Med. Chem. Lett.,2005,15,7,"Blagg JA, Noe MC, Wolf-Gouveia LA, Reiter LA, Laird ER, Chang SP, Danley DE, Downs JT, Elliott NC, Eskra JD, Griffiths RJ, Hardink JR, Haugeto AI, Jones CS, Liras JL, Lopresti-Morrow LL, Mitchell PG, Pandit J, Robinson RP, Subramanyam C, Vaughn-Bowser ML, Yocum SA",,305128,DTCT0024091,1753714,DTCC00384562,1340027,18917
CHEMBL183146,P50281,,ICCZTDHQUXGJEO-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,15780611,IC50,=,16,NM,,,,,,,,,,,,,,Inhibitory concentration against matrix metalloprotease 14,,Potent pyrimidinetrione-based inhibitors of MMP-13 with enhanced selectivity over MMP-14.,Bioorg. Med. Chem. Lett.,2005,15,7,"Blagg JA, Noe MC, Wolf-Gouveia LA, Reiter LA, Laird ER, Chang SP, Danley DE, Downs JT, Elliott NC, Eskra JD, Griffiths RJ, Hardink JR, Haugeto AI, Jones CS, Liras JL, Lopresti-Morrow LL, Mitchell PG, Pandit J, Robinson RP, Subramanyam C, Vaughn-Bowser ML, Yocum SA",,305128,DTCT0024091,1753195,DTCC00384417,1916102,18917
CHEMBL183216,P50281,,BGEFVHSKSARWDE-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,15780611,IC50,=,18,NM,,,,,,,,,,,,,,Inhibitory concentration against matrix metalloprotease 14,,Potent pyrimidinetrione-based inhibitors of MMP-13 with enhanced selectivity over MMP-14.,Bioorg. Med. Chem. Lett.,2005,15,7,"Blagg JA, Noe MC, Wolf-Gouveia LA, Reiter LA, Laird ER, Chang SP, Danley DE, Downs JT, Elliott NC, Eskra JD, Griffiths RJ, Hardink JR, Haugeto AI, Jones CS, Liras JL, Lopresti-Morrow LL, Mitchell PG, Pandit J, Robinson RP, Subramanyam C, Vaughn-Bowser ML, Yocum SA",,305128,DTCT0024091,1753198,DTCC00384431,660719,18917
CHEMBL183410,P50281,,ZTJUBPXNBSLSGL-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,15780611,IC50,=,220,NM,,,,,,,,,,,,,,Inhibitory concentration against matrix metalloprotease 14,,Potent pyrimidinetrione-based inhibitors of MMP-13 with enhanced selectivity over MMP-14.,Bioorg. Med. Chem. Lett.,2005,15,7,"Blagg JA, Noe MC, Wolf-Gouveia LA, Reiter LA, Laird ER, Chang SP, Danley DE, Downs JT, Elliott NC, Eskra JD, Griffiths RJ, Hardink JR, Haugeto AI, Jones CS, Liras JL, Lopresti-Morrow LL, Mitchell PG, Pandit J, Robinson RP, Subramanyam C, Vaughn-Bowser ML, Yocum SA",,305128,DTCT0024091,1754252,DTCC00384419,1113613,18917
CHEMBL1834420,P50281,,OWKCGOUEJMBBRA-NNBQYGFHSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,21866961,KI,=,28900,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP14 catalytic domain assessed as hydrolysis of MOCAcPLGLA2pr(Dnp)AR-NH2 by fluorescence spectrofluorometry ,,Selective water-soluble gelatinase inhibitor prodrugs.,J. Med. Chem.,2011,54,19,"Gooyit M, Lee M, Schroeder VA, Ikejiri M, Suckow MA, Mobashery S, Chang M",,771362,DTCT0024091,6116321,DTCC01109922,198681,46049
CHEMBL1834422,P50281,,AGULWCWMDMKUSF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,21866961,KI,=,210,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP14 catalytic domain assessed as hydrolysis of MOCAcPLGLA2pr(Dnp)AR-NH2 by fluorescence spectrofluorometry ,,Selective water-soluble gelatinase inhibitor prodrugs.,J. Med. Chem.,2011,54,19,"Gooyit M, Lee M, Schroeder VA, Ikejiri M, Suckow MA, Mobashery S, Chang M",,771362,DTCT0024091,6116322,DTCC01109924,1072947,46049
CHEMBL1834423,P50281,,FANDWSFYLCHFFT-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,21866961,KI,=,260,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP14 catalytic domain assessed as hydrolysis of MOCAcPLGLA2pr(Dnp)AR-NH2 by fluorescence spectrofluorometry ,,Selective water-soluble gelatinase inhibitor prodrugs.,J. Med. Chem.,2011,54,19,"Gooyit M, Lee M, Schroeder VA, Ikejiri M, Suckow MA, Mobashery S, Chang M",,771362,DTCT0024091,6116323,DTCC01109925,166772,46049
CHEMBL183697,P50281,,UIODHSBHBXTRBO-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,15780611,IC50,=,50,NM,,,,,,,,,,,,,,Inhibitory concentration against matrix metalloprotease 14,,Potent pyrimidinetrione-based inhibitors of MMP-13 with enhanced selectivity over MMP-14.,Bioorg. Med. Chem. Lett.,2005,15,7,"Blagg JA, Noe MC, Wolf-Gouveia LA, Reiter LA, Laird ER, Chang SP, Danley DE, Downs JT, Elliott NC, Eskra JD, Griffiths RJ, Hardink JR, Haugeto AI, Jones CS, Liras JL, Lopresti-Morrow LL, Mitchell PG, Pandit J, Robinson RP, Subramanyam C, Vaughn-Bowser ML, Yocum SA",,305128,DTCT0024091,1753612,DTCC00384397,1015951,18917
CHEMBL183713,P50281,,FRIYTZJGYCAFHL-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,15780611,IC50,=,18,NM,,,,,,,,,,,,,,Inhibitory concentration against matrix metalloprotease 14,,Potent pyrimidinetrione-based inhibitors of MMP-13 with enhanced selectivity over MMP-14.,Bioorg. Med. Chem. Lett.,2005,15,7,"Blagg JA, Noe MC, Wolf-Gouveia LA, Reiter LA, Laird ER, Chang SP, Danley DE, Downs JT, Elliott NC, Eskra JD, Griffiths RJ, Hardink JR, Haugeto AI, Jones CS, Liras JL, Lopresti-Morrow LL, Mitchell PG, Pandit J, Robinson RP, Subramanyam C, Vaughn-Bowser ML, Yocum SA",,305128,DTCT0024091,1752534,DTCC00384536,821901,18917
CHEMBL183848,P50281,,TUUOOTOFTLPOMW-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,15780611,IC50,=,11,NM,,,,,,,,,,,,,,Inhibitory concentration against matrix metalloprotease 14,,Potent pyrimidinetrione-based inhibitors of MMP-13 with enhanced selectivity over MMP-14.,Bioorg. Med. Chem. Lett.,2005,15,7,"Blagg JA, Noe MC, Wolf-Gouveia LA, Reiter LA, Laird ER, Chang SP, Danley DE, Downs JT, Elliott NC, Eskra JD, Griffiths RJ, Hardink JR, Haugeto AI, Jones CS, Liras JL, Lopresti-Morrow LL, Mitchell PG, Pandit J, Robinson RP, Subramanyam C, Vaughn-Bowser ML, Yocum SA",,305128,DTCT0024091,1752543,DTCC00384424,271737,18917
CHEMBL187092,P50281,,LTVIJEFEZVFIST-AZUAARDMSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,15953722,IC50,=,83,NM,,,,,,,,,,,,,,Inhibitory concentration against MMP-14,,Discovery of 3-OH-3-methylpipecolic hydroxamates: potent orally active inhibitors of aggrecanase and MMP-13.,Bioorg. Med. Chem. Lett.,2005,15,14,"Noe MC, Natarajan V, Snow SL, Wolf-Gouveia LA, Mitchell PG, Lopresti-Morrow L, Reeves LM, Yocum SA, Otterness I, Bliven MA, Carty TJ, Barberia JT, Sweeney FJ, Liras JL, Vaughn M",,304645,DTCT0024091,1774127,DTCC00390625,681417,18571
CHEMBL187092,P50281,,LTVIJEFEZVFIST-AZUAARDMSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,25415648,IC50,=,150,NM,,,,,,,,,,,,,,Inhibition of human MMP14 using Mca-PQG1 peptide substrate assessed as substrate cleavage after 2 to 4 hrs,,Identification of potent and selective hydantoin inhibitors of aggrecanase-1 and aggrecanase-2 that are efficacious in both chemical and surgical models of osteoarthritis.,J. Med. Chem.,2014,57,24,"Durham TB, Klimkowski VJ, Rito CJ, Marimuthu J, Toth JL, Liu C, Durbin JD, Stout SL, Adams L, Swearingen C, Lin C, Chambers MG, Thirunavukkarasu K, Wiley MR",,1435764,DTCT0024091,14000087,DTCC00390625,708051,60298
CHEMBL187523,P50281,,HJFONKSERLWIGE-DEOSSOPVSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,16005220,IC50,=,2200,NM,,,,,,,,,,,,,,Inhibitory concentration against MMP-14,,Identification of potent and selective MMP-13 inhibitors.,Bioorg. Med. Chem. Lett.,2005,15,18,"Wu J, Rush TS, Hotchandani R, Du X, Geck M, Collins E, Xu ZB, Skotnicki J, Levin JI, Lovering FE",,304646,DTCT0024091,1794811,DTCC00394634,435113,8231
CHEMBL1891384,P50281,,ODVPEBDDOWWMMT-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,,IC50,=,6880,NM,,,,,,,,,,,,,,PubChem BioAssay. SAR confirmation of uHTS hits for a small molecule inhibitors of MT1-MMP activation in a fluorescence assay. (Class of assay: confirmatory) ,active,PUBCHEM BIOASSAY DATA SET,,,,,,,954324,DTCT0024091,12304817,DTCC01140762,1897489,33038
CHEMBL189666,P50281,,BUOFCYNMGVUTSM-DEOSSOPVSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,16005220,IC50,=,5600,NM,,,,,,,,,,,,,,Inhibitory concentration against MMP-14,,Identification of potent and selective MMP-13 inhibitors.,Bioorg. Med. Chem. Lett.,2005,15,18,"Wu J, Rush TS, Hotchandani R, Du X, Geck M, Collins E, Xu ZB, Skotnicki J, Levin JI, Lovering FE",,304646,DTCT0024091,1797554,DTCC00394464,887175,8231
CHEMBL1898956,P50281,,BEHYKBFRROFORA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,,IC50,=,11900,NM,,,,,,,,,,,,,,PubChem BioAssay. Dose Response confirmation of uHTS hits for a small molecule inhibitors of MT1-MMP activation in a fluorescence assay set 1. (Class of assay: confirmatory) ,active,PUBCHEM BIOASSAY DATA SET,,,,,,,954361,DTCT0024091,12209098,DTCC01148116,1220128,33038
CHEMBL1898956,P50281,,BEHYKBFRROFORA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,,IC50,>,80000,NM,,,,,,,,,,,,,,PubChem BioAssay. SAR confirmation of uHTS hits for a small molecule inhibitors of MT1-MMP activation in a fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,954324,DTCT0024091,12304814,DTCC01148116,1222818,33038
CHEMBL189955,P50281,,PXPWUAKZNLIXJV-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,16005220,IC50,=,13900,NM,,,,,,,,,,,,,,Inhibitory concentration against MMP-14,,Identification of potent and selective MMP-13 inhibitors.,Bioorg. Med. Chem. Lett.,2005,15,18,"Wu J, Rush TS, Hotchandani R, Du X, Geck M, Collins E, Xu ZB, Skotnicki J, Levin JI, Lovering FE",,304646,DTCT0024091,1795491,DTCC00394485,239105,8231
CHEMBL191106,P50281,,BRRSHCMZHWWBNJ-KKFPZRRJSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,16005220,IC50,=,20000,NM,,,,,,,,,,,,,,Inhibitory concentration against MMP-14,,Identification of potent and selective MMP-13 inhibitors.,Bioorg. Med. Chem. Lett.,2005,15,18,"Wu J, Rush TS, Hotchandani R, Du X, Geck M, Collins E, Xu ZB, Skotnicki J, Levin JI, Lovering FE",,304646,DTCT0024091,1798370,DTCC00394741,1630851,8231
CHEMBL1914702,P50281,,CRPIWCWIMAOUCX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,21548582,IC50,=,9330,NM,,,,,,,,,,,,,,Inhibition of MMP14,,"Design, synthesis, docking, and biological evaluation of novel diazide-containing isoxazole- and pyrazole-based histone deacetylase probes.",J. Med. Chem.,2011,54,13,"Neelarapu R, Holzle DL, Velaparthi S, Bai H, Brunsteiner M, Blond SY, Petukhov PA",,785744,DTCT0024091,7517249,DTCC01159563,153491,46348
CHEMBL1914702,P50281,,CRPIWCWIMAOUCX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,21548582,RATIO IC50,=,22800,,,,,,,,,,,,,,,Selectivity ratio of compound IC50 to GM6001 IC50 for MMP14,,"Design, synthesis, docking, and biological evaluation of novel diazide-containing isoxazole- and pyrazole-based histone deacetylase probes.",J. Med. Chem.,2011,54,13,"Neelarapu R, Holzle DL, Velaparthi S, Bai H, Brunsteiner M, Blond SY, Petukhov PA",,785737,DTCT0024091,7517261,DTCC01159563,153491,46348
CHEMBL1914708,P50281,,IGNPXOQRVRXSKJ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,21548582,ACTIVITY,>,70,%,,,,,,,,,,,,,,Inhibition of MMP14 assessed as activity remaining at 10 mM,,"Design, synthesis, docking, and biological evaluation of novel diazide-containing isoxazole- and pyrazole-based histone deacetylase probes.",J. Med. Chem.,2011,54,13,"Neelarapu R, Holzle DL, Velaparthi S, Bai H, Brunsteiner M, Blond SY, Petukhov PA",,785741,DTCT0024091,7517254,DTCC01159569,185603,46348
CHEMBL1914708,P50281,,IGNPXOQRVRXSKJ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,21548582,RATIO IC50,,,,,,,,,,,,,,,,,Selectivity ratio of compound IC50 to GM6001 IC50 for MMP14,Not Determined,"Design, synthesis, docking, and biological evaluation of novel diazide-containing isoxazole- and pyrazole-based histone deacetylase probes.",J. Med. Chem.,2011,54,13,"Neelarapu R, Holzle DL, Velaparthi S, Bai H, Brunsteiner M, Blond SY, Petukhov PA",,785737,DTCT0024091,7517262,DTCC01159569,185603,46348
CHEMBL191613,P50281,"2,4-DICHLOROPHENYLAMINOMETHYLENEBISPHOSPHONIC ACID",KASHBTOPZJTDFP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,24071448,IC50,>,100000,NM,,,,,,,,,,,,,,Inhibition of MMP14 catalytic domain (unknown origin) using Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 as substrate incubated for 30 mins prior to substrate addition measured after 2 to 4 hrs by fluorometric assay,,Arylamino methylene bisphosphonate derivatives as bone seeking matrix metalloproteinase inhibitors.,Bioorg. Med. Chem.,2013,21,21,"Tauro M, Laghezza A, Loiodice F, Agamennone M, Campestre C, Tortorella P",,990167,DTCT0024091,12628976,DTCC00399306,383982,56259
CHEMBL1927183,P50281,,URQNIKFTQMJDKH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,22088955,IC50,=,51000,NM,,,,,,,,,,,,,,Inhibition of recombinant human MMP14 catalytic domain using Mca-Lys-Pro-Leu-Gly-Leu-Dap(Dnp)-Ala-Arg-NH2 as substrate pre-incubated for 4 hrs before substrate addition measured every 15 secs for 15 mins by fluorimetry,,Identification of novel molecular scaffolds for the design of MMP-13 inhibitors: a first round of lead optimization.,Eur. J. Med. Chem.,2012,47,,"La Pietra V, Marinelli L, Cosconati S, Di Leva FS, Nuti E, Santamaria S, Pugliesi I, Morelli M, Casalini F, Rossello A, La Motta C, Taliani S, Visse R, Nagase H, da Settimo F, Novellino E",,791982,DTCT0024091,7555543,DTCC01165287,2025754,46745
CHEMBL1927184,P50281,,MXDNHABTSLQECK-VEJZVKIUSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,22088955,IC50,=,21000,NM,,,,,,,,,,,,,,Inhibition of recombinant human MMP14 catalytic domain using Mca-Lys-Pro-Leu-Gly-Leu-Dap(Dnp)-Ala-Arg-NH2 as substrate pre-incubated for 4 hrs before substrate addition measured every 15 secs for 15 mins by fluorimetry,,Identification of novel molecular scaffolds for the design of MMP-13 inhibitors: a first round of lead optimization.,Eur. J. Med. Chem.,2012,47,,"La Pietra V, Marinelli L, Cosconati S, Di Leva FS, Nuti E, Santamaria S, Pugliesi I, Morelli M, Casalini F, Rossello A, La Motta C, Taliani S, Visse R, Nagase H, da Settimo F, Novellino E",,791982,DTCT0024091,7555544,DTCC01165288,1480457,46745
CHEMBL1927185,P50281,,KKYDQVAGMODEPF-VMPITWQZSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,22088955,IC50,=,55000,NM,,,,,,,,,,,,,,Inhibition of recombinant human MMP14 catalytic domain using Mca-Lys-Pro-Leu-Gly-Leu-Dap(Dnp)-Ala-Arg-NH2 as substrate pre-incubated for 4 hrs before substrate addition measured every 15 secs for 15 mins by fluorimetry,,Identification of novel molecular scaffolds for the design of MMP-13 inhibitors: a first round of lead optimization.,Eur. J. Med. Chem.,2012,47,,"La Pietra V, Marinelli L, Cosconati S, Di Leva FS, Nuti E, Santamaria S, Pugliesi I, Morelli M, Casalini F, Rossello A, La Motta C, Taliani S, Visse R, Nagase H, da Settimo F, Novellino E",,791982,DTCT0024091,7555545,DTCC01165289,671878,46745
CHEMBL1927186,P50281,,RMYNLYNJRHVJNU-RIYZIHGNSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,22088955,IC50,=,310000,NM,,,,,,,,,,,,,,Inhibition of recombinant human MMP14 catalytic domain using Mca-Lys-Pro-Leu-Gly-Leu-Dap(Dnp)-Ala-Arg-NH2 as substrate pre-incubated for 4 hrs before substrate addition measured every 15 secs for 15 mins by fluorimetry,,Identification of novel molecular scaffolds for the design of MMP-13 inhibitors: a first round of lead optimization.,Eur. J. Med. Chem.,2012,47,,"La Pietra V, Marinelli L, Cosconati S, Di Leva FS, Nuti E, Santamaria S, Pugliesi I, Morelli M, Casalini F, Rossello A, La Motta C, Taliani S, Visse R, Nagase H, da Settimo F, Novellino E",,791982,DTCT0024091,7555546,DTCC01165290,898397,46745
CHEMBL1927187,P50281,,UEOIUIPMEKCWHI-YJBIHYNGSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,22088955,IC50,=,150000,NM,,,,,,,,,,,,,,Inhibition of recombinant human MMP14 catalytic domain using Mca-Lys-Pro-Leu-Gly-Leu-Dap(Dnp)-Ala-Arg-NH2 as substrate pre-incubated for 4 hrs before substrate addition measured every 15 secs for 15 mins by fluorimetry,,Identification of novel molecular scaffolds for the design of MMP-13 inhibitors: a first round of lead optimization.,Eur. J. Med. Chem.,2012,47,,"La Pietra V, Marinelli L, Cosconati S, Di Leva FS, Nuti E, Santamaria S, Pugliesi I, Morelli M, Casalini F, Rossello A, La Motta C, Taliani S, Visse R, Nagase H, da Settimo F, Novellino E",,791982,DTCT0024091,7555547,DTCC01165291,1351218,46745
CHEMBL1939844,P50281,,FTRCUXMVUJZMHT-CYBMUJFWSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,22017477,IC50,=,2200,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP14 using Mca-Lys-Pro-Leu-Gly-Leu-Dap(Dnp)-Ala-Arg-NH2 as substrate preincubated for 4 hrs measured every 15 secs for 20 mins by fluorescence analysis,,"Novel 1-hydroxypiperazine-2,6-diones as new leads in the inhibition of metalloproteinases.",J. Med. Chem.,2011,54,24,"Marques SM, Tuccinardi T, Nuti E, Santamaria S, André V, Rossello A, Martinelli A, Santos MA",,799128,DTCT0024091,7595892,DTCC01171473,2071098,47023
CHEMBL1939845,P50281,,JVBFGGAYMSJQBZ-GOSISDBHSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,22017477,IC50,=,3900,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP14 using Mca-Lys-Pro-Leu-Gly-Leu-Dap(Dnp)-Ala-Arg-NH2 as substrate preincubated for 4 hrs measured every 15 secs for 20 mins by fluorescence analysis,,"Novel 1-hydroxypiperazine-2,6-diones as new leads in the inhibition of metalloproteinases.",J. Med. Chem.,2011,54,24,"Marques SM, Tuccinardi T, Nuti E, Santamaria S, André V, Rossello A, Martinelli A, Santos MA",,799128,DTCT0024091,7595893,DTCC01171474,1811871,47023
CHEMBL1939846,P50281,,RQCBSNJRFVZHOS-GOSISDBHSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,22017477,IC50,=,83,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP14 using Mca-Lys-Pro-Leu-Gly-Leu-Dap(Dnp)-Ala-Arg-NH2 as substrate preincubated for 4 hrs measured every 15 secs for 20 mins by fluorescence analysis,,"Novel 1-hydroxypiperazine-2,6-diones as new leads in the inhibition of metalloproteinases.",J. Med. Chem.,2011,54,24,"Marques SM, Tuccinardi T, Nuti E, Santamaria S, André V, Rossello A, Martinelli A, Santos MA",,799128,DTCT0024091,7595894,DTCC01171475,1461560,47023
CHEMBL1939861,P50281,,JIKNCQOTMSZCCM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,22017539,IC50,>,500000,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP14 after 60 mins by fluorimetry,,Fragment-based discovery of indole inhibitors of matrix metalloproteinase-13.,J. Med. Chem.,2011,54,23,"Taylor SJ, Abeywardane A, Liang S, Muegge I, Padyana AK, Xiong Z, Hill-Drzewi M, Farmer B, Li X, Collins B, Li JX, Heim-Riether A, Proudfoot J, Zhang Q, Goldberg D, Zuvela-Jelaska L, Zaher H, Li J, Farrow NA",,799146,DTCT0024091,7595964,DTCC01171489,1448052,47024
CHEMBL1939862,P50281,,HNSDWMLOQWSYEZ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,22017539,IC50,>,500000,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP14 after 60 mins by fluorimetry,,Fragment-based discovery of indole inhibitors of matrix metalloproteinase-13.,J. Med. Chem.,2011,54,23,"Taylor SJ, Abeywardane A, Liang S, Muegge I, Padyana AK, Xiong Z, Hill-Drzewi M, Farmer B, Li X, Collins B, Li JX, Heim-Riether A, Proudfoot J, Zhang Q, Goldberg D, Zuvela-Jelaska L, Zaher H, Li J, Farrow NA",,799146,DTCT0024091,7596004,DTCC01171490,1027241,47024
CHEMBL1939863,P50281,,NSMIRZBXLNLXDX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,22017539,IC50,>,500000,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP14 after 60 mins by fluorimetry,,Fragment-based discovery of indole inhibitors of matrix metalloproteinase-13.,J. Med. Chem.,2011,54,23,"Taylor SJ, Abeywardane A, Liang S, Muegge I, Padyana AK, Xiong Z, Hill-Drzewi M, Farmer B, Li X, Collins B, Li JX, Heim-Riether A, Proudfoot J, Zhang Q, Goldberg D, Zuvela-Jelaska L, Zaher H, Li J, Farrow NA",,799146,DTCT0024091,7596005,DTCC01171491,1766143,47024
CHEMBL1939864,P50281,,DUIOAVKMTLORSS-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,22017539,IC50,>,500000,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP14 after 60 mins by fluorimetry,,Fragment-based discovery of indole inhibitors of matrix metalloproteinase-13.,J. Med. Chem.,2011,54,23,"Taylor SJ, Abeywardane A, Liang S, Muegge I, Padyana AK, Xiong Z, Hill-Drzewi M, Farmer B, Li X, Collins B, Li JX, Heim-Riether A, Proudfoot J, Zhang Q, Goldberg D, Zuvela-Jelaska L, Zaher H, Li J, Farrow NA",,799146,DTCT0024091,7596006,DTCC01171492,994770,47024
CHEMBL1939865,P50281,,NPIPEGMWIPYGFS-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,22017539,IC50,>,500000,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP14 after 60 mins by fluorimetry,,Fragment-based discovery of indole inhibitors of matrix metalloproteinase-13.,J. Med. Chem.,2011,54,23,"Taylor SJ, Abeywardane A, Liang S, Muegge I, Padyana AK, Xiong Z, Hill-Drzewi M, Farmer B, Li X, Collins B, Li JX, Heim-Riether A, Proudfoot J, Zhang Q, Goldberg D, Zuvela-Jelaska L, Zaher H, Li J, Farrow NA",,799146,DTCT0024091,7596007,DTCC01171493,1480531,47024
CHEMBL1939866,P50281,,BPAGZGRJYMKXTM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,22017539,IC50,>,500000,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP14 after 60 mins by fluorimetry,,Fragment-based discovery of indole inhibitors of matrix metalloproteinase-13.,J. Med. Chem.,2011,54,23,"Taylor SJ, Abeywardane A, Liang S, Muegge I, Padyana AK, Xiong Z, Hill-Drzewi M, Farmer B, Li X, Collins B, Li JX, Heim-Riether A, Proudfoot J, Zhang Q, Goldberg D, Zuvela-Jelaska L, Zaher H, Li J, Farrow NA",,799146,DTCT0024091,7596008,DTCC01171494,1155846,47024
CHEMBL1939867,P50281,,LGCJHSHDRDEELV-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,22017539,IC50,>,500000,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP14 after 60 mins by fluorimetry,,Fragment-based discovery of indole inhibitors of matrix metalloproteinase-13.,J. Med. Chem.,2011,54,23,"Taylor SJ, Abeywardane A, Liang S, Muegge I, Padyana AK, Xiong Z, Hill-Drzewi M, Farmer B, Li X, Collins B, Li JX, Heim-Riether A, Proudfoot J, Zhang Q, Goldberg D, Zuvela-Jelaska L, Zaher H, Li J, Farrow NA",,799146,DTCT0024091,7596009,DTCC01171495,1577168,47024
CHEMBL1939868,P50281,,YCALHTWCQXREQN-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,22017539,IC50,>,500000,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP14 after 60 mins by fluorimetry,,Fragment-based discovery of indole inhibitors of matrix metalloproteinase-13.,J. Med. Chem.,2011,54,23,"Taylor SJ, Abeywardane A, Liang S, Muegge I, Padyana AK, Xiong Z, Hill-Drzewi M, Farmer B, Li X, Collins B, Li JX, Heim-Riether A, Proudfoot J, Zhang Q, Goldberg D, Zuvela-Jelaska L, Zaher H, Li J, Farrow NA",,799146,DTCT0024091,7596010,DTCC01171496,1383924,47024
CHEMBL1939869,P50281,,LOJFRPMFTHNIRX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,22017539,IC50,=,51000,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP14 after 60 mins by fluorimetry,,Fragment-based discovery of indole inhibitors of matrix metalloproteinase-13.,J. Med. Chem.,2011,54,23,"Taylor SJ, Abeywardane A, Liang S, Muegge I, Padyana AK, Xiong Z, Hill-Drzewi M, Farmer B, Li X, Collins B, Li JX, Heim-Riether A, Proudfoot J, Zhang Q, Goldberg D, Zuvela-Jelaska L, Zaher H, Li J, Farrow NA",,799146,DTCT0024091,7596011,DTCC01171497,348592,47024
CHEMBL1939870,P50281,,HESNUJSXTQZPIZ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,22017539,IC50,=,225000,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP14 after 60 mins by fluorimetry,,Fragment-based discovery of indole inhibitors of matrix metalloproteinase-13.,J. Med. Chem.,2011,54,23,"Taylor SJ, Abeywardane A, Liang S, Muegge I, Padyana AK, Xiong Z, Hill-Drzewi M, Farmer B, Li X, Collins B, Li JX, Heim-Riether A, Proudfoot J, Zhang Q, Goldberg D, Zuvela-Jelaska L, Zaher H, Li J, Farrow NA",,799146,DTCT0024091,7596012,DTCC01171498,1286070,47024
CHEMBL1939871,P50281,,BPFTZTNLEWSFNX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,22017539,IC50,>,500000,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP14 after 60 mins by fluorimetry,,Fragment-based discovery of indole inhibitors of matrix metalloproteinase-13.,J. Med. Chem.,2011,54,23,"Taylor SJ, Abeywardane A, Liang S, Muegge I, Padyana AK, Xiong Z, Hill-Drzewi M, Farmer B, Li X, Collins B, Li JX, Heim-Riether A, Proudfoot J, Zhang Q, Goldberg D, Zuvela-Jelaska L, Zaher H, Li J, Farrow NA",,799146,DTCT0024091,7596013,DTCC01171499,1092535,47024
CHEMBL1939872,P50281,,FOLNSFQIWULSJC-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,22017539,IC50,=,15000,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP14 after 60 mins by fluorimetry,,Fragment-based discovery of indole inhibitors of matrix metalloproteinase-13.,J. Med. Chem.,2011,54,23,"Taylor SJ, Abeywardane A, Liang S, Muegge I, Padyana AK, Xiong Z, Hill-Drzewi M, Farmer B, Li X, Collins B, Li JX, Heim-Riether A, Proudfoot J, Zhang Q, Goldberg D, Zuvela-Jelaska L, Zaher H, Li J, Farrow NA",,799146,DTCT0024091,7596014,DTCC01171500,1027242,47024
CHEMBL1939873,P50281,,BUDKKUJVRGJAJW-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,22017539,IC50,=,41000,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP14 after 60 mins by fluorimetry,,Fragment-based discovery of indole inhibitors of matrix metalloproteinase-13.,J. Med. Chem.,2011,54,23,"Taylor SJ, Abeywardane A, Liang S, Muegge I, Padyana AK, Xiong Z, Hill-Drzewi M, Farmer B, Li X, Collins B, Li JX, Heim-Riether A, Proudfoot J, Zhang Q, Goldberg D, Zuvela-Jelaska L, Zaher H, Li J, Farrow NA",,799146,DTCT0024091,7596015,DTCC01171501,51933,47024
CHEMBL1939874,P50281,,XYAPTVNWZXNGOT-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,22017539,IC50,>,500000,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP14 after 60 mins by fluorimetry,,Fragment-based discovery of indole inhibitors of matrix metalloproteinase-13.,J. Med. Chem.,2011,54,23,"Taylor SJ, Abeywardane A, Liang S, Muegge I, Padyana AK, Xiong Z, Hill-Drzewi M, Farmer B, Li X, Collins B, Li JX, Heim-Riether A, Proudfoot J, Zhang Q, Goldberg D, Zuvela-Jelaska L, Zaher H, Li J, Farrow NA",,799146,DTCT0024091,7596016,DTCC01171502,121152,47024
CHEMBL1939875,P50281,,REANBRVQFZEMPZ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,22017539,IC50,=,11000,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP14 after 60 mins by fluorimetry,,Fragment-based discovery of indole inhibitors of matrix metalloproteinase-13.,J. Med. Chem.,2011,54,23,"Taylor SJ, Abeywardane A, Liang S, Muegge I, Padyana AK, Xiong Z, Hill-Drzewi M, Farmer B, Li X, Collins B, Li JX, Heim-Riether A, Proudfoot J, Zhang Q, Goldberg D, Zuvela-Jelaska L, Zaher H, Li J, Farrow NA",,799146,DTCT0024091,7596017,DTCC01171503,994771,47024
CHEMBL1939876,P50281,,MMJPVSDTLGFIQW-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,22017539,IC50,=,8300,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP14 after 60 mins by fluorimetry,,Fragment-based discovery of indole inhibitors of matrix metalloproteinase-13.,J. Med. Chem.,2011,54,23,"Taylor SJ, Abeywardane A, Liang S, Muegge I, Padyana AK, Xiong Z, Hill-Drzewi M, Farmer B, Li X, Collins B, Li JX, Heim-Riether A, Proudfoot J, Zhang Q, Goldberg D, Zuvela-Jelaska L, Zaher H, Li J, Farrow NA",,799146,DTCT0024091,7596018,DTCC01171504,1734238,47024
CHEMBL1939877,P50281,,UHHFYGOUQISNPH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,22017539,IC50,>,22000,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP14 after 60 mins by fluorimetry,,Fragment-based discovery of indole inhibitors of matrix metalloproteinase-13.,J. Med. Chem.,2011,54,23,"Taylor SJ, Abeywardane A, Liang S, Muegge I, Padyana AK, Xiong Z, Hill-Drzewi M, Farmer B, Li X, Collins B, Li JX, Heim-Riether A, Proudfoot J, Zhang Q, Goldberg D, Zuvela-Jelaska L, Zaher H, Li J, Farrow NA",,799146,DTCT0024091,7596019,DTCC01171505,283179,47024
CHEMBL1939878,P50281,,DMKUTALHEIQGEX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,22017539,IC50,>,22000,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP14 after 60 mins by fluorimetry,,Fragment-based discovery of indole inhibitors of matrix metalloproteinase-13.,J. Med. Chem.,2011,54,23,"Taylor SJ, Abeywardane A, Liang S, Muegge I, Padyana AK, Xiong Z, Hill-Drzewi M, Farmer B, Li X, Collins B, Li JX, Heim-Riether A, Proudfoot J, Zhang Q, Goldberg D, Zuvela-Jelaska L, Zaher H, Li J, Farrow NA",,799146,DTCT0024091,7596020,DTCC01171506,1124652,47024
CHEMBL1940296,P50281,,CWFNNQMBLVACQD-QHCPKHFHSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,22153941,IC50,>,100000,NM,,,,,,,,,,,,,,Inhibition of MMP14 using Mca-Pro-cyclohexyl-Ala-Gly-Nva-His-Ala- Dap(Dnp)-NH2 as substrate by fluorometric analysis,,Lead optimisation of selective non-zinc binding inhibitors of MMP13. Part 2.,Bioorg. Med. Chem. Lett.,2012,22,1,"De Savi C, Morley AD, Nash I, Karoutchi G, Page K, Ting A, Gerhardt S",,798835,DTCT0024091,7601054,DTCC01171915,1124659,47049
CHEMBL1940308,P50281,,RMPYEISUTHEMLW-NDEPHWFRSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,22153941,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibition of MMP14 using Mca-Pro-cyclohexyl-Ala-Gly-Nva-His-Ala- Dap(Dnp)-NH2 as substrate by fluorometric analysis,,Lead optimisation of selective non-zinc binding inhibitors of MMP13. Part 2.,Bioorg. Med. Chem. Lett.,2012,22,1,"De Savi C, Morley AD, Nash I, Karoutchi G, Page K, Ting A, Gerhardt S",,798835,DTCT0024091,7601053,DTCC01171923,574793,47049
CHEMBL1940308,P50281,,RMPYEISUTHEMLW-NDEPHWFRSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,22153941,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibition of MMP14 using Mca-Pro-cyclohexyl-Ala-Gly-Nva-His-Ala- Dap(Dnp)-NH2 as substrate by fluorometric analysis,,Lead optimisation of selective non-zinc binding inhibitors of MMP13. Part 2.,Bioorg. Med. Chem. Lett.,2012,22,1,"De Savi C, Morley AD, Nash I, Karoutchi G, Page K, Ting A, Gerhardt S",,798835,DTCT0024091,7601066,DTCC01171923,574793,47049
CHEMBL1940309,P50281,,WHUKRVZMYYJSJL-NDEPHWFRSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,22153941,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibition of MMP14 using Mca-Pro-cyclohexyl-Ala-Gly-Nva-His-Ala- Dap(Dnp)-NH2 as substrate by fluorometric analysis,,Lead optimisation of selective non-zinc binding inhibitors of MMP13. Part 2.,Bioorg. Med. Chem. Lett.,2012,22,1,"De Savi C, Morley AD, Nash I, Karoutchi G, Page K, Ting A, Gerhardt S",,798835,DTCT0024091,7601065,DTCC01171924,1448056,47049
CHEMBL1940310,P50281,,IERBLZLEQYZHMU-LJAQVGFWSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,22153941,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibition of MMP14 using Mca-Pro-cyclohexyl-Ala-Gly-Nva-His-Ala- Dap(Dnp)-NH2 as substrate by fluorometric analysis,,Lead optimisation of selective non-zinc binding inhibitors of MMP13. Part 2.,Bioorg. Med. Chem. Lett.,2012,22,1,"De Savi C, Morley AD, Nash I, Karoutchi G, Page K, Ting A, Gerhardt S",,798835,DTCT0024091,7601063,DTCC01171925,1674314,47049
CHEMBL1940311,P50281,,LIYRHLZYJZBQCM-HKBQPEDESA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,22153941,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibition of MMP14 using Mca-Pro-cyclohexyl-Ala-Gly-Nva-His-Ala- Dap(Dnp)-NH2 as substrate by fluorometric analysis,,Lead optimisation of selective non-zinc binding inhibitors of MMP13. Part 2.,Bioorg. Med. Chem. Lett.,2012,22,1,"De Savi C, Morley AD, Nash I, Karoutchi G, Page K, Ting A, Gerhardt S",,798835,DTCT0024091,7601062,DTCC01171926,1416228,47049
CHEMBL1940312,P50281,,QAOWEZMLHINPHR-LJAQVGFWSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,22153941,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibition of MMP14 using Mca-Pro-cyclohexyl-Ala-Gly-Nva-His-Ala- Dap(Dnp)-NH2 as substrate by fluorometric analysis,,Lead optimisation of selective non-zinc binding inhibitors of MMP13. Part 2.,Bioorg. Med. Chem. Lett.,2012,22,1,"De Savi C, Morley AD, Nash I, Karoutchi G, Page K, Ting A, Gerhardt S",,798835,DTCT0024091,7601061,DTCC01171927,1830857,47049
CHEMBL1940313,P50281,,BVTIVQKMMMOOTF-PMERELPUSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,22153941,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibition of MMP14 using Mca-Pro-cyclohexyl-Ala-Gly-Nva-His-Ala- Dap(Dnp)-NH2 as substrate by fluorometric analysis,,Lead optimisation of selective non-zinc binding inhibitors of MMP13. Part 2.,Bioorg. Med. Chem. Lett.,2012,22,1,"De Savi C, Morley AD, Nash I, Karoutchi G, Page K, Ting A, Gerhardt S",,798835,DTCT0024091,7601060,DTCC01171928,1318627,47049
CHEMBL1940314,P50281,,OMQWCWIEQOEJBD-MHZLTWQESA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,22153941,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibition of MMP14 using Mca-Pro-cyclohexyl-Ala-Gly-Nva-His-Ala- Dap(Dnp)-NH2 as substrate by fluorometric analysis,,Lead optimisation of selective non-zinc binding inhibitors of MMP13. Part 2.,Bioorg. Med. Chem. Lett.,2012,22,1,"De Savi C, Morley AD, Nash I, Karoutchi G, Page K, Ting A, Gerhardt S",,798835,DTCT0024091,7601059,DTCC01171929,1286076,47049
CHEMBL1940315,P50281,,IOEYWFCDGXVEFG-JVHFYALYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,22153941,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibition of MMP14 using Mca-Pro-cyclohexyl-Ala-Gly-Nva-His-Ala- Dap(Dnp)-NH2 as substrate by fluorometric analysis,,Lead optimisation of selective non-zinc binding inhibitors of MMP13. Part 2.,Bioorg. Med. Chem. Lett.,2012,22,1,"De Savi C, Morley AD, Nash I, Karoutchi G, Page K, Ting A, Gerhardt S",,798835,DTCT0024091,7601052,DTCC01171930,1734240,47049
CHEMBL1940315,P50281,,IOEYWFCDGXVEFG-JVHFYALYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,22153941,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibition of MMP14 using Mca-Pro-cyclohexyl-Ala-Gly-Nva-His-Ala- Dap(Dnp)-NH2 as substrate by fluorometric analysis,,Lead optimisation of selective non-zinc binding inhibitors of MMP13. Part 2.,Bioorg. Med. Chem. Lett.,2012,22,1,"De Savi C, Morley AD, Nash I, Karoutchi G, Page K, Ting A, Gerhardt S",,798835,DTCT0024091,7601057,DTCC01171930,1734241,47049
CHEMBL1940315,P50281,,IOEYWFCDGXVEFG-JVHFYALYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,22153941,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibition of MMP14 using Mca-Pro-cyclohexyl-Ala-Gly-Nva-His-Ala- Dap(Dnp)-NH2 as substrate by fluorometric analysis,,Lead optimisation of selective non-zinc binding inhibitors of MMP13. Part 2.,Bioorg. Med. Chem. Lett.,2012,22,1,"De Savi C, Morley AD, Nash I, Karoutchi G, Page K, Ting A, Gerhardt S",,798835,DTCT0024091,7601058,DTCC01171930,1734240,47049
CHEMBL1940316,P50281,,NMPAJDNRYQXHBH-XGCAABAXSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,22153941,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibition of MMP14 using Mca-Pro-cyclohexyl-Ala-Gly-Nva-His-Ala- Dap(Dnp)-NH2 as substrate by fluorometric analysis,,Lead optimisation of selective non-zinc binding inhibitors of MMP13. Part 2.,Bioorg. Med. Chem. Lett.,2012,22,1,"De Savi C, Morley AD, Nash I, Karoutchi G, Page K, Ting A, Gerhardt S",,798835,DTCT0024091,7601056,DTCC01171931,1830858,47049
CHEMBL194377,P50281,,LRMGKWDRORXPRE-SANMLTNESA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,16153831,IC50,=,30000,NM,,,,,,,,,,,,,,Inhibitory concentration against MMP-14,,Synthesis and SAR of highly selective MMP-13 inhibitors.,Bioorg. Med. Chem. Lett.,2005,15,22,"Li J, Rush TS, Li W, DeVincentis D, Du X, Hu Y, Thomason JR, Xiang JS, Skotnicki JS, Tam S, Cunningham KM, Chockalingam PS, Morris EA, Levin JI",,321195,DTCT0024091,1860397,DTCC00407675,110120,19837
CHEMBL194377,P50281,,LRMGKWDRORXPRE-SANMLTNESA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,17275314,IC50,=,30199.52,NM,,,,,,,,,,,,,,Inhibition of MMP14,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458934,DTCT0024091,2258808,DTCC00407675,99396,24803
CHEMBL194430,P50281,,FXZROVPZUUATHR-SANMLTNESA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,16153831,IC50,=,50000,NM,,,,,,,,,,,,,,Inhibitory concentration against MMP-14,,Synthesis and SAR of highly selective MMP-13 inhibitors.,Bioorg. Med. Chem. Lett.,2005,15,22,"Li J, Rush TS, Li W, DeVincentis D, Du X, Hu Y, Thomason JR, Xiang JS, Skotnicki JS, Tam S, Cunningham KM, Chockalingam PS, Morris EA, Levin JI",,321195,DTCT0024091,1860445,DTCC00407681,596206,19837
CHEMBL194430,P50281,,FXZROVPZUUATHR-SANMLTNESA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,17275314,IC50,=,50118.72,NM,,,,,,,,,,,,,,Inhibition of MMP14,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458934,DTCT0024091,2258806,DTCC00407681,585415,24803
CHEMBL1956115,P50281,,GDYIQUFNICPYHF-GOSISDBHSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,22175825,KI,>,10000,NM,,,,,,,,,,,,,,Inhibition of human MMP14,,Potent inhibitors of LpxC for the treatment of Gram-negative infections.,J. Med. Chem.,2012,55,2,"Brown MF, Reilly U, Abramite JA, Arcari JT, Oliver R, Barham RA, Che Y, Chen JM, Collantes EM, Chung SW, Desbonnet C, Doty J, Doroski M, Engtrakul JJ, Harris TM, Huband M, Knafels JD, Leach KL, Liu S, Marfat A, Marra A, McElroy E, Melnick M, Menard CA, Montgomery JI, Mullins L, Noe MC, O'Donnell J, Penzien J, Plummer MS, Price LM, Shanmugasundaram V, Thoma C, Uccello DP, Warmus JS, Wishka DG",,806647,DTCT0024091,7652744,DTCC01177834,866270,47510
CHEMBL1957601,P50281,,CYFUZHPFHKFWQX-INIZCTEOSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,22386984,IC50,,,,,,,,,,,,,,,,,Inhibition of MMP14 catalytic domain using Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 as substrate preincubated for 1 hr prior substrate addition measured after 30 mins by spectrofluorimetry,Not Determined,In silico scaffold evaluation and solid phase approach to identify new gelatinase inhibitors.,Bioorg. Med. Chem.,2012,20,7,"Topai A, Breccia P, Minissi F, Padova A, Marini S, Cerbara I",,805647,DTCT0024091,7640553,DTCC01179286,1642107,47642
CHEMBL1957602,P50281,,UCAJNLLYTGJPBY-HNNXBMFYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,22386984,IC50,,,,,,,,,,,,,,,,,Inhibition of MMP14 catalytic domain using Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 as substrate preincubated for 1 hr prior substrate addition measured after 30 mins by spectrofluorimetry,Not Determined,In silico scaffold evaluation and solid phase approach to identify new gelatinase inhibitors.,Bioorg. Med. Chem.,2012,20,7,"Topai A, Breccia P, Minissi F, Padova A, Marini S, Cerbara I",,805647,DTCT0024091,7640554,DTCC01179287,1798652,47642
CHEMBL1957603,P50281,,WIOGWLUNCZARAP-HNNXBMFYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,22386984,IC50,,,,,,,,,,,,,,,,,Inhibition of MMP14 catalytic domain using Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 as substrate preincubated for 1 hr prior substrate addition measured after 30 mins by spectrofluorimetry,Not Determined,In silico scaffold evaluation and solid phase approach to identify new gelatinase inhibitors.,Bioorg. Med. Chem.,2012,20,7,"Topai A, Breccia P, Minissi F, Padova A, Marini S, Cerbara I",,805647,DTCT0024091,7640555,DTCC01179288,1027325,47642
CHEMBL1957604,P50281,,FYFJMQCWKQDEQR-FZADBTJQSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,22386984,IC50,=,160,NM,,,,,,,,,,,,,,Inhibition of MMP14 catalytic domain using Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 as substrate preincubated for 1 hr prior substrate addition measured after 30 mins by spectrofluorimetry,,In silico scaffold evaluation and solid phase approach to identify new gelatinase inhibitors.,Bioorg. Med. Chem.,2012,20,7,"Topai A, Breccia P, Minissi F, Padova A, Marini S, Cerbara I",,805647,DTCT0024091,7640556,DTCC01179289,1609806,47642
CHEMBL1957605,P50281,,VVEIZVKRPYJCPP-HNNXBMFYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,22386984,IC50,=,3800,NM,,,,,,,,,,,,,,Inhibition of MMP14 catalytic domain using Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 as substrate preincubated for 1 hr prior substrate addition measured after 30 mins by spectrofluorimetry,,In silico scaffold evaluation and solid phase approach to identify new gelatinase inhibitors.,Bioorg. Med. Chem.,2012,20,7,"Topai A, Breccia P, Minissi F, Padova A, Marini S, Cerbara I",,805647,DTCT0024091,7640557,DTCC01179290,1862951,47642
CHEMBL1957606,P50281,,LXQUQEBAZBLBEJ-HNNXBMFYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,22386984,IC50,=,5,NM,,,,,,,,,,,,,,Inhibition of MMP14 catalytic domain using Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 as substrate preincubated for 1 hr prior substrate addition measured after 30 mins by spectrofluorimetry,,In silico scaffold evaluation and solid phase approach to identify new gelatinase inhibitors.,Bioorg. Med. Chem.,2012,20,7,"Topai A, Breccia P, Minissi F, Padova A, Marini S, Cerbara I",,805647,DTCT0024091,7640558,DTCC01179291,1513073,47642
CHEMBL19611,P50281,ILOMASTAT,NITYDPDXAAFEIT-DYVFJYSZSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,9548812,IC50,=,13.4,NM,,,,,,,,,,,,,,Activity against deletion mutant of MT1-MMP lacking the transmembrane domain (deltaMT1),,Inhibition of membrane-type 1 matrix metalloproteinase by hydroxamate inhibitors: an examination of the subsite pocket.,J. Med. Chem.,1998,41,8,"Yamamoto M, Tsujishita H, Hori N, Ohishi Y, Inoue S, Ikeda S, Okada Y",,217867,DTCT0024091,997034,DTCC00151638,1884891,15116
CHEMBL19611,P50281,ILOMASTAT,NITYDPDXAAFEIT-DYVFJYSZSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,14684295,IC50,=,23,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-14 (MMP-14),,Tetrahydroisoquinoline based sulfonamide hydroxamates as potent matrix metalloproteinase inhibitors.,Bioorg. Med. Chem. Lett.,2004,14,1,"Ma D, Wu W, Yang G, Li J, Li J, Ye Q",,106791,DTCT0024091,877404,DTCC00151638,1883350,6330
CHEMBL19611,P50281,ILOMASTAT,NITYDPDXAAFEIT-DYVFJYSZSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,16420030,IC50,=,23,NM,,,,,,,,,,,,,,Inhibitory activity against MMP14,,Selective inhibition of matrix metalloproteinase isozymes and in vivo protection against emphysema by substituted gamma-keto carboxylic acids.,J. Med. Chem.,2006,49,2,"Ma D, Jiang Y, Chen F, Gong LK, Ding K, Xu Y, Wang R, Ge A, Ren J, Li J, Li J, Ye Q",,330171,DTCT0024091,1886110,DTCC00151638,1872716,20234
CHEMBL19611,P50281,ILOMASTAT,NITYDPDXAAFEIT-DYVFJYSZSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,17512742,IC50,=,13.4,NM,,,,,,,,,,,,,,Inhibition of MMP14,,Simultaneous presence of unsaturation and long alkyl chain at P'1 of Ilomastat confers selectivity for gelatinase A (MMP-2) over gelatinase B (MMP-9) inhibition as shown by molecular modelling studies.,Bioorg. Med. Chem.,2007,15,14,"Moroy G, Denhez C, El Mourabit H, Toribio A, Dassonville A, Decarme M, Renault JH, Mirand C, Bellon G, Sapi J, Alix AJ, Hornebeck W, Bourguet E",,447908,DTCT0024091,2176041,DTCC00151638,1873251,23716
CHEMBL19611,P50281,ILOMASTAT,NITYDPDXAAFEIT-DYVFJYSZSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,17623656,IC50,=,4.7,NM,,,,,,,,,,,,,,Inhibition of MMP14 catalytic domain,,Discovery and characterization of a novel inhibitor of matrix metalloprotease-13 that reduces cartilage damage in vivo without joint fibroplasia side effects.,J. Biol. Chem.,2007,282,38,"Johnson AR, Pavlovsky AG, Ortwine DF, Prior F, Man CF, Bornemeier DA, Banotai CA, Mueller WT, McConnell P, Yan C, Baragi V, Lesch C, Roark WH, Wilson M, Datta K, Guzman R, Han HK, Dyer RD",,507877,DTCT0024091,2388633,DTCC00151638,1885151,29282
CHEMBL19611,P50281,ILOMASTAT,NITYDPDXAAFEIT-DYVFJYSZSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,18782669,IC50,=,5.2,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP14 catalytic domain by spectrofluorimeter,,Introduction of the 4-(4-bromophenyl)benzenesulfonyl group to hydrazide analogs of Ilomastat leads to potent gelatinase B (MMP-9) inhibitors with improved selectivity.,Bioorg. Med. Chem.,2008,16,18,"Ledour G, Moroy G, Rouffet M, Bourguet E, Guillaume D, Decarme M, Elmourabit H, Augé F, Alix AJ, Laronze JY, Bellon G, Hornebeck W, Sapi J",,557956,DTCT0024091,2791165,DTCC00151638,1873635,31586
CHEMBL19611,P50281,ILOMASTAT,NITYDPDXAAFEIT-DYVFJYSZSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,21548582,IC50,=,0.41,NM,,,,,,,,,,,,,,Inhibition of MMP14,,"Design, synthesis, docking, and biological evaluation of novel diazide-containing isoxazole- and pyrazole-based histone deacetylase probes.",J. Med. Chem.,2011,54,13,"Neelarapu R, Holzle DL, Velaparthi S, Bai H, Brunsteiner M, Blond SY, Petukhov PA",,785744,DTCT0024091,7517250,DTCC00151638,1895024,46348
CHEMBL19611,P50281,ILOMASTAT,NITYDPDXAAFEIT-DYVFJYSZSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,23376997,IC50,=,4.7,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP14 catalytic domain using Mca-Lys-Pro- Leu-Gly-Leu-Dap(Dnp)-Ala-Arg-NH2 as substrate incubated for 2 hrs prior to substrate addition measured every 15 secs for 15 mins by fluorometric analysis,,Arylsulfonamide inhibitors of aggrecanases as potential therapeutic agents for osteoarthritis: Synthesis and biological evaluation.,Eur. J. Med. Chem.,2013,62,,"Nuti E, Santamaria S, Casalini F, Yamamoto K, Marinelli L, La Pietra V, Novellino E, Orlandini E, Nencetti S, Marini AM, Salerno S, Taliani S, Da Settimo F, Nagase H, Rossello A",,948651,DTCT0024091,11842581,DTCC00151638,1877524,53978
CHEMBL19623,P50281,,KEPYRBFIGNMAQF-MJGOQNOKSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,9548812,IC50,=,105,NM,,,,,,,,,,,,,,Activity against deletion mutant of MT1-MMP lacking the transmembrane domain (deltaMT1),,Inhibition of membrane-type 1 matrix metalloproteinase by hydroxamate inhibitors: an examination of the subsite pocket.,J. Med. Chem.,1998,41,8,"Yamamoto M, Tsujishita H, Hori N, Ohishi Y, Inoue S, Ikeda S, Okada Y",,217867,DTCT0024091,982751,DTCC00151639,1917024,15116
CHEMBL196647,P50281,,YZYVVJVNDAWVKA-NCRNUEESSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,15837315,IC50,=,1490,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-14 in MMPi assay,,A new development of matrix metalloproteinase inhibitors: twin hydroxamic acids as potent inhibitors of MMPs.,Bioorg. Med. Chem. Lett.,2005,15,9,"Rossello A, Nuti E, Catalani MP, Carelli P, Orlandini E, Rapposelli S, Tuccinardi T, Atkinson SJ, Murphy G, Balsamo A",,305723,DTCT0024091,1841396,DTCC00403116,1916287,18987
CHEMBL197842,P50281,,WHHAEBOHMHRZGW-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,23376997,IC50,=,71,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP14 catalytic domain using Mca-Lys-Pro- Leu-Gly-Leu-Dap(Dnp)-Ala-Arg-NH2 as substrate incubated for 2 hrs prior to substrate addition measured every 15 secs for 15 mins by fluorometric analysis,,Arylsulfonamide inhibitors of aggrecanases as potential therapeutic agents for osteoarthritis: Synthesis and biological evaluation.,Eur. J. Med. Chem.,2013,62,,"Nuti E, Santamaria S, Casalini F, Yamamoto K, Marinelli L, La Pietra V, Novellino E, Orlandini E, Nencetti S, Marini AM, Salerno S, Taliani S, Da Settimo F, Nagase H, Rossello A",,948651,DTCT0024091,11842583,DTCC00407684,1656720,53978
CHEMBL198039,P50281,,IRPQGYYABIPNQJ-DEOSSOPVSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,16153831,IC50,=,12400,NM,,,,,,,,,,,,,,Inhibitory concentration against MMP-14,,Synthesis and SAR of highly selective MMP-13 inhibitors.,Bioorg. Med. Chem. Lett.,2005,15,22,"Li J, Rush TS, Li W, DeVincentis D, Du X, Hu Y, Thomason JR, Xiang JS, Skotnicki JS, Tam S, Cunningham KM, Chockalingam PS, Morris EA, Levin JI",,321195,DTCT0024091,1860353,DTCC00407671,1048682,19837
CHEMBL198039,P50281,,IRPQGYYABIPNQJ-DEOSSOPVSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,17275314,IC50,=,12302.69,NM,,,,,,,,,,,,,,Inhibition of MMP14,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458934,DTCT0024091,2258810,DTCC00407671,1037856,24803
CHEMBL198262,P50281,,HHHAELOQIYTSIY-DEOSSOPVSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,16153831,IC50,=,15000,NM,,,,,,,,,,,,,,Inhibitory concentration against MMP-14,,Synthesis and SAR of highly selective MMP-13 inhibitors.,Bioorg. Med. Chem. Lett.,2005,15,22,"Li J, Rush TS, Li W, DeVincentis D, Du X, Hu Y, Thomason JR, Xiang JS, Skotnicki JS, Tam S, Cunningham KM, Chockalingam PS, Morris EA, Levin JI",,321195,DTCT0024091,1860307,DTCC00407624,1405256,19837
CHEMBL198262,P50281,,HHHAELOQIYTSIY-DEOSSOPVSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,17275314,IC50,=,15135.61,NM,,,,,,,,,,,,,,Inhibition of MMP14,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458934,DTCT0024091,2258786,DTCC00407624,1394255,24803
CHEMBL198389,P50281,,HAWUDCIVXQTNAF-VWLOTQADSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,16153831,IC50,,,,,,,,,,,,,,,,,Inhibitory concentration against MMP-14; - = not available,Not Determined,Synthesis and SAR of highly selective MMP-13 inhibitors.,Bioorg. Med. Chem. Lett.,2005,15,22,"Li J, Rush TS, Li W, DeVincentis D, Du X, Hu Y, Thomason JR, Xiang JS, Skotnicki JS, Tam S, Cunningham KM, Chockalingam PS, Morris EA, Levin JI",,321302,DTCT0024091,1860364,DTCC00407672,304937,19837
CHEMBL19843,P50281,,OFCWIPGKPUJTDP-CFVMTHIKSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,9548812,IC50,=,56,NM,,,,,,,,,,,,,,Activity against deletion mutant of MT1-MMP lacking the transmembrane domain (deltaMT1),,Inhibition of membrane-type 1 matrix metalloproteinase by hydroxamate inhibitors: an examination of the subsite pocket.,J. Med. Chem.,1998,41,8,"Yamamoto M, Tsujishita H, Hori N, Ohishi Y, Inoue S, Ikeda S, Okada Y",,217867,DTCT0024091,1012775,DTCC00151473,305658,15116
CHEMBL1986504,P50281,,KARVXBYKRRJYIH-LBBNCXDASA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,,IC50,=,31100,NM,,,,,,,,,,,,,,PubChem BioAssay. Dose Response confirmation of uHTS hits for a small molecule inhibitors of MT1-MMP activation in a fluorescence assay set 2. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,954348,DTCT0024091,12216202,DTCC01202582,1473662,33038
CHEMBL198778,P50281,,YJRJYIQWWPZSTM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,23376997,IC50,=,4,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP14 catalytic domain using Mca-Lys-Pro- Leu-Gly-Leu-Dap(Dnp)-Ala-Arg-NH2 as substrate incubated for 2 hrs prior to substrate addition measured every 15 secs for 15 mins by fluorometric analysis,,Arylsulfonamide inhibitors of aggrecanases as potential therapeutic agents for osteoarthritis: Synthesis and biological evaluation.,Eur. J. Med. Chem.,2013,62,,"Nuti E, Santamaria S, Casalini F, Yamamoto K, Marinelli L, La Pietra V, Novellino E, Orlandini E, Nencetti S, Marini AM, Salerno S, Taliani S, Da Settimo F, Nagase H, Rossello A",,948651,DTCT0024091,11842586,DTCC00407760,913494,53978
CHEMBL199018,P50281,,XTRLBSLKNQZDBD-VWLOTQADSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,16153831,IC50,,,,,,,,,,,,,,,,,Inhibitory concentration against MMP-14; - = not available,Not Determined,Synthesis and SAR of highly selective MMP-13 inhibitors.,Bioorg. Med. Chem. Lett.,2005,15,22,"Li J, Rush TS, Li W, DeVincentis D, Du X, Hu Y, Thomason JR, Xiang JS, Skotnicki JS, Tam S, Cunningham KM, Chockalingam PS, Morris EA, Levin JI",,321302,DTCT0024091,1860408,DTCC00407676,822181,19837
CHEMBL199241,P50281,,LSKSBHBGNRQEFN-DEOSSOPVSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,16153831,IC50,=,30000,NM,,,,,,,,,,,,,,Inhibitory concentration against MMP-14,,Synthesis and SAR of highly selective MMP-13 inhibitors.,Bioorg. Med. Chem. Lett.,2005,15,22,"Li J, Rush TS, Li W, DeVincentis D, Du X, Hu Y, Thomason JR, Xiang JS, Skotnicki JS, Tam S, Cunningham KM, Chockalingam PS, Morris EA, Levin JI",,321195,DTCT0024091,1860342,DTCC00407670,1787390,19837
CHEMBL199241,P50281,,LSKSBHBGNRQEFN-DEOSSOPVSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,17275314,IC50,=,30199.52,NM,,,,,,,,,,,,,,Inhibition of MMP14,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458934,DTCT0024091,2258785,DTCC00407670,1776500,24803
CHEMBL1992564,P50281,,MYQXDERWPVRDCS-UHFFFAOYSA-M,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,,IC50,=,6170,NM,,,,,,,,,,,,,,PubChem BioAssay. Dose Response confirmation of uHTS hits for a small molecule inhibitors of MT1-MMP activation in a fluorescence assay set 2. (Class of assay: confirmatory) ,active,PUBCHEM BIOASSAY DATA SET,,,,,,,954348,DTCT0024091,12216205,DTCC01208314,315642,33038
CHEMBL199314,P50281,,JIGAPWRVDSTJDZ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,16420030,ACTIVITY,,,,,,,,,,,,,,,,,Inhibitory activity against MMP14 upto 50uM,Not Active,Selective inhibition of matrix metalloproteinase isozymes and in vivo protection against emphysema by substituted gamma-keto carboxylic acids.,J. Med. Chem.,2006,49,2,"Ma D, Jiang Y, Chen F, Gong LK, Ding K, Xu Y, Wang R, Ge A, Ren J, Li J, Li J, Ye Q",,330179,DTCT0024091,1886343,DTCC00412581,98682,20234
CHEMBL19932,P50281,,RHWGGEKVTPKRQW-CFVMTHIKSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,9548812,IC50,=,13,NM,,,,,,,,,,,,,,Activity against deletion mutant of MT1-MMP lacking the transmembrane domain (deltaMT1),,Inhibition of membrane-type 1 matrix metalloproteinase by hydroxamate inhibitors: an examination of the subsite pocket.,J. Med. Chem.,1998,41,8,"Yamamoto M, Tsujishita H, Hori N, Ohishi Y, Inoue S, Ikeda S, Okada Y",,217867,DTCT0024091,982762,DTCC00151595,1308396,15116
CHEMBL20043,P50281,,ONJBMYIEKPLUOX-WBVHZDCISA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,9548812,IC50,=,2.5,NM,,,,,,,,,,,,,,Activity against deletion mutant of MT1-MMP lacking the transmembrane domain (deltaMT1),,Inhibition of membrane-type 1 matrix metalloproteinase by hydroxamate inhibitors: an examination of the subsite pocket.,J. Med. Chem.,1998,41,8,"Yamamoto M, Tsujishita H, Hori N, Ohishi Y, Inoue S, Ikeda S, Okada Y",,217867,DTCT0024091,988379,DTCC00151622,2047648,15116
CHEMBL2010824,P50281,,RKZDOJQKLCPUQZ-AIBWNMTMSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,22342144,KI,>,50000,NM,,,,,,,,,,,,,,Inhibition of MMP-14 using OmniMMP as substrate,,Antidotes to anthrax lethal factor intoxication. Part 3: Evaluation of core structures and further modifications to the C2-side chain.,Bioorg. Med. Chem. Lett.,2012,22,6,"Jiao GS, Kim S, Moayeri M, Crown D, Thai A, Cregar-Hernandez L, McKasson L, Sankaran B, Lehrer A, Wong T, Johns L, Margosiak SA, Leppla SH, Johnson AT",,811341,DTCT0024091,10427366,DTCC01227244,1811993,47718
CHEMBL2012836,P50281,,QKBHUOCFQAXIBG-BPGUCPLFSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,22342144,KI,>,50000,NM,,,,,,,,,,,,,,Inhibition of MMP-14 using OmniMMP as substrate,,Antidotes to anthrax lethal factor intoxication. Part 3: Evaluation of core structures and further modifications to the C2-side chain.,Bioorg. Med. Chem. Lett.,2012,22,6,"Jiao GS, Kim S, Moayeri M, Crown D, Thai A, Cregar-Hernandez L, McKasson L, Sankaran B, Lehrer A, Wong T, Johns L, Margosiak SA, Leppla SH, Johnson AT",,811341,DTCT0024091,10427368,DTCC01227243,653282,47718
CHEMBL2012837,P50281,,AWFIZJRPXRHSEA-BPGUCPLFSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,22342144,KI,>,50000,NM,,,,,,,,,,,,,,Inhibition of MMP-14 using OmniMMP as substrate,,Antidotes to anthrax lethal factor intoxication. Part 3: Evaluation of core structures and further modifications to the C2-side chain.,Bioorg. Med. Chem. Lett.,2012,22,6,"Jiao GS, Kim S, Moayeri M, Crown D, Thai A, Cregar-Hernandez L, McKasson L, Sankaran B, Lehrer A, Wong T, Johns L, Margosiak SA, Leppla SH, Johnson AT",,811341,DTCT0024091,10427364,DTCC01227245,2071212,47718
CHEMBL2012838,P50281,,BPGDVHWVHMDFBK-IQWVOLIVSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,22342144,KI,>,50000,NM,,,,,,,,,,,,,,Inhibition of MMP-14 using OmniMMP as substrate,,Antidotes to anthrax lethal factor intoxication. Part 3: Evaluation of core structures and further modifications to the C2-side chain.,Bioorg. Med. Chem. Lett.,2012,22,6,"Jiao GS, Kim S, Moayeri M, Crown D, Thai A, Cregar-Hernandez L, McKasson L, Sankaran B, Lehrer A, Wong T, Johns L, Margosiak SA, Leppla SH, Johnson AT",,811341,DTCT0024091,10427362,DTCC01227246,814410,47718
CHEMBL20154,P50281,,LPZWIAVKYXCHGC-NVXWUHKLSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,9548812,IC50,=,1.9,NM,,,,,,,,,,,,,,Activity against deletion mutant of MT1-MMP lacking the transmembrane domain (deltaMT1),,Inhibition of membrane-type 1 matrix metalloproteinase by hydroxamate inhibitors: an examination of the subsite pocket.,J. Med. Chem.,1998,41,8,"Yamamoto M, Tsujishita H, Hori N, Ohishi Y, Inoue S, Ikeda S, Okada Y",,217867,DTCT0024091,1004186,DTCC00151563,919876,15116
CHEMBL202875,P50281,,OQWWYXZJKRAMIK-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,16420030,IC50,=,30600,NM,,,,,,,,,,,,,,Inhibitory activity against MMP14,,Selective inhibition of matrix metalloproteinase isozymes and in vivo protection against emphysema by substituted gamma-keto carboxylic acids.,J. Med. Chem.,2006,49,2,"Ma D, Jiang Y, Chen F, Gong LK, Ding K, Xu Y, Wang R, Ge A, Ren J, Li J, Li J, Ye Q",,330171,DTCT0024091,1886124,DTCC00412620,1037173,20234
CHEMBL202932,P50281,,BZVYQWLRCHLAGK-QGZVFWFLSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,17088065,IC50,=,79,NM,,,,,,,,,,,,,,Inhibition of MMP14,,alpha-Biphenylsulfonylamino 2-methylpropyl phosphonates: enantioselective synthesis and selective inhibition of MMPs.,Bioorg. Med. Chem.,2007,15,2,"Biasone A, Tortorella P, Campestre C, Agamennone M, Preziuso S, Chiappini M, Nuti E, Carelli P, Rossello A, Mazza F, Gallina C",,432509,DTCT0024091,2061952,DTCC00413183,1263648,22402
CHEMBL203139,P50281,,IIMXFTNJRIHVRA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,16420030,ACTIVITY,,,,,,,,,,,,,,,,,Inhibitory activity against MMP14 upto 50uM,Not Active,Selective inhibition of matrix metalloproteinase isozymes and in vivo protection against emphysema by substituted gamma-keto carboxylic acids.,J. Med. Chem.,2006,49,2,"Ma D, Jiang Y, Chen F, Gong LK, Ding K, Xu Y, Wang R, Ge A, Ren J, Li J, Li J, Ye Q",,330179,DTCT0024091,1886344,DTCC00412582,1490531,20234
CHEMBL203199,P50281,,WJAZWFDODWLPHA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,16420030,ACTIVITY,,,,,,,,,,,,,,,,,Inhibitory activity against MMP14 upto 50uM,Not Active,Selective inhibition of matrix metalloproteinase isozymes and in vivo protection against emphysema by substituted gamma-keto carboxylic acids.,J. Med. Chem.,2006,49,2,"Ma D, Jiang Y, Chen F, Gong LK, Ding K, Xu Y, Wang R, Ge A, Ren J, Li J, Li J, Ye Q",,330179,DTCT0024091,1885243,DTCC00110088,195410,20234
CHEMBL204357,P50281,SR-973,WICQDDCNCVTFDX-VJGNERBWSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,16473009,KI,=,1200,NM,,,,,,,,,,,,,,Inhibition of MMP14,,Synthesis and evaluation of succinoyl-caprolactam gamma-secretase inhibitors.,Bioorg. Med. Chem. Lett.,2006,16,9,"Thompson LA, Liauw AY, Ramanjulu MM, Kasireddy-Polam P, Mercer SE, Maduskuie TP, Glicksman M, Roach AH, Meredith JE, Liu RQ, Combs AP, Higaki JN, Cordell B, Seiffert D, Zaczek RC, Robertson DW, Olson RE",,350096,DTCT0024091,1920768,DTCC00001675,1949133,20704
CHEMBL204593,P50281,,LUCFRFDOOYLALP-CYBMUJFWSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,16338135,IC50,=,6500,NM,,,,,,,,,,,,,,Inhibition of MMP14,,The discovery of a potent and selective lethal factor inhibitor for adjunct therapy of anthrax infection.,Bioorg. Med. Chem. Lett.,2006,16,4,"Xiong Y, Wiltsie J, Woods A, Guo J, Pivnichny JV, Tang W, Bansal A, Cummings RT, Cunningham BR, Friedlander AM, Douglas CM, Salowe SP, Zaller DM, Scolnick EM, Schmatz DM, Bartizal K, Hermes JD, MacCoss M, Chapman KT",,334087,DTCT0024091,1895867,DTCC00415249,1598833,20352
CHEMBL2047536,P50281,,DACARRUBIAXSBX-IBGZPJMESA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,22175799,IC50,>,20000,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP14 using MCA-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2.AcOH as substrate preincubated for 10 mins measured by fluorescence analysis,,"Discovery and evaluation of a non-Zn chelating, selective matrix metalloproteinase 13 (MMP-13) inhibitor for potential intra-articular treatment of osteoarthritis.",J. Med. Chem.,2012,55,2,"Gege C, Bao B, Bluhm H, Boer J, Gallagher BM, Korniski B, Powers TS, Steeneck C, Taveras AG, Baragi VM",,827028,DTCT0024091,10526944,DTCC01242723,653432,48586
CHEMBL2047537,P50281,,CZRLAOXITNZAJA-FQEVSTJZSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,22175799,IC50,>,20000,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP14 using MCA-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2.AcOH as substrate preincubated for 10 mins measured by fluorescence analysis,,"Discovery and evaluation of a non-Zn chelating, selective matrix metalloproteinase 13 (MMP-13) inhibitor for potential intra-articular treatment of osteoarthritis.",J. Med. Chem.,2012,55,2,"Gege C, Bao B, Bluhm H, Boer J, Gallagher BM, Korniski B, Powers TS, Steeneck C, Taveras AG, Baragi VM",,827028,DTCT0024091,10526945,DTCC01242724,1655819,48586
CHEMBL2063270,P50281,,CXKWJJJVWDMSAG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,,KI,=,580,NM,,,,,,,,,,,,,,Competitive inhibition of human MMP14 using fluorogenic substrate by Dixon plot analysis,,,ACS Med. Chem. Lett.,2012,3,6,,,831080,DTCT0024091,10566545,DTCC01247512,186720,48923
CHEMBL2063271,P50281,,LEBLJISYPUWAJY-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,,KI,=,190,NM,,,,,,,,,,,,,,Competitive inhibition of human MMP14 using fluorogenic substrate by Dixon plot analysis,,,ACS Med. Chem. Lett.,2012,3,6,,,831080,DTCT0024091,10566546,DTCC01247513,2090921,48923
CHEMBL2063273,P50281,,BGRGANYQQMRQLM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,,KI,=,215,NM,,,,,,,,,,,,,,Competitive inhibition of human MMP14 using fluorogenic substrate by Dixon plot analysis,,,ACS Med. Chem. Lett.,2012,3,6,,,831080,DTCT0024091,10566547,DTCC01247515,316901,48923
CHEMBL2063274,P50281,,AHDPJKYOQXMDIX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,,KI,=,90,NM,,,,,,,,,,,,,,Competitive inhibition of human MMP14 using fluorogenic substrate by Dixon plot analysis,,,ACS Med. Chem. Lett.,2012,3,6,,,831080,DTCT0024091,10566548,DTCC01247516,834451,48923
CHEMBL2063275,P50281,,GPZUWAHQDYJABE-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,,KI,=,280,NM,,,,,,,,,,,,,,Competitive inhibition of human MMP14 using fluorogenic substrate by Dixon plot analysis,,,ACS Med. Chem. Lett.,2012,3,6,,,831080,DTCT0024091,10566549,DTCC01247517,1546082,48923
CHEMBL2063276,P50281,,STSMSPOAFPZOFC-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,,KI,=,140,NM,,,,,,,,,,,,,,Competitive inhibition of human MMP14 using fluorogenic substrate by Dixon plot analysis,,,ACS Med. Chem. Lett.,2012,3,6,,,831080,DTCT0024091,10566550,DTCC01247518,349672,48923
CHEMBL2063277,P50281,,RMRUTHBBMQENKJ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,,KI,=,5080,NM,,,,,,,,,,,,,,Competitive inhibition of human MMP14 using fluorogenic substrate by Dixon plot analysis,,,ACS Med. Chem. Lett.,2012,3,6,,,831080,DTCT0024091,10566552,DTCC01247519,543747,48923
CHEMBL207305,P50281,,NUVSGXIVCJBRBF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,16516466,KI,>,5290,NM,,,,,,,,,,,,,,Binding affinity to MMP14,,"Synthesis and structure-activity relationship of a novel, achiral series of TNF-alpha converting enzyme inhibitors.",Bioorg. Med. Chem. Lett.,2006,16,10,"Gilmore JL, King BW, Harris C, Maduskuie T, Mercer SE, Liu RQ, Covington MB, Qian M, Ribadeneria MD, Vaddi K, Trzaskos JM, Newton RC, Decicco CP, Duan JJ",,354472,DTCT0024091,1926608,DTCC00421580,552632,20786
CHEMBL207305,P50281,,NUVSGXIVCJBRBF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,18790648,KI,>,5290,NM,,,,,,,,,,,,,,Inhibition of MMP14,,Specific targeting of metzincin family members with small-molecule inhibitors: progress toward a multifarious challenge.,Bioorg. Med. Chem.,2008,16,19,"Georgiadis D, Yiotakis A",,497410,DTCT0024091,2457275,DTCC00421580,565360,32556
CHEMBL208009,P50281,,BODLESUVCQEUII-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,16516466,KI,>,5290,NM,,,,,,,,,,,,,,Binding affinity to MMP14,,"Synthesis and structure-activity relationship of a novel, achiral series of TNF-alpha converting enzyme inhibitors.",Bioorg. Med. Chem. Lett.,2006,16,10,"Gilmore JL, King BW, Harris C, Maduskuie T, Mercer SE, Liu RQ, Covington MB, Qian M, Ribadeneria MD, Vaddi K, Trzaskos JM, Newton RC, Decicco CP, Duan JJ",,354472,DTCT0024091,1926607,DTCC00421655,1037257,20786
CHEMBL208841,P50281,,BNKOGVVBAYMLMZ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,16723229,IC50,=,2080,NM,,,,,,,,,,,,,,Inhibition of MMP14,,Design and synthesis of butynyloxyphenyl beta-sulfone piperidine hydroxamates as TACE inhibitors.,Bioorg. Med. Chem. Lett.,2006,16,15,"Park K, Aplasca A, Du MT, Sun L, Zhu Y, Zhang Y, Levin JI",,377989,DTCT0024091,1969684,DTCC00428615,2067649,21111
CHEMBL2096775,P50281,,FBLGEUMPZQFQFF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,15780611,IC50,=,420,NM,,,,,,,,,,,,,,Inhibitory concentration against matrix metalloprotease 14,,Potent pyrimidinetrione-based inhibitors of MMP-13 with enhanced selectivity over MMP-14.,Bioorg. Med. Chem. Lett.,2005,15,7,"Blagg JA, Noe MC, Wolf-Gouveia LA, Reiter LA, Laird ER, Chang SP, Danley DE, Downs JT, Elliott NC, Eskra JD, Griffiths RJ, Hardink JR, Haugeto AI, Jones CS, Liras JL, Lopresti-Morrow LL, Mitchell PG, Pandit J, Robinson RP, Subramanyam C, Vaughn-Bowser ML, Yocum SA",,305128,DTCT0024091,1752682,DTCC01256933,1436928,18917
CHEMBL209970,P50281,,CEVLUPQNDFOYSI-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,16723229,IC50,=,4710,NM,,,,,,,,,,,,,,Inhibition of MMP14,,Design and synthesis of butynyloxyphenyl beta-sulfone piperidine hydroxamates as TACE inhibitors.,Bioorg. Med. Chem. Lett.,2006,16,15,"Park K, Aplasca A, Du MT, Sun L, Zhu Y, Zhang Y, Levin JI",,377989,DTCT0024091,1969602,DTCC00428551,1426125,21111
CHEMBL209970,P50281,,CEVLUPQNDFOYSI-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,17606376,IC50,=,3642,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP14,,Structure-based design of TACE selective inhibitors: manipulations in the S1'-S3' pocket.,Bioorg. Med. Chem.,2007,15,18,"Huang A, Joseph-McCarthy D, Lovering F, Sun L, Wang W, Xu W, Zhu Y, Cui J, Zhang Y, Levin JI",,448561,DTCT0024091,2180844,DTCC00428551,1426485,23780
CHEMBL209970,P50281,,CEVLUPQNDFOYSI-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,18790648,IC50,=,4710,NM,,,,,,,,,,,,,,Inhibition of MMP14,,Specific targeting of metzincin family members with small-molecule inhibitors: progress toward a multifarious challenge.,Bioorg. Med. Chem.,2008,16,19,"Georgiadis D, Yiotakis A",,497410,DTCT0024091,2456488,DTCC00428551,1438568,32556
CHEMBL210084,P50281,,RNHOXGSFKJUDNY-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,16723229,IC50,=,5910,NM,,,,,,,,,,,,,,Inhibition of MMP14,,Design and synthesis of butynyloxyphenyl beta-sulfone piperidine hydroxamates as TACE inhibitors.,Bioorg. Med. Chem. Lett.,2006,16,15,"Park K, Aplasca A, Du MT, Sun L, Zhu Y, Zhang Y, Levin JI",,377989,DTCT0024091,1969617,DTCC00110502,1522899,21111
CHEMBL210133,P50281,,BXOTYZMFPUKYAU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,16723229,IC50,=,12,NM,,,,,,,,,,,,,,Inhibition of MMP14,,Design and synthesis of butynyloxyphenyl beta-sulfone piperidine hydroxamates as TACE inhibitors.,Bioorg. Med. Chem. Lett.,2006,16,15,"Park K, Aplasca A, Du MT, Sun L, Zhu Y, Zhang Y, Levin JI",,377989,DTCT0024091,1969610,DTCC00110503,1619858,21111
CHEMBL210208,P50281,PYROGALLOL RED,JTZKNOUMMWIARI-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,,IC50,=,19600,NM,,,,,,,,,,,,,,PubChem BioAssay. Dose Response confirmation of uHTS hits for a small molecule inhibitors of MT1-MMP activation in a fluorescence assay set 2. (Class of assay: confirmatory) ,active,PUBCHEM BIOASSAY DATA SET,,,,,,,954348,DTCT0024091,12216210,DTCC00423743,2054859,33038
CHEMBL211274,P50281,,NILIMKWDWHKQOZ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,16723229,IC50,=,889,NM,,,,,,,,,,,,,,Inhibition of MMP14,,Design and synthesis of butynyloxyphenyl beta-sulfone piperidine hydroxamates as TACE inhibitors.,Bioorg. Med. Chem. Lett.,2006,16,15,"Park K, Aplasca A, Du MT, Sun L, Zhu Y, Zhang Y, Levin JI",,377989,DTCT0024091,1969668,DTCC00428620,227939,21111
CHEMBL211487,P50281,,MTSOZTJGECJILJ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,16723229,IC50,=,725,NM,,,,,,,,,,,,,,Inhibition of MMP14,,Design and synthesis of butynyloxyphenyl beta-sulfone piperidine hydroxamates as TACE inhibitors.,Bioorg. Med. Chem. Lett.,2006,16,15,"Park K, Aplasca A, Du MT, Sun L, Zhu Y, Zhang Y, Levin JI",,377989,DTCT0024091,1969708,DTCC00428518,520596,21111
CHEMBL211726,P50281,,LWFCUEQJXZSHMP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,16723229,IC50,=,488,NM,,,,,,,,,,,,,,Inhibition of MMP14,,Design and synthesis of butynyloxyphenyl beta-sulfone piperidine hydroxamates as TACE inhibitors.,Bioorg. Med. Chem. Lett.,2006,16,15,"Park K, Aplasca A, Du MT, Sun L, Zhu Y, Zhang Y, Levin JI",,377989,DTCT0024091,1969652,DTCC00428523,326079,21111
CHEMBL211770,P50281,,WPYFTDWGMAINBU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,16723229,IC50,=,257,NM,,,,,,,,,,,,,,Inhibition of MMP14,,Design and synthesis of butynyloxyphenyl beta-sulfone piperidine hydroxamates as TACE inhibitors.,Bioorg. Med. Chem. Lett.,2006,16,15,"Park K, Aplasca A, Du MT, Sun L, Zhu Y, Zhang Y, Levin JI",,377989,DTCT0024091,1969622,DTCC00428541,163652,21111
CHEMBL212205,P50281,,ZUMRSIZQUOZFGG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,16723229,IC50,=,4850,NM,,,,,,,,,,,,,,Inhibition of MMP14,,Design and synthesis of butynyloxyphenyl beta-sulfone piperidine hydroxamates as TACE inhibitors.,Bioorg. Med. Chem. Lett.,2006,16,15,"Park K, Aplasca A, Du MT, Sun L, Zhu Y, Zhang Y, Levin JI",,377989,DTCT0024091,1969694,DTCC00428527,1134656,21111
CHEMBL212411,P50281,,LNPBBURQSUEIHO-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,16723229,IC50,=,97,NM,,,,,,,,,,,,,,Inhibition of MMP14,,Design and synthesis of butynyloxyphenyl beta-sulfone piperidine hydroxamates as TACE inhibitors.,Bioorg. Med. Chem. Lett.,2006,16,15,"Park K, Aplasca A, Du MT, Sun L, Zhu Y, Zhang Y, Levin JI",,377989,DTCT0024091,1969638,DTCC00428532,1652105,21111
CHEMBL212481,P50281,,HNEDFPGSHTUVKZ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,16723229,IC50,=,489,NM,,,,,,,,,,,,,,Inhibition of MMP14,,Design and synthesis of butynyloxyphenyl beta-sulfone piperidine hydroxamates as TACE inhibitors.,Bioorg. Med. Chem. Lett.,2006,16,15,"Park K, Aplasca A, Du MT, Sun L, Zhu Y, Zhang Y, Levin JI",,377989,DTCT0024091,1969660,DTCC00428522,1872868,21111
CHEMBL215074,P50281,"3,2'-DIGUANIDINONEAMINE",SOBOASBOKGPTNI-HKEUSBCWSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,16870442,KI,>,300000,NM,,,,,,,,,,,,,,Activity at MMP14,,Selectively guanidinylated derivatives of neamine. Syntheses and inhibition of anthrax lethal factor protease.,Bioorg. Med. Chem. Lett.,2006,16,19,"Jiao GS, Simo O, Nagata M, O'Malley S, Hemscheidt T, Cregar L, Millis SZ, Goldman ME, Tang C",,393602,DTCT0024091,1981422,DTCC00001986,1852268,21299
CHEMBL215269,P50281,"1,3,2',6'-TETRAGUANIDINONEAMINE",BNWODYWXZNMCKX-HKEUSBCWSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,16870442,KI,>,300000,NM,,,,,,,,,,,,,,Activity at MMP14,,Selectively guanidinylated derivatives of neamine. Syntheses and inhibition of anthrax lethal factor protease.,Bioorg. Med. Chem. Lett.,2006,16,19,"Jiao GS, Simo O, Nagata M, O'Malley S, Hemscheidt T, Cregar L, Millis SZ, Goldman ME, Tang C",,393602,DTCT0024091,1981423,DTCC00001992,1437410,21299
CHEMBL2153260,P50281,,MJNLEGDDXDONRO-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,21413800,IC50,=,3.2,UG.ML-1,,,,,,,,,,,,,,Inhibition of MMP14 using MOCAc-Pro-Leu-Gly-Leu-A2pr(Dnp)-Ala-Arg- NH2 as substrate preincubated for 10 mins measured after 3 hrs by fluorescence assay,,A one-pot synthesis and biological activity of ageladine A and analogues.,J. Med. Chem.,2011,54,7,"Shengule SR, Loa-Kum-Cheung WL, Parish CR, Blairvacq M, Meijer L, Nakao Y, Karuso P",,853831,DTCT0024091,11368672,DTCC01286244,155289,50935
CHEMBL2153261,P50281,,MYOCPUSBKSPROQ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,21413800,IC50,=,0.57,UG.ML-1,,,,,,,,,,,,,,Inhibition of MMP14 using MOCAc-Pro-Leu-Gly-Leu-A2pr(Dnp)-Ala-Arg- NH2 as substrate preincubated for 10 mins measured after 3 hrs by fluorescence assay,,A one-pot synthesis and biological activity of ageladine A and analogues.,J. Med. Chem.,2011,54,7,"Shengule SR, Loa-Kum-Cheung WL, Parish CR, Blairvacq M, Meijer L, Nakao Y, Karuso P",,853831,DTCT0024091,11368673,DTCC01286245,1482141,50935
CHEMBL2153263,P50281,,VHNMVIBGZONBAO-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,21413800,IC50,=,6.4,UG.ML-1,,,,,,,,,,,,,,Inhibition of MMP14 using MOCAc-Pro-Leu-Gly-Leu-A2pr(Dnp)-Ala-Arg- NH2 as substrate preincubated for 10 mins measured after 3 hrs by fluorescence assay,,A one-pot synthesis and biological activity of ageladine A and analogues.,J. Med. Chem.,2011,54,7,"Shengule SR, Loa-Kum-Cheung WL, Parish CR, Blairvacq M, Meijer L, Nakao Y, Karuso P",,853831,DTCT0024091,11368674,DTCC01286247,187262,50935
CHEMBL2153264,P50281,,JZRNXAPRPJTGOG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,21413800,INHIBITION,=,6,%,,,,,,,,,,,,,,Inhibition of MMP14 using MOCAc-Pro-Leu-Gly-Leu-A2pr(Dnp)-Ala-Arg- NH2 as substrate at 20 ug/ml preincubated for 10 mins measured after 3 hrs by fluorescence assay,,A one-pot synthesis and biological activity of ageladine A and analogues.,J. Med. Chem.,2011,54,7,"Shengule SR, Loa-Kum-Cheung WL, Parish CR, Blairvacq M, Meijer L, Nakao Y, Karuso P",,853832,DTCT0024091,11368676,DTCC01286248,317467,50935
CHEMBL2153266,P50281,,IEJOMJUTRBOWNE-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,21413800,INHIBITION,=,9,%,,,,,,,,,,,,,,Inhibition of MMP14 using MOCAc-Pro-Leu-Gly-Leu-A2pr(Dnp)-Ala-Arg- NH2 as substrate at 20 ug/ml preincubated for 10 mins measured after 3 hrs by fluorescence assay,,A one-pot synthesis and biological activity of ageladine A and analogues.,J. Med. Chem.,2011,54,7,"Shengule SR, Loa-Kum-Cheung WL, Parish CR, Blairvacq M, Meijer L, Nakao Y, Karuso P",,853832,DTCT0024091,11368677,DTCC01286250,317468,50935
CHEMBL2153268,P50281,,DJAYVQDFUAOEKN-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,21413800,INHIBITION,=,17,%,,,,,,,,,,,,,,Inhibition of MMP14 using MOCAc-Pro-Leu-Gly-Leu-A2pr(Dnp)-Ala-Arg- NH2 as substrate at 20 ug/ml preincubated for 10 mins measured after 3 hrs by fluorescence assay,,A one-pot synthesis and biological activity of ageladine A and analogues.,J. Med. Chem.,2011,54,7,"Shengule SR, Loa-Kum-Cheung WL, Parish CR, Blairvacq M, Meijer L, Nakao Y, Karuso P",,853832,DTCT0024091,11368678,DTCC01286252,1126162,50935
CHEMBL2153737,P50281,,LHVGXRIIQBVWQU-JHOVWCEZSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,21780776,KI,=,105,NM,,,,,,,,,,,,,,Inhibition of MMP-14,,Remarkable potential of the a-aminophosphonate/phosphinate structural motif in medicinal chemistry.,J. Med. Chem.,2011,54,17,"Mucha A, Kafarski P, Berlicki L",,850715,DTCT0024091,11357598,DTCC01286634,284807,50957
CHEMBL2153738,P50281,,CGPJRIXIBMANTN-PHCUSUGSSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,21780776,KI,=,30000,NM,,,,,,,,,,,,,,Inhibition of MMP-14,,Remarkable potential of the a-aminophosphonate/phosphinate structural motif in medicinal chemistry.,J. Med. Chem.,2011,54,17,"Mucha A, Kafarski P, Berlicki L",,850715,DTCT0024091,11357599,DTCC01286635,705682,50957
CHEMBL2153739,P50281,,SGHHKDAEMQQYOU-CEURZZNXSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,21780776,KI,=,5100,NM,,,,,,,,,,,,,,Inhibition of MMP-14,,Remarkable potential of the a-aminophosphonate/phosphinate structural motif in medicinal chemistry.,J. Med. Chem.,2011,54,17,"Mucha A, Kafarski P, Berlicki L",,850715,DTCT0024091,11357600,DTCC01286636,512150,50957
CHEMBL215715,P50281,,DDPWNYDFUBXVGQ-MLFNNEOSSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,16870442,KI,>,300000,NM,,,,,,,,,,,,,,Activity at MMP14,,Selectively guanidinylated derivatives of neamine. Syntheses and inhibition of anthrax lethal factor protease.,Bioorg. Med. Chem. Lett.,2006,16,19,"Jiao GS, Simo O, Nagata M, O'Malley S, Hemscheidt T, Cregar L, Millis SZ, Goldman ME, Tang C",,393602,DTCT0024091,1981408,DTCC00433950,1469832,21299
CHEMBL222002,P50281,,XRSYNYGEEYTXJV-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,17275314,IC50,=,22.91,NM,,,,,,,,,,,,,,Inhibition of MMP14,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458934,DTCT0024091,2258805,DTCC00440858,1620403,24803
CHEMBL226439,P50281,,ICISPHGVMHWYTI-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,20180536,IC50,=,9500,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP14 by fluorometric assay,,Potent arylsulfonamide inhibitors of tumor necrosis factor-alpha converting enzyme able to reduce activated leukocyte cell adhesion molecule shedding in cancer cell models.,J. Med. Chem.,2010,53,6,"Nuti E, Casalini F, Avramova SI, Santamaria S, Fabbi M, Ferrini S, Marinelli L, La Pietra V, Limongelli V, Novellino E, Cercignani G, Orlandini E, Nencetti S, Rossello A",,624095,DTCT0024091,3286006,DTCC00449741,437752,38228
CHEMBL226630,P50281,UK-383367,ARJCBSRIPGJMAD-LLVKDONJSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,17591762,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibition of MMP14,,Potent and selective nonpeptidic inhibitors of procollagen C-proteinase.,J. Med. Chem.,2007,50,15,"Fish PV, Allan GA, Bailey S, Blagg J, Butt R, Collis MG, Greiling D, James K, Kendall J, McElroy A, McCleverty D, Reed C, Webster R, Whitlock GA",,440141,DTCT0024091,2113799,DTCC00002834,1523163,23023
CHEMBL226630,P50281,UK-383367,ARJCBSRIPGJMAD-LLVKDONJSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,17591762,INHIBITION,<,50,%,,,,,,,,,,,,,,Inhibition of MMP14 at 10 uM,,Potent and selective nonpeptidic inhibitors of procollagen C-proteinase.,J. Med. Chem.,2007,50,15,"Fish PV, Allan GA, Bailey S, Blagg J, Butt R, Collis MG, Greiling D, James K, Kendall J, McElroy A, McCleverty D, Reed C, Webster R, Whitlock GA",,440147,DTCT0024091,2113827,DTCC00002834,1523163,23023
CHEMBL226630,P50281,UK-383367,ARJCBSRIPGJMAD-LLVKDONJSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,17591762,INHIBITION,<,50,%,,,,,,,,,,,,,,Inhibition of MMP14 at 100 uM,,Potent and selective nonpeptidic inhibitors of procollagen C-proteinase.,J. Med. Chem.,2007,50,15,"Fish PV, Allan GA, Bailey S, Blagg J, Butt R, Collis MG, Greiling D, James K, Kendall J, McElroy A, McCleverty D, Reed C, Webster R, Whitlock GA",,440153,DTCT0024091,2113855,DTCC00002834,1523163,23023
CHEMBL226630,P50281,UK-383367,ARJCBSRIPGJMAD-LLVKDONJSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,17591762,INHIBITION,<,50,%,,,,,,,,,,,,,,Inhibition of MMP14 at 30 uM,,Potent and selective nonpeptidic inhibitors of procollagen C-proteinase.,J. Med. Chem.,2007,50,15,"Fish PV, Allan GA, Bailey S, Blagg J, Butt R, Collis MG, Greiling D, James K, Kendall J, McElroy A, McCleverty D, Reed C, Webster R, Whitlock GA",,440159,DTCT0024091,2113884,DTCC00002834,1523163,23023
CHEMBL226630,P50281,UK-383367,ARJCBSRIPGJMAD-LLVKDONJSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,18945617,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibition of human MMP14 catalytic domain by fluorescence assay,,"Succinyl hydroxamates as potent and selective non-peptidic inhibitors of procollagen C-proteinase: design, synthesis, and evaluation as topically applied, dermal anti-scarring agents.",Bioorg. Med. Chem. Lett.,2008,18,24,"Bailey S, Fish PV, Billotte S, Bordner J, Greiling D, James K, McElroy A, Mills JE, Reed C, Webster R",,518966,DTCT0024091,2690025,DTCC00002834,1535490,32223
CHEMBL226686,P50281,,FRASWKFJOBLAQF-CYBMUJFWSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,18945617,IC50,,,,,,,,,,,,,,,,,Inhibition of human MMP14 catalytic domain by fluorescence assay,Not Determined,"Succinyl hydroxamates as potent and selective non-peptidic inhibitors of procollagen C-proteinase: design, synthesis, and evaluation as topically applied, dermal anti-scarring agents.",Bioorg. Med. Chem. Lett.,2008,18,24,"Bailey S, Fish PV, Billotte S, Bordner J, Greiling D, James K, McElroy A, Mills JE, Reed C, Webster R",,518966,DTCT0024091,2690035,DTCC00452728,1726167,32223
CHEMBL226852,P50281,,SWOIHXOGQYPPNC-GFCCVEGCSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,17591762,IC50,>,100000,NM,,,,,,,,,,,,,,Inhibition of MMP14,,Potent and selective nonpeptidic inhibitors of procollagen C-proteinase.,J. Med. Chem.,2007,50,15,"Fish PV, Allan GA, Bailey S, Blagg J, Butt R, Collis MG, Greiling D, James K, Kendall J, McElroy A, McCleverty D, Reed C, Webster R, Whitlock GA",,440141,DTCT0024091,2113802,DTCC00452681,1361615,23023
CHEMBL226852,P50281,,SWOIHXOGQYPPNC-GFCCVEGCSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,17591762,INHIBITION,<,50,%,,,,,,,,,,,,,,Inhibition of MMP14 at 10 uM,,Potent and selective nonpeptidic inhibitors of procollagen C-proteinase.,J. Med. Chem.,2007,50,15,"Fish PV, Allan GA, Bailey S, Blagg J, Butt R, Collis MG, Greiling D, James K, Kendall J, McElroy A, McCleverty D, Reed C, Webster R, Whitlock GA",,440147,DTCT0024091,2113830,DTCC00452681,1361615,23023
CHEMBL226852,P50281,,SWOIHXOGQYPPNC-GFCCVEGCSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,17591762,INHIBITION,<,50,%,,,,,,,,,,,,,,Inhibition of MMP14 at 100 uM,,Potent and selective nonpeptidic inhibitors of procollagen C-proteinase.,J. Med. Chem.,2007,50,15,"Fish PV, Allan GA, Bailey S, Blagg J, Butt R, Collis MG, Greiling D, James K, Kendall J, McElroy A, McCleverty D, Reed C, Webster R, Whitlock GA",,440153,DTCT0024091,2113859,DTCC00452681,1361615,23023
CHEMBL226852,P50281,,SWOIHXOGQYPPNC-GFCCVEGCSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,17591762,INHIBITION,<,50,%,,,,,,,,,,,,,,Inhibition of MMP14 at 30 uM,,Potent and selective nonpeptidic inhibitors of procollagen C-proteinase.,J. Med. Chem.,2007,50,15,"Fish PV, Allan GA, Bailey S, Blagg J, Butt R, Collis MG, Greiling D, James K, Kendall J, McElroy A, McCleverty D, Reed C, Webster R, Whitlock GA",,440159,DTCT0024091,2113887,DTCC00452681,1361615,23023
CHEMBL227484,P50281,,CJTUBZULFXKTAT-QGZVFWFLSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,17088065,IC50,=,11,NM,,,,,,,,,,,,,,Inhibition of MMP14,,alpha-Biphenylsulfonylamino 2-methylpropyl phosphonates: enantioselective synthesis and selective inhibition of MMPs.,Bioorg. Med. Chem.,2007,15,2,"Biasone A, Tortorella P, Campestre C, Agamennone M, Preziuso S, Chiappini M, Nuti E, Carelli P, Rossello A, Mazza F, Gallina C",,432509,DTCT0024091,2061958,DTCC00447716,326283,22402
CHEMBL227484,P50281,,CJTUBZULFXKTAT-QGZVFWFLSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,17088065,IC50,=,11,NM,,,,,,,,,,,,,,Inhibition of MMP14,,alpha-Biphenylsulfonylamino 2-methylpropyl phosphonates: enantioselective synthesis and selective inhibition of MMPs.,Bioorg. Med. Chem.,2007,15,2,"Biasone A, Tortorella P, Campestre C, Agamennone M, Preziuso S, Chiappini M, Nuti E, Carelli P, Rossello A, Mazza F, Gallina C",,432509,DTCT0024091,2062007,DTCC00447716,326284,22402
CHEMBL227501,P50281,,WNLZTTHHHYZJMB-QGZVFWFLSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,17088065,IC50,=,26,NM,,,,,,,,,,,,,,Inhibition of MMP14,,alpha-Biphenylsulfonylamino 2-methylpropyl phosphonates: enantioselective synthesis and selective inhibition of MMPs.,Bioorg. Med. Chem.,2007,15,2,"Biasone A, Tortorella P, Campestre C, Agamennone M, Preziuso S, Chiappini M, Nuti E, Carelli P, Rossello A, Mazza F, Gallina C",,432509,DTCT0024091,2061955,DTCC00447830,1426294,22402
CHEMBL227553,P50281,,FHZGYMLWCVBBPM-GOSISDBHSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,17088065,IC50,=,6000,NM,,,,,,,,,,,,,,Inhibition of MMP14,,alpha-Biphenylsulfonylamino 2-methylpropyl phosphonates: enantioselective synthesis and selective inhibition of MMPs.,Bioorg. Med. Chem.,2007,15,2,"Biasone A, Tortorella P, Campestre C, Agamennone M, Preziuso S, Chiappini M, Nuti E, Carelli P, Rossello A, Mazza F, Gallina C",,432509,DTCT0024091,2061954,DTCC00447831,1166105,22402
CHEMBL227598,P50281,,VKFNDAOTTJONML-LJQANCHMSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,17088065,IC50,=,130,NM,,,,,,,,,,,,,,Inhibition of MMP14,,alpha-Biphenylsulfonylamino 2-methylpropyl phosphonates: enantioselective synthesis and selective inhibition of MMPs.,Bioorg. Med. Chem.,2007,15,2,"Biasone A, Tortorella P, Campestre C, Agamennone M, Preziuso S, Chiappini M, Nuti E, Carelli P, Rossello A, Mazza F, Gallina C",,432509,DTCT0024091,2061961,DTCC00447803,972589,22402
CHEMBL227824,P50281,,RVKPGECPCLBLDB-GOSISDBHSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,17088065,IC50,=,11,NM,,,,,,,,,,,,,,Inhibition of MMP14,,alpha-Biphenylsulfonylamino 2-methylpropyl phosphonates: enantioselective synthesis and selective inhibition of MMPs.,Bioorg. Med. Chem.,2007,15,2,"Biasone A, Tortorella P, Campestre C, Agamennone M, Preziuso S, Chiappini M, Nuti E, Carelli P, Rossello A, Mazza F, Gallina C",,432509,DTCT0024091,2061962,DTCC00447798,940549,22402
CHEMBL228141,P50281,,AGSXHHFUSDGSSO-LJQANCHMSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,17088065,IC50,=,40000,NM,,,,,,,,,,,,,,Inhibition of MMP14,,alpha-Biphenylsulfonylamino 2-methylpropyl phosphonates: enantioselective synthesis and selective inhibition of MMPs.,Bioorg. Med. Chem.,2007,15,2,"Biasone A, Tortorella P, Campestre C, Agamennone M, Preziuso S, Chiappini M, Nuti E, Carelli P, Rossello A, Mazza F, Gallina C",,432509,DTCT0024091,2061953,DTCC00447839,520801,22402
CHEMBL228187,P50281,,NZKKRYAESABOSS-MRXNPFEDSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,17088065,IC50,=,180,NM,,,,,,,,,,,,,,Inhibition of MMP14,,alpha-Biphenylsulfonylamino 2-methylpropyl phosphonates: enantioselective synthesis and selective inhibition of MMPs.,Bioorg. Med. Chem.,2007,15,2,"Biasone A, Tortorella P, Campestre C, Agamennone M, Preziuso S, Chiappini M, Nuti E, Carelli P, Rossello A, Mazza F, Gallina C",,432509,DTCT0024091,2061957,DTCC00447819,1684493,22402
CHEMBL228188,P50281,,BGBWSADVPWNBME-MRXNPFEDSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,17088065,IC50,=,75,NM,,,,,,,,,,,,,,Inhibition of MMP14,,alpha-Biphenylsulfonylamino 2-methylpropyl phosphonates: enantioselective synthesis and selective inhibition of MMPs.,Bioorg. Med. Chem.,2007,15,2,"Biasone A, Tortorella P, Campestre C, Agamennone M, Preziuso S, Chiappini M, Nuti E, Carelli P, Rossello A, Mazza F, Gallina C",,432509,DTCT0024091,2061956,DTCC00447820,1102691,22402
CHEMBL230194,P50281,,BPADIXRUNSRDOT-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,21413800,IC50,=,1.6,UG.ML-1,,,,,,,,,,,,,,Inhibition of MMP14 using MOCAc-Pro-Leu-Gly-Leu-A2pr(Dnp)-Ala-Arg- NH2 as substrate preincubated for 10 mins measured after 3 hrs by fluorescence assay,,A one-pot synthesis and biological activity of ageladine A and analogues.,J. Med. Chem.,2011,54,7,"Shengule SR, Loa-Kum-Cheung WL, Parish CR, Blairvacq M, Meijer L, Nakao Y, Karuso P",,853831,DTCT0024091,11368671,DTCC00454330,1578808,50935
CHEMBL230806,P50281,AGELADINE A,QAKGJAQGTQLMFN-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,21413800,IC50,=,0.2,UG.ML-1,,,,,,,,,,,,,,Inhibition of MMP14 using MOCAc-Pro-Leu-Gly-Leu-A2pr(Dnp)-Ala-Arg- NH2 as substrate preincubated for 10 mins measured after 3 hrs by fluorescence assay,,A one-pot synthesis and biological activity of ageladine A and analogues.,J. Med. Chem.,2011,54,7,"Shengule SR, Loa-Kum-Cheung WL, Parish CR, Blairvacq M, Meijer L, Nakao Y, Karuso P",,853831,DTCT0024091,11368670,DTCC00454296,1189861,50935
CHEMBL2316256,P50281,,RXBMEHOLQJITJI-LEOXJPRUSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,23343195,INHIBITION,,,,,,,,,,,,,,,,,Inhibition of human MMP14 using Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 as substrate by spectrophotometry,Active,Molecular determinants of a selective matrix metalloprotease-12 inhibitor: insights from crystallography and thermodynamic studies.,J. Med. Chem.,2013,56,3,"Czarny B, Stura EA, Devel L, Vera L, Cassar-Lajeunesse E, Beau F, Calderone V, Fragai M, Luchinat C, Dive V",,935209,DTCT0024091,11751195,DTCC01339596,71045,53441
CHEMBL2316257,P50281,,LIUMDGLYGBIKBM-SFYKDHMMSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,23343195,INHIBITION,,,,,,,,,,,,,,,,,Inhibition of human MMP14 using Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 as substrate by spectrophotometry,Not Active,Molecular determinants of a selective matrix metalloprotease-12 inhibitor: insights from crystallography and thermodynamic studies.,J. Med. Chem.,2013,56,3,"Czarny B, Stura EA, Devel L, Vera L, Cassar-Lajeunesse E, Beau F, Calderone V, Fragai M, Luchinat C, Dive V",,935209,DTCT0024091,11751194,DTCC01339597,589403,53441
CHEMBL232086,P50281,,FGPWEPZCTGVLNA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,17064892,IC50,=,14800,NM,,,,,,,,,,,,,,Inhibition of MMP14,,Identification of potent and selective TACE inhibitors via the S1 pocket.,Bioorg. Med. Chem. Lett.,2007,17,1,"Condon JS, Joseph-McCarthy D, Levin JI, Lombart HG, Lovering FE, Sun L, Wang W, Xu W, Zhang Y",,440767,DTCT0024091,2154036,DTCC00461927,1037560,23077
CHEMBL2326363,P50281,,UIVFNXLDHQCJRY-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,23458498,IC50,=,1600,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP-14 catalytic domain using Mca-Lys-Pro-Leu-Gly-Leu-Dap(Dnp)-Ala-Arg-NH2 as substrate after 4 hrs by fluorometric assay,,Synthesis and preliminary evaluation in tumor bearing mice of new (18)f-labeled arylsulfone matrix metalloproteinase inhibitors as tracers for positron emission tomography.,J. Med. Chem.,2013,56,6,"Casalini F, Fugazza L, Esposito G, Cabella C, Brioschi C, Cordaro A, D'Angeli L, Bartoli A, Filannino AM, Gringeri CV, Longo DL, Muzio V, Nuti E, Orlandini E, Figlia G, Quattrini A, Tei L, Digilio G, Rossello A, Maiocchi A",,940798,DTCT0024091,11795553,DTCC01344669,199799,53669
CHEMBL2326364,P50281,,XXBXRJDBCMCGGD-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,23458498,IC50,=,4800,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP-14 catalytic domain using Mca-Lys-Pro-Leu-Gly-Leu-Dap(Dnp)-Ala-Arg-NH2 as substrate after 4 hrs by fluorometric assay,,Synthesis and preliminary evaluation in tumor bearing mice of new (18)f-labeled arylsulfone matrix metalloproteinase inhibitors as tracers for positron emission tomography.,J. Med. Chem.,2013,56,6,"Casalini F, Fugazza L, Esposito G, Cabella C, Brioschi C, Cordaro A, D'Angeli L, Bartoli A, Filannino AM, Gringeri CV, Longo DL, Muzio V, Nuti E, Orlandini E, Figlia G, Quattrini A, Tei L, Digilio G, Rossello A, Maiocchi A",,940798,DTCT0024091,11795552,DTCC01344670,2040368,53669
CHEMBL2326365,P50281,,CREFCFAJHQSGNR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,23458498,IC50,=,4600,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP-14 catalytic domain using Mca-Lys-Pro-Leu-Gly-Leu-Dap(Dnp)-Ala-Arg-NH2 as substrate after 4 hrs by fluorometric assay,,Synthesis and preliminary evaluation in tumor bearing mice of new (18)f-labeled arylsulfone matrix metalloproteinase inhibitors as tracers for positron emission tomography.,J. Med. Chem.,2013,56,6,"Casalini F, Fugazza L, Esposito G, Cabella C, Brioschi C, Cordaro A, D'Angeli L, Bartoli A, Filannino AM, Gringeri CV, Longo DL, Muzio V, Nuti E, Orlandini E, Figlia G, Quattrini A, Tei L, Digilio G, Rossello A, Maiocchi A",,940798,DTCT0024091,11795551,DTCC01344671,913412,53669
CHEMBL2337690,P50281,,FGQTUBBIXYISNM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,23376997,IC50,=,82,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP14 catalytic domain using Mca-Lys-Pro- Leu-Gly-Leu-Dap(Dnp)-Ala-Arg-NH2 as substrate incubated for 2 hrs prior to substrate addition measured every 15 secs for 15 mins by fluorometric analysis,,Arylsulfonamide inhibitors of aggrecanases as potential therapeutic agents for osteoarthritis: Synthesis and biological evaluation.,Eur. J. Med. Chem.,2013,62,,"Nuti E, Santamaria S, Casalini F, Yamamoto K, Marinelli L, La Pietra V, Novellino E, Orlandini E, Nencetti S, Marini AM, Salerno S, Taliani S, Da Settimo F, Nagase H, Rossello A",,948651,DTCT0024091,11842588,DTCC01351073,1527535,53978
CHEMBL2337691,P50281,,ZVJILQAAQQNBOP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,23376997,IC50,=,310,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP14 catalytic domain using Mca-Lys-Pro- Leu-Gly-Leu-Dap(Dnp)-Ala-Arg-NH2 as substrate incubated for 2 hrs prior to substrate addition measured every 15 secs for 15 mins by fluorometric analysis,,Arylsulfonamide inhibitors of aggrecanases as potential therapeutic agents for osteoarthritis: Synthesis and biological evaluation.,Eur. J. Med. Chem.,2013,62,,"Nuti E, Santamaria S, Casalini F, Yamamoto K, Marinelli L, La Pietra V, Novellino E, Orlandini E, Nencetti S, Marini AM, Salerno S, Taliani S, Da Settimo F, Nagase H, Rossello A",,948651,DTCT0024091,11842587,DTCC01351074,848343,53978
CHEMBL2337691,P50281,,ZVJILQAAQQNBOP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,24044434,IC50,=,310,NM,,,,,,,,,,,,,,Inhibition of recombinant human MMP-14 catalytic domain using Mca-Lys-Pro-Leu-Gly-Leu-Dap(Dnp)-Ala-Arg-NH2 as substrate incubated for 4 hrs measured every 15 secs for 20 mins by fluorimetric assay,,Selective arylsulfonamide inhibitors of ADAM-17: hit optimization and activity in ovarian cancer cell models.,J. Med. Chem.,2013,56,20,"Nuti E, Casalini F, Santamaria S, Fabbi M, Carbotti G, Ferrini S, Marinelli L, La Pietra V, Novellino E, Camodeca C, Orlandini E, Nencetti S, Rossello A",,984237,DTCT0024091,12586871,DTCC01351074,868999,55984
CHEMBL2337696,P50281,,UGRPRGWEEBXORM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,23376997,IC50,=,135,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP14 catalytic domain using Mca-Lys-Pro- Leu-Gly-Leu-Dap(Dnp)-Ala-Arg-NH2 as substrate incubated for 2 hrs prior to substrate addition measured every 15 secs for 15 mins by fluorometric analysis,,Arylsulfonamide inhibitors of aggrecanases as potential therapeutic agents for osteoarthritis: Synthesis and biological evaluation.,Eur. J. Med. Chem.,2013,62,,"Nuti E, Santamaria S, Casalini F, Yamamoto K, Marinelli L, La Pietra V, Novellino E, Orlandini E, Nencetti S, Marini AM, Salerno S, Taliani S, Da Settimo F, Nagase H, Rossello A",,948651,DTCT0024091,11842585,DTCC01351079,1462678,53978
CHEMBL2337697,P50281,,BTMSEVQRJBBBAY-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,23376997,IC50,=,24,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP14 catalytic domain using Mca-Lys-Pro- Leu-Gly-Leu-Dap(Dnp)-Ala-Arg-NH2 as substrate incubated for 2 hrs prior to substrate addition measured every 15 secs for 15 mins by fluorometric analysis,,Arylsulfonamide inhibitors of aggrecanases as potential therapeutic agents for osteoarthritis: Synthesis and biological evaluation.,Eur. J. Med. Chem.,2013,62,,"Nuti E, Santamaria S, Casalini F, Yamamoto K, Marinelli L, La Pietra V, Novellino E, Orlandini E, Nencetti S, Marini AM, Salerno S, Taliani S, Da Settimo F, Nagase H, Rossello A",,948651,DTCT0024091,11842584,DTCC01351080,1559589,53978
CHEMBL2337698,P50281,,CHTZMALPRVCUIK-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,23376997,IC50,=,3700,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP14 catalytic domain using Mca-Lys-Pro- Leu-Gly-Leu-Dap(Dnp)-Ala-Arg-NH2 as substrate incubated for 2 hrs prior to substrate addition measured every 15 secs for 15 mins by fluorometric analysis,,Arylsulfonamide inhibitors of aggrecanases as potential therapeutic agents for osteoarthritis: Synthesis and biological evaluation.,Eur. J. Med. Chem.,2013,62,,"Nuti E, Santamaria S, Casalini F, Yamamoto K, Marinelli L, La Pietra V, Novellino E, Orlandini E, Nencetti S, Marini AM, Salerno S, Taliani S, Da Settimo F, Nagase H, Rossello A",,948651,DTCT0024091,11842582,DTCC01351081,492967,53978
CHEMBL2338554,P50281,SYMPLOSTATIN 5,KPKJQINJXGFAPS-NBGICTFWSA-M,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,23350733,ACTIVITY,=,100,%,,,,,,,,,,,,,,Inhibition of MMP14 (unknown origin) using (5-FAM/QXLTM) FRET peptide substrate assessed as residual activity at 10 uM incubated for 15 mins prior to substrate addition measured for 2 hrs,,Potent elastase inhibitors from cyanobacteria: structural basis and mechanisms mediating cytoprotective and anti-inflammatory effects in bronchial epithelial cells.,J. Med. Chem.,2013,56,3,"Salvador LA, Taori K, Biggs JS, Jakoncic J, Ostrov DA, Paul VJ, Luesch H",,944680,DTCT0024091,11803591,DTCC01351885,686495,53882
CHEMBL234034,P50281,,NMHJSIJTDAPUMQ-RBBKRZOGSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,17276676,IC50,>,5000,NM,,,,,,,,,,,,,,Inhibition of MMP14,,A new 4-(2-methylquinolin-4-ylmethyl)phenyl P1' group for the beta-amino hydroxamic acid derived TACE inhibitors.,Bioorg. Med. Chem. Lett.,2007,17,7,"Chen XT, Ghavimi B, Corbett RL, Xue CB, Liu RQ, Covington MB, Qian M, Vaddi KG, Christ DD, Hartman KD, Ribadeneira MD, Trzaskos JM, Newton RC, Decicco CP, Duan JJ",,447090,DTCT0024091,2169402,DTCC00464775,876465,23623
CHEMBL234529,P50281,,QSOYTCHABFMDFV-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,19053764,IC50,=,89.8,NM,,,,,,,,,,,,,,Inhibition of MMP14,,Dual inhibitors of matrix metalloproteinases and carbonic anhydrases: iminodiacetyl-based hydroxamate-benzenesulfonamide conjugates.,J. Med. Chem.,2008,51,24,"Marques SM, Nuti E, Rossello A, Supuran CT, Tuccinardi T, Martinelli A, Santos MA",,561990,DTCT0024091,2800855,DTCC00463157,1071223,31524
CHEMBL234530,P50281,,HFLSBITWFGZVGL-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,19053764,IC50,=,2.1,NM,,,,,,,,,,,,,,Inhibition of MMP14,,Dual inhibitors of matrix metalloproteinases and carbonic anhydrases: iminodiacetyl-based hydroxamate-benzenesulfonamide conjugates.,J. Med. Chem.,2008,51,24,"Marques SM, Nuti E, Rossello A, Supuran CT, Tuccinardi T, Martinelli A, Santos MA",,561990,DTCT0024091,2800873,DTCC00111741,1071224,31524
CHEMBL234567,P50281,,BIGQJQKSDHOEOM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,17064892,IC50,=,24000,NM,,,,,,,,,,,,,,Inhibition of MMP14,,Identification of potent and selective TACE inhibitors via the S1 pocket.,Bioorg. Med. Chem. Lett.,2007,17,1,"Condon JS, Joseph-McCarthy D, Levin JI, Lombart HG, Lovering FE, Sun L, Wang W, Xu W, Zhang Y",,440767,DTCT0024091,2154039,DTCC00461914,1808694,23077
CHEMBL234735,P50281,,LQNSDZTXHZUYKJ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,19053764,IC50,=,260,NM,,,,,,,,,,,,,,Inhibition of MMP14,,Dual inhibitors of matrix metalloproteinases and carbonic anhydrases: iminodiacetyl-based hydroxamate-benzenesulfonamide conjugates.,J. Med. Chem.,2008,51,24,"Marques SM, Nuti E, Rossello A, Supuran CT, Tuccinardi T, Martinelli A, Santos MA",,561990,DTCT0024091,2800864,DTCC00111742,1685708,31524
CHEMBL234737,P50281,,IIOCRGOBAHXAAI-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,19053764,IC50,>,100000,NM,,,,,,,,,,,,,,Inhibition of MMP14,,Dual inhibitors of matrix metalloproteinases and carbonic anhydrases: iminodiacetyl-based hydroxamate-benzenesulfonamide conjugates.,J. Med. Chem.,2008,51,24,"Marques SM, Nuti E, Rossello A, Supuran CT, Tuccinardi T, Martinelli A, Santos MA",,561990,DTCT0024091,2800835,DTCC00463160,392918,31524
CHEMBL2347847,P50281,,JFYUPKXGFNQNTK-KPKJPENVSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,23453070,IC50,>,30000,NM,,,,,,,,,,,,,,Inhibition of MMP14 (unknown origin) by FRET method,,A series of thiazole derivatives bearing thiazolidin-4-one as non-competitive ADAMTS-5 (aggrecanase-2) inhibitors.,Bioorg. Med. Chem. Lett.,2013,23,7,"Atobe M, Maekawara N, Ishiguro N, Sogame S, Suenaga Y, Kawanishi M, Suzuki H, Jinno N, Tanaka E, Miyoshi S",,953676,DTCT0024091,11856626,DTCC01353178,156183,54221
CHEMBL2348091,P50281,,FXCKSJPZDBQRLO-KPKJPENVSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,23453070,IC50,=,24000,NM,,,,,,,,,,,,,,Inhibition of MMP14 (unknown origin) by FRET method,,A series of thiazole derivatives bearing thiazolidin-4-one as non-competitive ADAMTS-5 (aggrecanase-2) inhibitors.,Bioorg. Med. Chem. Lett.,2013,23,7,"Atobe M, Maekawara N, Ishiguro N, Sogame S, Suenaga Y, Kawanishi M, Suzuki H, Jinno N, Tanaka E, Miyoshi S",,953676,DTCT0024091,11856625,DTCC01353415,868718,54221
CHEMBL2348091,P50281,,FXCKSJPZDBQRLO-KPKJPENVSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,24316668,IC50,=,24000,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP-14 using fluorescence peptide matrix as substrate after 45 mins by fluorescence plate reader analysis,,Discovery of a benzimidazole series of ADAMTS-5 (aggrecanase-2) inhibitors by scaffold hopping.,Eur. J. Med. Chem.,2014,71,,"Sogame S, Suenaga Y, Atobe M, Kawanishi M, Tanaka E, Miyoshi S",,1283986,DTCT0024091,12983850,DTCC01353415,848823,56872
CHEMBL2348094,P50281,,IBACCBWOEGUMMV-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,23453072,INH,>,30000,NM,,,,,,,,,,,,,,Inhibition of MMP14 (unknown origin),,"Design, synthesis and SAR investigation of thienosultam derivatives as ADAMTS-5 (aggrecanase-2) inhibitors.",Bioorg. Med. Chem. Lett.,2013,23,7,"Atobe M, Maekawara N, Kawanishi M, Suzuki H, Tanaka E, Miyoshi S",,953884,DTCT0024091,11856700,DTCC01353418,1559615,54223
CHEMBL2348100,P50281,,MTZSGZVRTUPRNT-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,23453072,INH,>,30000,NM,,,,,,,,,,,,,,Inhibition of MMP14 (unknown origin),,"Design, synthesis and SAR investigation of thienosultam derivatives as ADAMTS-5 (aggrecanase-2) inhibitors.",Bioorg. Med. Chem. Lett.,2013,23,7,"Atobe M, Maekawara N, Kawanishi M, Suzuki H, Tanaka E, Miyoshi S",,953884,DTCT0024091,11856701,DTCC01353424,1009477,54223
CHEMBL2348113,P50281,,WVVARRFLFPIQLC-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,23453072,INH,<,5100,NM,,,,,,,,,,,,,,Inhibition of MMP14 (unknown origin),,"Design, synthesis and SAR investigation of thienosultam derivatives as ADAMTS-5 (aggrecanase-2) inhibitors.",Bioorg. Med. Chem. Lett.,2013,23,7,"Atobe M, Maekawara N, Kawanishi M, Suzuki H, Tanaka E, Miyoshi S",,953884,DTCT0024091,11856702,DTCC01353437,557370,54223
CHEMBL2348114,P50281,,LUCYEPUXPXFUTP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,23453072,INH,<,30000,NM,,,,,,,,,,,,,,Inhibition of MMP14 (unknown origin),,"Design, synthesis and SAR investigation of thienosultam derivatives as ADAMTS-5 (aggrecanase-2) inhibitors.",Bioorg. Med. Chem. Lett.,2013,23,7,"Atobe M, Maekawara N, Kawanishi M, Suzuki H, Tanaka E, Miyoshi S",,953884,DTCT0024091,11856703,DTCC01353438,1300729,54223
CHEMBL2348115,P50281,,MCCUBPXKRMEWLF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,23453072,INH,=,1200,NM,,,,,,,,,,,,,,Inhibition of MMP14 (unknown origin),,"Design, synthesis and SAR investigation of thienosultam derivatives as ADAMTS-5 (aggrecanase-2) inhibitors.",Bioorg. Med. Chem. Lett.,2013,23,7,"Atobe M, Maekawara N, Kawanishi M, Suzuki H, Tanaka E, Miyoshi S",,953884,DTCT0024091,11856705,DTCC01353439,330809,54223
CHEMBL2348116,P50281,,FIWXKDPCZMMNRI-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,23453072,INH,>,30000,NM,,,,,,,,,,,,,,Inhibition of MMP14 (unknown origin),,"Design, synthesis and SAR investigation of thienosultam derivatives as ADAMTS-5 (aggrecanase-2) inhibitors.",Bioorg. Med. Chem. Lett.,2013,23,7,"Atobe M, Maekawara N, Kawanishi M, Suzuki H, Tanaka E, Miyoshi S",,953884,DTCT0024091,11856704,DTCC01353440,1333389,54223
CHEMBL235559,P50281,,DYUKSKSACQYNBM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,17606376,IC50,=,4891,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP14,,Structure-based design of TACE selective inhibitors: manipulations in the S1'-S3' pocket.,Bioorg. Med. Chem.,2007,15,18,"Huang A, Joseph-McCarthy D, Lovering F, Sun L, Wang W, Xu W, Zhu Y, Cui J, Zhang Y, Levin JI",,448561,DTCT0024091,2180845,DTCC00470412,1744477,23780
CHEMBL236400,P50281,,IHSDOJRAORURAS-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,17606376,IC50,=,1000,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP14,,Structure-based design of TACE selective inhibitors: manipulations in the S1'-S3' pocket.,Bioorg. Med. Chem.,2007,15,18,"Huang A, Joseph-McCarthy D, Lovering F, Sun L, Wang W, Xu W, Zhu Y, Cui J, Zhang Y, Levin JI",,448561,DTCT0024091,2180847,DTCC00470410,1005301,23780
CHEMBL236446,P50281,,QROXNPLBULDOSL-QGRTWZNFSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,17512742,IC50,=,2660,NM,,,,,,,,,,,,,,Inhibition of MMP14,,Simultaneous presence of unsaturation and long alkyl chain at P'1 of Ilomastat confers selectivity for gelatinase A (MMP-2) over gelatinase B (MMP-9) inhibition as shown by molecular modelling studies.,Bioorg. Med. Chem.,2007,15,14,"Moroy G, Denhez C, El Mourabit H, Toribio A, Dassonville A, Decarme M, Renault JH, Mirand C, Bellon G, Sapi J, Alix AJ, Hornebeck W, Bourguet E",,447908,DTCT0024091,2176051,DTCC00468601,163984,23716
CHEMBL236572,P50281,,XOBSNYRLSVUYKY-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,17606376,IC50,,,,,,,,,,,,,,,,,Inhibition of human recombinant MMP14,Not Determined,Structure-based design of TACE selective inhibitors: manipulations in the S1'-S3' pocket.,Bioorg. Med. Chem.,2007,15,18,"Huang A, Joseph-McCarthy D, Lovering F, Sun L, Wang W, Xu W, Zhu Y, Cui J, Zhang Y, Levin JI",,448561,DTCT0024091,2180851,DTCC00470402,2003455,23780
CHEMBL236573,P50281,,RXFCFGLSOUOCEA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,17606376,IC50,=,2370,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP14,,Structure-based design of TACE selective inhibitors: manipulations in the S1'-S3' pocket.,Bioorg. Med. Chem.,2007,15,18,"Huang A, Joseph-McCarthy D, Lovering F, Sun L, Wang W, Xu W, Zhu Y, Cui J, Zhang Y, Levin JI",,448561,DTCT0024091,2180850,DTCC00470403,909129,23780
CHEMBL236574,P50281,,VYJYRILYFYRPCK-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,17606376,IC50,,,,,,,,,,,,,,,,,Inhibition of human recombinant MMP14,Not Determined,Structure-based design of TACE selective inhibitors: manipulations in the S1'-S3' pocket.,Bioorg. Med. Chem.,2007,15,18,"Huang A, Joseph-McCarthy D, Lovering F, Sun L, Wang W, Xu W, Zhu Y, Cui J, Zhang Y, Levin JI",,448561,DTCT0024091,2180857,DTCC00470404,876482,23780
CHEMBL236806,P50281,,UFOCAFMHHPCHKN-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,17606376,IC50,,,,,,,,,,,,,,,,,Inhibition of human recombinant MMP14,Not Determined,Structure-based design of TACE selective inhibitors: manipulations in the S1'-S3' pocket.,Bioorg. Med. Chem.,2007,15,18,"Huang A, Joseph-McCarthy D, Lovering F, Sun L, Wang W, Xu W, Zhu Y, Cui J, Zhang Y, Levin JI",,448561,DTCT0024091,2180853,DTCC00470413,131505,23780
CHEMBL237078,P50281,,BBUFBPSZYHVWGA-RSKCKNFOSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,17512742,IC50,=,913,NM,,,,,,,,,,,,,,Inhibition of MMP14,,Simultaneous presence of unsaturation and long alkyl chain at P'1 of Ilomastat confers selectivity for gelatinase A (MMP-2) over gelatinase B (MMP-9) inhibition as shown by molecular modelling studies.,Bioorg. Med. Chem.,2007,15,14,"Moroy G, Denhez C, El Mourabit H, Toribio A, Dassonville A, Decarme M, Renault JH, Mirand C, Bellon G, Sapi J, Alix AJ, Hornebeck W, Bourguet E",,447908,DTCT0024091,2176049,DTCC00468626,972772,23716
CHEMBL237466,P50281,,CEVWXUVNZJTNNB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,17606376,IC50,,,,,,,,,,,,,,,,,Inhibition of human recombinant MMP14,Not Determined,Structure-based design of TACE selective inhibitors: manipulations in the S1'-S3' pocket.,Bioorg. Med. Chem.,2007,15,18,"Huang A, Joseph-McCarthy D, Lovering F, Sun L, Wang W, Xu W, Zhu Y, Cui J, Zhang Y, Levin JI",,448561,DTCT0024091,2180855,DTCC00470406,131504,23780
CHEMBL237467,P50281,,CIPRRERRNXDHQR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,17606376,IC50,,,,,,,,,,,,,,,,,Inhibition of human recombinant MMP14,Not Determined,Structure-based design of TACE selective inhibitors: manipulations in the S1'-S3' pocket.,Bioorg. Med. Chem.,2007,15,18,"Huang A, Joseph-McCarthy D, Lovering F, Sun L, Wang W, Xu W, Zhu Y, Cui J, Zhang Y, Levin JI",,448561,DTCT0024091,2180854,DTCC00470407,1135053,23780
CHEMBL237468,P50281,,CLSBMSGIRGYRMI-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,17606376,IC50,=,4320,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP14,,Structure-based design of TACE selective inhibitors: manipulations in the S1'-S3' pocket.,Bioorg. Med. Chem.,2007,15,18,"Huang A, Joseph-McCarthy D, Lovering F, Sun L, Wang W, Xu W, Zhu Y, Cui J, Zhang Y, Levin JI",,448561,DTCT0024091,2180849,DTCC00470408,228328,23780
CHEMBL2380314,P50281,,ZXVWNUSVQOQAIY-ZEQRLZLVSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,23631440,KI,=,21,NM,,,,,,,,,,,,,,Inhibition of MMP-14 (unknown origin) using Mca-PLGLDpa-AR-NH2 as substrate preincubated for 30 mins by fluorescence assay,,Matrix metalloproteinase inhibitors based on the 3-mercaptopyrrolidine core.,J. Med. Chem.,2013,56,11,"Jin Y, Roycik MD, Bosco DB, Cao Q, Constantino MH, Schwartz MA, Sang QX",,959632,DTCT0024091,12429856,DTCC01373961,1256045,54589
CHEMBL2380387,P50281,,WSFQQGCWUCOARG-NMLBUPMWSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,23631440,KI,=,6.2,NM,,,,,,,,,,,,,,Inhibition of MMP-14 (unknown origin) using Mca-PLGLDpa-AR-NH2 as substrate preincubated for 30 mins by fluorescence assay,,Matrix metalloproteinase inhibitors based on the 3-mercaptopyrrolidine core.,J. Med. Chem.,2013,56,11,"Jin Y, Roycik MD, Bosco DB, Cao Q, Constantino MH, Schwartz MA, Sang QX",,959632,DTCT0024091,12429872,DTCC01373946,1865323,54589
CHEMBL2380388,P50281,,KJNZDUKNEQXTSO-LIONHTAISA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,23631440,KI,=,70,NM,,,,,,,,,,,,,,Inhibition of MMP-14 (unknown origin) using Mca-PLGLDpa-AR-NH2 as substrate preincubated for 30 mins by fluorescence assay,,Matrix metalloproteinase inhibitors based on the 3-mercaptopyrrolidine core.,J. Med. Chem.,2013,56,11,"Jin Y, Roycik MD, Bosco DB, Cao Q, Constantino MH, Schwartz MA, Sang QX",,959632,DTCT0024091,12429871,DTCC01373947,123665,54589
CHEMBL2380389,P50281,,QDPILJAKSNERSV-YAOOYPAMSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,23631440,KI,=,6,NM,,,,,,,,,,,,,,Inhibition of MMP-14 (unknown origin) using Mca-PLGLDpa-AR-NH2 as substrate preincubated for 30 mins by fluorescence assay,,Matrix metalloproteinase inhibitors based on the 3-mercaptopyrrolidine core.,J. Med. Chem.,2013,56,11,"Jin Y, Roycik MD, Bosco DB, Cao Q, Constantino MH, Schwartz MA, Sang QX",,959632,DTCT0024091,12429870,DTCC01373948,1062010,54589
CHEMBL2380390,P50281,,RYDPXGZLAKQPJB-AUAHOFGGSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,23631440,KI,=,7,NM,,,,,,,,,,,,,,Inhibition of MMP-14 (unknown origin) using Mca-PLGLDpa-AR-NH2 as substrate preincubated for 30 mins by fluorescence assay,,Matrix metalloproteinase inhibitors based on the 3-mercaptopyrrolidine core.,J. Med. Chem.,2013,56,11,"Jin Y, Roycik MD, Bosco DB, Cao Q, Constantino MH, Schwartz MA, Sang QX",,959632,DTCT0024091,12429869,DTCC01373949,577338,54589
CHEMBL2380391,P50281,,YTQYMJLEQVXIPD-SJORKVTESA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,23631440,KI,=,410,NM,,,,,,,,,,,,,,Inhibition of MMP-14 (unknown origin) using Mca-PLGLDpa-AR-NH2 as substrate preincubated for 30 mins by fluorescence assay,,Matrix metalloproteinase inhibitors based on the 3-mercaptopyrrolidine core.,J. Med. Chem.,2013,56,11,"Jin Y, Roycik MD, Bosco DB, Cao Q, Constantino MH, Schwartz MA, Sang QX",,959632,DTCT0024091,12429868,DTCC01373950,1995520,54589
CHEMBL2380391,P50281,,YTQYMJLEQVXIPD-SJORKVTESA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,23631440,KI,=,25000,NM,,,,,,,,,,,,,,Inhibition of MMP-14 (unknown origin) using Mca-PLGLDpa-AR-NH2 as substrate preincubated for 30 mins by fluorescence assay,,Matrix metalloproteinase inhibitors based on the 3-mercaptopyrrolidine core.,J. Med. Chem.,2013,56,11,"Jin Y, Roycik MD, Bosco DB, Cao Q, Constantino MH, Schwartz MA, Sang QX",,959632,DTCT0024091,12429867,DTCC01373950,1995521,54589
CHEMBL2380392,P50281,,YTQYMJLEQVXIPD-DLBZAZTESA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,23631440,KI,=,68,NM,,,,,,,,,,,,,,Inhibition of MMP-14 (unknown origin) using Mca-PLGLDpa-AR-NH2 as substrate preincubated for 30 mins by fluorescence assay,,Matrix metalloproteinase inhibitors based on the 3-mercaptopyrrolidine core.,J. Med. Chem.,2013,56,11,"Jin Y, Roycik MD, Bosco DB, Cao Q, Constantino MH, Schwartz MA, Sang QX",,959632,DTCT0024091,12429866,DTCC01373951,1929711,54589
CHEMBL2380393,P50281,,IVYZHWRIIPQLOI-QWRGUYRKSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,23631440,KI,=,3000,NM,,,,,,,,,,,,,,Inhibition of MMP-14 (unknown origin) using Mca-PLGLDpa-AR-NH2 as substrate preincubated for 30 mins by fluorescence assay,,Matrix metalloproteinase inhibitors based on the 3-mercaptopyrrolidine core.,J. Med. Chem.,2013,56,11,"Jin Y, Roycik MD, Bosco DB, Cao Q, Constantino MH, Schwartz MA, Sang QX",,959632,DTCT0024091,12429865,DTCC01373952,1929712,54589
CHEMBL2380394,P50281,,XBPHJVRPJAQGKS-IRXDYDNUSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,23631440,KI,=,1200,NM,,,,,,,,,,,,,,Inhibition of MMP-14 (unknown origin) using Mca-PLGLDpa-AR-NH2 as substrate preincubated for 30 mins by fluorescence assay,,Matrix metalloproteinase inhibitors based on the 3-mercaptopyrrolidine core.,J. Med. Chem.,2013,56,11,"Jin Y, Roycik MD, Bosco DB, Cao Q, Constantino MH, Schwartz MA, Sang QX",,959632,DTCT0024091,12429864,DTCC01373953,706586,54589
CHEMBL2380395,P50281,,YTQYMJLEQVXIPD-IRXDYDNUSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,23631440,KI,=,18,NM,,,,,,,,,,,,,,Inhibition of MMP-14 (unknown origin) using Mca-PLGLDpa-AR-NH2 as substrate preincubated for 30 mins by fluorescence assay,,Matrix metalloproteinase inhibitors based on the 3-mercaptopyrrolidine core.,J. Med. Chem.,2013,56,11,"Jin Y, Roycik MD, Bosco DB, Cao Q, Constantino MH, Schwartz MA, Sang QX",,959632,DTCT0024091,12429863,DTCC01373954,1962829,54589
CHEMBL2380395,P50281,,YTQYMJLEQVXIPD-IRXDYDNUSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,23631440,KI,=,31,NM,,,,,,,,,,,,,,Inhibition of MMP-14 (unknown origin) using Mca-PLGLDpa-AR-NH2 as substrate preincubated for 30 mins by fluorescence assay,,Matrix metalloproteinase inhibitors based on the 3-mercaptopyrrolidine core.,J. Med. Chem.,2013,56,11,"Jin Y, Roycik MD, Bosco DB, Cao Q, Constantino MH, Schwartz MA, Sang QX",,959632,DTCT0024091,12429862,DTCC01373954,1962830,54589
CHEMBL2380396,P50281,,YTQYMJLEQVXIPD-IAGOWNOFSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,23631440,KI,=,10,NM,,,,,,,,,,,,,,Inhibition of MMP-14 (unknown origin) using Mca-PLGLDpa-AR-NH2 as substrate preincubated for 30 mins by fluorescence assay,,Matrix metalloproteinase inhibitors based on the 3-mercaptopyrrolidine core.,J. Med. Chem.,2013,56,11,"Jin Y, Roycik MD, Bosco DB, Cao Q, Constantino MH, Schwartz MA, Sang QX",,959632,DTCT0024091,12429861,DTCC01373955,156243,54589
CHEMBL2380397,P50281,,GPFVSBBSRCFVPP-IRXDYDNUSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,23631440,KI,>,200000,NM,,,,,,,,,,,,,,Inhibition of MMP-14 (unknown origin) using Mca-PLGLDpa-AR-NH2 as substrate preincubated for 30 mins by fluorescence assay,,Matrix metalloproteinase inhibitors based on the 3-mercaptopyrrolidine core.,J. Med. Chem.,2013,56,11,"Jin Y, Roycik MD, Bosco DB, Cao Q, Constantino MH, Schwartz MA, Sang QX",,959632,DTCT0024091,12429860,DTCC01373956,738899,54589
CHEMBL2380398,P50281,,WOUSJKQGCHWOAQ-IRXDYDNUSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,23631440,KI,>,25000,NM,,,,,,,,,,,,,,Inhibition of MMP-14 (unknown origin) using Mca-PLGLDpa-AR-NH2 as substrate preincubated for 30 mins by fluorescence assay,,Matrix metalloproteinase inhibitors based on the 3-mercaptopyrrolidine core.,J. Med. Chem.,2013,56,11,"Jin Y, Roycik MD, Bosco DB, Cao Q, Constantino MH, Schwartz MA, Sang QX",,959632,DTCT0024091,12429859,DTCC01373957,480801,54589
CHEMBL2380400,P50281,,UJWXVGWYDPXCST-HOTGVXAUSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,23631440,KI,=,11,NM,,,,,,,,,,,,,,Inhibition of MMP-14 (unknown origin) using Mca-PLGLDpa-AR-NH2 as substrate preincubated for 30 mins by fluorescence assay,,Matrix metalloproteinase inhibitors based on the 3-mercaptopyrrolidine core.,J. Med. Chem.,2013,56,11,"Jin Y, Roycik MD, Bosco DB, Cao Q, Constantino MH, Schwartz MA, Sang QX",,959632,DTCT0024091,12429858,DTCC01373959,1579765,54589
CHEMBL2380401,P50281,,BTCYLUBBXQARQV-IRXDYDNUSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,23631440,KI,=,62,NM,,,,,,,,,,,,,,Inhibition of MMP-14 (unknown origin) using Mca-PLGLDpa-AR-NH2 as substrate preincubated for 30 mins by fluorescence assay,,Matrix metalloproteinase inhibitors based on the 3-mercaptopyrrolidine core.,J. Med. Chem.,2013,56,11,"Jin Y, Roycik MD, Bosco DB, Cao Q, Constantino MH, Schwartz MA, Sang QX",,959632,DTCT0024091,12429857,DTCC01373960,706587,54589
CHEMBL2380402,P50281,,MUWDEQLPHWVPPA-GOTSBHOMSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,23631440,KI,=,4,NM,,,,,,,,,,,,,,Inhibition of MMP-14 (unknown origin) using Mca-PLGLDpa-AR-NH2 as substrate preincubated for 30 mins by fluorescence assay,,Matrix metalloproteinase inhibitors based on the 3-mercaptopyrrolidine core.,J. Med. Chem.,2013,56,11,"Jin Y, Roycik MD, Bosco DB, Cao Q, Constantino MH, Schwartz MA, Sang QX",,959632,DTCT0024091,12429855,DTCC01373962,156244,54589
CHEMBL2380403,P50281,,FHORSTUZHMJGTR-GUTACTQSSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,23631440,KI,=,6.6,NM,,,,,,,,,,,,,,Inhibition of MMP-14 (unknown origin) using Mca-PLGLDpa-AR-NH2 as substrate preincubated for 30 mins by fluorescence assay,,Matrix metalloproteinase inhibitors based on the 3-mercaptopyrrolidine core.,J. Med. Chem.,2013,56,11,"Jin Y, Roycik MD, Bosco DB, Cao Q, Constantino MH, Schwartz MA, Sang QX",,959632,DTCT0024091,12429854,DTCC01373963,318346,54589
CHEMBL2380404,P50281,,NCMGDRDFDQYIHA-GUTACTQSSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,23631440,KI,=,85000,NM,,,,,,,,,,,,,,Inhibition of MMP-14 (unknown origin) using Mca-PLGLDpa-AR-NH2 as substrate preincubated for 30 mins by fluorescence assay,,Matrix metalloproteinase inhibitors based on the 3-mercaptopyrrolidine core.,J. Med. Chem.,2013,56,11,"Jin Y, Roycik MD, Bosco DB, Cao Q, Constantino MH, Schwartz MA, Sang QX",,959632,DTCT0024091,12429853,DTCC01373964,1962831,54589
CHEMBL2380406,P50281,,IZCZBRLGTKWIIZ-VWTOLEPZSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,23631440,KI,=,310,NM,,,,,,,,,,,,,,Inhibition of MMP-14 (unknown origin) using Mca-PLGLDpa-AR-NH2 as substrate preincubated for 30 mins by fluorescence assay,,Matrix metalloproteinase inhibitors based on the 3-mercaptopyrrolidine core.,J. Med. Chem.,2013,56,11,"Jin Y, Roycik MD, Bosco DB, Cao Q, Constantino MH, Schwartz MA, Sang QX",,959632,DTCT0024091,12429873,DTCC01373966,1515507,54589
CHEMBL2407117,P50281,,PVVGPDUDEJOIAA-QGZVFWFLSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,23810497,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP-14 using Mca-Pro-Leu-Ala-Nva-Dpa-Ala-Arg-NH2 as substrate after 20 hrs by fluorescence assay,,Hydantoin based inhibitors of MMP13-Discovery of AZD6605.,Bioorg. Med. Chem. Lett.,2013,23,16,"De Savi C, Waterson D, Pape A, Lamont S, Hadley E, Mills M, Page KM, Bowyer J, Maciewicz RA",,973500,DTCT0024091,12515693,DTCC01388072,1062170,55294
CHEMBL2409674,P50281,,IKFFESJLELVFMG-GOSISDBHSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,23810497,IC50,>,100000,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP-14 using Mca-Pro-Leu-Ala-Nva-Dpa-Ala-Arg-NH2 as substrate after 20 hrs by fluorescence assay,,Hydantoin based inhibitors of MMP13-Discovery of AZD6605.,Bioorg. Med. Chem. Lett.,2013,23,16,"De Savi C, Waterson D, Pape A, Lamont S, Hadley E, Mills M, Page KM, Bowyer J, Maciewicz RA",,973500,DTCT0024091,12515694,DTCC01388071,1897835,55294
CHEMBL2409675,P50281,,QEDQJMCQDYBMTN-LJQANCHMSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,23810497,IC50,=,98907,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP-14 using Mca-Pro-Leu-Ala-Nva-Dpa-Ala-Arg-NH2 as substrate after 20 hrs by fluorescence assay,,Hydantoin based inhibitors of MMP13-Discovery of AZD6605.,Bioorg. Med. Chem. Lett.,2013,23,16,"De Savi C, Waterson D, Pape A, Lamont S, Hadley E, Mills M, Page KM, Bowyer J, Maciewicz RA",,973500,DTCT0024091,12515692,DTCC01388073,513182,55294
CHEMBL2409676,P50281,,VUNVHTRIAQAVIJ-GOSISDBHSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,23810497,IC50,=,33882,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP-14 using Mca-Pro-Leu-Ala-Nva-Dpa-Ala-Arg-NH2 as substrate after 20 hrs by fluorescence assay,,Hydantoin based inhibitors of MMP13-Discovery of AZD6605.,Bioorg. Med. Chem. Lett.,2013,23,16,"De Savi C, Waterson D, Pape A, Lamont S, Hadley E, Mills M, Page KM, Bowyer J, Maciewicz RA",,973500,DTCT0024091,12515691,DTCC01388074,1547688,55294
CHEMBL2409677,P50281,,INEQIZHJKBPXON-GOSISDBHSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,23810497,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP-14 using Mca-Pro-Leu-Ala-Nva-Dpa-Ala-Arg-NH2 as substrate after 20 hrs by fluorescence assay,,Hydantoin based inhibitors of MMP13-Discovery of AZD6605.,Bioorg. Med. Chem. Lett.,2013,23,16,"De Savi C, Waterson D, Pape A, Lamont S, Hadley E, Mills M, Page KM, Bowyer J, Maciewicz RA",,973500,DTCT0024091,12515690,DTCC01388075,480932,55294
CHEMBL2409678,P50281,,PUMWDRFJNKAWSM-LJQANCHMSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,23810497,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP-14 using Mca-Pro-Leu-Ala-Nva-Dpa-Ala-Arg-NH2 as substrate after 20 hrs by fluorescence assay,,Hydantoin based inhibitors of MMP13-Discovery of AZD6605.,Bioorg. Med. Chem. Lett.,2013,23,16,"De Savi C, Waterson D, Pape A, Lamont S, Hadley E, Mills M, Page KM, Bowyer J, Maciewicz RA",,973500,DTCT0024091,12515712,DTCC01388076,447452,55294
CHEMBL2409682,P50281,,HEKVSVDHQDDIEK-HSZRJFAPSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,23810497,IC50,=,671,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP-14 using Mca-Pro-Leu-Ala-Nva-Dpa-Ala-Arg-NH2 as substrate after 20 hrs by fluorescence assay,,Hydantoin based inhibitors of MMP13-Discovery of AZD6605.,Bioorg. Med. Chem. Lett.,2013,23,16,"De Savi C, Waterson D, Pape A, Lamont S, Hadley E, Mills M, Page KM, Bowyer J, Maciewicz RA",,973500,DTCT0024091,12515711,DTCC01388080,91482,55294
CHEMBL2409683,P50281,,SYNSXJHFJAEBFU-XMMPIXPASA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,23810497,IC50,=,62,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP-14 using Mca-Pro-Leu-Ala-Nva-Dpa-Ala-Arg-NH2 as substrate after 20 hrs by fluorescence assay,,Hydantoin based inhibitors of MMP13-Discovery of AZD6605.,Bioorg. Med. Chem. Lett.,2013,23,16,"De Savi C, Waterson D, Pape A, Lamont S, Hadley E, Mills M, Page KM, Bowyer J, Maciewicz RA",,973500,DTCT0024091,12515710,DTCC01388081,1515661,55294
CHEMBL2409684,P50281,,PSLRKUXEVFQKIV-XMMPIXPASA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,23810497,IC50,=,116,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP-14 using Mca-Pro-Leu-Ala-Nva-Dpa-Ala-Arg-NH2 as substrate after 20 hrs by fluorescence assay,,Hydantoin based inhibitors of MMP13-Discovery of AZD6605.,Bioorg. Med. Chem. Lett.,2013,23,16,"De Savi C, Waterson D, Pape A, Lamont S, Hadley E, Mills M, Page KM, Bowyer J, Maciewicz RA",,973500,DTCT0024091,12515709,DTCC01388082,1676919,55294
CHEMBL2409685,P50281,,UUVAUHUMINHXNV-XMMPIXPASA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,23810497,IC50,=,915,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP-14 using Mca-Pro-Leu-Ala-Nva-Dpa-Ala-Arg-NH2 as substrate after 20 hrs by fluorescence assay,,Hydantoin based inhibitors of MMP13-Discovery of AZD6605.,Bioorg. Med. Chem. Lett.,2013,23,16,"De Savi C, Waterson D, Pape A, Lamont S, Hadley E, Mills M, Page KM, Bowyer J, Maciewicz RA",,973500,DTCT0024091,12515708,DTCC01388083,706731,55294
CHEMBL2409686,P50281,,KOMMTFBIYYINQN-XMMPIXPASA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,23810497,IC50,=,1080,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP-14 using Mca-Pro-Leu-Ala-Nva-Dpa-Ala-Arg-NH2 as substrate after 20 hrs by fluorescence assay,,Hydantoin based inhibitors of MMP13-Discovery of AZD6605.,Bioorg. Med. Chem. Lett.,2013,23,16,"De Savi C, Waterson D, Pape A, Lamont S, Hadley E, Mills M, Page KM, Bowyer J, Maciewicz RA",,973500,DTCT0024091,12515707,DTCC01388084,1676920,55294
CHEMBL2409687,P50281,,QTGLBCRCOSPUMG-HSZRJFAPSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,23810497,IC50,=,7731,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP-14 using Mca-Pro-Leu-Ala-Nva-Dpa-Ala-Arg-NH2 as substrate after 20 hrs by fluorescence assay,,Hydantoin based inhibitors of MMP13-Discovery of AZD6605.,Bioorg. Med. Chem. Lett.,2013,23,16,"De Savi C, Waterson D, Pape A, Lamont S, Hadley E, Mills M, Page KM, Bowyer J, Maciewicz RA",,973500,DTCT0024091,12515706,DTCC01388085,901138,55294
CHEMBL2409688,P50281,,BIHFFXMAAJBXAB-HSZRJFAPSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,23810497,IC50,=,764,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP-14 using Mca-Pro-Leu-Ala-Nva-Dpa-Ala-Arg-NH2 as substrate after 20 hrs by fluorescence assay,,Hydantoin based inhibitors of MMP13-Discovery of AZD6605.,Bioorg. Med. Chem. Lett.,2013,23,16,"De Savi C, Waterson D, Pape A, Lamont S, Hadley E, Mills M, Page KM, Bowyer J, Maciewicz RA",,973500,DTCT0024091,12515705,DTCC01388086,91483,55294
CHEMBL2409689,P50281,,JZZAWBZYLOHRQP-JOCHJYFZSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,23810497,IC50,=,450,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP-14 using Mca-Pro-Leu-Ala-Nva-Dpa-Ala-Arg-NH2 as substrate after 20 hrs by fluorescence assay,,Hydantoin based inhibitors of MMP13-Discovery of AZD6605.,Bioorg. Med. Chem. Lett.,2013,23,16,"De Savi C, Waterson D, Pape A, Lamont S, Hadley E, Mills M, Page KM, Bowyer J, Maciewicz RA",,973500,DTCT0024091,12515704,DTCC01388087,901139,55294
CHEMBL2409690,P50281,,IDSFPGOHXLYSBI-JOCHJYFZSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,23810497,IC50,=,1282,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP-14 using Mca-Pro-Leu-Ala-Nva-Dpa-Ala-Arg-NH2 as substrate after 20 hrs by fluorescence assay,,Hydantoin based inhibitors of MMP13-Discovery of AZD6605.,Bioorg. Med. Chem. Lett.,2013,23,16,"De Savi C, Waterson D, Pape A, Lamont S, Hadley E, Mills M, Page KM, Bowyer J, Maciewicz RA",,973500,DTCT0024091,12515703,DTCC01388088,642529,55294
CHEMBL2409691,P50281,,JHHVLAYNAWPINK-JOCHJYFZSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,23810497,IC50,=,6897,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP-14 using Mca-Pro-Leu-Ala-Nva-Dpa-Ala-Arg-NH2 as substrate after 20 hrs by fluorescence assay,,Hydantoin based inhibitors of MMP13-Discovery of AZD6605.,Bioorg. Med. Chem. Lett.,2013,23,16,"De Savi C, Waterson D, Pape A, Lamont S, Hadley E, Mills M, Page KM, Bowyer J, Maciewicz RA",,973500,DTCT0024091,12515702,DTCC01388089,383856,55294
CHEMBL2409692,P50281,,SXPZZTMIBGJPCR-HXUWFJFHSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,23810497,IC50,=,4090,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP-14 using Mca-Pro-Leu-Ala-Nva-Dpa-Ala-Arg-NH2 as substrate after 20 hrs by fluorescence assay,,Hydantoin based inhibitors of MMP13-Discovery of AZD6605.,Bioorg. Med. Chem. Lett.,2013,23,16,"De Savi C, Waterson D, Pape A, Lamont S, Hadley E, Mills M, Page KM, Bowyer J, Maciewicz RA",,973500,DTCT0024091,12515701,DTCC01388090,156365,55294
CHEMBL2409693,P50281,,HGHQBSHHIZJUCO-LJQANCHMSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,23810497,IC50,=,350,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP-14 using Mca-Pro-Leu-Ala-Nva-Dpa-Ala-Arg-NH2 as substrate after 20 hrs by fluorescence assay,,Hydantoin based inhibitors of MMP13-Discovery of AZD6605.,Bioorg. Med. Chem. Lett.,2013,23,16,"De Savi C, Waterson D, Pape A, Lamont S, Hadley E, Mills M, Page KM, Bowyer J, Maciewicz RA",,973500,DTCT0024091,12515700,DTCC01388091,2028561,55294
CHEMBL2409694,P50281,,PUGYNRMGOHDNQM-OAQYLSRUSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,23810497,IC50,=,1858,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP-14 using Mca-Pro-Leu-Ala-Nva-Dpa-Ala-Arg-NH2 as substrate after 20 hrs by fluorescence assay,,Hydantoin based inhibitors of MMP13-Discovery of AZD6605.,Bioorg. Med. Chem. Lett.,2013,23,16,"De Savi C, Waterson D, Pape A, Lamont S, Hadley E, Mills M, Page KM, Bowyer J, Maciewicz RA",,973500,DTCT0024091,12515699,DTCC01388092,1801225,55294
CHEMBL2409695,P50281,,QJVAYGYFNIIDHO-HXUWFJFHSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,23810497,IC50,>,99999,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP-14 using Mca-Pro-Leu-Ala-Nva-Dpa-Ala-Arg-NH2 as substrate after 20 hrs by fluorescence assay,,Hydantoin based inhibitors of MMP13-Discovery of AZD6605.,Bioorg. Med. Chem. Lett.,2013,23,16,"De Savi C, Waterson D, Pape A, Lamont S, Hadley E, Mills M, Page KM, Bowyer J, Maciewicz RA",,973500,DTCT0024091,12515698,DTCC01388093,1801226,55294
CHEMBL2409696,P50281,,PKCWEIUDUFDFAG-OAQYLSRUSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,23810497,IC50,=,53584,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP-14 using Mca-Pro-Leu-Ala-Nva-Dpa-Ala-Arg-NH2 as substrate after 20 hrs by fluorescence assay,,Hydantoin based inhibitors of MMP13-Discovery of AZD6605.,Bioorg. Med. Chem. Lett.,2013,23,16,"De Savi C, Waterson D, Pape A, Lamont S, Hadley E, Mills M, Page KM, Bowyer J, Maciewicz RA",,973500,DTCT0024091,12515697,DTCC01388094,56838,55294
CHEMBL2409697,P50281,,VSJFQUSZEQOOSY-OAQYLSRUSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,23810497,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP-14 using Mca-Pro-Leu-Ala-Nva-Dpa-Ala-Arg-NH2 as substrate after 20 hrs by fluorescence assay,,Hydantoin based inhibitors of MMP13-Discovery of AZD6605.,Bioorg. Med. Chem. Lett.,2013,23,16,"De Savi C, Waterson D, Pape A, Lamont S, Hadley E, Mills M, Page KM, Bowyer J, Maciewicz RA",,973500,DTCT0024091,12515695,DTCC01388095,351317,55294
CHEMBL2409699,P50281,,AYZMSYVMXDNCPT-GOSISDBHSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,23810497,IC50,=,2817,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP-14 using Mca-Pro-Leu-Ala-Nva-Dpa-Ala-Arg-NH2 as substrate after 20 hrs by fluorescence assay,,Hydantoin based inhibitors of MMP13-Discovery of AZD6605.,Bioorg. Med. Chem. Lett.,2013,23,16,"De Savi C, Waterson D, Pape A, Lamont S, Hadley E, Mills M, Page KM, Bowyer J, Maciewicz RA",,973500,DTCT0024091,12515720,DTCC01388097,2060484,55294
CHEMBL2409700,P50281,,DJXZXNHJKPAVOT-MRXNPFEDSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,23810497,IC50,=,9501,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP-14 using Mca-Pro-Leu-Ala-Nva-Dpa-Ala-Arg-NH2 as substrate after 20 hrs by fluorescence assay,,Hydantoin based inhibitors of MMP13-Discovery of AZD6605.,Bioorg. Med. Chem. Lett.,2013,23,16,"De Savi C, Waterson D, Pape A, Lamont S, Hadley E, Mills M, Page KM, Bowyer J, Maciewicz RA",,973500,DTCT0024091,12515719,DTCC01388098,156366,55294
CHEMBL2409702,P50281,,YSUBCUHCVFDMIT-QGZVFWFLSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,23810497,IC50,=,1950,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP-14 using Mca-Pro-Leu-Ala-Nva-Dpa-Ala-Arg-NH2 as substrate after 20 hrs by fluorescence assay,,Hydantoin based inhibitors of MMP13-Discovery of AZD6605.,Bioorg. Med. Chem. Lett.,2013,23,16,"De Savi C, Waterson D, Pape A, Lamont S, Hadley E, Mills M, Page KM, Bowyer J, Maciewicz RA",,973500,DTCT0024091,12515718,DTCC01388100,771224,55294
CHEMBL2409704,P50281,,ZVFKJDDERIYYSN-GOSISDBHSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,23810497,IC50,=,3121,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP-14 using Mca-Pro-Leu-Ala-Nva-Dpa-Ala-Arg-NH2 as substrate after 20 hrs by fluorescence assay,,Hydantoin based inhibitors of MMP13-Discovery of AZD6605.,Bioorg. Med. Chem. Lett.,2013,23,16,"De Savi C, Waterson D, Pape A, Lamont S, Hadley E, Mills M, Page KM, Bowyer J, Maciewicz RA",,973500,DTCT0024091,12515717,DTCC01388102,123817,55294
CHEMBL2409705,P50281,,FZWJDQVSTLXMHL-QGZVFWFLSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,23810497,IC50,=,4735,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP-14 using Mca-Pro-Leu-Ala-Nva-Dpa-Ala-Arg-NH2 as substrate after 20 hrs by fluorescence assay,,Hydantoin based inhibitors of MMP13-Discovery of AZD6605.,Bioorg. Med. Chem. Lett.,2013,23,16,"De Savi C, Waterson D, Pape A, Lamont S, Hadley E, Mills M, Page KM, Bowyer J, Maciewicz RA",,973500,DTCT0024091,12515716,DTCC01388103,1418900,55294
CHEMBL2409706,P50281,,NWYAUZLEGMZWIR-GOSISDBHSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,23810497,IC50,=,553,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP-14 using Mca-Pro-Leu-Ala-Nva-Dpa-Ala-Arg-NH2 as substrate after 20 hrs by fluorescence assay,,Hydantoin based inhibitors of MMP13-Discovery of AZD6605.,Bioorg. Med. Chem. Lett.,2013,23,16,"De Savi C, Waterson D, Pape A, Lamont S, Hadley E, Mills M, Page KM, Bowyer J, Maciewicz RA",,973500,DTCT0024091,12515715,DTCC01388104,739055,55294
CHEMBL2409707,P50281,,SBVAXUGOISPYPX-QGZVFWFLSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,23810497,IC50,=,2220,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP-14 using Mca-Pro-Leu-Ala-Nva-Dpa-Ala-Arg-NH2 as substrate after 20 hrs by fluorescence assay,,Hydantoin based inhibitors of MMP13-Discovery of AZD6605.,Bioorg. Med. Chem. Lett.,2013,23,16,"De Savi C, Waterson D, Pape A, Lamont S, Hadley E, Mills M, Page KM, Bowyer J, Maciewicz RA",,973500,DTCT0024091,12515714,DTCC01388105,351318,55294
CHEMBL2409708,P50281,,PIMSLVWUPZQPML-MRXNPFEDSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,23810497,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP-14 using Mca-Pro-Leu-Ala-Nva-Dpa-Ala-Arg-NH2 as substrate after 20 hrs by fluorescence assay,,Hydantoin based inhibitors of MMP13-Discovery of AZD6605.,Bioorg. Med. Chem. Lett.,2013,23,16,"De Savi C, Waterson D, Pape A, Lamont S, Hadley E, Mills M, Page KM, Bowyer J, Maciewicz RA",,973500,DTCT0024091,12515713,DTCC01388106,252837,55294
CHEMBL2430289,P50281,,GWRAQHGIJHUVNF-QNGWXLTQSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,23999043,IC50,=,100,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP14 using Mca-Lys-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 as substrate by fluorescence plate reader analysis,,Design and synthesis of MMP inhibitors with appended fluorescent tags for imaging and visualization of matrix metalloproteinase enzymes.,Bioorg. Med. Chem. Lett.,2013,23,20,"Freskos JN, Asmelash B, Gaston KR, Karwa A, Marzan TA, Nickols MA, Rogers TE, Schoenstein T, Sympson CJ, Vu B",,985893,DTCT0024091,12592004,DTCC01396242,1256256,55953
CHEMBL2431015,P50281,,YGTYRNSBOZPWFY-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,24044434,IC50,=,1600,NM,,,,,,,,,,,,,,Inhibition of recombinant human MMP-14 catalytic domain using Mca-Lys-Pro-Leu-Gly-Leu-Dap(Dnp)-Ala-Arg-NH2 as substrate incubated for 4 hrs measured every 15 secs for 20 mins by fluorimetric assay,,Selective arylsulfonamide inhibitors of ADAM-17: hit optimization and activity in ovarian cancer cell models.,J. Med. Chem.,2013,56,20,"Nuti E, Casalini F, Santamaria S, Fabbi M, Carbotti G, Ferrini S, Marinelli L, La Pietra V, Novellino E, Camodeca C, Orlandini E, Nencetti S, Rossello A",,984237,DTCT0024091,12586866,DTCC01396971,803495,55984
CHEMBL2431016,P50281,,IVQNYNVXTUYYFR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,24044434,IC50,=,940,NM,,,,,,,,,,,,,,Inhibition of recombinant human MMP-14 catalytic domain using Mca-Lys-Pro-Leu-Gly-Leu-Dap(Dnp)-Ala-Arg-NH2 as substrate incubated for 4 hrs measured every 15 secs for 20 mins by fluorimetric assay,,Selective arylsulfonamide inhibitors of ADAM-17: hit optimization and activity in ovarian cancer cell models.,J. Med. Chem.,2013,56,20,"Nuti E, Casalini F, Santamaria S, Fabbi M, Carbotti G, Ferrini S, Marinelli L, La Pietra V, Novellino E, Camodeca C, Orlandini E, Nencetti S, Rossello A",,984237,DTCT0024091,12586865,DTCC01396972,771296,55984
CHEMBL2431017,P50281,,RMRVSLSYZNRHKL-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,24044434,IC50,=,2900,NM,,,,,,,,,,,,,,Inhibition of recombinant human MMP-14 catalytic domain using Mca-Lys-Pro-Leu-Gly-Leu-Dap(Dnp)-Ala-Arg-NH2 as substrate incubated for 4 hrs measured every 15 secs for 20 mins by fluorimetric assay,,Selective arylsulfonamide inhibitors of ADAM-17: hit optimization and activity in ovarian cancer cell models.,J. Med. Chem.,2013,56,20,"Nuti E, Casalini F, Santamaria S, Fabbi M, Carbotti G, Ferrini S, Marinelli L, La Pietra V, Novellino E, Camodeca C, Orlandini E, Nencetti S, Rossello A",,984237,DTCT0024091,12586864,DTCC01396973,1995757,55984
CHEMBL2431018,P50281,,URIKLEJPYMMEBH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,24044434,IC50,=,1700,NM,,,,,,,,,,,,,,Inhibition of recombinant human MMP-14 catalytic domain using Mca-Lys-Pro-Leu-Gly-Leu-Dap(Dnp)-Ala-Arg-NH2 as substrate incubated for 4 hrs measured every 15 secs for 20 mins by fluorimetric assay,,Selective arylsulfonamide inhibitors of ADAM-17: hit optimization and activity in ovarian cancer cell models.,J. Med. Chem.,2013,56,20,"Nuti E, Casalini F, Santamaria S, Fabbi M, Carbotti G, Ferrini S, Marinelli L, La Pietra V, Novellino E, Camodeca C, Orlandini E, Nencetti S, Rossello A",,984237,DTCT0024091,12586863,DTCC01396974,57073,55984
CHEMBL2431019,P50281,,GPJRFRUTVIKWFY-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,24044434,IC50,=,120000,NM,,,,,,,,,,,,,,Inhibition of recombinant human MMP-14 catalytic domain using Mca-Lys-Pro-Leu-Gly-Leu-Dap(Dnp)-Ala-Arg-NH2 as substrate incubated for 4 hrs measured every 15 secs for 20 mins by fluorimetric assay,,Selective arylsulfonamide inhibitors of ADAM-17: hit optimization and activity in ovarian cancer cell models.,J. Med. Chem.,2013,56,20,"Nuti E, Casalini F, Santamaria S, Fabbi M, Carbotti G, Ferrini S, Marinelli L, La Pietra V, Novellino E, Camodeca C, Orlandini E, Nencetti S, Rossello A",,984237,DTCT0024091,12586862,DTCC01396975,771297,55984
CHEMBL2431020,P50281,,WVHOOIOSMOLBGZ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,24044434,IC50,=,890,NM,,,,,,,,,,,,,,Inhibition of recombinant human MMP-14 catalytic domain using Mca-Lys-Pro-Leu-Gly-Leu-Dap(Dnp)-Ala-Arg-NH2 as substrate incubated for 4 hrs measured every 15 secs for 20 mins by fluorimetric assay,,Selective arylsulfonamide inhibitors of ADAM-17: hit optimization and activity in ovarian cancer cell models.,J. Med. Chem.,2013,56,20,"Nuti E, Casalini F, Santamaria S, Fabbi M, Carbotti G, Ferrini S, Marinelli L, La Pietra V, Novellino E, Camodeca C, Orlandini E, Nencetti S, Rossello A",,984237,DTCT0024091,12586861,DTCC01396976,1029966,55984
CHEMBL2431021,P50281,,VONWNPCXOBRHMT-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,24044434,IC50,=,113000,NM,,,,,,,,,,,,,,Inhibition of recombinant human MMP-14 catalytic domain using Mca-Lys-Pro-Leu-Gly-Leu-Dap(Dnp)-Ala-Arg-NH2 as substrate incubated for 4 hrs measured every 15 secs for 20 mins by fluorimetric assay,,Selective arylsulfonamide inhibitors of ADAM-17: hit optimization and activity in ovarian cancer cell models.,J. Med. Chem.,2013,56,20,"Nuti E, Casalini F, Santamaria S, Fabbi M, Carbotti G, Ferrini S, Marinelli L, La Pietra V, Novellino E, Camodeca C, Orlandini E, Nencetti S, Rossello A",,984237,DTCT0024091,12586860,DTCC01396977,220582,55984
CHEMBL2431022,P50281,,JFSQCRNERBWFRT-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,24044434,IC50,=,123000,NM,,,,,,,,,,,,,,Inhibition of recombinant human MMP-14 catalytic domain using Mca-Lys-Pro-Leu-Gly-Leu-Dap(Dnp)-Ala-Arg-NH2 as substrate incubated for 4 hrs measured every 15 secs for 20 mins by fluorimetric assay,,Selective arylsulfonamide inhibitors of ADAM-17: hit optimization and activity in ovarian cancer cell models.,J. Med. Chem.,2013,56,20,"Nuti E, Casalini F, Santamaria S, Fabbi M, Carbotti G, Ferrini S, Marinelli L, La Pietra V, Novellino E, Camodeca C, Orlandini E, Nencetti S, Rossello A",,984237,DTCT0024091,12586858,DTCC01396978,1483276,55984
CHEMBL2431023,P50281,,QXELZFZRJLTGNV-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,24044434,IC50,,,,,,,,,,,,,,,,,Inhibition of recombinant human MMP-14 catalytic domain using Mca-Lys-Pro-Leu-Gly-Leu-Dap(Dnp)-Ala-Arg-NH2 as substrate incubated for 4 hrs measured every 15 secs for 20 mins by fluorimetric assay,Not Determined,Selective arylsulfonamide inhibitors of ADAM-17: hit optimization and activity in ovarian cancer cell models.,J. Med. Chem.,2013,56,20,"Nuti E, Casalini F, Santamaria S, Fabbi M, Carbotti G, Ferrini S, Marinelli L, La Pietra V, Novellino E, Camodeca C, Orlandini E, Nencetti S, Rossello A",,984237,DTCT0024091,12586857,DTCC01396979,545458,55984
CHEMBL2431024,P50281,,HPKAGMQWGBOAOT-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,24044434,IC50,=,170000,NM,,,,,,,,,,,,,,Inhibition of recombinant human MMP-14 catalytic domain using Mca-Lys-Pro-Leu-Gly-Leu-Dap(Dnp)-Ala-Arg-NH2 as substrate incubated for 4 hrs measured every 15 secs for 20 mins by fluorimetric assay,,Selective arylsulfonamide inhibitors of ADAM-17: hit optimization and activity in ovarian cancer cell models.,J. Med. Chem.,2013,56,20,"Nuti E, Casalini F, Santamaria S, Fabbi M, Carbotti G, Ferrini S, Marinelli L, La Pietra V, Novellino E, Camodeca C, Orlandini E, Nencetti S, Rossello A",,984237,DTCT0024091,12586856,DTCC01396980,1547767,55984
CHEMBL2431025,P50281,,AACHNFJXJZIPFX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,24044434,IC50,=,21400,NM,,,,,,,,,,,,,,Inhibition of recombinant human MMP-14 catalytic domain using Mca-Lys-Pro-Leu-Gly-Leu-Dap(Dnp)-Ala-Arg-NH2 as substrate incubated for 4 hrs measured every 15 secs for 20 mins by fluorimetric assay,,Selective arylsulfonamide inhibitors of ADAM-17: hit optimization and activity in ovarian cancer cell models.,J. Med. Chem.,2013,56,20,"Nuti E, Casalini F, Santamaria S, Fabbi M, Carbotti G, Ferrini S, Marinelli L, La Pietra V, Novellino E, Camodeca C, Orlandini E, Nencetti S, Rossello A",,984237,DTCT0024091,12586855,DTCC01396981,1158643,55984
CHEMBL2431026,P50281,,TZCXUSWHXSLZNB-HSZRJFAPSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,24044434,IC50,=,104000,NM,,,,,,,,,,,,,,Inhibition of recombinant human MMP-14 catalytic domain using Mca-Lys-Pro-Leu-Gly-Leu-Dap(Dnp)-Ala-Arg-NH2 as substrate incubated for 4 hrs measured every 15 secs for 20 mins by fluorimetric assay,,Selective arylsulfonamide inhibitors of ADAM-17: hit optimization and activity in ovarian cancer cell models.,J. Med. Chem.,2013,56,20,"Nuti E, Casalini F, Santamaria S, Fabbi M, Carbotti G, Ferrini S, Marinelli L, La Pietra V, Novellino E, Camodeca C, Orlandini E, Nencetti S, Rossello A",,984237,DTCT0024091,12586854,DTCC01396982,803496,55984
CHEMBL2431027,P50281,,HJLAUHYNMNIAAR-XMMPIXPASA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,24044434,IC50,=,68000,NM,,,,,,,,,,,,,,Inhibition of recombinant human MMP-14 catalytic domain using Mca-Lys-Pro-Leu-Gly-Leu-Dap(Dnp)-Ala-Arg-NH2 as substrate incubated for 4 hrs measured every 15 secs for 20 mins by fluorimetric assay,,Selective arylsulfonamide inhibitors of ADAM-17: hit optimization and activity in ovarian cancer cell models.,J. Med. Chem.,2013,56,20,"Nuti E, Casalini F, Santamaria S, Fabbi M, Carbotti G, Ferrini S, Marinelli L, La Pietra V, Novellino E, Camodeca C, Orlandini E, Nencetti S, Rossello A",,984237,DTCT0024091,12586853,DTCC01396983,1191062,55984
CHEMBL2431027,P50281,,HJLAUHYNMNIAAR-XMMPIXPASA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,26871660,IC50,=,68000,NM,,,,,,,,,,,,,,Inhibition of recombinant human MMP-14 using Mca-Lys-Pro-Leu-Gly-Leu-Dap(Dnp)-Ala-Arg-NH2 as substrate after 3 hrs by fluorometric assay,,Discovery of a new selective inhibitor of A Disintegrin And Metalloprotease 10 (ADAM-10) able to reduce the shedding of NKG2D ligands in Hodgkin's lymphoma cell models.,Eur. J. Med. Chem.,2016,111,,"Camodeca C, Nuti E, Tepshi L, Boero S, Tuccinardi T, Stura EA, Poggi A, Zocchi MR, Rossello A.",,1559051,DTCT0024091,101505,DTCC01396983,1162293,66304
CHEMBL2431028,P50281,,QTXVPJOTKLUYMQ-QGZVFWFLSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,24044434,IC50,=,19500,NM,,,,,,,,,,,,,,Inhibition of recombinant human MMP-14 catalytic domain using Mca-Lys-Pro-Leu-Gly-Leu-Dap(Dnp)-Ala-Arg-NH2 as substrate incubated for 4 hrs measured every 15 secs for 20 mins by fluorimetric assay,,Selective arylsulfonamide inhibitors of ADAM-17: hit optimization and activity in ovarian cancer cell models.,J. Med. Chem.,2013,56,20,"Nuti E, Casalini F, Santamaria S, Fabbi M, Carbotti G, Ferrini S, Marinelli L, La Pietra V, Novellino E, Camodeca C, Orlandini E, Nencetti S, Rossello A",,984237,DTCT0024091,12586852,DTCC01396984,1897905,55984
CHEMBL2431029,P50281,,QPWBTJDQYIYLND-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,24044434,IC50,=,630,NM,,,,,,,,,,,,,,Inhibition of recombinant human MMP-14 catalytic domain using Mca-Lys-Pro-Leu-Gly-Leu-Dap(Dnp)-Ala-Arg-NH2 as substrate incubated for 4 hrs measured every 15 secs for 20 mins by fluorimetric assay,,Selective arylsulfonamide inhibitors of ADAM-17: hit optimization and activity in ovarian cancer cell models.,J. Med. Chem.,2013,56,20,"Nuti E, Casalini F, Santamaria S, Fabbi M, Carbotti G, Ferrini S, Marinelli L, La Pietra V, Novellino E, Camodeca C, Orlandini E, Nencetti S, Rossello A",,984237,DTCT0024091,12586870,DTCC01396985,1865390,55984
CHEMBL2431030,P50281,,VCASEBIJMMTOBI-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,24044434,IC50,=,590,NM,,,,,,,,,,,,,,Inhibition of recombinant human MMP-14 catalytic domain using Mca-Lys-Pro-Leu-Gly-Leu-Dap(Dnp)-Ala-Arg-NH2 as substrate incubated for 4 hrs measured every 15 secs for 20 mins by fluorimetric assay,,Selective arylsulfonamide inhibitors of ADAM-17: hit optimization and activity in ovarian cancer cell models.,J. Med. Chem.,2013,56,20,"Nuti E, Casalini F, Santamaria S, Fabbi M, Carbotti G, Ferrini S, Marinelli L, La Pietra V, Novellino E, Camodeca C, Orlandini E, Nencetti S, Rossello A",,984237,DTCT0024091,12586869,DTCC01396986,1354063,55984
CHEMBL2431031,P50281,,APPNLLFVKPQJGQ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,24044434,IC50,=,7200,NM,,,,,,,,,,,,,,Inhibition of recombinant human MMP-14 catalytic domain using Mca-Lys-Pro-Leu-Gly-Leu-Dap(Dnp)-Ala-Arg-NH2 as substrate incubated for 4 hrs measured every 15 secs for 20 mins by fluorimetric assay,,Selective arylsulfonamide inhibitors of ADAM-17: hit optimization and activity in ovarian cancer cell models.,J. Med. Chem.,2013,56,20,"Nuti E, Casalini F, Santamaria S, Fabbi M, Carbotti G, Ferrini S, Marinelli L, La Pietra V, Novellino E, Camodeca C, Orlandini E, Nencetti S, Rossello A",,984237,DTCT0024091,12586868,DTCC01396987,1579986,55984
CHEMBL2431032,P50281,,LGTBURVEOHTXLS-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,24044434,IC50,=,72000,NM,,,,,,,,,,,,,,Inhibition of recombinant human MMP-14 catalytic domain using Mca-Lys-Pro-Leu-Gly-Leu-Dap(Dnp)-Ala-Arg-NH2 as substrate incubated for 4 hrs measured every 15 secs for 20 mins by fluorimetric assay,,Selective arylsulfonamide inhibitors of ADAM-17: hit optimization and activity in ovarian cancer cell models.,J. Med. Chem.,2013,56,20,"Nuti E, Casalini F, Santamaria S, Fabbi M, Carbotti G, Ferrini S, Marinelli L, La Pietra V, Novellino E, Camodeca C, Orlandini E, Nencetti S, Rossello A",,984237,DTCT0024091,12586867,DTCC01396988,642634,55984
CHEMBL24398,P50281,,UACUZULRKJKTHE-CZYKHXBRSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,21417219,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP14 after 60 mins by fluorescence plate reader,,"Discovery of (1S,2R,3R)-2,3-Dimethyl-2-phenyl-1-sulfamidocyclopropanecarboxylates: Novel and Highly Selective Aggrecanase Inhibitors.",J. Med. Chem.,2011,54,8,"Shiozaki M, Maeda K, Miura T, Kotoku M, Yamasaki T, Matsuda I, Aoki K, Yasue K, Imai H, Ubukata M, Suma A, Yokota M, Hotta T, Tanaka M, Hase Y, Haas J, Fryer AM, Laird ER, Littmann NM, Andrews SW, Josey JA, Mimura T, Shinozaki Y, Yoshiuchi H, Inaba T",,743597,DTCT0024091,5926787,DTCC00158787,1687040,44276
CHEMBL2440429,P50281,,MDQNHUVXMAEAFD-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,24071448,IC50,=,69000,NM,,,,,,,,,,,,,,Inhibition of MMP14 catalytic domain (unknown origin) using Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 as substrate incubated for 30 mins prior to substrate addition measured after 2 to 4 hrs by fluorometric assay,,Arylamino methylene bisphosphonate derivatives as bone seeking matrix metalloproteinase inhibitors.,Bioorg. Med. Chem.,2013,21,21,"Tauro M, Laghezza A, Loiodice F, Agamennone M, Campestre C, Tortorella P",,990167,DTCT0024091,12628970,DTCC01400793,1158679,56259
CHEMBL2440430,P50281,,GPHBFHLZRQMFLJ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,24071448,IC50,=,43000,NM,,,,,,,,,,,,,,Inhibition of MMP14 catalytic domain (unknown origin) using Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 as substrate incubated for 30 mins prior to substrate addition measured after 2 to 4 hrs by fluorometric assay,,Arylamino methylene bisphosphonate derivatives as bone seeking matrix metalloproteinase inhibitors.,Bioorg. Med. Chem.,2013,21,21,"Tauro M, Laghezza A, Loiodice F, Agamennone M, Campestre C, Tortorella P",,990167,DTCT0024091,12628974,DTCC01400794,1708742,56259
CHEMBL2440431,P50281,,VRCNSKZUURJQAN-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,24071448,IC50,=,76000,NM,,,,,,,,,,,,,,Inhibition of MMP14 catalytic domain (unknown origin) using Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 as substrate incubated for 30 mins prior to substrate addition measured after 2 to 4 hrs by fluorometric assay,,Arylamino methylene bisphosphonate derivatives as bone seeking matrix metalloproteinase inhibitors.,Bioorg. Med. Chem.,2013,21,21,"Tauro M, Laghezza A, Loiodice F, Agamennone M, Campestre C, Tortorella P",,990167,DTCT0024091,12628973,DTCC01400795,252959,56259
CHEMBL2440432,P50281,,ZSBBJNVNCGRSOS-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,24071448,IC50,=,49500,NM,,,,,,,,,,,,,,Inhibition of MMP14 catalytic domain (unknown origin) using Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 as substrate incubated for 30 mins prior to substrate addition measured after 2 to 4 hrs by fluorometric assay,,Arylamino methylene bisphosphonate derivatives as bone seeking matrix metalloproteinase inhibitors.,Bioorg. Med. Chem.,2013,21,21,"Tauro M, Laghezza A, Loiodice F, Agamennone M, Campestre C, Tortorella P",,990167,DTCT0024091,12628972,DTCC01400796,1158680,56259
CHEMBL2440433,P50281,"3,4-DICHLOROPHENYLAMINOMETHYLENEBISPHOSPHONIC ACID",ADHSWFUIIRWNHD-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,24071448,IC50,=,20000,NM,,,,,,,,,,,,,,Inhibition of MMP14 catalytic domain (unknown origin) using Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 as substrate incubated for 30 mins prior to substrate addition measured after 2 to 4 hrs by fluorometric assay,,Arylamino methylene bisphosphonate derivatives as bone seeking matrix metalloproteinase inhibitors.,Bioorg. Med. Chem.,2013,21,21,"Tauro M, Laghezza A, Loiodice F, Agamennone M, Campestre C, Tortorella P",,990167,DTCT0024091,12628978,DTCC01400797,220619,56259
CHEMBL2440434,P50281,,GSMGLRFAXIPFLS-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,24071448,IC50,>,100000,NM,,,,,,,,,,,,,,Inhibition of MMP14 catalytic domain (unknown origin) using Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 as substrate incubated for 30 mins prior to substrate addition measured after 2 to 4 hrs by fluorometric assay,,Arylamino methylene bisphosphonate derivatives as bone seeking matrix metalloproteinase inhibitors.,Bioorg. Med. Chem.,2013,21,21,"Tauro M, Laghezza A, Loiodice F, Agamennone M, Campestre C, Tortorella P",,990167,DTCT0024091,12628977,DTCC01400798,1062292,56259
CHEMBL2440435,P50281,,SENUMOHBDKDZCG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,24071448,IC50,>,100000,NM,,,,,,,,,,,,,,Inhibition of MMP14 catalytic domain (unknown origin) using Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 as substrate incubated for 30 mins prior to substrate addition measured after 2 to 4 hrs by fluorometric assay,,Arylamino methylene bisphosphonate derivatives as bone seeking matrix metalloproteinase inhibitors.,Bioorg. Med. Chem.,2013,21,21,"Tauro M, Laghezza A, Loiodice F, Agamennone M, Campestre C, Tortorella P",,990167,DTCT0024091,12628982,DTCC01400799,1127369,56259
CHEMBL2440436,P50281,,SCLGFWTXZFUITP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,24071448,IC50,>,100000,NM,,,,,,,,,,,,,,Inhibition of MMP14 catalytic domain (unknown origin) using Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 as substrate incubated for 30 mins prior to substrate addition measured after 2 to 4 hrs by fluorometric assay,,Arylamino methylene bisphosphonate derivatives as bone seeking matrix metalloproteinase inhibitors.,Bioorg. Med. Chem.,2013,21,21,"Tauro M, Laghezza A, Loiodice F, Agamennone M, Campestre C, Tortorella P",,990167,DTCT0024091,12628980,DTCC01400800,1321323,56259
CHEMBL2440437,P50281,,ZEZSYIYQVUYORL-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,24071448,IC50,>,100000,NM,,,,,,,,,,,,,,Inhibition of MMP14 catalytic domain (unknown origin) using Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 as substrate incubated for 30 mins prior to substrate addition measured after 2 to 4 hrs by fluorometric assay,,Arylamino methylene bisphosphonate derivatives as bone seeking matrix metalloproteinase inhibitors.,Bioorg. Med. Chem.,2013,21,21,"Tauro M, Laghezza A, Loiodice F, Agamennone M, Campestre C, Tortorella P",,990167,DTCT0024091,12628985,DTCC01400801,1256310,56259
CHEMBL2440438,P50281,,XQVNOYYFZWUDCV-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,24071448,IC50,>,100000,NM,,,,,,,,,,,,,,Inhibition of MMP14 catalytic domain (unknown origin) using Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 as substrate incubated for 30 mins prior to substrate addition measured after 2 to 4 hrs by fluorometric assay,,Arylamino methylene bisphosphonate derivatives as bone seeking matrix metalloproteinase inhibitors.,Bioorg. Med. Chem.,2013,21,21,"Tauro M, Laghezza A, Loiodice F, Agamennone M, Campestre C, Tortorella P",,990167,DTCT0024091,12628984,DTCC01400802,1095361,56259
CHEMBL2440439,P50281,(P-TOLYLAMINO)METHYLENEDIPHOSPHONIC ACID,FVJHDPVFVSTFKH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,24071448,IC50,>,100000,NM,,,,,,,,,,,,,,Inhibition of MMP14 catalytic domain (unknown origin) using Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 as substrate incubated for 30 mins prior to substrate addition measured after 2 to 4 hrs by fluorometric assay,,Arylamino methylene bisphosphonate derivatives as bone seeking matrix metalloproteinase inhibitors.,Bioorg. Med. Chem.,2013,21,21,"Tauro M, Laghezza A, Loiodice F, Agamennone M, Campestre C, Tortorella P",,990167,DTCT0024091,12628987,DTCC01400803,642669,56259
CHEMBL2440440,P50281,,RBHODZPTKHWXDX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,24071448,IC50,>,100000,NM,,,,,,,,,,,,,,Inhibition of MMP14 catalytic domain (unknown origin) using Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 as substrate incubated for 30 mins prior to substrate addition measured after 2 to 4 hrs by fluorometric assay,,Arylamino methylene bisphosphonate derivatives as bone seeking matrix metalloproteinase inhibitors.,Bioorg. Med. Chem.,2013,21,21,"Tauro M, Laghezza A, Loiodice F, Agamennone M, Campestre C, Tortorella P",,990167,DTCT0024091,12628986,DTCC01400804,1062293,56259
CHEMBL2440441,P50281,,AXIAQHKDCQVIKV-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,24071448,IC50,=,3900,NM,,,,,,,,,,,,,,Inhibition of MMP14 catalytic domain (unknown origin) using Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 as substrate incubated for 30 mins prior to substrate addition measured after 2 to 4 hrs by fluorometric assay,,Arylamino methylene bisphosphonate derivatives as bone seeking matrix metalloproteinase inhibitors.,Bioorg. Med. Chem.,2013,21,21,"Tauro M, Laghezza A, Loiodice F, Agamennone M, Campestre C, Tortorella P",,990167,DTCT0024091,12628989,DTCC01400805,318637,56259
CHEMBL2440578,P50281,,HTWBLJFKBSZUAN-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,24071448,IC50,=,26000,NM,,,,,,,,,,,,,,Inhibition of MMP14 catalytic domain (unknown origin) using Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 as substrate incubated for 30 mins prior to substrate addition measured after 2 to 4 hrs by fluorometric assay,,Arylamino methylene bisphosphonate derivatives as bone seeking matrix metalloproteinase inhibitors.,Bioorg. Med. Chem.,2013,21,21,"Tauro M, Laghezza A, Loiodice F, Agamennone M, Campestre C, Tortorella P",,990167,DTCT0024091,12628988,DTCC01400943,1938015,56259
CHEMBL2440579,P50281,(4-CHLOROPHENYLAMINO)METHYLENEDIPHOSPHONIC ACID,PPOZCMYPJMEBPT-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,24071448,IC50,>,100000,NM,,,,,,,,,,,,,,Inhibition of MMP14 catalytic domain (unknown origin) using Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 as substrate incubated for 30 mins prior to substrate addition measured after 2 to 4 hrs by fluorometric assay,,Arylamino methylene bisphosphonate derivatives as bone seeking matrix metalloproteinase inhibitors.,Bioorg. Med. Chem.,2013,21,21,"Tauro M, Laghezza A, Loiodice F, Agamennone M, Campestre C, Tortorella P",,990167,DTCT0024091,12628990,DTCC01400944,416940,56259
CHEMBL2440580,P50281,(PHENYLAMINO)METHYLENEDIPHOSPHONIC ACID,XVNZXEWQQDCZSM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,24071448,IC50,>,100000,NM,,,,,,,,,,,,,,Inhibition of MMP14 catalytic domain (unknown origin) using Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 as substrate incubated for 30 mins prior to substrate addition measured after 2 to 4 hrs by fluorometric assay,,Arylamino methylene bisphosphonate derivatives as bone seeking matrix metalloproteinase inhibitors.,Bioorg. Med. Chem.,2013,21,21,"Tauro M, Laghezza A, Loiodice F, Agamennone M, Campestre C, Tortorella P",,990167,DTCT0024091,12628992,DTCC01400945,1515790,56259
CHEMBL2440581,P50281,,CXOBNZQSLVRTMZ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,24071448,IC50,>,100000,NM,,,,,,,,,,,,,,Inhibition of MMP14 catalytic domain (unknown origin) using Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 as substrate incubated for 30 mins prior to substrate addition measured after 2 to 4 hrs by fluorometric assay,,Arylamino methylene bisphosphonate derivatives as bone seeking matrix metalloproteinase inhibitors.,Bioorg. Med. Chem.,2013,21,21,"Tauro M, Laghezza A, Loiodice F, Agamennone M, Campestre C, Tortorella P",,990167,DTCT0024091,12628991,DTCC01400946,383983,56259
CHEMBL2442878,P50281,,KXYWMKRIKCLADT-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,24028490,KI,=,17000,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP-14 catalytic domain using MOCAcPLGLA2pr(Dnp)AR-NH2 as substrate by fluorescence spectrophotometric analysis,,O-phenyl carbamate and phenyl urea thiiranes as selective matrix metalloproteinase-2 inhibitors that cross the blood-brain barrier.,J. Med. Chem.,2013,56,20,"Gooyit M, Song W, Mahasenan KV, Lichtenwalter K, Suckow MA, Schroeder VA, Wolter WR, Mobashery S, Chang M",,991001,DTCT0024091,12640763,DTCC01403249,188424,56235
CHEMBL2442879,P50281,,VFVIUYYQHAEKJX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,24028490,KI,=,27000,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP-14 catalytic domain using MOCAcPLGLA2pr(Dnp)AR-NH2 as substrate by fluorescence spectrophotometric analysis,,O-phenyl carbamate and phenyl urea thiiranes as selective matrix metalloproteinase-2 inhibitors that cross the blood-brain barrier.,J. Med. Chem.,2013,56,20,"Gooyit M, Song W, Mahasenan KV, Lichtenwalter K, Suckow MA, Schroeder VA, Wolter WR, Mobashery S, Chang M",,991001,DTCT0024091,12640762,DTCC01403250,91625,56235
CHEMBL2442880,P50281,,SJWVELZZBPYZRG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,24028490,INHIBITION,=,30,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP-14 catalytic domain using MOCAcPLGLA2pr(Dnp)AR-NH2 as substrate at 50 uM by fluorescence spectrophotometric analysis relative to control,,O-phenyl carbamate and phenyl urea thiiranes as selective matrix metalloproteinase-2 inhibitors that cross the blood-brain barrier.,J. Med. Chem.,2013,56,20,"Gooyit M, Song W, Mahasenan KV, Lichtenwalter K, Suckow MA, Schroeder VA, Wolter WR, Mobashery S, Chang M",,991000,DTCT0024091,12639888,DTCC01403251,220656,56235
CHEMBL2442881,P50281,,NPWUBXHYMWVDKN-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,24028490,KI,=,19000,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP-14 catalytic domain using MOCAcPLGLA2pr(Dnp)AR-NH2 as substrate by fluorescence spectrophotometric analysis,,O-phenyl carbamate and phenyl urea thiiranes as selective matrix metalloproteinase-2 inhibitors that cross the blood-brain barrier.,J. Med. Chem.,2013,56,20,"Gooyit M, Song W, Mahasenan KV, Lichtenwalter K, Suckow MA, Schroeder VA, Wolter WR, Mobashery S, Chang M",,991001,DTCT0024091,12640760,DTCC01403252,351448,56235
CHEMBL2442882,P50281,,XCRZYFVDWZHDQG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,24028490,INHIBITION,=,17,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP-14 catalytic domain using MOCAcPLGLA2pr(Dnp)AR-NH2 as substrate at 50 uM by fluorescence spectrophotometric analysis relative to control,,O-phenyl carbamate and phenyl urea thiiranes as selective matrix metalloproteinase-2 inhibitors that cross the blood-brain barrier.,J. Med. Chem.,2013,56,20,"Gooyit M, Song W, Mahasenan KV, Lichtenwalter K, Suckow MA, Schroeder VA, Wolter WR, Mobashery S, Chang M",,991000,DTCT0024091,12639887,DTCC01403253,1547821,56235
CHEMBL2442883,P50281,,IUYSNQXMHWEVJW-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,24028490,INHIBITION,=,8,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP-14 catalytic domain using MOCAcPLGLA2pr(Dnp)AR-NH2 as substrate at 50 uM by fluorescence spectrophotometric analysis relative to control,,O-phenyl carbamate and phenyl urea thiiranes as selective matrix metalloproteinase-2 inhibitors that cross the blood-brain barrier.,J. Med. Chem.,2013,56,20,"Gooyit M, Song W, Mahasenan KV, Lichtenwalter K, Suckow MA, Schroeder VA, Wolter WR, Mobashery S, Chang M",,991000,DTCT0024091,12639886,DTCC01403254,252989,56235
CHEMBL2442884,P50281,,PXYTTWPKWBWEHH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,24028490,INHIBITION,=,37,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP-14 catalytic domain using MOCAcPLGLA2pr(Dnp)AR-NH2 as substrate at 50 uM by fluorescence spectrophotometric analysis relative to control,,O-phenyl carbamate and phenyl urea thiiranes as selective matrix metalloproteinase-2 inhibitors that cross the blood-brain barrier.,J. Med. Chem.,2013,56,20,"Gooyit M, Song W, Mahasenan KV, Lichtenwalter K, Suckow MA, Schroeder VA, Wolter WR, Mobashery S, Chang M",,991000,DTCT0024091,12639885,DTCC01403255,2092731,56235
CHEMBL2442885,P50281,,NKVKCTYTQNQNIH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,24028490,KI,=,2600,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP-14 catalytic domain using MOCAcPLGLA2pr(Dnp)AR-NH2 as substrate by fluorescence spectrophotometric analysis,,O-phenyl carbamate and phenyl urea thiiranes as selective matrix metalloproteinase-2 inhibitors that cross the blood-brain barrier.,J. Med. Chem.,2013,56,20,"Gooyit M, Song W, Mahasenan KV, Lichtenwalter K, Suckow MA, Schroeder VA, Wolter WR, Mobashery S, Chang M",,991001,DTCT0024091,12640759,DTCC01403256,1256330,56235
CHEMBL2442886,P50281,,LJRIZWAWUQHHTF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,24028490,KI,=,1900,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP-14 catalytic domain using MOCAcPLGLA2pr(Dnp)AR-NH2 as substrate by fluorescence spectrophotometric analysis,,O-phenyl carbamate and phenyl urea thiiranes as selective matrix metalloproteinase-2 inhibitors that cross the blood-brain barrier.,J. Med. Chem.,2013,56,20,"Gooyit M, Song W, Mahasenan KV, Lichtenwalter K, Suckow MA, Schroeder VA, Wolter WR, Mobashery S, Chang M",,991001,DTCT0024091,12640758,DTCC01403257,1354112,56235
CHEMBL2442887,P50281,,KDYJIWZXMZGJQG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,24028490,KI,=,2100,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP-14 catalytic domain using MOCAcPLGLA2pr(Dnp)AR-NH2 as substrate by fluorescence spectrophotometric analysis,,O-phenyl carbamate and phenyl urea thiiranes as selective matrix metalloproteinase-2 inhibitors that cross the blood-brain barrier.,J. Med. Chem.,2013,56,20,"Gooyit M, Song W, Mahasenan KV, Lichtenwalter K, Suckow MA, Schroeder VA, Wolter WR, Mobashery S, Chang M",,991001,DTCT0024091,12640757,DTCC01403258,2060629,56235
CHEMBL2442888,P50281,,FNTWGXGOCVTLKR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,24028490,KI,=,2500,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP-14 catalytic domain using MOCAcPLGLA2pr(Dnp)AR-NH2 as substrate by fluorescence spectrophotometric analysis,,O-phenyl carbamate and phenyl urea thiiranes as selective matrix metalloproteinase-2 inhibitors that cross the blood-brain barrier.,J. Med. Chem.,2013,56,20,"Gooyit M, Song W, Mahasenan KV, Lichtenwalter K, Suckow MA, Schroeder VA, Wolter WR, Mobashery S, Chang M",,991001,DTCT0024091,12639889,DTCC01403259,1030030,56235
CHEMBL2442889,P50281,,MWMLZWBDIRKPMD-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,24028490,KI,=,2400,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP-14 catalytic domain using MOCAcPLGLA2pr(Dnp)AR-NH2 as substrate by fluorescence spectrophotometric analysis,,O-phenyl carbamate and phenyl urea thiiranes as selective matrix metalloproteinase-2 inhibitors that cross the blood-brain barrier.,J. Med. Chem.,2013,56,20,"Gooyit M, Song W, Mahasenan KV, Lichtenwalter K, Suckow MA, Schroeder VA, Wolter WR, Mobashery S, Chang M",,991001,DTCT0024091,12640768,DTCC01403260,1450847,56235
CHEMBL2442890,P50281,,JOSPLESHDLLQSD-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,24028490,KI,=,2700,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP-14 catalytic domain using MOCAcPLGLA2pr(Dnp)AR-NH2 as substrate by fluorescence spectrophotometric analysis,,O-phenyl carbamate and phenyl urea thiiranes as selective matrix metalloproteinase-2 inhibitors that cross the blood-brain barrier.,J. Med. Chem.,2013,56,20,"Gooyit M, Song W, Mahasenan KV, Lichtenwalter K, Suckow MA, Schroeder VA, Wolter WR, Mobashery S, Chang M",,991001,DTCT0024091,12640767,DTCC01403261,1062314,56235
CHEMBL2442891,P50281,,NDWDLJQCZNKAHG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,24028490,KI,=,2800,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP-14 catalytic domain using MOCAcPLGLA2pr(Dnp)AR-NH2 as substrate by fluorescence spectrophotometric analysis,,O-phenyl carbamate and phenyl urea thiiranes as selective matrix metalloproteinase-2 inhibitors that cross the blood-brain barrier.,J. Med. Chem.,2013,56,20,"Gooyit M, Song W, Mahasenan KV, Lichtenwalter K, Suckow MA, Schroeder VA, Wolter WR, Mobashery S, Chang M",,991001,DTCT0024091,12640766,DTCC01403262,481047,56235
CHEMBL2442892,P50281,,FWECVAAARPJXSH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,24028490,KI,=,3000,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP-14 catalytic domain using MOCAcPLGLA2pr(Dnp)AR-NH2 as substrate by fluorescence spectrophotometric analysis,,O-phenyl carbamate and phenyl urea thiiranes as selective matrix metalloproteinase-2 inhibitors that cross the blood-brain barrier.,J. Med. Chem.,2013,56,20,"Gooyit M, Song W, Mahasenan KV, Lichtenwalter K, Suckow MA, Schroeder VA, Wolter WR, Mobashery S, Chang M",,991001,DTCT0024091,12640765,DTCC01403263,57219,56235
CHEMBL2442893,P50281,,LYYLWOIDTXRRLW-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,24028490,KI,=,12000,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP-14 catalytic domain using MOCAcPLGLA2pr(Dnp)AR-NH2 as substrate by fluorescence spectrophotometric analysis,,O-phenyl carbamate and phenyl urea thiiranes as selective matrix metalloproteinase-2 inhibitors that cross the blood-brain barrier.,J. Med. Chem.,2013,56,20,"Gooyit M, Song W, Mahasenan KV, Lichtenwalter K, Suckow MA, Schroeder VA, Wolter WR, Mobashery S, Chang M",,991001,DTCT0024091,12640764,DTCC01403264,1547822,56235
CHEMBL2448145,P50281,,HWIAZSZOEMGGKM-GQKPGDGXSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,21417219,IC50,=,1400,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP14 after 60 mins by fluorescence plate reader,,"Discovery of (1S,2R,3R)-2,3-Dimethyl-2-phenyl-1-sulfamidocyclopropanecarboxylates: Novel and Highly Selective Aggrecanase Inhibitors.",J. Med. Chem.,2011,54,8,"Shiozaki M, Maeda K, Miura T, Kotoku M, Yamasaki T, Matsuda I, Aoki K, Yasue K, Imai H, Ubukata M, Suma A, Yokota M, Hotta T, Tanaka M, Hase Y, Haas J, Fryer AM, Laird ER, Littmann NM, Andrews SW, Josey JA, Mimura T, Shinozaki Y, Yoshiuchi H, Inaba T",,743597,DTCT0024091,5926806,DTCC01404012,166401,44276
CHEMBL244883,P50281,METHOTREXATE GAMMA-HYDROXAMIC ACID,YUQBNZUBNMWBAQ-ZDUSSCGKSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,17127067,INHIBITION,=,48,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP14 at 100 uM,,Methotrexate gamma-hydroxamate derivatives as potential dual target antitumor drugs.,Bioorg. Med. Chem.,2007,15,3,"Santos MA, Enyedy EA, Nuti E, Rossello A, Krupenko NI, Krupenko SA",,441107,DTCT0024091,2148758,DTCC00003032,1308171,23121
CHEMBL250093,P50281,,RZISBFWRHNXABZ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,17531482,IC50,=,3440,NM,,,,,,,,,,,,,,Inhibition of MMP14,,"Design and synthesis of 3,3-piperidine hydroxamate analogs as selective TACE inhibitors.",Bioorg. Med. Chem. Lett.,2007,17,15,"Lombart HG, Feyfant E, Joseph-McCarthy D, Huang A, Lovering F, Sun L, Zhu Y, Zeng C, Zhang Y, Levin J",,456211,DTCT0024091,2237273,DTCC00480948,1716176,24495
CHEMBL250094,P50281,,PPNXUTAPILQZQN-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,17531482,IC50,=,7440,NM,,,,,,,,,,,,,,Inhibition of MMP14,,"Design and synthesis of 3,3-piperidine hydroxamate analogs as selective TACE inhibitors.",Bioorg. Med. Chem. Lett.,2007,17,15,"Lombart HG, Feyfant E, Joseph-McCarthy D, Huang A, Lovering F, Sun L, Zhu Y, Zeng C, Zhang Y, Levin J",,456211,DTCT0024091,2237297,DTCC00480949,1684812,24495
CHEMBL250266,P50281,UK-370106,NSMABJUGSNPHMN-BHYWQNONSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,18029177,IC50,=,66900,NM,,,,,,,,,,,,,,Inhibition of MMP14,,A novel series of highly selective inhibitors of MMP-3.,Bioorg. Med. Chem. Lett.,2007,17,24,"Whitlock GA, Dack KN, Dickinson RP, Lewis ML",,459996,DTCT0024091,2266852,DTCC00003798,779009,24951
CHEMBL250266,P50281,UK-370106,NSMABJUGSNPHMN-BHYWQNONSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,18790648,IC50,=,66900,NM,,,,,,,,,,,,,,Inhibition of MMP14,,Specific targeting of metzincin family members with small-molecule inhibitors: progress toward a multifarious challenge.,Bioorg. Med. Chem.,2008,16,19,"Georgiadis D, Yiotakis A",,497410,DTCT0024091,2457454,DTCC00003798,791164,32556
CHEMBL250297,P50281,,NYRVSWKULSLJMD-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,17531482,IC50,=,4160,NM,,,,,,,,,,,,,,Inhibition of MMP14,,"Design and synthesis of 3,3-piperidine hydroxamate analogs as selective TACE inhibitors.",Bioorg. Med. Chem. Lett.,2007,17,15,"Lombart HG, Feyfant E, Joseph-McCarthy D, Huang A, Lovering F, Sun L, Zhu Y, Zeng C, Zhang Y, Levin J",,456211,DTCT0024091,2237295,DTCC00480951,1426591,24495
CHEMBL250298,P50281,,UVFPNZAMZZIJLE-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,17531482,IC50,=,5640,NM,,,,,,,,,,,,,,Inhibition of MMP14,,"Design and synthesis of 3,3-piperidine hydroxamate analogs as selective TACE inhibitors.",Bioorg. Med. Chem. Lett.,2007,17,15,"Lombart HG, Feyfant E, Joseph-McCarthy D, Huang A, Lovering F, Sun L, Zhu Y, Zeng C, Zhang Y, Levin J",,456211,DTCT0024091,2237294,DTCC00480952,196054,24495
CHEMBL250299,P50281,,GRFJGGIFOFQTRL-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,17531482,IC50,=,1460,NM,,,,,,,,,,,,,,Inhibition of MMP14,,"Design and synthesis of 3,3-piperidine hydroxamate analogs as selective TACE inhibitors.",Bioorg. Med. Chem. Lett.,2007,17,15,"Lombart HG, Feyfant E, Joseph-McCarthy D, Huang A, Lovering F, Sun L, Zhu Y, Zeng C, Zhang Y, Levin J",,456211,DTCT0024091,2237293,DTCC00480953,1361831,24495
CHEMBL250502,P50281,,SQWKFISUTRRKSE-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,17531482,IC50,=,1860,NM,,,,,,,,,,,,,,Inhibition of MMP14,,"Design and synthesis of 3,3-piperidine hydroxamate analogs as selective TACE inhibitors.",Bioorg. Med. Chem. Lett.,2007,17,15,"Lombart HG, Feyfant E, Joseph-McCarthy D, Huang A, Lovering F, Sun L, Zhu Y, Zeng C, Zhang Y, Levin J",,456211,DTCT0024091,2237291,DTCC00480955,2036345,24495
CHEMBL250503,P50281,,RYUNWXPVOIGBCD-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,17531482,IC50,=,3020,NM,,,,,,,,,,,,,,Inhibition of MMP14,,"Design and synthesis of 3,3-piperidine hydroxamate analogs as selective TACE inhibitors.",Bioorg. Med. Chem. Lett.,2007,17,15,"Lombart HG, Feyfant E, Joseph-McCarthy D, Huang A, Lovering F, Sun L, Zhu Y, Zeng C, Zhang Y, Levin J",,456211,DTCT0024091,2237290,DTCC00480956,1620344,24495
CHEMBL250504,P50281,,OAXXNDPRBWJXOJ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,17531482,IC50,=,3290,NM,,,,,,,,,,,,,,Inhibition of MMP14,,"Design and synthesis of 3,3-piperidine hydroxamate analogs as selective TACE inhibitors.",Bioorg. Med. Chem. Lett.,2007,17,15,"Lombart HG, Feyfant E, Joseph-McCarthy D, Huang A, Lovering F, Sun L, Zhu Y, Zeng C, Zhang Y, Levin J",,456211,DTCT0024091,2237289,DTCC00480958,8867,24495
CHEMBL250708,P50281,,YFKTVOCECCSHLJ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,17531482,IC50,=,5640,NM,,,,,,,,,,,,,,Inhibition of MMP14,,"Design and synthesis of 3,3-piperidine hydroxamate analogs as selective TACE inhibitors.",Bioorg. Med. Chem. Lett.,2007,17,15,"Lombart HG, Feyfant E, Joseph-McCarthy D, Huang A, Lovering F, Sun L, Zhu Y, Zeng C, Zhang Y, Levin J",,456211,DTCT0024091,2237288,DTCC00480959,714559,24495
CHEMBL250709,P50281,,ZXFJUXBYVRDBQU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,17531482,IC50,=,1250,NM,,,,,,,,,,,,,,Inhibition of MMP14,,"Design and synthesis of 3,3-piperidine hydroxamate analogs as selective TACE inhibitors.",Bioorg. Med. Chem. Lett.,2007,17,15,"Lombart HG, Feyfant E, Joseph-McCarthy D, Huang A, Lovering F, Sun L, Zhu Y, Zeng C, Zhang Y, Levin J",,456211,DTCT0024091,2237287,DTCC00480960,1937696,24495
CHEMBL250710,P50281,,KLUBFNJJJWONQA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,17531482,IC50,=,1650,NM,,,,,,,,,,,,,,Inhibition of MMP14,,"Design and synthesis of 3,3-piperidine hydroxamate analogs as selective TACE inhibitors.",Bioorg. Med. Chem. Lett.,2007,17,15,"Lombart HG, Feyfant E, Joseph-McCarthy D, Huang A, Lovering F, Sun L, Zhu Y, Zeng C, Zhang Y, Levin J",,456211,DTCT0024091,2237286,DTCC00480961,1231111,24495
CHEMBL250905,P50281,,CBVWAXQRTCTDDH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,17531482,IC50,=,1020,NM,,,,,,,,,,,,,,Inhibition of MMP14,,"Design and synthesis of 3,3-piperidine hydroxamate analogs as selective TACE inhibitors.",Bioorg. Med. Chem. Lett.,2007,17,15,"Lombart HG, Feyfant E, Joseph-McCarthy D, Huang A, Lovering F, Sun L, Zhu Y, Zeng C, Zhang Y, Levin J",,456211,DTCT0024091,2237231,DTCC00480963,844150,24495
CHEMBL251253,P50281,,RMPAKJHKSCQYEB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,17275314,KI,=,91.2,NM,,,,,,,,,,,,,,Inhibition of MMP14,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458934,DTCT0024091,2258295,DTCC00486974,714623,24803
CHEMBL251917,P50281,,YVBOXQAMDNUBQA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,18029177,IC50,=,20100,NM,,,,,,,,,,,,,,Inhibition of MMP14,,A novel series of highly selective inhibitors of MMP-3.,Bioorg. Med. Chem. Lett.,2007,17,24,"Whitlock GA, Dack KN, Dickinson RP, Lewis ML",,459996,DTCT0024091,2266902,DTCC00486122,1296611,24951
CHEMBL251917,P50281,,YVBOXQAMDNUBQA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,18790648,IC50,=,20100,NM,,,,,,,,,,,,,,Inhibition of MMP14,,Specific targeting of metzincin family members with small-molecule inhibitors: progress toward a multifarious challenge.,Bioorg. Med. Chem.,2008,16,19,"Georgiadis D, Yiotakis A",,497410,DTCT0024091,2457465,DTCC00486122,1309117,32556
CHEMBL252067,P50281,,KNEXKJXFTWTRQB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,17275314,IC50,=,15.85,NM,,,,,,,,,,,,,,Inhibition of MMP14,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458934,DTCT0024091,2258803,DTCC00487217,1005461,24803
CHEMBL252267,P50281,,ZTBBWIUGXAACLX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,17275314,IC50,=,18.2,NM,,,,,,,,,,,,,,Inhibition of MMP14,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458934,DTCT0024091,2258802,DTCC00487218,1776501,24803
CHEMBL252268,P50281,,QFTOVLPHYNPHCP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,17275314,IC50,=,120.23,NM,,,,,,,,,,,,,,Inhibition of MMP14,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458934,DTCT0024091,2258801,DTCC00487219,99397,24803
CHEMBL252269,P50281,,KHJPMGOSPGHZJP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,17275314,IC50,=,22.91,NM,,,,,,,,,,,,,,Inhibition of MMP14,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458934,DTCT0024091,2258799,DTCC00487221,714630,24803
CHEMBL252464,P50281,,GKBMXAGIBGGTHX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,17275314,IC50,=,50.12,NM,,,,,,,,,,,,,,Inhibition of MMP14,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458934,DTCT0024091,2258798,DTCC00487222,1523436,24803
CHEMBL252465,P50281,,XSTJNJFEEIMLBJ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,17275314,IC50,=,70.79,NM,,,,,,,,,,,,,,Inhibition of MMP14,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458934,DTCT0024091,2258797,DTCC00487223,1684870,24803
CHEMBL252466,P50281,,UTJVVBHKHKDVLB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,17275314,IC50,=,151.36,NM,,,,,,,,,,,,,,Inhibition of MMP14,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458934,DTCT0024091,2258795,DTCC00487225,1652643,24803
CHEMBL252664,P50281,,UJALFRAYPBNYQJ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,17275314,IC50,=,6760.83,NM,,,,,,,,,,,,,,Inhibition of MMP14,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458934,DTCT0024091,2258794,DTCC00487226,1716223,24803
CHEMBL252665,P50281,,VILSIPIFOWNDJJ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,17275314,IC50,=,218.78,NM,,,,,,,,,,,,,,Inhibition of MMP14,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458934,DTCT0024091,2258792,DTCC00487228,2068209,24803
CHEMBL252666,P50281,,SHISYUWYQPLRTA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,17275314,IC50,=,8709.64,NM,,,,,,,,,,,,,,Inhibition of MMP14,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458934,DTCT0024091,2258791,DTCC00487229,1005462,24803
CHEMBL252867,P50281,,HEQLCOMATGPJOI-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,17275314,IC50,=,199.53,NM,,,,,,,,,,,,,,Inhibition of MMP14,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458934,DTCT0024091,2258790,DTCC00487230,778993,24803
CHEMBL252868,P50281,,IWJZEADZIMWQAP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,17275314,IC50,=,645.65,NM,,,,,,,,,,,,,,Inhibition of MMP14,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458934,DTCT0024091,2258788,DTCC00487232,1296591,24803
CHEMBL253275,P50281,BMS-566394,PGVYYPZKXKGBLD-JKSUJKDBSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,18242982,KI,>,10000,NM,,,,,,,,,,,,,,Inhibition of MMP14,,"Potent, exceptionally selective, orally bioavailable inhibitors of TNF-alpha Converting Enzyme (TACE): novel 2-substituted-1H-benzo[d]imidazol-1-yl)methyl)benzamide P1' substituents.",Bioorg. Med. Chem. Lett.,2008,18,5,"Ott GR, Asakawa N, Lu Z, Anand R, Liu RQ, Covington MB, Vaddi K, Qian M, Newton RC, Christ DD, Trzaskos JM, Duan JJ",,462371,DTCT0024091,2282469,DTCC00003908,392011,25163
CHEMBL253275,P50281,BMS-566394,PGVYYPZKXKGBLD-JKSUJKDBSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,18790648,KI,>,10000,NM,,,,,,,,,,,,,,Inhibition of MMP14,,Specific targeting of metzincin family members with small-molecule inhibitors: progress toward a multifarious challenge.,Bioorg. Med. Chem.,2008,16,19,"Georgiadis D, Yiotakis A",,497410,DTCT0024091,2457231,DTCC00003908,404569,32556
CHEMBL263094,P50281,CARMINIC ACID,DGQLVPJVXFOQEV-JNVSTXMASA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,,IC50,=,19500,NM,,,,,,,,,,,,,,PubChem BioAssay. Dose Response confirmation of uHTS hits for a small molecule inhibitors of MT1-MMP activation in a fluorescence assay set 2. (Class of assay: confirmatory) ,active,PUBCHEM BIOASSAY DATA SET,,,,,,,954348,DTCT0024091,12216203,DTCC00448834,1122114,33038
CHEMBL263750,P50281,,JDKMZILZEJPWTA-VWLOTQADSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,16005220,IC50,=,1.5,NM,,,,,,,,,,,,,,Inhibitory concentration against MMP-14,,Identification of potent and selective MMP-13 inhibitors.,Bioorg. Med. Chem. Lett.,2005,15,18,"Wu J, Rush TS, Hotchandani R, Du X, Geck M, Collins E, Xu ZB, Skotnicki J, Levin JI, Lovering FE",,304646,DTCT0024091,1798741,DTCC00394441,142392,8231
CHEMBL267603,P50281,FOLATE GAMMA-L-PHENYLALANINEHYDROXAMIC ACID,WYBGJFMKGROIBY-PMACEKPBSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,17127067,IC50,=,80000,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP14,,Methotrexate gamma-hydroxamate derivatives as potential dual target antitumor drugs.,Bioorg. Med. Chem.,2007,15,3,"Santos MA, Enyedy EA, Nuti E, Rossello A, Krupenko NI, Krupenko SA",,441091,DTCT0024091,2143987,DTCC00003031,2079521,23121
CHEMBL267603,P50281,FOLATE GAMMA-L-PHENYLALANINEHYDROXAMIC ACID,WYBGJFMKGROIBY-PMACEKPBSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,17127067,RATIO IC50,=,3478,,,,,,,,,,,,,,,Ratio of IC50 of drug to CGS 27023A for human recombinant MMP14,,Methotrexate gamma-hydroxamate derivatives as potential dual target antitumor drugs.,Bioorg. Med. Chem.,2007,15,3,"Santos MA, Enyedy EA, Nuti E, Rossello A, Krupenko NI, Krupenko SA",,441103,DTCT0024091,2144008,DTCC00003031,2079521,23121
CHEMBL269834,P50281,,ZWPPXQSIUHCIOD-XXBNENTESA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,18835710,KI,=,2400000,NM,,,,,,,,,,,,,,Inhibition of MMP14,,Discovery of novel hydroxamates as highly potent tumor necrosis factor-alpha converting enzyme inhibitors. Part II: optimization of the S3' pocket.,Bioorg. Med. Chem. Lett.,2008,18,21,"Mazzola RD, Zhu Z, Sinning L, McKittrick B, Lavey B, Spitler J, Kozlowski J, Neng-Yang S, Zhou G, Guo Z, Orth P, Madison V, Sun J, Lundell D, Niu X",,496901,DTCT0024091,2456644,DTCC00505033,985373,31825
CHEMBL270050,P50281,,YOFJHCFIKFPSLE-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,18251495,ACTIVITY,,,,,,,,,,,,,,,,,Inhibition of MMP14 catalytic domain,Not Active,"Quinazolinones and pyrido[3,4-d]pyrimidin-4-ones as orally active and specific matrix metalloproteinase-13 inhibitors for the treatment of osteoarthritis.",J. Med. Chem.,2008,51,4,"Li JJ, Nahra J, Johnson AR, Bunker A, O'Brien P, Yue WS, Ortwine DF, Man CF, Baragi V, Kilgore K, Dyer RD, Han HK",,465552,DTCT0024091,2311295,DTCC00503704,1636500,25409
CHEMBL270050,P50281,,YOFJHCFIKFPSLE-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,18790648,ACTIVITY,,,,,,,,,,,,,,,,,Inhibition of MMP14,Not Active,Specific targeting of metzincin family members with small-molecule inhibitors: progress toward a multifarious challenge.,Bioorg. Med. Chem.,2008,16,19,"Georgiadis D, Yiotakis A",,497410,DTCT0024091,2457319,DTCC00503704,1632393,32556
CHEMBL271235,P50281,,SIICAQVADMFEDB-LADGPHEKSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,18061445,KI,=,2800,NM,,,,,,,,,,,,,,Binding affinity to MMP14,,"Alpha,beta-cyclic-beta-benzamido hydroxamic acids: novel templates for the design, synthesis, and evaluation of selective inhibitors of TNF-alpha converting enzyme (TACE).",Bioorg. Med. Chem. Lett.,2008,18,2,"Ott GR, Asakawa N, Lu Z, Liu RQ, Covington MB, Vaddi K, Qian M, Newton RC, Christ DD, Traskos JM, Decicco CP, Duan JJ",,463244,DTCT0024091,2296563,DTCC00502102,1776559,25233
CHEMBL277792,P50281,,KKRBZYCHOUTMBU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,10411481,KI,=,22,NM,,,,,,,,,,,,,,Binding affinity against matrix metalloprotease-14 MTI-MMP.,,Phosphinic pseudo-tripeptides as potent inhibitors of matrix metalloproteinases: a structure-activity study.,J. Med. Chem.,1999,42,14,"Vassiliou S, Mucha A, Cuniasse P, Georgiadis D, Lucet-Levannier K, Beau F, Kannan R, Murphy G, Knäuper V, Rio MC, Basset P, Yiotakis A, Dive V",,106782,DTCT0024091,1083347,DTCC00249127,615165,15258
CHEMBL279078,P50281,,OBJBBLBMOOBABD-BEVDRBHNSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,9548812,IC50,=,2.08,NM,,,,,,,,,,,,,,Activity against deletion mutant of MT1-MMP lacking the transmembrane domain (deltaMT1),,Inhibition of membrane-type 1 matrix metalloproteinase by hydroxamate inhibitors: an examination of the subsite pocket.,J. Med. Chem.,1998,41,8,"Yamamoto M, Tsujishita H, Hori N, Ohishi Y, Inoue S, Ikeda S, Okada Y",,217867,DTCT0024091,982756,DTCC00151610,1308397,15116
CHEMBL279785,P50281,MARIMASTAT,OCSMOTCMPXTDND-OUAUKWLOSA-N,3,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,9548812,IC50,=,1.82,NM,,,,,,,,,,,,,,Activity against deletion mutant of MT1-MMP lacking the transmembrane domain (deltaMT1),,Inhibition of membrane-type 1 matrix metalloproteinase by hydroxamate inhibitors: an examination of the subsite pocket.,J. Med. Chem.,1998,41,8,"Yamamoto M, Tsujishita H, Hori N, Ohishi Y, Inoue S, Ikeda S, Okada Y",,217867,DTCT0024091,980293,DTCC00151612,919877,15116
CHEMBL279785,P50281,MARIMASTAT,OCSMOTCMPXTDND-OUAUKWLOSA-N,3,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,26653735,IC50,=,10000,NM,,,,,,,,,,,,,,Inhibition of MMP14 (unknown origin) catalytic domain using MCA-Arg-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-Glu-Arg-NH2 as substrate preincubated for 60 mins followed by substrate addition by fluorescence assay,,"Discovery of N-(4-Fluoro-3-methoxybenzyl)-6-(2-(((2S,5R)-5-(hydroxymethyl)-1,4-dioxan-2-yl)methyl)-2H-tetrazol-5-yl)-2-methylpyrimidine-4-carboxamide. A Highly Selective and Orally Bioavailable Matrix Metalloproteinase-13 Inhibitor for the Potential Treatment of Osteoarthritis.",J. Med. Chem.,2016,59,1,"Ruminski PG, Massa M, Strohbach J, Hanau CE, Schmidt M, Scholten JA, Fletcher TR, Hamper BC, Carroll JN, Shieh HS, Caspers N, Collins B, Grapperhaus M, Palmquist KE, Collins J, Baldus JE, Hitchcock J, Kleine HP, Rogers MD, McDonald J, Munie GE, Messing DM, Portolan S, Whiteley LO, Sunyer T, Schnute ME.",,1552519,DTCT0024091,73309,DTCC00151612,915925,65989
CHEMBL279786,P50281,BATIMASTAT,XFILPEOLDIKJHX-QYZOEREBSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,9548812,IC50,=,3,NM,,,,,,,,,,,,,,Activity against deletion mutant of MT1-MMP lacking the transmembrane domain (deltaMT1),,Inhibition of membrane-type 1 matrix metalloproteinase by hydroxamate inhibitors: an examination of the subsite pocket.,J. Med. Chem.,1998,41,8,"Yamamoto M, Tsujishita H, Hori N, Ohishi Y, Inoue S, Ikeda S, Okada Y",,217867,DTCT0024091,1014092,DTCC00151611,984634,15116
CHEMBL279786,P50281,BATIMASTAT,XFILPEOLDIKJHX-QYZOEREBSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,11229773,IC50,=,2.9,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-14,,Selectivity of inhibition of matrix metalloproteases MMP-3 and MMP-2 by succinyl hydroxamates and their carboxylic acid analogues is dependent on P3' group chirality.,Bioorg. Med. Chem. Lett.,2001,11,4,"Fray MJ, Burslem MF, Dickinson RP",,106773,DTCT0024091,1135163,DTCC00151611,983181,4691
CHEMBL279786,P50281,BATIMASTAT,XFILPEOLDIKJHX-QYZOEREBSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,12877590,IC50,=,4.6,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-14,,"A potent, selective inhibitor of matrix metalloproteinase-3 for the topical treatment of chronic dermal ulcers.",J. Med. Chem.,2003,46,16,"Fray MJ, Dickinson RP, Huggins JP, Occleston NL",,106775,DTCT0024091,1526049,DTCC00151611,970901,17445
CHEMBL279786,P50281,BATIMASTAT,XFILPEOLDIKJHX-QYZOEREBSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,15582436,IC50,=,47,NM,,,,,,,,,,,,,,Inhibition of human matrix metalloprotease-14 expressed in Escherichia coli,,"N-hydroxy-2-(naphthalene-2-ylsulfanyl)-acetamide, a novel hydroxamic acid-based inhibitor of aminopeptidase N and its anti-angiogenic activity.",Bioorg. Med. Chem. Lett.,2005,15,1,"Lee J, Shim JS, Jung SA, Lee ST, Kwon HJ",,306147,DTCT0024091,1757717,DTCC00151611,983688,18428
CHEMBL279964,P50281,,GTBJTISRJIZWKE-HIFRSBDPSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,9548812,IC50,=,19.3,NM,,,,,,,,,,,,,,Activity against deletion mutant of MT1-MMP lacking the transmembrane domain (deltaMT1),,Inhibition of membrane-type 1 matrix metalloproteinase by hydroxamate inhibitors: an examination of the subsite pocket.,J. Med. Chem.,1998,41,8,"Yamamoto M, Tsujishita H, Hori N, Ohishi Y, Inoue S, Ikeda S, Okada Y",,217867,DTCT0024091,999330,DTCC00151073,1114498,15116
CHEMBL281371,P50281,,YOZKFIDLBXLPFF-HIFRSBDPSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,9548812,IC50,=,2.3,NM,,,,,,,,,,,,,,Activity against deletion mutant of MT1-MMP lacking the transmembrane domain (deltaMT1),,Inhibition of membrane-type 1 matrix metalloproteinase by hydroxamate inhibitors: an examination of the subsite pocket.,J. Med. Chem.,1998,41,8,"Yamamoto M, Tsujishita H, Hori N, Ohishi Y, Inoue S, Ikeda S, Okada Y",,217867,DTCT0024091,1015391,DTCC00151650,1437901,15116
CHEMBL29292,P50281,UBENIMEX,VGGGPCQERPFHOB-RDBSUJKOSA-N,2,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,15582436,IC50,,,,,,,,,,,,,,,,,Inhibition of human matrix metalloprotease-14 expressed in Escherichia coli; ND=Not determined,Not Determined,"N-hydroxy-2-(naphthalene-2-ylsulfanyl)-acetamide, a novel hydroxamic acid-based inhibitor of aminopeptidase N and its anti-angiogenic activity.",Bioorg. Med. Chem. Lett.,2005,15,1,"Lee J, Shim JS, Jung SA, Lee ST, Kwon HJ",,306516,DTCT0024091,1757722,DTCC00165773,109891,18428
CHEMBL293479,P50281,,BHTYFFISFVNOLJ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,24071448,IC50,=,33500,NM,,,,,,,,,,,,,,Inhibition of MMP14 catalytic domain (unknown origin) using Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 as substrate incubated for 30 mins prior to substrate addition measured after 2 to 4 hrs by fluorometric assay,,Arylamino methylene bisphosphonate derivatives as bone seeking matrix metalloproteinase inhibitors.,Bioorg. Med. Chem.,2013,21,21,"Tauro M, Laghezza A, Loiodice F, Agamennone M, Campestre C, Tortorella P",,990167,DTCT0024091,12628975,DTCC00200892,318636,56259
CHEMBL294264,P50281,PURPURIN,BBNQQADTFFCFGB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,,IC50,=,30600,NM,,,,,,,,,,,,,,PubChem BioAssay. Dose Response confirmation of uHTS hits for a small molecule inhibitors of MT1-MMP activation in a fluorescence assay set 1. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,954361,DTCT0024091,12209073,DTCC00205633,216279,33038
CHEMBL296196,P50281,,PTONAIKVYGVBIS-INIZCTEOSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,17088065,IC50,,,,,,,,,,,,,,,,,Inhibition of MMP14,Not Determined,alpha-Biphenylsulfonylamino 2-methylpropyl phosphonates: enantioselective synthesis and selective inhibition of MMPs.,Bioorg. Med. Chem.,2007,15,2,"Biasone A, Tortorella P, Campestre C, Agamennone M, Preziuso S, Chiappini M, Nuti E, Carelli P, Rossello A, Mazza F, Gallina C",,432509,DTCT0024091,2061986,DTCC00186419,228138,22402
CHEMBL297453,P50281,EPIGALOCATECHIN GALLATE,WMBWREPUVVBILR-WIYYLYMNSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,19524436,IC50,=,6800,NM,,,,,,,,,,,,,,Inhibition of human recombinant MT1-MMP expressed in Escherichia coli by fluorogenic peptide cleavage assay,,Regioselective synthesis of methylated epigallocatechin gallate via nitrobenzenesulfonyl (Ns) protecting group.,Bioorg. Med. Chem. Lett.,2009,19,15,"Aihara Y, Yoshida A, Furuta T, Wakimoto T, Akizawa T, Konishi M, Kan T",,579664,DTCT0024091,2894215,DTCC00187987,985698,35073
CHEMBL3104658,P50281,,VVXZPLQFCWCGBS-MDWZMJQESA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,24316668,IC50,=,4300,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP-14 using fluorescence peptide matrix as substrate after 45 mins by fluorescence plate reader analysis,,Discovery of a benzimidazole series of ADAMTS-5 (aggrecanase-2) inhibitors by scaffold hopping.,Eur. J. Med. Chem.,2014,71,,"Sogame S, Suenaga Y, Atobe M, Kawanishi M, Tanaka E, Miyoshi S",,1283986,DTCT0024091,12983849,DTCC01417897,783634,56872
CHEMBL3110281,P50281,,QQYCFXUASOHQCY-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,24304348,INHIBITION,,,,,,,,,,,,,,,,,Inhibition of MMP-14 (unknown origin) using omniMMP as fluorogenic substrate at 10 uM preincubated for 30 mins followed by substrate addition measured after 30 mins by fluorescence assay,Not Active,Synthesis and structure-activity relationship of 3-hydroxypyridine-2-thione-based histone deacetylase inhibitors.,J. Med. Chem.,2013,56,24,"Sodji QH, Patil V, Kornacki JR, Mrksich M, Oyelere AK",,1286647,DTCT0024091,12997863,DTCC01420618,1107623,57022
CHEMBL3110287,P50281,,YYRBBLSWPCHZTE-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,24304348,INHIBITION,,,,,,,,,,,,,,,,,Inhibition of MMP-14 (unknown origin) using omniMMP as fluorogenic substrate at 10 uM preincubated for 30 mins followed by substrate addition measured after 30 mins by fluorescence assay,Not Active,Synthesis and structure-activity relationship of 3-hydroxypyridine-2-thione-based histone deacetylase inhibitors.,J. Med. Chem.,2013,56,24,"Sodji QH, Patil V, Kornacki JR, Mrksich M, Oyelere AK",,1286647,DTCT0024091,12997864,DTCC01420624,945416,57022
CHEMBL311932,P50281,,JIRXORZYIXSWOB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,20180536,IC50,=,13,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP14 by fluorometric assay,,Potent arylsulfonamide inhibitors of tumor necrosis factor-alpha converting enzyme able to reduce activated leukocyte cell adhesion molecule shedding in cancer cell models.,J. Med. Chem.,2010,53,6,"Nuti E, Casalini F, Avramova SI, Santamaria S, Fabbi M, Ferrini S, Marinelli L, La Pietra V, Limongelli V, Novellino E, Cercignani G, Orlandini E, Nencetti S, Rossello A",,624095,DTCT0024091,3286012,DTCC00243867,598684,38228
CHEMBL313360,P50281,,UFJUEKAJZPTZED-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,10411481,KI,=,41,NM,,,,,,,,,,,,,,Binding affinity against matrix metalloprotease-14 MTI-MMP.,,Phosphinic pseudo-tripeptides as potent inhibitors of matrix metalloproteinases: a structure-activity study.,J. Med. Chem.,1999,42,14,"Vassiliou S, Mucha A, Cuniasse P, Georgiadis D, Lucet-Levannier K, Beau F, Kannan R, Murphy G, Knäuper V, Rio MC, Basset P, Yiotakis A, Dive V",,106782,DTCT0024091,1078553,DTCC00249036,1424200,15258
CHEMBL313386,P50281,,XYZHDRSTLPUTBX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,10411481,KI,=,1350,NM,,,,,,,,,,,,,,Binding affinity against matrix metalloprotease-14 MTI-MMP.,,Phosphinic pseudo-tripeptides as potent inhibitors of matrix metalloproteinases: a structure-activity study.,J. Med. Chem.,1999,42,14,"Vassiliou S, Mucha A, Cuniasse P, Georgiadis D, Lucet-Levannier K, Beau F, Kannan R, Murphy G, Knäuper V, Rio MC, Basset P, Yiotakis A, Dive V",,106782,DTCT0024091,1084515,DTCC00249347,291450,15258
CHEMBL313472,P50281,,RFNUTMXSNZMOSL-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,10411481,KI,=,41,NM,,,,,,,,,,,,,,Binding affinity against matrix metalloprotease-14 MTI-MMP.,,Phosphinic pseudo-tripeptides as potent inhibitors of matrix metalloproteinases: a structure-activity study.,J. Med. Chem.,1999,42,14,"Vassiliou S, Mucha A, Cuniasse P, Georgiadis D, Lucet-Levannier K, Beau F, Kannan R, Murphy G, Knäuper V, Rio MC, Basset P, Yiotakis A, Dive V",,106782,DTCT0024091,1059541,DTCC00249282,1002960,15258
CHEMBL313896,P50281,,NFDNOGJHVSTSMJ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,10411481,KI,=,60,NM,,,,,,,,,,,,,,Binding affinity against matrix metalloprotease-14 MTI-MMP.,,Phosphinic pseudo-tripeptides as potent inhibitors of matrix metalloproteinases: a structure-activity study.,J. Med. Chem.,1999,42,14,"Vassiliou S, Mucha A, Cuniasse P, Georgiadis D, Lucet-Levannier K, Beau F, Kannan R, Murphy G, Knäuper V, Rio MC, Basset P, Yiotakis A, Dive V",,106782,DTCT0024091,1085849,DTCC00249106,422043,15258
CHEMBL314199,P50281,,GKNHTZOPKGQBHE-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,10411481,KI,=,2960,NM,,,,,,,,,,,,,,Binding affinity against matrix metalloprotease-14 MTI-MMP.,,Phosphinic pseudo-tripeptides as potent inhibitors of matrix metalloproteinases: a structure-activity study.,J. Med. Chem.,1999,42,14,"Vassiliou S, Mucha A, Cuniasse P, Georgiadis D, Lucet-Levannier K, Beau F, Kannan R, Murphy G, Knäuper V, Rio MC, Basset P, Yiotakis A, Dive V",,106782,DTCT0024091,1084522,DTCC00249345,291449,15258
CHEMBL314565,P50281,,YQEMFOGNUTYMTJ-URCIPWINSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,10411481,INHIBITION,=,10,%,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-14 membrane-type-MMP at 10 uM,,Phosphinic pseudo-tripeptides as potent inhibitors of matrix metalloproteinases: a structure-activity study.,J. Med. Chem.,1999,42,14,"Vassiliou S, Mucha A, Cuniasse P, Georgiadis D, Lucet-Levannier K, Beau F, Kannan R, Murphy G, Knäuper V, Rio MC, Basset P, Yiotakis A, Dive V",,106777,DTCT0024091,1059534,DTCC00248816,2065651,15258
CHEMBL315046,P50281,,JPTZDOYPNCQOTF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,10411481,KI,=,217,NM,,,,,,,,,,,,,,Binding affinity against matrix metalloprotease-14 MTI-MMP.,,Phosphinic pseudo-tripeptides as potent inhibitors of matrix metalloproteinases: a structure-activity study.,J. Med. Chem.,1999,42,14,"Vassiliou S, Mucha A, Cuniasse P, Georgiadis D, Lucet-Levannier K, Beau F, Kannan R, Murphy G, Knäuper V, Rio MC, Basset P, Yiotakis A, Dive V",,106782,DTCT0024091,1092142,DTCC00249105,291444,15258
CHEMBL315843,P50281,,WYBFHVSAXDKMJV-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,10411481,KI,=,45,NM,,,,,,,,,,,,,,Binding affinity against matrix metalloprotease-14 MTI-MMP.,,Phosphinic pseudo-tripeptides as potent inhibitors of matrix metalloproteinases: a structure-activity study.,J. Med. Chem.,1999,42,14,"Vassiliou S, Mucha A, Cuniasse P, Georgiadis D, Lucet-Levannier K, Beau F, Kannan R, Murphy G, Knäuper V, Rio MC, Basset P, Yiotakis A, Dive V",,106782,DTCT0024091,1073914,DTCC00248711,1326511,15258
CHEMBL315900,P50281,,KSMVGBPYLIRIKO-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,10411481,INHIBITION,=,0,%,,,,,,,,,,,,,,Inhibition of MMP-14 membrane-type-MMP at 10 uM,,Phosphinic pseudo-tripeptides as potent inhibitors of matrix metalloproteinases: a structure-activity study.,J. Med. Chem.,1999,42,14,"Vassiliou S, Mucha A, Cuniasse P, Georgiadis D, Lucet-Levannier K, Beau F, Kannan R, Murphy G, Knäuper V, Rio MC, Basset P, Yiotakis A, Dive V",,106776,DTCT0024091,1062034,DTCC00249774,1100495,15258
CHEMBL315901,P50281,,LHVGXRIIQBVWQU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,10411481,KI,=,660,NM,,,,,,,,,,,,,,Binding affinity against matrix metalloprotease-14 MTI-MMP.,,Phosphinic pseudo-tripeptides as potent inhibitors of matrix metalloproteinases: a structure-activity study.,J. Med. Chem.,1999,42,14,"Vassiliou S, Mucha A, Cuniasse P, Georgiadis D, Lucet-Levannier K, Beau F, Kannan R, Murphy G, Knäuper V, Rio MC, Basset P, Yiotakis A, Dive V",,106782,DTCT0024091,1062042,DTCC00249775,1035362,15258
CHEMBL316200,P50281,,MERYKHOGOUEPIA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,10411481,KI,=,90,NM,,,,,,,,,,,,,,Binding affinity against matrix metalloprotease-14 MTI-MMP.,,Phosphinic pseudo-tripeptides as potent inhibitors of matrix metalloproteinases: a structure-activity study.,J. Med. Chem.,1999,42,14,"Vassiliou S, Mucha A, Cuniasse P, Georgiadis D, Lucet-Levannier K, Beau F, Kannan R, Murphy G, Knäuper V, Rio MC, Basset P, Yiotakis A, Dive V",,106782,DTCT0024091,1063246,DTCC00248814,582756,15258
CHEMBL318252,P50281,,ODPDWLUYVWCNHO-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,18790648,IC50,>,100000,NM,,,,,,,,,,,,,,Inhibition of MMP14,,Specific targeting of metzincin family members with small-molecule inhibitors: progress toward a multifarious challenge.,Bioorg. Med. Chem.,2008,16,19,"Georgiadis D, Yiotakis A",,497410,DTCT0024091,2456475,DTCC00265469,920644,32556
CHEMBL3198298,P50281,,OJXJFHGWKNZSAB-NBYKJDAVSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,,IC50,=,6000,NM,,,,,,,,,,,,,,PubChem BioAssay. Dose Response confirmation of uHTS hits for a small molecule inhibitors of MT1-MMP activation in a fluorescence assay set 1. (Class of assay: confirmatory) ,active,PUBCHEM BIOASSAY DATA SET,,,,,,,954361,DTCT0024091,12209084,DTCC01453611,535308,33038
CHEMBL321213,P50281,,UVGAWIJNBYCHSP-LBPRGKRZSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,11563922,KI,=,290,NM,,,,,,,,,,,,,,In vitro inhibitory activity against the catalytic domain of human matrix metalloprotease-14,,"Structure-based design and synthesis of potent matrix metalloproteinase inhibitors derived from a 6H-1,3,4-thiadiazine scaffold.",J. Med. Chem.,2001,44,20,"Schröder J, Henke A, Wenzel H, Brandstetter H, Stammler HG, Stammler A, Pfeiffer WD, Tschesche H",,106783,DTCT0024091,1681724,DTCC00282582,874479,16424
CHEMBL3221863,P50281,,BJIOETDXHXZDRQ-LEAFIULHSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,,IC50,=,1067,NM,,,,,,,,,,,,,,Inhibition of MMP14 (unknown origin) by fluorescence-based FRET assay,,,MedChemComm,2011,2,10,,,1328288,DTCT0024091,13574321,DTCC01468798,1845949,39059
CHEMBL3221864,P50281,,OKHKINWJYOOKOF-GGXMVOPNSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,,IC50,=,1085,NM,,,,,,,,,,,,,,Inhibition of MMP14 (unknown origin) by fluorescence-based FRET assay,,,MedChemComm,2011,2,10,,,1328288,DTCT0024091,13574322,DTCC01468799,396851,39059
CHEMBL322795,P50281,,LEDMBBYIVRLZAS-GFCCVEGCSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,11563922,KI,=,330,NM,,,,,,,,,,,,,,In vitro inhibitory activity against the ectodomain of the human matrix metalloprotease-14,,"Structure-based design and synthesis of potent matrix metalloproteinase inhibitors derived from a 6H-1,3,4-thiadiazine scaffold.",J. Med. Chem.,2001,44,20,"Schröder J, Henke A, Wenzel H, Brandstetter H, Stammler HG, Stammler A, Pfeiffer WD, Tschesche H",,106784,DTCT0024091,1707164,DTCC00282335,389662,16424
CHEMBL322795,P50281,,LEDMBBYIVRLZAS-GFCCVEGCSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,11563922,KI,=,390,NM,,,,,,,,,,,,,,In vitro inhibitory activity against the catalytic domain of human matrix metalloprotease-14,,"Structure-based design and synthesis of potent matrix metalloproteinase inhibitors derived from a 6H-1,3,4-thiadiazine scaffold.",J. Med. Chem.,2001,44,20,"Schröder J, Henke A, Wenzel H, Brandstetter H, Stammler HG, Stammler A, Pfeiffer WD, Tschesche H",,106783,DTCT0024091,1707163,DTCC00282335,389662,16424
CHEMBL3235911,P50281,,RNBZJLOFSRJJMQ-RUPCYPOASA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,26192023,IC50,>,100000,NM,,,,,,,,,,,,,,Inhibition of MMP14 (unknown origin) using Mca-KLPGL-Dnp-AR as substrate preincubated for 30 mins followed by substrate addition measured after 1 hr by fluorescence assay,,SAR Studies of Exosite-Binding Substrate-Selective Inhibitors of A Disintegrin And Metalloprotease 17 (ADAM17) and Application as Selective in Vitro Probes.,J. Med. Chem.,2015,58,15,"Knapinska AM, Dreymuller D, Ludwig A, Smith L, Golubkov V, Sohail A, Fridman R, Giulianotti M, LaVoi TM, Houghten RA, Fields GB, Minond D",,1505522,DTCT0024091,14475889,DTCC01474946,235426,63066
CHEMBL3235911,P50281,,RNBZJLOFSRJJMQ-RUPCYPOASA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,26192023,INHIBITION,=,0,%,,cell_based,,,,,,,,,,,,Inhibition of MMP14 in human SW480 cells assessed as inhibition of PMA-stimulated wild type PTK7 shedding at 25 to 100 uM after 16 hrs by Western blot analysis,,SAR Studies of Exosite-Binding Substrate-Selective Inhibitors of A Disintegrin And Metalloprotease 17 (ADAM17) and Application as Selective in Vitro Probes.,J. Med. Chem.,2015,58,15,"Knapinska AM, Dreymuller D, Ludwig A, Smith L, Golubkov V, Sohail A, Fridman R, Giulianotti M, LaVoi TM, Houghten RA, Fields GB, Minond D",,1505542,DTCT0024091,14476047,DTCC01474946,235426,63066
CHEMBL3235911,P50281,,RNBZJLOFSRJJMQ-RUPCYPOASA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,26192023,INHIBITION,=,27,%,,,,,,,,,,,,,,Inhibition of MMP14 (unknown origin) using Mca-KLPGL-Dnp-AR as substrate at 100 uM preincubated for 30 mins followed by substrate addition measured after 1 hr by fluorescence assay relative to control,,SAR Studies of Exosite-Binding Substrate-Selective Inhibitors of A Disintegrin And Metalloprotease 17 (ADAM17) and Application as Selective in Vitro Probes.,J. Med. Chem.,2015,58,15,"Knapinska AM, Dreymuller D, Ludwig A, Smith L, Golubkov V, Sohail A, Fridman R, Giulianotti M, LaVoi TM, Houghten RA, Fields GB, Minond D",,1505526,DTCT0024091,14475973,DTCC01474946,235426,63066
CHEMBL3235911,P50281,,RNBZJLOFSRJJMQ-RUPCYPOASA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,26192023,INHIBITION,,,,,,,,,,,,,,,,,Inhibition of MMP14 in HTSMC assessed as inhibition of DDR1 shedding at 10 to 40 uM by immunoblot analysis relative to control,Not Determined,SAR Studies of Exosite-Binding Substrate-Selective Inhibitors of A Disintegrin And Metalloprotease 17 (ADAM17) and Application as Selective in Vitro Probes.,J. Med. Chem.,2015,58,15,"Knapinska AM, Dreymuller D, Ludwig A, Smith L, Golubkov V, Sohail A, Fridman R, Giulianotti M, LaVoi TM, Houghten RA, Fields GB, Minond D",,1505543,DTCT0024091,14476084,DTCC01474946,235426,63066
CHEMBL3235912,P50281,,ILECMSXDFSLYHA-XOXLXNDPSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,26192023,IC50,>,100000,NM,,,,,,,,,,,,,,Inhibition of MMP14 (unknown origin) using Mca-KLPGL-Dnp-AR as substrate preincubated for 30 mins followed by substrate addition measured after 1 hr by fluorescence assay,,SAR Studies of Exosite-Binding Substrate-Selective Inhibitors of A Disintegrin And Metalloprotease 17 (ADAM17) and Application as Selective in Vitro Probes.,J. Med. Chem.,2015,58,15,"Knapinska AM, Dreymuller D, Ludwig A, Smith L, Golubkov V, Sohail A, Fridman R, Giulianotti M, LaVoi TM, Houghten RA, Fields GB, Minond D",,1505522,DTCT0024091,14475887,DTCC01474947,1433423,63066
CHEMBL3235912,P50281,,ILECMSXDFSLYHA-XOXLXNDPSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,26192023,INHIBITION,=,0,%,,,,,,,,,,,,,,Inhibition of MMP14 (unknown origin) using Mca-KLPGL-Dnp-AR as substrate at 100 uM preincubated for 30 mins followed by substrate addition measured after 1 hr by fluorescence assay relative to control,,SAR Studies of Exosite-Binding Substrate-Selective Inhibitors of A Disintegrin And Metalloprotease 17 (ADAM17) and Application as Selective in Vitro Probes.,J. Med. Chem.,2015,58,15,"Knapinska AM, Dreymuller D, Ludwig A, Smith L, Golubkov V, Sohail A, Fridman R, Giulianotti M, LaVoi TM, Houghten RA, Fields GB, Minond D",,1505526,DTCT0024091,14475975,DTCC01474947,1433423,63066
CHEMBL3235912,P50281,,ILECMSXDFSLYHA-XOXLXNDPSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,26192023,INHIBITION,,,,,,,,,,,,,,,,,Inhibition of MMP14 in HTSMC assessed as inhibition of DDR1 shedding at 10 to 40 uM by immunoblot analysis relative to control,Not Determined,SAR Studies of Exosite-Binding Substrate-Selective Inhibitors of A Disintegrin And Metalloprotease 17 (ADAM17) and Application as Selective in Vitro Probes.,J. Med. Chem.,2015,58,15,"Knapinska AM, Dreymuller D, Ludwig A, Smith L, Golubkov V, Sohail A, Fridman R, Giulianotti M, LaVoi TM, Houghten RA, Fields GB, Minond D",,1505543,DTCT0024091,14476086,DTCC01474947,1433423,63066
CHEMBL3235912,P50281,,ILECMSXDFSLYHA-XOXLXNDPSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,26192023,INHIBITION,,,,,cell_based,,,,,,,,,,,,Inhibition of MMP14 in human SW480 cells assessed as inhibition of PMA-stimulated wild type PTK7 shedding at 25 to 100 uM after 16 hrs by Western blot analysis,Not Determined,SAR Studies of Exosite-Binding Substrate-Selective Inhibitors of A Disintegrin And Metalloprotease 17 (ADAM17) and Application as Selective in Vitro Probes.,J. Med. Chem.,2015,58,15,"Knapinska AM, Dreymuller D, Ludwig A, Smith L, Golubkov V, Sohail A, Fridman R, Giulianotti M, LaVoi TM, Houghten RA, Fields GB, Minond D",,1505542,DTCT0024091,14476049,DTCC01474947,1433423,63066
CHEMBL323885,P50281,,NRVATKFKFLOMDK-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,14711305,KI,=,30000,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-14,,Evaluation of P1'-diversified phosphinic peptides leads to the development of highly selective inhibitors of MMP-11.,J. Med. Chem.,2004,47,2,"Matziari M, Beau F, Cuniasse P, Dive V, Yiotakis A",,106780,DTCT0024091,1265940,DTCC00287362,1079825,17924
CHEMBL324891,P50281,,YDDMVPLLJTZTQL-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,14711305,KI,=,160000,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-14,,Evaluation of P1'-diversified phosphinic peptides leads to the development of highly selective inhibitors of MMP-11.,J. Med. Chem.,2004,47,2,"Matziari M, Beau F, Cuniasse P, Dive V, Yiotakis A",,106780,DTCT0024091,1257645,DTCC00287325,30861,17924
CHEMBL325163,P50281,,RWKJBOMUESGCBO-REUBFRLUSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,11585440,KI,=,2000,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-14,,"Discovery of macrocyclic hydroxamic acids containing biphenylmethyl derivatives at P1', a series of selective TNF-alpha converting enzyme inhibitors with potent cellular activity in the inhibition of TNF-alpha release.",J. Med. Chem.,2001,44,21,"Xue CB, He X, Corbett RL, Roderick J, Wasserman ZR, Liu RQ, Jaffee BD, Covington MB, Qian M, Trzaskos JM, Newton RC, Magolda RL, Wexler RR, Decicco CP",,106787,DTCT0024091,1311928,DTCC00287408,1500490,16439
CHEMBL325163,P50281,,RWKJBOMUESGCBO-REUBFRLUSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,18790648,KI,>,2000,NM,,,,,,,,,,,,,,Inhibition of MMP14,,Specific targeting of metzincin family members with small-molecule inhibitors: progress toward a multifarious challenge.,Bioorg. Med. Chem.,2008,16,19,"Georgiadis D, Yiotakis A",,497410,DTCT0024091,2457310,DTCC00287408,1503285,32556
CHEMBL326489,P50281,,MDNBGABATBOAOY-YCLCTBJKSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,12877590,IC50,=,930,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-14,,"A potent, selective inhibitor of matrix metalloproteinase-3 for the topical treatment of chronic dermal ulcers.",J. Med. Chem.,2003,46,16,"Fray MJ, Dickinson RP, Huggins JP, Occleston NL",,106775,DTCT0024091,1547327,DTCC00293235,258687,17445
CHEMBL327108,P50281,,ONKQNWHNBOMBCR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,14711305,KI,=,30100,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-14,,Evaluation of P1'-diversified phosphinic peptides leads to the development of highly selective inhibitors of MMP-11.,J. Med. Chem.,2004,47,2,"Matziari M, Beau F, Cuniasse P, Dive V, Yiotakis A",,106780,DTCT0024091,1256338,DTCC00287264,917661,17924
CHEMBL327617,P50281,,COMOZYQMQPSLMB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,10411481,KI,=,92,NM,,,,,,,,,,,,,,Binding affinity against matrix metalloprotease-14 MTI-MMP.,,Phosphinic pseudo-tripeptides as potent inhibitors of matrix metalloproteinases: a structure-activity study.,J. Med. Chem.,1999,42,14,"Vassiliou S, Mucha A, Cuniasse P, Georgiadis D, Lucet-Levannier K, Beau F, Kannan R, Murphy G, Knäuper V, Rio MC, Basset P, Yiotakis A, Dive V",,106782,DTCT0024091,1056159,DTCC00249769,1806421,15258
CHEMBL327641,P50281,,DVBWYFQJLIUTJA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,10411481,KI,=,580,NM,,,,,,,,,,,,,,Binding affinity against matrix metalloprotease-14 MTI-MMP.,,Phosphinic pseudo-tripeptides as potent inhibitors of matrix metalloproteinases: a structure-activity study.,J. Med. Chem.,1999,42,14,"Vassiliou S, Mucha A, Cuniasse P, Georgiadis D, Lucet-Levannier K, Beau F, Kannan R, Murphy G, Knäuper V, Rio MC, Basset P, Yiotakis A, Dive V",,106782,DTCT0024091,1059527,DTCC00249776,776445,15258
CHEMBL328886,P50281,,YQEMFOGNUTYMTJ-BUAFSUBRSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,10411481,KI,=,105,NM,,,,,,,,,,,,,,Binding affinity against matrix metalloprotease-14 MTI-MMP.,,Phosphinic pseudo-tripeptides as potent inhibitors of matrix metalloproteinases: a structure-activity study.,J. Med. Chem.,1999,42,14,"Vassiliou S, Mucha A, Cuniasse P, Georgiadis D, Lucet-Levannier K, Beau F, Kannan R, Murphy G, Knäuper V, Rio MC, Basset P, Yiotakis A, Dive V",,106782,DTCT0024091,1085842,DTCC00249311,1326512,15258
CHEMBL329651,P50281,,BRKOQUQULDVEDN-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,10411481,KI,=,550,NM,,,,,,,,,,,,,,Binding affinity against matrix metalloprotease-14 MTI-MMP.,,Phosphinic pseudo-tripeptides as potent inhibitors of matrix metalloproteinases: a structure-activity study.,J. Med. Chem.,1999,42,14,"Vassiliou S, Mucha A, Cuniasse P, Georgiadis D, Lucet-Levannier K, Beau F, Kannan R, Murphy G, Knäuper V, Rio MC, Basset P, Yiotakis A, Dive V",,106782,DTCT0024091,1084508,DTCC00249770,1903191,15258
CHEMBL330731,P50281,,ZRMAXAMITMCTTB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,10411481,KI,=,2030,NM,,,,,,,,,,,,,,Binding affinity against matrix metalloprotease-14 MTI-MMP.,,Phosphinic pseudo-tripeptides as potent inhibitors of matrix metalloproteinases: a structure-activity study.,J. Med. Chem.,1999,42,14,"Vassiliou S, Mucha A, Cuniasse P, Georgiadis D, Lucet-Levannier K, Beau F, Kannan R, Murphy G, Knäuper V, Rio MC, Basset P, Yiotakis A, Dive V",,106782,DTCT0024091,1083340,DTCC00249768,1713982,15258
CHEMBL3337869,P50281,,AARSEFXVCWMMKV-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,25192810,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP14 using fluorescence peptide Cy3-PLGLK(Cy5Q)AR-NH2 substrate by fluorescence assay,,"Thieno[2,3-d]pyrimidine-2-carboxamides bearing a carboxybenzene group at 5-position: highly potent, selective, and orally available MMP-13 inhibitors interacting with the S1¿ binding site.",Bioorg. Med. Chem.,2014,22,19,"Nara H, Sato K, Naito T, Mototani H, Oki H, Yamamoto Y, Kuno H, Santou T, Kanzaki N, Terauchi J, Uchikawa O, Kori M",,1442068,DTCT0024091,13992258,DTCC01523362,1322384,59837
CHEMBL3337869,P50281,,AARSEFXVCWMMKV-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,25264600,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibition of human recombinant GST-tagged MMP14 using Cy3-PLGLK(Cy5Q)AR-NH2 as substrate after 40 mins by spectrofluorimetry,,"Discovery of Novel, Highly Potent, and Selective Quinazoline-2-carboxamide-Based Matrix Metalloproteinase (MMP)-13 Inhibitors without a Zinc Binding Group Using a Structure-Based Design Approach.",J. Med. Chem.,2014,57,21,"Nara H, Sato K, Naito T, Mototani H, Oki H, Yamamoto Y, Kuno H, Santou T, Kanzaki N, Terauchi J, Uchikawa O, Kori M",,1431426,DTCT0024091,13989086,DTCC01523362,1302071,60036
CHEMBL3337894,P50281,,CDQRIIUMNLMHRH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,25192810,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP14 using fluorescence peptide Cy3-PLGLK(Cy5Q)AR-NH2 substrate by fluorescence assay,,"Thieno[2,3-d]pyrimidine-2-carboxamides bearing a carboxybenzene group at 5-position: highly potent, selective, and orally available MMP-13 inhibitors interacting with the S1¿ binding site.",Bioorg. Med. Chem.,2014,22,19,"Nara H, Sato K, Naito T, Mototani H, Oki H, Yamamoto Y, Kuno H, Santou T, Kanzaki N, Terauchi J, Uchikawa O, Kori M",,1442068,DTCT0024091,13992259,DTCC01523387,966370,59837
CHEMBL3358151,P50281,,LNIRXDCIYOBRPL-CYBMUJFWSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,25415648,IC50,>,50000,NM,,,,,,,,,,,,,,Inhibition of human MMP14 using Mca-PQG1 peptide substrate assessed as substrate cleavage after 2 to 4 hrs,,Identification of potent and selective hydantoin inhibitors of aggrecanase-1 and aggrecanase-2 that are efficacious in both chemical and surgical models of osteoarthritis.,J. Med. Chem.,2014,57,24,"Durham TB, Klimkowski VJ, Rito CJ, Marimuthu J, Toth JL, Liu C, Durbin JD, Stout SL, Adams L, Swearingen C, Lin C, Chambers MG, Thirunavukkarasu K, Wiley MR",,1435764,DTCT0024091,14000079,DTCC01535600,2061710,60298
CHEMBL3358152,P50281,,GPHYVVDMOPSOAK-CQSZACIVSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,25415648,IC50,,,,,,,,,,,,,,,,,Inhibition of human MMP14 using Mca-PQG1 peptide substrate assessed as substrate cleavage after 2 to 4 hrs,Not Determined,Identification of potent and selective hydantoin inhibitors of aggrecanase-1 and aggrecanase-2 that are efficacious in both chemical and surgical models of osteoarthritis.,J. Med. Chem.,2014,57,24,"Durham TB, Klimkowski VJ, Rito CJ, Marimuthu J, Toth JL, Liu C, Durbin JD, Stout SL, Adams L, Swearingen C, Lin C, Chambers MG, Thirunavukkarasu K, Wiley MR",,1435764,DTCT0024091,14000080,DTCC01535601,1769989,60298
CHEMBL3358153,P50281,,KDEHHSHGVKUYEZ-IBGZPJMESA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,25415648,IC50,=,3500,NM,,,,,,,,,,,,,,Inhibition of human MMP14 using Mca-PQG1 peptide substrate assessed as substrate cleavage after 2 to 4 hrs,,Identification of potent and selective hydantoin inhibitors of aggrecanase-1 and aggrecanase-2 that are efficacious in both chemical and surgical models of osteoarthritis.,J. Med. Chem.,2014,57,24,"Durham TB, Klimkowski VJ, Rito CJ, Marimuthu J, Toth JL, Liu C, Durbin JD, Stout SL, Adams L, Swearingen C, Lin C, Chambers MG, Thirunavukkarasu K, Wiley MR",,1435764,DTCT0024091,14000081,DTCC01535602,1063499,60298
CHEMBL3358154,P50281,,WIKRDIGSYVQGTH-IBGZPJMESA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,25415648,IC50,=,18000,NM,,,,,,,,,,,,,,Inhibition of human MMP14 using Mca-PQG1 peptide substrate assessed as substrate cleavage after 2 to 4 hrs,,Identification of potent and selective hydantoin inhibitors of aggrecanase-1 and aggrecanase-2 that are efficacious in both chemical and surgical models of osteoarthritis.,J. Med. Chem.,2014,57,24,"Durham TB, Klimkowski VJ, Rito CJ, Marimuthu J, Toth JL, Liu C, Durbin JD, Stout SL, Adams L, Swearingen C, Lin C, Chambers MG, Thirunavukkarasu K, Wiley MR",,1435764,DTCT0024091,14000082,DTCC01535603,1996998,60298
CHEMBL3358155,P50281,,LBVBVIKJOWWVJX-MRXNPFEDSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,25415648,IC50,=,870,NM,,,,,,,,,,,,,,Inhibition of human MMP14 using Mca-PQG1 peptide substrate assessed as substrate cleavage after 2 to 4 hrs,,Identification of potent and selective hydantoin inhibitors of aggrecanase-1 and aggrecanase-2 that are efficacious in both chemical and surgical models of osteoarthritis.,J. Med. Chem.,2014,57,24,"Durham TB, Klimkowski VJ, Rito CJ, Marimuthu J, Toth JL, Liu C, Durbin JD, Stout SL, Adams L, Swearingen C, Lin C, Chambers MG, Thirunavukkarasu K, Wiley MR",,1435764,DTCT0024091,14000083,DTCC01535604,385128,60298
CHEMBL3358156,P50281,,NPWGFJCNOCYDSO-KRWDZBQOSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,25415648,IC50,>,100000,NM,,,,,,,,,,,,,,Inhibition of human MMP14 using Mca-PQG1 peptide substrate assessed as substrate cleavage after 2 to 4 hrs,,Identification of potent and selective hydantoin inhibitors of aggrecanase-1 and aggrecanase-2 that are efficacious in both chemical and surgical models of osteoarthritis.,J. Med. Chem.,2014,57,24,"Durham TB, Klimkowski VJ, Rito CJ, Marimuthu J, Toth JL, Liu C, Durbin JD, Stout SL, Adams L, Swearingen C, Lin C, Chambers MG, Thirunavukkarasu K, Wiley MR",,1435764,DTCT0024091,14000084,DTCC01535605,1387876,60298
CHEMBL3358157,P50281,,SZDCEHDWAAZEPH-KRWDZBQOSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,25415648,IC50,=,8600,NM,,,,,,,,,,,,,,Inhibition of human MMP14 using Mca-PQG1 peptide substrate assessed as substrate cleavage after 2 to 4 hrs,,Identification of potent and selective hydantoin inhibitors of aggrecanase-1 and aggrecanase-2 that are efficacious in both chemical and surgical models of osteoarthritis.,J. Med. Chem.,2014,57,24,"Durham TB, Klimkowski VJ, Rito CJ, Marimuthu J, Toth JL, Liu C, Durbin JD, Stout SL, Adams L, Swearingen C, Lin C, Chambers MG, Thirunavukkarasu K, Wiley MR",,1435764,DTCT0024091,14000085,DTCC01535606,676013,60298
CHEMBL3358158,P50281,,PDBQNZHFRVAZBC-KRWDZBQOSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,25415648,IC50,=,86000,NM,,,,,,,,,,,,,,Inhibition of human MMP14 using Mca-PQG1 peptide substrate assessed as substrate cleavage after 2 to 4 hrs,,Identification of potent and selective hydantoin inhibitors of aggrecanase-1 and aggrecanase-2 that are efficacious in both chemical and surgical models of osteoarthritis.,J. Med. Chem.,2014,57,24,"Durham TB, Klimkowski VJ, Rito CJ, Marimuthu J, Toth JL, Liu C, Durbin JD, Stout SL, Adams L, Swearingen C, Lin C, Chambers MG, Thirunavukkarasu K, Wiley MR",,1435764,DTCT0024091,14000086,DTCC01535607,1128498,60298
CHEMBL3359091,P50281,,YNHGVYGMFAREOF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,25264600,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibition of human recombinant GST-tagged MMP14 using Cy3-PLGLK(Cy5Q)AR-NH2 as substrate after 40 mins by spectrofluorimetry,,"Discovery of Novel, Highly Potent, and Selective Quinazoline-2-carboxamide-Based Matrix Metalloproteinase (MMP)-13 Inhibitors without a Zinc Binding Group Using a Structure-Based Design Approach.",J. Med. Chem.,2014,57,21,"Nara H, Sato K, Naito T, Mototani H, Oki H, Yamamoto Y, Kuno H, Santou T, Kanzaki N, Terauchi J, Uchikawa O, Kori M",,1431426,DTCT0024091,13989085,DTCC01536542,1108444,60036
CHEMBL3394285,P50281,,ABKAFUZUCJSIKV-ZZXKWVIFSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,26753813,IC50,>,100000,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP14 expressed in Escherichia coli using (5-FAM/QXLTM) FRET peptide as substrate,,Design and synthesis of an activity-based protein profiling probe derived from cinnamic hydroxamic acid.,Bioorg. Med. Chem.,2016,24,4,"Ai T, Qiu L, Xie J, Geraghty RJ, Chen L.",,1547679,DTCT0024091,50490,DTCC01541321,1869229,65891
CHEMBL3394306,P50281,,DPMAWPWZDLKEFJ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,25490700,INHIBITION,,,,,,,,,,,,,,,,,Inhibition of human recombinant MMP12 catalytic domain (112 to 298 aa) expressed in Escherichia coli,Active,Hydroxamic acids block replication of hepatitis C virus.,J. Med. Chem.,2015,58,2,"Ai T, Xu Y, Qiu L, Geraghty RJ, Chen L",,1461380,DTCT0024091,14029928,DTCC01541343,740501,61325
CHEMBL3417742,P50281,,GHWPTWVNZOSEBR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,25686153,INHIBITION,>,90,%,,,,,,,,,,,,,,Inhibition of MMP-14 (unknown origin),,"Design, synthesis, and biological evaluation of novel matrix metalloproteinase inhibitors as potent antihemorrhagic agents: from hit identification to an optimized lead.",J. Med. Chem.,2015,58,5,"Orbe J, Sánchez-Arias JA, Rabal O, Rodríguez JA, Salicio A, Ugarte A, Belzunce M, Xu M, Wu W, Tan H, Ma H, Páramo JA, Oyarzabal J",,1472750,DTCT0024091,14105253,DTCC01554158,1140955,61965
CHEMBL3417745,P50281,,PJTIDEQBVYCKIC-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,25686153,INHIBITION,>,90,%,,,,,,,,,,,,,,Inhibition of MMP-14 (unknown origin),,"Design, synthesis, and biological evaluation of novel matrix metalloproteinase inhibitors as potent antihemorrhagic agents: from hit identification to an optimized lead.",J. Med. Chem.,2015,58,5,"Orbe J, Sánchez-Arias JA, Rabal O, Rodríguez JA, Salicio A, Ugarte A, Belzunce M, Xu M, Wu W, Tan H, Ma H, Páramo JA, Oyarzabal J",,1472750,DTCT0024091,14105254,DTCC01554161,1561095,61965
CHEMBL3417751,P50281,,ZUZGJCNWNOCKEB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,25686153,INHIBITION,>,90,%,,,,,,,,,,,,,,Inhibition of MMP-14 (unknown origin),,"Design, synthesis, and biological evaluation of novel matrix metalloproteinase inhibitors as potent antihemorrhagic agents: from hit identification to an optimized lead.",J. Med. Chem.,2015,58,5,"Orbe J, Sánchez-Arias JA, Rabal O, Rodríguez JA, Salicio A, Ugarte A, Belzunce M, Xu M, Wu W, Tan H, Ma H, Páramo JA, Oyarzabal J",,1472750,DTCT0024091,14105255,DTCC01554167,946456,61965
CHEMBL3417763,P50281,,MKCKIGOKGYMJOH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,25686153,INHIBITION,>,90,%,,,,,,,,,,,,,,Inhibition of MMP-14 (unknown origin),,"Design, synthesis, and biological evaluation of novel matrix metalloproteinase inhibitors as potent antihemorrhagic agents: from hit identification to an optimized lead.",J. Med. Chem.,2015,58,5,"Orbe J, Sánchez-Arias JA, Rabal O, Rodríguez JA, Salicio A, Ugarte A, Belzunce M, Xu M, Wu W, Tan H, Ma H, Páramo JA, Oyarzabal J",,1472750,DTCT0024091,14105256,DTCC01554179,1976632,61965
CHEMBL3417764,P50281,,ZQKGUWOTJVDTGX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,25686153,INHIBITION,>,90,%,,,,,,,,,,,,,,Inhibition of MMP-14 (unknown origin),,"Design, synthesis, and biological evaluation of novel matrix metalloproteinase inhibitors as potent antihemorrhagic agents: from hit identification to an optimized lead.",J. Med. Chem.,2015,58,5,"Orbe J, Sánchez-Arias JA, Rabal O, Rodríguez JA, Salicio A, Ugarte A, Belzunce M, Xu M, Wu W, Tan H, Ma H, Páramo JA, Oyarzabal J",,1472750,DTCT0024091,14105257,DTCC01554180,1943630,61965
CHEMBL355496,P50281,,SAQUSDSPQYQNBG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,,IC50,=,1780,NM,,,,,,,,,,,,,,PubChem BioAssay. Dose Response confirmation of uHTS hits for a small molecule inhibitors of MT1-MMP activation in a fluorescence assay set 1. (Class of assay: confirmatory) ,active,PUBCHEM BIOASSAY DATA SET,,,,,,,954361,DTCT0024091,12209083,DTCC00370652,344802,33038
CHEMBL355496,P50281,,SAQUSDSPQYQNBG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,,IC50,=,8890,NM,,,,,,,,,,,,,,PubChem BioAssay. SAR confirmation of uHTS hits for a small molecule inhibitors of MT1-MMP activation in a fluorescence assay. (Class of assay: confirmatory) ,active,PUBCHEM BIOASSAY DATA SET,,,,,,,954324,DTCT0024091,12304816,DTCC00370652,350990,33038
CHEMBL355727,P50281,,FYJZCIXAWTVIOU-IUCAKERBSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,11958997,INHIBITION,=,80,%,,,,,,,,,,,,,,Inhibition of membrane type MT1-MMP (Matrix metalloprotease-14)catalytic domain,,Oxal hydroxamic acid derivatives with inhibitory activity against matrix metalloproteinases.,Bioorg. Med. Chem. Lett.,2002,12,6,"Krumme D, Tschesche H",,106779,DTCT0024091,1096957,DTCC00371202,2067064,5419
CHEMBL355727,P50281,,FYJZCIXAWTVIOU-IUCAKERBSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,11958997,KI,=,180000,NM,,,,,,,,,,,,,,Inhibition of membrane type MT1-MMP (Matrix metalloprotease-14)catalytic domain,,Oxal hydroxamic acid derivatives with inhibitory activity against matrix metalloproteinases.,Bioorg. Med. Chem. Lett.,2002,12,6,"Krumme D, Tschesche H",,106788,DTCT0024091,1096956,DTCC00371202,2067064,5419
CHEMBL355756,P50281,,JAWBGTRXBCUBLS-JTQLQIEISA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,11958997,INHIBITION,=,15,%,,,,,,,,,,,,,,Percent remaining enzyme activity (RA) in catalytic domains of the membrane type MT1-MMP (matrix metalloprotease-14),,Oxal hydroxamic acid derivatives with inhibitory activity against matrix metalloproteinases.,Bioorg. Med. Chem. Lett.,2002,12,6,"Krumme D, Tschesche H",,106778,DTCT0024091,1111697,DTCC00371502,1904588,5419
CHEMBL355756,P50281,,JAWBGTRXBCUBLS-JTQLQIEISA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,11958997,KI,=,9500,NM,,,,,,,,,,,,,,Inhibition of membrane type MT1-MMP (Matrix metalloprotease-14)catalytic domain,,Oxal hydroxamic acid derivatives with inhibitory activity against matrix metalloproteinases.,Bioorg. Med. Chem. Lett.,2002,12,6,"Krumme D, Tschesche H",,106788,DTCT0024091,1111696,DTCC00371502,1904588,5419
CHEMBL356124,P50281,,ZJOQXNGTEXFLLO-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,14684295,IC50,=,3108,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-14 (MMP-14),,Tetrahydroisoquinoline based sulfonamide hydroxamates as potent matrix metalloproteinase inhibitors.,Bioorg. Med. Chem. Lett.,2004,14,1,"Ma D, Wu W, Yang G, Li J, Li J, Ye Q",,106791,DTCT0024091,880006,DTCC00334202,173919,6330
CHEMBL358539,P50281,,OVUDWXYTKUKYAX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,14684295,IC50,=,34,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-14 (MMP-14),,Tetrahydroisoquinoline based sulfonamide hydroxamates as potent matrix metalloproteinase inhibitors.,Bioorg. Med. Chem. Lett.,2004,14,1,"Ma D, Wu W, Yang G, Li J, Li J, Ye Q",,106791,DTCT0024091,880016,DTCC00334156,1565409,6330
CHEMBL3593549,P50281,,DFINJLCZWBDBQX-KDNYSNCWSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,26192023,IC50,>,100000,NM,,,,,,,,,,,,,,Inhibition of MMP14 (unknown origin) using Mca-KLPGL-Dnp-AR as substrate preincubated for 30 mins followed by substrate addition measured after 1 hr by fluorescence assay,,SAR Studies of Exosite-Binding Substrate-Selective Inhibitors of A Disintegrin And Metalloprotease 17 (ADAM17) and Application as Selective in Vitro Probes.,J. Med. Chem.,2015,58,15,"Knapinska AM, Dreymuller D, Ludwig A, Smith L, Golubkov V, Sohail A, Fridman R, Giulianotti M, LaVoi TM, Houghten RA, Fields GB, Minond D",,1505522,DTCT0024091,14475891,DTCC01651896,333622,63066
CHEMBL3593549,P50281,,DFINJLCZWBDBQX-KDNYSNCWSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,26192023,INHIBITION,=,0,%,,,,,,,,,,,,,,Inhibition of MMP14 (unknown origin) using Mca-KLPGL-Dnp-AR as substrate at 100 uM preincubated for 30 mins followed by substrate addition measured after 1 hr by fluorescence assay relative to control,,SAR Studies of Exosite-Binding Substrate-Selective Inhibitors of A Disintegrin And Metalloprotease 17 (ADAM17) and Application as Selective in Vitro Probes.,J. Med. Chem.,2015,58,15,"Knapinska AM, Dreymuller D, Ludwig A, Smith L, Golubkov V, Sohail A, Fridman R, Giulianotti M, LaVoi TM, Houghten RA, Fields GB, Minond D",,1505526,DTCT0024091,14475971,DTCC01651896,333622,63066
CHEMBL3593549,P50281,,DFINJLCZWBDBQX-KDNYSNCWSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,26192023,INHIBITION,=,0,%,,cell_based,,,,,,,,,,,,Inhibition of MMP14 in human SW480 cells assessed as inhibition of PMA-stimulated wild type PTK7 shedding at 25 to 100 uM after 16 hrs by Western blot analysis,,SAR Studies of Exosite-Binding Substrate-Selective Inhibitors of A Disintegrin And Metalloprotease 17 (ADAM17) and Application as Selective in Vitro Probes.,J. Med. Chem.,2015,58,15,"Knapinska AM, Dreymuller D, Ludwig A, Smith L, Golubkov V, Sohail A, Fridman R, Giulianotti M, LaVoi TM, Houghten RA, Fields GB, Minond D",,1505542,DTCT0024091,14476045,DTCC01651896,333622,63066
CHEMBL3593549,P50281,,DFINJLCZWBDBQX-KDNYSNCWSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,26192023,INHIBITION,,,,,,,,,,,,,,,,,Inhibition of MMP14 in HTSMC assessed as inhibition of DDR1 shedding at 10 to 40 uM by immunoblot analysis relative to control,Not Determined,SAR Studies of Exosite-Binding Substrate-Selective Inhibitors of A Disintegrin And Metalloprotease 17 (ADAM17) and Application as Selective in Vitro Probes.,J. Med. Chem.,2015,58,15,"Knapinska AM, Dreymuller D, Ludwig A, Smith L, Golubkov V, Sohail A, Fridman R, Giulianotti M, LaVoi TM, Houghten RA, Fields GB, Minond D",,1505543,DTCT0024091,14476082,DTCC01651896,333622,63066
CHEMBL3593550,P50281,,SWCOKZUOBSVFCL-NROLRVEYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,26192023,IC50,>,100000,NM,,,,,,,,,,,,,,Inhibition of MMP14 (unknown origin) using Mca-KLPGL-Dnp-AR as substrate preincubated for 30 mins followed by substrate addition measured after 1 hr by fluorescence assay,,SAR Studies of Exosite-Binding Substrate-Selective Inhibitors of A Disintegrin And Metalloprotease 17 (ADAM17) and Application as Selective in Vitro Probes.,J. Med. Chem.,2015,58,15,"Knapinska AM, Dreymuller D, Ludwig A, Smith L, Golubkov V, Sohail A, Fridman R, Giulianotti M, LaVoi TM, Houghten RA, Fields GB, Minond D",,1505522,DTCT0024091,14475890,DTCC01651897,2010871,63066
CHEMBL3593550,P50281,,SWCOKZUOBSVFCL-NROLRVEYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,26192023,INHIBITION,=,0,%,,cell_based,,,,,,,,,,,,Inhibition of MMP14 in human SW480 cells assessed as inhibition of PMA-stimulated wild type PTK7 shedding at 25 to 100 uM after 16 hrs by Western blot analysis,,SAR Studies of Exosite-Binding Substrate-Selective Inhibitors of A Disintegrin And Metalloprotease 17 (ADAM17) and Application as Selective in Vitro Probes.,J. Med. Chem.,2015,58,15,"Knapinska AM, Dreymuller D, Ludwig A, Smith L, Golubkov V, Sohail A, Fridman R, Giulianotti M, LaVoi TM, Houghten RA, Fields GB, Minond D",,1505542,DTCT0024091,14476046,DTCC01651897,2010871,63066
CHEMBL3593550,P50281,,SWCOKZUOBSVFCL-NROLRVEYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,26192023,INHIBITION,=,25,%,,,,,,,,,,,,,,Inhibition of MMP14 (unknown origin) using Mca-KLPGL-Dnp-AR as substrate at 100 uM preincubated for 30 mins followed by substrate addition measured after 1 hr by fluorescence assay relative to control,,SAR Studies of Exosite-Binding Substrate-Selective Inhibitors of A Disintegrin And Metalloprotease 17 (ADAM17) and Application as Selective in Vitro Probes.,J. Med. Chem.,2015,58,15,"Knapinska AM, Dreymuller D, Ludwig A, Smith L, Golubkov V, Sohail A, Fridman R, Giulianotti M, LaVoi TM, Houghten RA, Fields GB, Minond D",,1505526,DTCT0024091,14475972,DTCC01651897,2010871,63066
CHEMBL3593550,P50281,,SWCOKZUOBSVFCL-NROLRVEYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,26192023,INHIBITION,=,59,%,,,,,,,,,,,,,,Inhibition of MMP14 in HTSMC assessed as inhibition of DDR1 shedding at 10 to 40 uM by immunoblot analysis relative to control,,SAR Studies of Exosite-Binding Substrate-Selective Inhibitors of A Disintegrin And Metalloprotease 17 (ADAM17) and Application as Selective in Vitro Probes.,J. Med. Chem.,2015,58,15,"Knapinska AM, Dreymuller D, Ludwig A, Smith L, Golubkov V, Sohail A, Fridman R, Giulianotti M, LaVoi TM, Houghten RA, Fields GB, Minond D",,1505543,DTCT0024091,14476083,DTCC01651897,2010871,63066
CHEMBL3593550,P50281,,SWCOKZUOBSVFCL-NROLRVEYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,26192023,INHIBITION,,,,,,,,,,,,,,,,,Inhibition of MMP14 in HTSMC assessed as inhibition of DDR1 shedding by immunoblot analysis,Dose-dependent effect,SAR Studies of Exosite-Binding Substrate-Selective Inhibitors of A Disintegrin And Metalloprotease 17 (ADAM17) and Application as Selective in Vitro Probes.,J. Med. Chem.,2015,58,15,"Knapinska AM, Dreymuller D, Ludwig A, Smith L, Golubkov V, Sohail A, Fridman R, Giulianotti M, LaVoi TM, Houghten RA, Fields GB, Minond D",,1505539,DTCT0024091,14476031,DTCC01651897,2010871,63066
CHEMBL3593551,P50281,,ZEPWGRQYGKUKNA-KFIZHRIMSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,26192023,IC50,>,100000,NM,,,,,,,,,,,,,,Inhibition of MMP14 (unknown origin) using Mca-KLPGL-Dnp-AR as substrate preincubated for 30 mins followed by substrate addition measured after 1 hr by fluorescence assay,,SAR Studies of Exosite-Binding Substrate-Selective Inhibitors of A Disintegrin And Metalloprotease 17 (ADAM17) and Application as Selective in Vitro Probes.,J. Med. Chem.,2015,58,15,"Knapinska AM, Dreymuller D, Ludwig A, Smith L, Golubkov V, Sohail A, Fridman R, Giulianotti M, LaVoi TM, Houghten RA, Fields GB, Minond D",,1505522,DTCT0024091,14475888,DTCC01651898,818354,63066
CHEMBL3593551,P50281,,ZEPWGRQYGKUKNA-KFIZHRIMSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,26192023,INHIBITION,=,0,%,,,,,,,,,,,,,,Inhibition of MMP14 (unknown origin) using Mca-KLPGL-Dnp-AR as substrate at 100 uM preincubated for 30 mins followed by substrate addition measured after 1 hr by fluorescence assay relative to control,,SAR Studies of Exosite-Binding Substrate-Selective Inhibitors of A Disintegrin And Metalloprotease 17 (ADAM17) and Application as Selective in Vitro Probes.,J. Med. Chem.,2015,58,15,"Knapinska AM, Dreymuller D, Ludwig A, Smith L, Golubkov V, Sohail A, Fridman R, Giulianotti M, LaVoi TM, Houghten RA, Fields GB, Minond D",,1505526,DTCT0024091,14475974,DTCC01651898,818354,63066
CHEMBL3593551,P50281,,ZEPWGRQYGKUKNA-KFIZHRIMSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,26192023,INHIBITION,=,0,%,,cell_based,,,,,,,,,,,,Inhibition of MMP14 in human SW480 cells assessed as inhibition of PMA-stimulated wild type PTK7 shedding at 25 to 100 uM after 16 hrs by Western blot analysis,,SAR Studies of Exosite-Binding Substrate-Selective Inhibitors of A Disintegrin And Metalloprotease 17 (ADAM17) and Application as Selective in Vitro Probes.,J. Med. Chem.,2015,58,15,"Knapinska AM, Dreymuller D, Ludwig A, Smith L, Golubkov V, Sohail A, Fridman R, Giulianotti M, LaVoi TM, Houghten RA, Fields GB, Minond D",,1505542,DTCT0024091,14476048,DTCC01651898,818354,63066
CHEMBL3593551,P50281,,ZEPWGRQYGKUKNA-KFIZHRIMSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,26192023,INHIBITION,,,,,,,,,,,,,,,,,Inhibition of MMP14 in HTSMC assessed as inhibition of DDR1 shedding at 10 to 40 uM by immunoblot analysis relative to control,Not Determined,SAR Studies of Exosite-Binding Substrate-Selective Inhibitors of A Disintegrin And Metalloprotease 17 (ADAM17) and Application as Selective in Vitro Probes.,J. Med. Chem.,2015,58,15,"Knapinska AM, Dreymuller D, Ludwig A, Smith L, Golubkov V, Sohail A, Fridman R, Giulianotti M, LaVoi TM, Houghten RA, Fields GB, Minond D",,1505543,DTCT0024091,14476085,DTCC01651898,818354,63066
CHEMBL3593552,P50281,,QABDTPJMJYQBCF-KQQMQGIYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,26192023,IC50,>,100000,NM,,,,,,,,,,,,,,Inhibition of MMP14 (unknown origin) using Mca-KLPGL-Dnp-AR as substrate preincubated for 30 mins followed by substrate addition measured after 1 hr by fluorescence assay,,SAR Studies of Exosite-Binding Substrate-Selective Inhibitors of A Disintegrin And Metalloprotease 17 (ADAM17) and Application as Selective in Vitro Probes.,J. Med. Chem.,2015,58,15,"Knapinska AM, Dreymuller D, Ludwig A, Smith L, Golubkov V, Sohail A, Fridman R, Giulianotti M, LaVoi TM, Houghten RA, Fields GB, Minond D",,1505522,DTCT0024091,14475886,DTCC01651899,980185,63066
CHEMBL3593552,P50281,,QABDTPJMJYQBCF-KQQMQGIYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,26192023,INHIBITION,=,0,%,,,,,,,,,,,,,,Inhibition of MMP14 (unknown origin) using Mca-KLPGL-Dnp-AR as substrate at 100 uM preincubated for 30 mins followed by substrate addition measured after 1 hr by fluorescence assay relative to control,,SAR Studies of Exosite-Binding Substrate-Selective Inhibitors of A Disintegrin And Metalloprotease 17 (ADAM17) and Application as Selective in Vitro Probes.,J. Med. Chem.,2015,58,15,"Knapinska AM, Dreymuller D, Ludwig A, Smith L, Golubkov V, Sohail A, Fridman R, Giulianotti M, LaVoi TM, Houghten RA, Fields GB, Minond D",,1505526,DTCT0024091,14475976,DTCC01651899,980185,63066
CHEMBL3593552,P50281,,QABDTPJMJYQBCF-KQQMQGIYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,26192023,INHIBITION,,,,,,,,,,,,,,,,,Inhibition of MMP14 in HTSMC assessed as inhibition of DDR1 shedding at 10 to 40 uM by immunoblot analysis relative to control,Not Determined,SAR Studies of Exosite-Binding Substrate-Selective Inhibitors of A Disintegrin And Metalloprotease 17 (ADAM17) and Application as Selective in Vitro Probes.,J. Med. Chem.,2015,58,15,"Knapinska AM, Dreymuller D, Ludwig A, Smith L, Golubkov V, Sohail A, Fridman R, Giulianotti M, LaVoi TM, Houghten RA, Fields GB, Minond D",,1505543,DTCT0024091,14476087,DTCC01651899,980185,63066
CHEMBL3593552,P50281,,QABDTPJMJYQBCF-KQQMQGIYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,26192023,INHIBITION,,,,,cell_based,,,,,,,,,,,,Inhibition of MMP14 in human SW480 cells assessed as inhibition of PMA-stimulated wild type PTK7 shedding at 25 to 100 uM after 16 hrs by Western blot analysis,Not Determined,SAR Studies of Exosite-Binding Substrate-Selective Inhibitors of A Disintegrin And Metalloprotease 17 (ADAM17) and Application as Selective in Vitro Probes.,J. Med. Chem.,2015,58,15,"Knapinska AM, Dreymuller D, Ludwig A, Smith L, Golubkov V, Sohail A, Fridman R, Giulianotti M, LaVoi TM, Houghten RA, Fields GB, Minond D",,1505542,DTCT0024091,14476050,DTCC01651899,980185,63066
CHEMBL359519,P50281,,SLUQTAQKAIYNRS-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,15780611,IC50,=,27,NM,,,,,,,,,,,,,,Inhibitory concentration against matrix metalloprotease 14,,Potent pyrimidinetrione-based inhibitors of MMP-13 with enhanced selectivity over MMP-14.,Bioorg. Med. Chem. Lett.,2005,15,7,"Blagg JA, Noe MC, Wolf-Gouveia LA, Reiter LA, Laird ER, Chang SP, Danley DE, Downs JT, Elliott NC, Eskra JD, Griffiths RJ, Hardink JR, Haugeto AI, Jones CS, Liras JL, Lopresti-Morrow LL, Mitchell PG, Pandit J, Robinson RP, Subramanyam C, Vaughn-Bowser ML, Yocum SA",,305128,DTCT0024091,1752540,DTCC00384410,1015950,18917
CHEMBL359669,P50281,,ASSONXJFMGBTAQ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,15780611,IC50,=,650,NM,,,,,,,,,,,,,,Inhibitory concentration against matrix metalloprotease 14,,Potent pyrimidinetrione-based inhibitors of MMP-13 with enhanced selectivity over MMP-14.,Bioorg. Med. Chem. Lett.,2005,15,7,"Blagg JA, Noe MC, Wolf-Gouveia LA, Reiter LA, Laird ER, Chang SP, Danley DE, Downs JT, Elliott NC, Eskra JD, Griffiths RJ, Hardink JR, Haugeto AI, Jones CS, Liras JL, Lopresti-Morrow LL, Mitchell PG, Pandit J, Robinson RP, Subramanyam C, Vaughn-Bowser ML, Yocum SA",,305128,DTCT0024091,1754138,DTCC00384432,1663007,18917
CHEMBL359873,P50281,,AHZYHNGWSULLBY-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,15780611,IC50,>,30000,NM,,,,,,,,,,,,,,Inhibitory concentration against matrix metalloprotease 14,,Potent pyrimidinetrione-based inhibitors of MMP-13 with enhanced selectivity over MMP-14.,Bioorg. Med. Chem. Lett.,2005,15,7,"Blagg JA, Noe MC, Wolf-Gouveia LA, Reiter LA, Laird ER, Chang SP, Danley DE, Downs JT, Elliott NC, Eskra JD, Griffiths RJ, Hardink JR, Haugeto AI, Jones CS, Liras JL, Lopresti-Morrow LL, Mitchell PG, Pandit J, Robinson RP, Subramanyam C, Vaughn-Bowser ML, Yocum SA",,305128,DTCT0024091,1754144,DTCC00384461,271739,18917
CHEMBL360916,P50281,,BIHSFSZDPRDVEE-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,15780611,IC50,=,23,NM,,,,,,,,,,,,,,Inhibitory concentration against matrix metalloprotease 14,,Potent pyrimidinetrione-based inhibitors of MMP-13 with enhanced selectivity over MMP-14.,Bioorg. Med. Chem. Lett.,2005,15,7,"Blagg JA, Noe MC, Wolf-Gouveia LA, Reiter LA, Laird ER, Chang SP, Danley DE, Downs JT, Elliott NC, Eskra JD, Griffiths RJ, Hardink JR, Haugeto AI, Jones CS, Liras JL, Lopresti-Morrow LL, Mitchell PG, Pandit J, Robinson RP, Subramanyam C, Vaughn-Bowser ML, Yocum SA",,305128,DTCT0024091,1753189,DTCC00384528,499439,18917
CHEMBL360925,P50281,,KOKCTGWRLDNNGZ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,15780611,IC50,=,510,NM,,,,,,,,,,,,,,Inhibitory concentration against matrix metalloprotease 14,,Potent pyrimidinetrione-based inhibitors of MMP-13 with enhanced selectivity over MMP-14.,Bioorg. Med. Chem. Lett.,2005,15,7,"Blagg JA, Noe MC, Wolf-Gouveia LA, Reiter LA, Laird ER, Chang SP, Danley DE, Downs JT, Elliott NC, Eskra JD, Griffiths RJ, Hardink JR, Haugeto AI, Jones CS, Liras JL, Lopresti-Morrow LL, Mitchell PG, Pandit J, Robinson RP, Subramanyam C, Vaughn-Bowser ML, Yocum SA",,305128,DTCT0024091,1753602,DTCC00384460,1048425,18917
CHEMBL361326,P50281,,ZEEUPEFKULHDHM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,15780611,IC50,=,8700,NM,,,,,,,,,,,,,,Inhibitory concentration against matrix metalloprotease 14,,Potent pyrimidinetrione-based inhibitors of MMP-13 with enhanced selectivity over MMP-14.,Bioorg. Med. Chem. Lett.,2005,15,7,"Blagg JA, Noe MC, Wolf-Gouveia LA, Reiter LA, Laird ER, Chang SP, Danley DE, Downs JT, Elliott NC, Eskra JD, Griffiths RJ, Hardink JR, Haugeto AI, Jones CS, Liras JL, Lopresti-Morrow LL, Mitchell PG, Pandit J, Robinson RP, Subramanyam C, Vaughn-Bowser ML, Yocum SA",,305128,DTCT0024091,1753728,DTCC00384535,628495,18917
CHEMBL3617400,P50281,,NUFBSNVYZRUJSW-XMMPIXPASA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,26263024,IC50,=,94,NM,,,,,,,,,,,,,,Inhibition of recombinant human catalytic domain MMP14 using Mca-Lys-Pro-Leu-Gly-Leu-Dap(Dnp)-Ala-Arg-NH2 as fluorogenic substrate incubated for 4 hrs followed by substrate addition measured every 10 secs for 20 mins by fluorometric assay,,N-O-Isopropyl Sulfonamido-Based Hydroxamates as Matrix Metalloproteinase Inhibitors: Hit Selection and in Vivo Antiangiogenic Activity.,J. Med. Chem.,2015,58,18,"Nuti E, Cantelmo AR, Gallo C, Bruno A, Bassani B, Camodeca C, Tuccinardi T, Vera L, Orlandini E, Nencetti S, Stura EA, Martinelli A, Dive V, Albini A, Rossello A",,1518241,DTCT0024091,14545640,DTCC01663485,1291518,63632
CHEMBL3617401,P50281,,KUDQLMASLRCXLF-LJQANCHMSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,26263024,IC50,=,95,NM,,,,,,,,,,,,,,Inhibition of recombinant human catalytic domain MMP14 using Mca-Lys-Pro-Leu-Gly-Leu-Dap(Dnp)-Ala-Arg-NH2 as fluorogenic substrate incubated for 4 hrs followed by substrate addition measured every 10 secs for 20 mins by fluorometric assay,,N-O-Isopropyl Sulfonamido-Based Hydroxamates as Matrix Metalloproteinase Inhibitors: Hit Selection and in Vivo Antiangiogenic Activity.,J. Med. Chem.,2015,58,18,"Nuti E, Cantelmo AR, Gallo C, Bruno A, Bassani B, Camodeca C, Tuccinardi T, Vera L, Orlandini E, Nencetti S, Stura EA, Martinelli A, Dive V, Albini A, Rossello A",,1518241,DTCT0024091,14545641,DTCC01663486,839147,63632
CHEMBL3617402,P50281,,QHHHTEGVVKPDKH-HXUWFJFHSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,26263024,IC50,=,41,NM,,,,,,,,,,,,,,Inhibition of recombinant human catalytic domain MMP14 using Mca-Lys-Pro-Leu-Gly-Leu-Dap(Dnp)-Ala-Arg-NH2 as fluorogenic substrate incubated for 4 hrs followed by substrate addition measured every 10 secs for 20 mins by fluorometric assay,,N-O-Isopropyl Sulfonamido-Based Hydroxamates as Matrix Metalloproteinase Inhibitors: Hit Selection and in Vivo Antiangiogenic Activity.,J. Med. Chem.,2015,58,18,"Nuti E, Cantelmo AR, Gallo C, Bruno A, Bassani B, Camodeca C, Tuccinardi T, Vera L, Orlandini E, Nencetti S, Stura EA, Martinelli A, Dive V, Albini A, Rossello A",,1518241,DTCT0024091,14545642,DTCC01663487,126658,63632
CHEMBL3617403,P50281,,NJZUERVIVLYZMO-RUZDIDTESA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,26263024,IC50,=,81,NM,,,,,,,,,,,,,,Inhibition of recombinant human catalytic domain MMP14 using Mca-Lys-Pro-Leu-Gly-Leu-Dap(Dnp)-Ala-Arg-NH2 as fluorogenic substrate incubated for 4 hrs followed by substrate addition measured every 10 secs for 20 mins by fluorometric assay,,N-O-Isopropyl Sulfonamido-Based Hydroxamates as Matrix Metalloproteinase Inhibitors: Hit Selection and in Vivo Antiangiogenic Activity.,J. Med. Chem.,2015,58,18,"Nuti E, Cantelmo AR, Gallo C, Bruno A, Bassani B, Camodeca C, Tuccinardi T, Vera L, Orlandini E, Nencetti S, Stura EA, Martinelli A, Dive V, Albini A, Rossello A",,1518241,DTCT0024091,14545643,DTCC01663488,94439,63632
CHEMBL3617404,P50281,,UJKKQEHHLXCTJE-OAQYLSRUSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,26263024,IC50,=,23,NM,,,,,,,,,,,,,,Inhibition of recombinant human catalytic domain MMP14 using Mca-Lys-Pro-Leu-Gly-Leu-Dap(Dnp)-Ala-Arg-NH2 as fluorogenic substrate incubated for 4 hrs followed by substrate addition measured every 10 secs for 20 mins by fluorometric assay,,N-O-Isopropyl Sulfonamido-Based Hydroxamates as Matrix Metalloproteinase Inhibitors: Hit Selection and in Vivo Antiangiogenic Activity.,J. Med. Chem.,2015,58,18,"Nuti E, Cantelmo AR, Gallo C, Bruno A, Bassani B, Camodeca C, Tuccinardi T, Vera L, Orlandini E, Nencetti S, Stura EA, Martinelli A, Dive V, Albini A, Rossello A",,1518241,DTCT0024091,14545644,DTCC01663489,1161438,63632
CHEMBL3617405,P50281,,WVPKYEATTXWJLC-AREMUKBSSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,26263024,IC50,=,25,NM,,,,,,,,,,,,,,Inhibition of recombinant human catalytic domain MMP14 using Mca-Lys-Pro-Leu-Gly-Leu-Dap(Dnp)-Ala-Arg-NH2 as fluorogenic substrate incubated for 4 hrs followed by substrate addition measured every 10 secs for 20 mins by fluorometric assay,,N-O-Isopropyl Sulfonamido-Based Hydroxamates as Matrix Metalloproteinase Inhibitors: Hit Selection and in Vivo Antiangiogenic Activity.,J. Med. Chem.,2015,58,18,"Nuti E, Cantelmo AR, Gallo C, Bruno A, Bassani B, Camodeca C, Tuccinardi T, Vera L, Orlandini E, Nencetti S, Stura EA, Martinelli A, Dive V, Albini A, Rossello A",,1518241,DTCT0024091,14545645,DTCC01663490,1739733,63632
CHEMBL3617406,P50281,,RAYJCTCOKFKWEF-CQSZACIVSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,26263024,IC50,=,5500,NM,,,,,,,,,,,,,,Inhibition of recombinant human catalytic domain MMP14 using Mca-Lys-Pro-Leu-Gly-Leu-Dap(Dnp)-Ala-Arg-NH2 as fluorogenic substrate incubated for 4 hrs followed by substrate addition measured every 10 secs for 20 mins by fluorometric assay,,N-O-Isopropyl Sulfonamido-Based Hydroxamates as Matrix Metalloproteinase Inhibitors: Hit Selection and in Vivo Antiangiogenic Activity.,J. Med. Chem.,2015,58,18,"Nuti E, Cantelmo AR, Gallo C, Bruno A, Bassani B, Camodeca C, Tuccinardi T, Vera L, Orlandini E, Nencetti S, Stura EA, Martinelli A, Dive V, Albini A, Rossello A",,1518241,DTCT0024091,14545647,DTCC01663491,871801,63632
CHEMBL3617407,P50281,,WQCXDERWRJMJQA-RUZDIDTESA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,26263024,IC50,=,3.9,NM,,,,,,,,,,,,,,Inhibition of recombinant human catalytic domain MMP14 using Mca-Lys-Pro-Leu-Gly-Leu-Dap(Dnp)-Ala-Arg-NH2 as fluorogenic substrate incubated for 4 hrs followed by substrate addition measured every 10 secs for 20 mins by fluorometric assay,,N-O-Isopropyl Sulfonamido-Based Hydroxamates as Matrix Metalloproteinase Inhibitors: Hit Selection and in Vivo Antiangiogenic Activity.,J. Med. Chem.,2015,58,18,"Nuti E, Cantelmo AR, Gallo C, Bruno A, Bassani B, Camodeca C, Tuccinardi T, Vera L, Orlandini E, Nencetti S, Stura EA, Martinelli A, Dive V, Albini A, Rossello A",,1518241,DTCT0024091,14545648,DTCC01663492,2063303,63632
CHEMBL361783,P50281,,FQEZYKOXVAISOF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,15780611,IC50,=,75,NM,,,,,,,,,,,,,,Inhibitory concentration against matrix metalloprotease 14,,Potent pyrimidinetrione-based inhibitors of MMP-13 with enhanced selectivity over MMP-14.,Bioorg. Med. Chem. Lett.,2005,15,7,"Blagg JA, Noe MC, Wolf-Gouveia LA, Reiter LA, Laird ER, Chang SP, Danley DE, Downs JT, Elliott NC, Eskra JD, Griffiths RJ, Hardink JR, Haugeto AI, Jones CS, Liras JL, Lopresti-Morrow LL, Mitchell PG, Pandit J, Robinson RP, Subramanyam C, Vaughn-Bowser ML, Yocum SA",,305128,DTCT0024091,1754260,DTCC00384563,1048426,18917
CHEMBL361818,P50281,,BRYABXWERJYEAH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,15780611,IC50,=,70,NM,,,,,,,,,,,,,,Inhibitory concentration against matrix metalloprotease 14,,Potent pyrimidinetrione-based inhibitors of MMP-13 with enhanced selectivity over MMP-14.,Bioorg. Med. Chem. Lett.,2005,15,7,"Blagg JA, Noe MC, Wolf-Gouveia LA, Reiter LA, Laird ER, Chang SP, Danley DE, Downs JT, Elliott NC, Eskra JD, Griffiths RJ, Hardink JR, Haugeto AI, Jones CS, Liras JL, Lopresti-Morrow LL, Mitchell PG, Pandit J, Robinson RP, Subramanyam C, Vaughn-Bowser ML, Yocum SA",,305128,DTCT0024091,1753615,DTCC00384418,369928,18917
CHEMBL362194,P50281,,YHSMTPXGPORQER-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,15780611,IC50,=,340,NM,,,,,,,,,,,,,,Inhibitory concentration against matrix metalloprotease 14,,Potent pyrimidinetrione-based inhibitors of MMP-13 with enhanced selectivity over MMP-14.,Bioorg. Med. Chem. Lett.,2005,15,7,"Blagg JA, Noe MC, Wolf-Gouveia LA, Reiter LA, Laird ER, Chang SP, Danley DE, Downs JT, Elliott NC, Eskra JD, Griffiths RJ, Hardink JR, Haugeto AI, Jones CS, Liras JL, Lopresti-Morrow LL, Mitchell PG, Pandit J, Robinson RP, Subramanyam C, Vaughn-Bowser ML, Yocum SA",,305128,DTCT0024091,1754149,DTCC00384512,1081003,18917
CHEMBL362284,P50281,,FCGHMWYAKRLIIN-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,15780611,IC50,=,1400,NM,,,,,,,,,,,,,,Inhibitory concentration against matrix metalloprotease 14,,Potent pyrimidinetrione-based inhibitors of MMP-13 with enhanced selectivity over MMP-14.,Bioorg. Med. Chem. Lett.,2005,15,7,"Blagg JA, Noe MC, Wolf-Gouveia LA, Reiter LA, Laird ER, Chang SP, Danley DE, Downs JT, Elliott NC, Eskra JD, Griffiths RJ, Hardink JR, Haugeto AI, Jones CS, Liras JL, Lopresti-Morrow LL, Mitchell PG, Pandit J, Robinson RP, Subramanyam C, Vaughn-Bowser ML, Yocum SA",,305128,DTCT0024091,1754146,DTCC00384492,1916103,18917
CHEMBL362651,P50281,,PKVXJRTWUNPBJP-RUZDIDTESA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,15713379,IC50,=,7.7,NM,,,,,,,,,,,,,,Inhibition of human matrix metalloprotease-14,,N-i-Propoxy-N-biphenylsulfonylaminobutylhydroxamic acids as potent and selective inhibitors of MMP-2 and MT1-MMP.,Bioorg. Med. Chem. Lett.,2005,15,5,"Rossello A, Nuti E, Carelli P, Orlandini E, Macchia M, Nencetti S, Zandomeneghi M, Balzano F, Uccello Barretta G, Albini A, Benelli R, Cercignani G, Murphy G, Balsamo A",,305766,DTCT0024091,1747890,DTCC00381850,1936708,18841
CHEMBL362651,P50281,,PKVXJRTWUNPBJP-RUZDIDTESA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,15837315,IC50,=,7.7,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-14 in MMPi assay,,A new development of matrix metalloproteinase inhibitors: twin hydroxamic acids as potent inhibitors of MMPs.,Bioorg. Med. Chem. Lett.,2005,15,9,"Rossello A, Nuti E, Catalani MP, Carelli P, Orlandini E, Rapposelli S, Tuccinardi T, Atkinson SJ, Murphy G, Balsamo A",,305723,DTCT0024091,1841418,DTCC00381850,1948929,18987
CHEMBL362832,P50281,,KSGNBXMXFPLVKJ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,15780611,IC50,=,230,NM,,,,,,,,,,,,,,Inhibitory concentration against matrix metalloprotease 14,,Potent pyrimidinetrione-based inhibitors of MMP-13 with enhanced selectivity over MMP-14.,Bioorg. Med. Chem. Lett.,2005,15,7,"Blagg JA, Noe MC, Wolf-Gouveia LA, Reiter LA, Laird ER, Chang SP, Danley DE, Downs JT, Elliott NC, Eskra JD, Griffiths RJ, Hardink JR, Haugeto AI, Jones CS, Liras JL, Lopresti-Morrow LL, Mitchell PG, Pandit J, Robinson RP, Subramanyam C, Vaughn-Bowser ML, Yocum SA",,305128,DTCT0024091,1752658,DTCC00384438,499438,18917
CHEMBL3639695,P50281,,PZMQNEDVJSDLAW-SFTDATJTSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,248096,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535033,DTCT0024091,180546,DTCC01703280,1130506,64498
CHEMBL3639744,P50281,,SAIHVCSOGMUZPK-OALUTQOASA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,,KI,>,5000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,248130,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535033,DTCT0024091,159468,DTCC01708180,1615862,64498
CHEMBL364185,P50281,,MAGGVGMLDUAYRI-DEOSSOPVSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,16005220,IC50,=,10900,NM,,,,,,,,,,,,,,Inhibitory concentration against MMP-14,,Identification of potent and selective MMP-13 inhibitors.,Bioorg. Med. Chem. Lett.,2005,15,18,"Wu J, Rush TS, Hotchandani R, Du X, Geck M, Collins E, Xu ZB, Skotnicki J, Levin JI, Lovering FE",,304646,DTCT0024091,1798988,DTCC00394788,1113706,8231
CHEMBL365947,P50281,,WXPUJRINFGPEGC-VWLOTQADSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,16153831,IC50,,,,,,,,,,,,,,,,,Inhibitory concentration against MMP-14; - = not available,Not Determined,Synthesis and SAR of highly selective MMP-13 inhibitors.,Bioorg. Med. Chem. Lett.,2005,15,22,"Li J, Rush TS, Li W, DeVincentis D, Du X, Hu Y, Thomason JR, Xiang JS, Skotnicki JS, Tam S, Cunningham KM, Chockalingam PS, Morris EA, Levin JI",,321302,DTCT0024091,1860386,DTCC00407674,1695368,19837
CHEMBL366111,P50281,,WJULIBHPWZXMJA-IEBWSBKVSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,15324896,IC50,=,150,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease 14,,3-Hydroxy-4-arylsulfonyltetrahydropyranyl-3-hydroxamic acids are novel inhibitors of MMP-13 and aggrecanase.,Bioorg. Med. Chem. Lett.,2004,14,18,"Noe MC, Snow SL, Wolf-Gouveia LA, Mitchell PG, Lopresti-Morrow L, Reeves LM, Yocum SA, Liras JL, Vaughn M",,305095,DTCT0024091,1768938,DTCC00388400,142333,18227
CHEMBL366997,P50281,,UOBVGDSSMCMKCH-INIZCTEOSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,11958997,INHIBITION,=,53,%,,,,,,,,,,,,,,Percent remaining enzyme activity (RA) in catalytic domains of the membrane type MT1-MMP (matrix metalloprotease-14),,Oxal hydroxamic acid derivatives with inhibitory activity against matrix metalloproteinases.,Bioorg. Med. Chem. Lett.,2002,12,6,"Krumme D, Tschesche H",,106778,DTCT0024091,1103412,DTCC00371651,681217,5419
CHEMBL3670691,P50281,,FBDOWURNGYMLPJ-IBGZPJMESA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,248090,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535033,DTCT0024091,174951,DTCC01703274,839513,64498
CHEMBL3670692,P50281,,KOVQMCGGWATESY-YADHBBJMSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,248091,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535033,DTCT0024091,163856,DTCC01703275,127019,64498
CHEMBL3670693,P50281,,KOVQMCGGWATESY-FCHUYYIVSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,,KI,>,10000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,248092,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535033,DTCT0024091,163092,DTCC01703276,1098405,64498
CHEMBL3670694,P50281,,KOVQMCGGWATESY-FGZHOGPDSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,,KI,>,10000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,248093,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535033,DTCT0024091,169570,DTCC01703277,289306,64498
CHEMBL3670695,P50281,,QCVLVTVGVJUODZ-UNMCSNQZSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,248094,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535033,DTCT0024091,180929,DTCC01703278,2031908,64498
CHEMBL3670696,P50281,,MFTZEUCXFCXINH-UNMCSNQZSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,,KI,>,5000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,248095,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535033,DTCT0024091,180254,DTCC01703279,1518861,64498
CHEMBL3670697,P50281,,CNPRJTXDIHRZPF-ZEQRLZLVSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,,KI,>,10000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,248097,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535033,DTCT0024091,166353,DTCC01703281,1357220,64498
CHEMBL3670698,P50281,,LFUNCOOVDREPBK-GOTSBHOMSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,,KI,>,5000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,248098,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535033,DTCT0024091,166913,DTCC01703282,1711859,64498
CHEMBL3670699,P50281,,QDHXNZRPVLUOML-DQEYMECFSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,,KI,=,553,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,248099,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535033,DTCT0024091,176919,DTCC01703283,774361,64498
CHEMBL3670700,P50281,,HCTHWCGSCVVHLJ-ZDUSSCGKSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,248101,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535033,DTCT0024091,159293,DTCC01703284,1583049,64498
CHEMBL3670701,P50281,,FFHINXVCVWQCSG-VXKWHMMOSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,248102,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535033,DTCT0024091,164140,DTCC01703285,904397,64498
CHEMBL3670702,P50281,,HXOLPPZDNXMRHR-UNMCSNQZSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,,KI,>,5000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,248103,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535033,DTCT0024091,182613,DTCC01703286,1357221,64498
CHEMBL3670703,P50281,,BMJUABISSDGKOA-UNMCSNQZSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,248104,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535033,DTCT0024091,176758,DTCC01703287,580739,64498
CHEMBL3670704,P50281,,NZUPMMOEPOVBQE-SFTDATJTSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,248105,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535033,DTCT0024091,183227,DTCC01703288,1680152,64498
CHEMBL3670705,P50281,,JUEZHKLAFJJQNE-VXKWHMMOSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,,KI,>,10000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,248106,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535033,DTCT0024091,172337,DTCC01703289,1389860,64498
CHEMBL3670706,P50281,,OFRXWZGHEVNQHU-VXKWHMMOSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,248107,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535033,DTCT0024091,167415,DTCC01703290,1836770,64498
CHEMBL3670707,P50281,,VFEIVMVXXWQZER-VXKWHMMOSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,,KI,>,10000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,248108,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535033,DTCT0024091,178048,DTCC01703291,1259462,64498
CHEMBL3670708,P50281,,IIUXBHAJTPNCIR-KKSFZXQISA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,248109,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535033,DTCT0024091,165828,DTCC01703292,1291821,64498
CHEMBL3670709,P50281,,KNJBHXZWYFARSA-HOTGVXAUSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,,KI,>,5000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,248110,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535033,DTCT0024091,178632,DTCC01703293,1647965,64498
CHEMBL3670710,P50281,,FRXRVVOCWBNHOQ-HOTGVXAUSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,248111,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535033,DTCT0024091,170332,DTCC01703294,1065482,64498
CHEMBL3670711,P50281,,MNXXFUIRJNLTHG-KBPBESRZSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,,KI,>,5000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,248112,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535033,DTCT0024091,174158,DTCC01703295,1771871,64498
CHEMBL3670712,P50281,,XNQPIVCSZRQAQO-HOTGVXAUSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,,KI,>,5000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,248113,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535033,DTCT0024091,168983,DTCC01703296,420053,64498
CHEMBL3670713,P50281,,ACXIBBRPTTWRDM-PMACEKPBSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,248114,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535033,DTCT0024091,171277,DTCC01703297,839514,64498
CHEMBL3670714,P50281,,RAOGWYCOADLHPD-SFTDATJTSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,,KI,>,5000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,248115,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535033,DTCT0024091,171664,DTCC01703298,548550,64498
CHEMBL3670715,P50281,,AVFCHUYQSZAIFE-VXKWHMMOSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,248116,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535033,DTCT0024091,184908,DTCC01703299,1998926,64498
CHEMBL3670716,P50281,,GSEYFLJSDKPLAI-KBPBESRZSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,248117,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535033,DTCT0024091,160109,DTCC01703300,1550906,64498
CHEMBL3670717,P50281,,VIPIKALUTUDDKU-IRXDYDNUSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,248118,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535033,DTCT0024091,164171,DTCC01703301,1771872,64498
CHEMBL3670718,P50281,,YUQQWAKBRAEWQZ-ROUUACIJSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,248119,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535033,DTCT0024091,168150,DTCC01703302,710012,64498
CHEMBL3670719,P50281,,PLIPLRCYJWMTFY-HOTGVXAUSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,248120,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535033,DTCT0024091,173737,DTCC01703303,968343,64498
CHEMBL3670720,P50281,,BFJIOGLKGISOKV-GJZGRUSLSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,,KI,=,438,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,248121,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535033,DTCT0024091,178532,DTCC01703304,1226403,64498
CHEMBL3670721,P50281,,UOTSSZSXOLHXGG-ROUUACIJSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,,KI,>,5000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,248122,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535033,DTCT0024091,179713,DTCC01703305,1291822,64498
CHEMBL367133,P50281,,RLDSXGKXSYXTOQ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,15780611,IC50,=,3,NM,,,,,,,,,,,,,,Inhibitory concentration against matrix metalloprotease 14,,Potent pyrimidinetrione-based inhibitors of MMP-13 with enhanced selectivity over MMP-14.,Bioorg. Med. Chem. Lett.,2005,15,7,"Blagg JA, Noe MC, Wolf-Gouveia LA, Reiter LA, Laird ER, Chang SP, Danley DE, Downs JT, Elliott NC, Eskra JD, Griffiths RJ, Hardink JR, Haugeto AI, Jones CS, Liras JL, Lopresti-Morrow LL, Mitchell PG, Pandit J, Robinson RP, Subramanyam C, Vaughn-Bowser ML, Yocum SA",,305128,DTCT0024091,1754249,DTCC00384404,595977,18917
CHEMBL367331,P50281,,AWCFKZLKKUVLGN-KFJBMODSSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,11958997,INHIBITION,=,66,%,,,,,,,,,,,,,,Percent remaining enzyme activity (RA) in catalytic domains of the membrane type MT1-MMP (matrix metalloprotease-14),,Oxal hydroxamic acid derivatives with inhibitory activity against matrix metalloproteinases.,Bioorg. Med. Chem. Lett.,2002,12,6,"Krumme D, Tschesche H",,106778,DTCT0024091,1095533,DTCC00371299,1036733,5419
CHEMBL3675541,P50281,,RESDGLIYQGGYGR-HOTGVXAUSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,248123,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535033,DTCT0024091,157329,DTCC01708173,1615861,64498
CHEMBL3675542,P50281,,AEOWLQGPNGMHBP-ROUUACIJSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,,KI,=,410,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,248124,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535033,DTCT0024091,158143,DTCC01708174,613076,64498
CHEMBL3675543,P50281,,XLKQIIIKETWLMI-HKUYNNGSSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,,KI,=,547,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,248125,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535033,DTCT0024091,169946,DTCC01708175,742365,64498
CHEMBL3675544,P50281,,YWXFICBFTYVHJU-PMACEKPBSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,,KI,>,5000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,248126,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535033,DTCT0024091,166484,DTCC01708176,1324414,64498
CHEMBL3675545,P50281,,JYGPMNNMAQCQMG-PMACEKPBSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,248127,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535033,DTCT0024091,182719,DTCC01708177,645830,64498
CHEMBL3675546,P50281,,VXYUSBYRYYLNHT-PMACEKPBSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,,KI,>,5000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,248128,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535033,DTCT0024091,173795,DTCC01708178,2031940,64498
CHEMBL3675547,P50281,,DKTMPYACSYBQIF-VXKWHMMOSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,,KI,>,5000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,248129,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535033,DTCT0024091,184235,DTCC01708179,1194373,64498
CHEMBL3675548,P50281,,IIRLMDJELCRLPB-DQEYMECFSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,,KI,>,5000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,248131,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535033,DTCT0024091,158178,DTCC01708181,548584,64498
CHEMBL3675549,P50281,,MXXLMDWJDJQNCZ-KXBFYZLASA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,,KI,>,5000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,248132,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535033,DTCT0024091,180891,DTCC01708182,968371,64498
CHEMBL3675550,P50281,,OTOPPWBRBAVQCM-VXKWHMMOSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,,KI,>,10000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,248133,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535033,DTCT0024091,170531,DTCC01708183,450759,64498
CHEMBL3675551,P50281,,LHURUBKIFBZDNZ-OALUTQOASA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,248134,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535033,DTCT0024091,173630,DTCC01708184,2031941,64498
CHEMBL3675552,P50281,,MTMSSQNYFAAJSR-VXKWHMMOSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,,KI,>,5000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,248135,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535033,DTCT0024091,182501,DTCC01708185,321876,64498
CHEMBL3675553,P50281,,XTHLTIMASWPNRH-AKRCKQFNSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,,KI,>,5000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,248136,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535033,DTCT0024091,174195,DTCC01708186,904423,64498
CHEMBL3675554,P50281,,SJWYFGLDVUQIEF-DEOSSOPVSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,248137,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535033,DTCT0024091,178987,DTCC01708187,1259488,64498
CHEMBL3675555,P50281,,HXQNDQXHRNVKIA-PMACEKPBSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,248138,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535033,DTCT0024091,167959,DTCC01708188,127053,64498
CHEMBL3675556,P50281,,UIEDXQBYCVBGGE-PMACEKPBSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,,KI,>,10000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,248139,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535033,DTCT0024091,162003,DTCC01708189,1966318,64498
CHEMBL3675557,P50281,,BBERXYYXGJGELS-PMACEKPBSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,,KI,>,5000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,248140,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535033,DTCT0024091,181493,DTCC01708190,127054,64498
CHEMBL3675558,P50281,,YUUVADHCMFJYGO-PMACEKPBSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,,KI,>,10000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,248141,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535033,DTCT0024091,169115,DTCC01708191,872152,64498
CHEMBL3675559,P50281,,MVSSFLIDOBOIBL-PMACEKPBSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,,KI,>,10000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,248142,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535033,DTCT0024091,178044,DTCC01708192,1098436,64498
CHEMBL3675560,P50281,,YWAKWFLUKNCYMP-PMACEKPBSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,248143,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535033,DTCT0024091,165492,DTCC01708193,1194374,64498
CHEMBL3675561,P50281,,FHLZDDVMTVCEOC-SFTDATJTSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,,KI,>,10000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,248144,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535033,DTCT0024091,162069,DTCC01708194,1804477,64498
CHEMBL3675562,P50281,,ZQBDVTJLOHIYJN-SFTDATJTSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,,KI,>,10000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,248145,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535033,DTCT0024091,163858,DTCC01708195,1550939,64498
CHEMBL3675563,P50281,,MXFJZXDWWXHXMV-UIOOFZCWSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,248146,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535033,DTCT0024091,161364,DTCC01708196,645831,64498
CHEMBL3675563,P50281,,MXFJZXDWWXHXMV-UIOOFZCWSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,,KI,>,5000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,248157,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535033,DTCT0024091,157708,DTCC01708196,645831,64498
CHEMBL3675564,P50281,,RIICMTINBCLPOY-UIOOFZCWSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,248147,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535033,DTCT0024091,168749,DTCC01708197,806748,64498
CHEMBL3675565,P50281,,BVKYTKVUMKYONQ-NSOVKSMOSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,248148,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535033,DTCT0024091,176664,DTCC01708198,1389896,64498
CHEMBL3675566,P50281,,XHPUXKQBUUHEIP-DQEYMECFSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,,KI,>,5000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,248149,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535033,DTCT0024091,177453,DTCC01708199,1130545,64498
CHEMBL3675567,P50281,,NHZSRXRDEWWJJS-CONSDPRKSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,248150,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535033,DTCT0024091,166431,DTCC01708200,1065520,64498
CHEMBL3675568,P50281,,MDMQULYGCYNXQN-DFBJGRDBSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,,KI,>,10000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,248151,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535033,DTCT0024091,173992,DTCC01708201,321877,64498
CHEMBL3675569,P50281,,SAJAWNZBKHGJOW-MBMZGMDYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,248152,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535033,DTCT0024091,171405,DTCC01708202,1550940,64498
CHEMBL3675570,P50281,,ZQUJAHCTHDEZMJ-DQEYMECFSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,248153,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535033,DTCT0024091,176194,DTCC01708203,211,64498
CHEMBL3675571,P50281,,CKYKLNXMCJIGPN-NSOVKSMOSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,,KI,>,5000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,248154,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535033,DTCT0024091,184835,DTCC01708204,839552,64498
CHEMBL3675572,P50281,,WLZQVNRDQZYTID-PEFOLFAWSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,248155,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535033,DTCT0024091,174647,DTCC01708205,2063689,64498
CHEMBL3675573,P50281,,OUZMHHWAGJCAFA-PMERELPUSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,,KI,=,696,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,248156,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535033,DTCT0024091,163692,DTCC01708206,1000927,64498
CHEMBL3675574,P50281,,TYSBKRRVVCMKQG-NSOVKSMOSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,,KI,>,10000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,248158,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535033,DTCT0024091,159563,DTCC01708207,1518882,64498
CHEMBL3675575,P50281,,BICNEVCTASLTLM-DQEYMECFSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,248159,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535033,DTCT0024091,166611,DTCC01708208,1161801,64498
CHEMBL3675576,P50281,,CWSSLFKLYYDKBD-CONSDPRKSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,,KI,>,10000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,248160,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535033,DTCT0024091,163252,DTCC01708209,516548,64498
CHEMBL3675577,P50281,,NLIWJNDBQYUCSF-DFBJGRDBSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,,KI,>,5000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,248161,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535033,DTCT0024091,159780,DTCC01708210,321878,64498
CHEMBL3675578,P50281,,KHHNQNYSKXXUCV-NSOVKSMOSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,,KI,>,10000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,248162,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535033,DTCT0024091,177489,DTCC01708211,2063690,64498
CHEMBL3675579,P50281,,KAUWQENTXQTKQG-DQEYMECFSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,248163,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535033,DTCT0024091,176709,DTCC01708212,1771918,64498
CHEMBL3675580,P50281,,IADFBNIHFKDTRS-NSOVKSMOSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,,KI,>,10000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,248164,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535033,DTCT0024091,180260,DTCC01708213,1194375,64498
CHEMBL3675581,P50281,,CXPHOOFGGKZGTC-IRXDYDNUSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,248165,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535033,DTCT0024091,175420,DTCC01708214,212,64498
CHEMBL3675582,P50281,,GIEQMQWMJSYCKB-IRXDYDNUSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,248166,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535033,DTCT0024091,170831,DTCC01708215,1033284,64498
CHEMBL3675583,P50281,,CPYISUHNJGFCRY-OALUTQOASA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,248167,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535033,DTCT0024091,166080,DTCC01708216,1486575,64498
CHEMBL3675584,P50281,,VCJGVCZITQVJET-HOTGVXAUSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,248168,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535033,DTCT0024091,157267,DTCC01708217,1901139,64498
CHEMBL3675585,P50281,,QQGKYSPTORHWNZ-VXKWHMMOSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,248169,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535033,DTCT0024091,157559,DTCC01708218,1804478,64498
CHEMBL3675586,P50281,,UWVBDELWTIGPFO-BBRMVZONSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,248170,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535033,DTCT0024091,181957,DTCC01708219,62372,64498
CHEMBL3675587,P50281,,ZMGHGYMGQVMACZ-OALUTQOASA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,248171,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535033,DTCT0024091,177826,DTCC01708220,1486576,64498
CHEMBL3675588,P50281,,GWHSSPUFNDIEEQ-HOTGVXAUSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,248172,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535033,DTCT0024091,158134,DTCC01708221,677985,64498
CHEMBL3675589,P50281,,CTCTZAXBKWKMKL-OALUTQOASA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,248173,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535033,DTCT0024091,162520,DTCC01708222,904424,64498
CHEMBL3675590,P50281,,PXQPONLRTWLOTH-IJHRGXPZSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,248174,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535033,DTCT0024091,160766,DTCC01708223,1000928,64498
CHEMBL3675591,P50281,,DUPWUQYVKWCUOG-NRFANRHFSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,,KI,=,430,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,248175,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535033,DTCT0024091,166747,DTCC01708224,839553,64498
CHEMBL3675592,P50281,,KEHDBOGRIVHUBV-ROUUACIJSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,248176,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535033,DTCT0024091,174176,DTCC01708225,968372,64498
CHEMBL3675593,P50281,,QFGALMYSDQBVRH-VXKWHMMOSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,248177,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535033,DTCT0024091,168340,DTCC01708226,936273,64498
CHEMBL3675594,P50281,,ZWXRGJMHGHMUMB-SFTDATJTSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,,KI,>,5000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,248178,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535033,DTCT0024091,170610,DTCC01708227,1740101,64498
CHEMBL3675595,P50281,,VLFDPMJDVIHWPI-ROUUACIJSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,,KI,>,10000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,248179,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535033,DTCT0024091,184511,DTCC01708228,645832,64498
CHEMBL3675596,P50281,,KGPPRBTYRFIDAL-GOTSBHOMSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,,KI,>,10000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,248183,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535033,DTCT0024091,167091,DTCC01708229,904425,64498
CHEMBL3675597,P50281,,MUGAWCXYWNGHML-GOTSBHOMSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,248184,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535033,DTCT0024091,163995,DTCC01708230,420085,64498
CHEMBL3675598,P50281,,JMWVTDZGNUFBMO-VXKWHMMOSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,248185,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535033,DTCT0024091,161354,DTCC01708231,1740102,64498
CHEMBL3675599,P50281,,UUDTVMMARAFNKG-VXKWHMMOSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,248186,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535033,DTCT0024091,185082,DTCC01708232,904426,64498
CHEMBL3675600,P50281,,GOLLITFKIKKRMV-DQEYMECFSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,,KI,>,10000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,248187,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535033,DTCT0024091,179701,DTCC01708233,1259489,64498
CHEMBL3675601,P50281,,BLDFRIYOIZRRJI-ZEQRLZLVSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,248188,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535033,DTCT0024091,178320,DTCC01708234,645833,64498
CHEMBL3675602,P50281,,FXBVEEBXIZYGRY-DQEYMECFSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,,KI,>,5000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,248189,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535033,DTCT0024091,172067,DTCC01708235,580782,64498
CHEMBL3675603,P50281,,FKTHQTYGTOEBAW-MHZLTWQESA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,248191,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535033,DTCT0024091,172465,DTCC01708236,159656,64498
CHEMBL3675604,P50281,,KSDQQJBQFBNDIC-ROUUACIJSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,,KI,>,5000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,248192,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535033,DTCT0024091,172221,DTCC01708237,159657,64498
CHEMBL3675605,P50281,,NIAIEBGBRXKPAO-NHTMILBNSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,,KI,=,118,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,248226,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535033,DTCT0024091,179448,DTCC01708238,256074,64498
CHEMBL3675606,P50281,,MMIHYNVQXYWTFM-PKTZIBPZSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,248182,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535033,DTCT0024091,165446,DTCC01708239,1901140,64498
CHEMBL3675607,P50281,,KDDWLGBIYXTPJG-FQEVSTJZSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,248190,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535033,DTCT0024091,157316,DTCC01708240,289344,64498
CHEMBL367722,P50281,,AEBYYXPQFGRZDC-FCHUYYIVSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,11958997,INHIBITION,=,29,%,,,,,,,,,,,,,,Percent remaining enzyme activity (RA) in catalytic domains of the membrane type MT1-MMP (matrix metalloprotease-14),,Oxal hydroxamic acid derivatives with inhibitory activity against matrix metalloproteinases.,Bioorg. Med. Chem. Lett.,2002,12,6,"Krumme D, Tschesche H",,106778,DTCT0024091,1118071,DTCC00371709,681216,5419
CHEMBL367722,P50281,,AEBYYXPQFGRZDC-FCHUYYIVSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,11958997,KI,=,33000,NM,,,,,,,,,,,,,,Inhibition of membrane type MT1-MMP (Matrix metalloprotease-14)catalytic domain,,Oxal hydroxamic acid derivatives with inhibitory activity against matrix metalloproteinases.,Bioorg. Med. Chem. Lett.,2002,12,6,"Krumme D, Tschesche H",,106788,DTCT0024091,1118070,DTCC00371709,681216,5419
CHEMBL367959,P50281,,IHNYAHCZDRILEC-AAEUAGOBSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,11958997,INHIBITION,=,54,%,,,,,,,,,,,,,,Percent remaining enzyme activity (RA) in catalytic domains of the membrane type MT1-MMP (matrix metalloprotease-14),,Oxal hydroxamic acid derivatives with inhibitory activity against matrix metalloproteinases.,Bioorg. Med. Chem. Lett.,2002,12,6,"Krumme D, Tschesche H",,106778,DTCT0024091,1094287,DTCC00373679,1554396,5419
CHEMBL367959,P50281,,IHNYAHCZDRILEC-AAEUAGOBSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,11958997,KI,=,20000,NM,,,,,,,,,,,,,,Inhibition of membrane type MT1-MMP (Matrix metalloprotease-14)catalytic domain,,Oxal hydroxamic acid derivatives with inhibitory activity against matrix metalloproteinases.,Bioorg. Med. Chem. Lett.,2002,12,6,"Krumme D, Tschesche H",,106788,DTCT0024091,1094286,DTCC00373679,1554396,5419
CHEMBL368180,P50281,,ONDDWGCONIGAEF-RARQCXRASA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,11958997,INHIBITION,=,71,%,,,,,,,,,,,,,,Percent remaining enzyme activity (RA) in catalytic domains of the membrane type MT1-MMP (matrix metalloprotease-14),,Oxal hydroxamic acid derivatives with inhibitory activity against matrix metalloproteinases.,Bioorg. Med. Chem. Lett.,2002,12,6,"Krumme D, Tschesche H",,106778,DTCT0024091,1104960,DTCC00371855,520001,5419
CHEMBL368966,P50281,,DBMDIXBZZAINQH-MBSDFSHPSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,11958997,INHIBITION,=,76,%,,,,,,,,,,,,,,Percent remaining enzyme activity (RA) in catalytic domains of the membrane type MT1-MMP (matrix metalloprotease-14),,Oxal hydroxamic acid derivatives with inhibitory activity against matrix metalloproteinases.,Bioorg. Med. Chem. Lett.,2002,12,6,"Krumme D, Tschesche H",,106778,DTCT0024091,1131289,DTCC00371356,1683653,5419
CHEMBL369184,P50281,,LWQVGCDPZDYMHI-BBRMVZONSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,11958997,INHIBITION,=,36,%,,,,,,,,,,,,,,Percent remaining enzyme activity (RA) in catalytic domains of the membrane type MT1-MMP (matrix metalloprotease-14),,Oxal hydroxamic acid derivatives with inhibitory activity against matrix metalloproteinases.,Bioorg. Med. Chem. Lett.,2002,12,6,"Krumme D, Tschesche H",,106778,DTCT0024091,1121063,DTCC00371503,1743528,5419
CHEMBL369184,P50281,,LWQVGCDPZDYMHI-BBRMVZONSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,11958997,KI,=,14000,NM,,,,,,,,,,,,,,Inhibition of membrane type MT1-MMP (Matrix metalloprotease-14)catalytic domain,,Oxal hydroxamic acid derivatives with inhibitory activity against matrix metalloproteinases.,Bioorg. Med. Chem. Lett.,2002,12,6,"Krumme D, Tschesche H",,106788,DTCT0024091,1121062,DTCC00371503,1743528,5419
CHEMBL369317,P50281,,ODABXNMRQKCARG-GOSISDBHSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,15713379,IC50,>,300,NM,,,,,,,,,,,,,,Inhibition of human matrix metalloprotease-14,,N-i-Propoxy-N-biphenylsulfonylaminobutylhydroxamic acids as potent and selective inhibitors of MMP-2 and MT1-MMP.,Bioorg. Med. Chem. Lett.,2005,15,5,"Rossello A, Nuti E, Carelli P, Orlandini E, Macchia M, Nencetti S, Zandomeneghi M, Balzano F, Uccello Barretta G, Albini A, Benelli R, Cercignani G, Murphy G, Balsamo A",,305766,DTCT0024091,1745778,DTCC00381878,6892,18841
CHEMBL369419,P50281,,BNFQSPBDDPIXCF-SECBINFHSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,11958997,INHIBITION,=,54,%,,,,,,,,,,,,,,Percent remaining enzyme activity (RA) in catalytic domains of the membrane type MT1-MMP (matrix metalloprotease-14),,Oxal hydroxamic acid derivatives with inhibitory activity against matrix metalloproteinases.,Bioorg. Med. Chem. Lett.,2002,12,6,"Krumme D, Tschesche H",,106778,DTCT0024091,1107700,DTCC00370757,1069142,5419
CHEMBL369495,P50281,,FWBWWWORJVQVID-YOEHRIQHSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,11958997,INHIBITION,=,53,%,,,,,,,,,,,,,,Percent remaining enzyme activity (RA) in catalytic domains of the membrane type MT1-MMP (matrix metalloprotease-14),,Oxal hydroxamic acid derivatives with inhibitory activity against matrix metalloproteinases.,Bioorg. Med. Chem. Lett.,2002,12,6,"Krumme D, Tschesche H",,106778,DTCT0024091,1104955,DTCC00370781,487803,5419
CHEMBL369505,P50281,,XVVZROOOIUBICS-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,15780611,IC50,=,150,NM,,,,,,,,,,,,,,Inhibitory concentration against matrix metalloprotease 14,,Potent pyrimidinetrione-based inhibitors of MMP-13 with enhanced selectivity over MMP-14.,Bioorg. Med. Chem. Lett.,2005,15,7,"Blagg JA, Noe MC, Wolf-Gouveia LA, Reiter LA, Laird ER, Chang SP, Danley DE, Downs JT, Elliott NC, Eskra JD, Griffiths RJ, Hardink JR, Haugeto AI, Jones CS, Liras JL, Lopresti-Morrow LL, Mitchell PG, Pandit J, Robinson RP, Subramanyam C, Vaughn-Bowser ML, Yocum SA",,305128,DTCT0024091,1753717,DTCC00384574,174496,18917
CHEMBL369524,P50281,,OCENTDLFDAKGHV-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,15780611,IC50,=,23,NM,,,,,,,,,,,,,,Inhibitory concentration against matrix metalloprotease 14,,Potent pyrimidinetrione-based inhibitors of MMP-13 with enhanced selectivity over MMP-14.,Bioorg. Med. Chem. Lett.,2005,15,7,"Blagg JA, Noe MC, Wolf-Gouveia LA, Reiter LA, Laird ER, Chang SP, Danley DE, Downs JT, Elliott NC, Eskra JD, Griffiths RJ, Hardink JR, Haugeto AI, Jones CS, Liras JL, Lopresti-Morrow LL, Mitchell PG, Pandit J, Robinson RP, Subramanyam C, Vaughn-Bowser ML, Yocum SA",,305128,DTCT0024091,1753605,DTCC00384491,1724683,18917
CHEMBL369773,P50281,,UCAWMWVVLBTIHU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,15780611,IC50,=,9300,NM,,,,,,,,,,,,,,Inhibitory concentration against matrix metalloprotease 14,,Potent pyrimidinetrione-based inhibitors of MMP-13 with enhanced selectivity over MMP-14.,Bioorg. Med. Chem. Lett.,2005,15,7,"Blagg JA, Noe MC, Wolf-Gouveia LA, Reiter LA, Laird ER, Chang SP, Danley DE, Downs JT, Elliott NC, Eskra JD, Griffiths RJ, Hardink JR, Haugeto AI, Jones CS, Liras JL, Lopresti-Morrow LL, Mitchell PG, Pandit J, Robinson RP, Subramanyam C, Vaughn-Bowser ML, Yocum SA",,305128,DTCT0024091,1754141,DTCC00384446,1501625,18917
CHEMBL370333,P50281,,HOXYEQZQHOZJQN-NDEPHWFRSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,16153831,IC50,,,,,,,,,,,,,,,,,Inhibitory concentration against MMP-14; - = not available,Not Determined,Synthesis and SAR of highly selective MMP-13 inhibitors.,Bioorg. Med. Chem. Lett.,2005,15,22,"Li J, Rush TS, Li W, DeVincentis D, Du X, Hu Y, Thomason JR, Xiang JS, Skotnicki JS, Tam S, Cunningham KM, Chockalingam PS, Morris EA, Levin JI",,321302,DTCT0024091,1860434,DTCC00407680,370185,19837
CHEMBL370631,P50281,,RPOIZUWTBLHTNU-YTTGMZPUSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,16153831,IC50,,,,,,,,,,,,,,,,,Inhibitory concentration against MMP-14; - = not available,Not Determined,Synthesis and SAR of highly selective MMP-13 inhibitors.,Bioorg. Med. Chem. Lett.,2005,15,22,"Li J, Rush TS, Li W, DeVincentis D, Du X, Hu Y, Thomason JR, Xiang JS, Skotnicki JS, Tam S, Cunningham KM, Chockalingam PS, Morris EA, Levin JI",,321302,DTCT0024091,338872,DTCC00407679,1566231,19837
CHEMBL370662,P50281,(3-BROMOPHENYLAMINO)METHYLENEDIPHOSPHONIC ACID,SYHPXVAOJHTCRU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,24071448,IC50,>,100000,NM,,,,,,,,,,,,,,Inhibition of MMP14 catalytic domain (unknown origin) using Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 as substrate incubated for 30 mins prior to substrate addition measured after 2 to 4 hrs by fluorometric assay,,Arylamino methylene bisphosphonate derivatives as bone seeking matrix metalloproteinase inhibitors.,Bioorg. Med. Chem.,2013,21,21,"Tauro M, Laghezza A, Loiodice F, Agamennone M, Campestre C, Tortorella P",,990167,DTCT0024091,12628979,DTCC00001220,2060610,56259
CHEMBL372405,P50281,,CNVJYZPKUZXAML-MUUNZHRXSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,16275085,IC50,=,3000,NM,,,,,,,,,,,,,,Inhibitory activity against MMP14,,Synthesis and biological evaluation of biphenylsulfonamide carboxylate aggrecanase-1 inhibitors.,Bioorg. Med. Chem. Lett.,2006,16,2,"Xiang JS, Hu Y, Rush TS, Thomason JR, Ipek M, Sum PE, Abrous L, Sabatini JJ, Georgiadis K, Reifenberg E, Majumdar M, Morris EA, Tam S",,327745,DTCT0024091,1878760,DTCC00411555,1490519,19995
CHEMBL373275,P50281,,JJPRJMIBECZYNN-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,16420030,ACTIVITY,,,,,,,,,,,,,,,,,Inhibitory activity against MMP14 upto 50uM,Not Active,Selective inhibition of matrix metalloproteinase isozymes and in vivo protection against emphysema by substituted gamma-keto carboxylic acids.,J. Med. Chem.,2006,49,2,"Ma D, Jiang Y, Chen F, Gong LK, Ding K, Xu Y, Wang R, Ge A, Ren J, Li J, Li J, Ye Q",,330179,DTCT0024091,1886341,DTCC00110065,66437,20234
CHEMBL374377,P50281,,VWKXFDZWHLCIIU-MRXNPFEDSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,17088065,IC50,=,32,NM,,,,,,,,,,,,,,Inhibition of MMP14,,alpha-Biphenylsulfonylamino 2-methylpropyl phosphonates: enantioselective synthesis and selective inhibition of MMPs.,Bioorg. Med. Chem.,2007,15,2,"Biasone A, Tortorella P, Campestre C, Agamennone M, Preziuso S, Chiappini M, Nuti E, Carelli P, Rossello A, Mazza F, Gallina C",,432509,DTCT0024091,2061960,DTCC00447804,1684492,22402
CHEMBL376557,P50281,,BUKCBCDGRPOFJP-MRXNPFEDSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,17088065,IC50,=,47,NM,,,,,,,,,,,,,,Inhibition of MMP14,,alpha-Biphenylsulfonylamino 2-methylpropyl phosphonates: enantioselective synthesis and selective inhibition of MMPs.,Bioorg. Med. Chem.,2007,15,2,"Biasone A, Tortorella P, Campestre C, Agamennone M, Preziuso S, Chiappini M, Nuti E, Carelli P, Rossello A, Mazza F, Gallina C",,432509,DTCT0024091,2061959,DTCC00447810,1005132,22402
CHEMBL3770688,P50281,,,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,26871660,IC50,=,50000,NM,,,,,,,,,,,,,,Inhibition of recombinant human MMP-14 using Mca-Lys-Pro-Leu-Gly-Leu-Dap(Dnp)-Ala-Arg-NH2 as substrate after 3 hrs by fluorometric assay,,Discovery of a new selective inhibitor of A Disintegrin And Metalloprotease 10 (ADAM-10) able to reduce the shedding of NKG2D ligands in Hodgkin's lymphoma cell models.,Eur. J. Med. Chem.,2016,111,,"Camodeca C, Nuti E, Tepshi L, Boero S, Tuccinardi T, Stura EA, Poggi A, Zocchi MR, Rossello A.",,1559051,DTCT0024091,101504,DTCC00079604,62862,66304
CHEMBL3770935,P50281,,,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,26871660,IC50,=,100000,NM,,,,,,,,,,,,,,Inhibition of recombinant human MMP-14 using Mca-Lys-Pro-Leu-Gly-Leu-Dap(Dnp)-Ala-Arg-NH2 as substrate after 3 hrs by fluorometric assay,,Discovery of a new selective inhibitor of A Disintegrin And Metalloprotease 10 (ADAM-10) able to reduce the shedding of NKG2D ligands in Hodgkin's lymphoma cell models.,Eur. J. Med. Chem.,2016,111,,"Camodeca C, Nuti E, Tepshi L, Boero S, Tuccinardi T, Stura EA, Poggi A, Zocchi MR, Rossello A.",,1559051,DTCT0024091,101503,DTCC00079605,678496,66304
CHEMBL377272,P50281,,LIJQQAFTSYEDRO-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,16723229,IC50,=,891,NM,,,,,,,,,,,,,,Inhibition of MMP14,,Design and synthesis of butynyloxyphenyl beta-sulfone piperidine hydroxamates as TACE inhibitors.,Bioorg. Med. Chem. Lett.,2006,16,15,"Park K, Aplasca A, Du MT, Sun L, Zhu Y, Zhang Y, Levin JI",,377989,DTCT0024091,1969702,DTCC00428526,1004972,21111
CHEMBL377317,P50281,,SFHMNFHDIRPFKM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,16723229,IC50,=,553,NM,,,,,,,,,,,,,,Inhibition of MMP14,,Design and synthesis of butynyloxyphenyl beta-sulfone piperidine hydroxamates as TACE inhibitors.,Bioorg. Med. Chem. Lett.,2006,16,15,"Park K, Aplasca A, Du MT, Sun L, Zhu Y, Zhang Y, Levin JI",,377989,DTCT0024091,1969644,DTCC00428531,778474,21111
CHEMBL377317,P50281,,SFHMNFHDIRPFKM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,17064892,IC50,=,583,NM,,,,,,,,,,,,,,Inhibition of MMP14,,Identification of potent and selective TACE inhibitors via the S1 pocket.,Bioorg. Med. Chem. Lett.,2007,17,1,"Condon JS, Joseph-McCarthy D, Levin JI, Lombart HG, Lovering FE, Sun L, Wang W, Xu W, Zhang Y",,440767,DTCT0024091,2154037,DTCC00428531,778734,23077
CHEMBL377862,P50281,,KRGBAILWDVNOCW-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,16723229,IC50,=,1515,NM,,,,,,,,,,,,,,Inhibition of MMP14,,Design and synthesis of butynyloxyphenyl beta-sulfone piperidine hydroxamates as TACE inhibitors.,Bioorg. Med. Chem. Lett.,2006,16,15,"Park K, Aplasca A, Du MT, Sun L, Zhu Y, Zhang Y, Levin JI",,377989,DTCT0024091,1969629,DTCC00428540,649907,21111
CHEMBL379287,P50281,,RBTIHKNARDNLNU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,16723229,IC50,=,1900,NM,,,,,,,,,,,,,,Inhibition of MMP14,,Design and synthesis of butynyloxyphenyl beta-sulfone piperidine hydroxamates as TACE inhibitors.,Bioorg. Med. Chem. Lett.,2006,16,15,"Park K, Aplasca A, Du MT, Sun L, Zhu Y, Zhang Y, Levin JI",,377989,DTCT0024091,1969581,DTCC00428563,617188,21111
CHEMBL379763,P50281,,MXMCYIBSFFNNTF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,16723229,IC50,=,1380,NM,,,,,,,,,,,,,,Inhibition of MMP14,,Design and synthesis of butynyloxyphenyl beta-sulfone piperidine hydroxamates as TACE inhibitors.,Bioorg. Med. Chem. Lett.,2006,16,15,"Park K, Aplasca A, Du MT, Sun L, Zhu Y, Zhang Y, Levin JI",,377989,DTCT0024091,1969596,DTCC00428552,131113,21111
CHEMBL380049,P50281,,NPWNPFHGYNOBOO-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,16723229,IC50,=,963,NM,,,,,,,,,,,,,,Inhibition of MMP14,,Design and synthesis of butynyloxyphenyl beta-sulfone piperidine hydroxamates as TACE inhibitors.,Bioorg. Med. Chem. Lett.,2006,16,15,"Park K, Aplasca A, Du MT, Sun L, Zhu Y, Zhang Y, Levin JI",,377989,DTCT0024091,1969715,DTCC00428568,1393760,21111
CHEMBL382201,P50281,,BZVYQWLRCHLAGK-KRWDZBQOSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,17088065,INHIBITION,=,63,%,,,,,,,,,,,,,,Inhibition of MMP14 at 100 uM,,alpha-Biphenylsulfonylamino 2-methylpropyl phosphonates: enantioselective synthesis and selective inhibition of MMPs.,Bioorg. Med. Chem.,2007,15,2,"Biasone A, Tortorella P, Campestre C, Agamennone M, Preziuso S, Chiappini M, Nuti E, Carelli P, Rossello A, Mazza F, Gallina C",,432515,DTCT0024091,2061734,DTCC00413190,552885,22402
CHEMBL3827073,P50281,,,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,27452283,IC50,=,427,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP14 by colorimetric analysis,,Robust design of some selective matrix metalloproteinase-2 inhibitors over matrix metalloproteinase-9 through in silico/fragment-based lead identification and de novo lead modification: Syntheses and biological assays.,Bioorg. Med. Chem.,2016,24,18,"Adhikari N, Halder AK, Mallick S, Saha A, Saha KD, Jha T.",,1589858,DTCT0024091,317169,DTCC00102284,1869506,67557
CHEMBL3827162,P50281,,,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,27452283,IC50,=,1000,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP14 by colorimetric analysis,,Robust design of some selective matrix metalloproteinase-2 inhibitors over matrix metalloproteinase-9 through in silico/fragment-based lead identification and de novo lead modification: Syntheses and biological assays.,Bioorg. Med. Chem.,2016,24,18,"Adhikari N, Halder AK, Mallick S, Saha A, Saha KD, Jha T.",,1589858,DTCT0024091,317165,DTCC00102280,1422905,67557
CHEMBL3827243,P50281,,,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,27452283,IC50,=,1614,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP14 by colorimetric analysis,,Robust design of some selective matrix metalloproteinase-2 inhibitors over matrix metalloproteinase-9 through in silico/fragment-based lead identification and de novo lead modification: Syntheses and biological assays.,Bioorg. Med. Chem.,2016,24,18,"Adhikari N, Halder AK, Mallick S, Saha A, Saha KD, Jha T.",,1589858,DTCT0024091,317174,DTCC00102294,192238,67557
CHEMBL3827250,P50281,,,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,27452283,IC50,=,4639,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP14 by colorimetric analysis,,Robust design of some selective matrix metalloproteinase-2 inhibitors over matrix metalloproteinase-9 through in silico/fragment-based lead identification and de novo lead modification: Syntheses and biological assays.,Bioorg. Med. Chem.,2016,24,18,"Adhikari N, Halder AK, Mallick S, Saha A, Saha KD, Jha T.",,1589858,DTCT0024091,317163,DTCC00102277,1162527,67557
CHEMBL3827306,P50281,,,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,27452283,IC50,=,7783,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP14 by colorimetric analysis,,Robust design of some selective matrix metalloproteinase-2 inhibitors over matrix metalloproteinase-9 through in silico/fragment-based lead identification and de novo lead modification: Syntheses and biological assays.,Bioorg. Med. Chem.,2016,24,18,"Adhikari N, Halder AK, Mallick S, Saha A, Saha KD, Jha T.",,1589858,DTCT0024091,317162,DTCC00102275,646584,67557
CHEMBL3827453,P50281,,,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,27452283,IC50,=,807,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP14 by colorimetric analysis,,Robust design of some selective matrix metalloproteinase-2 inhibitors over matrix metalloproteinase-9 through in silico/fragment-based lead identification and de novo lead modification: Syntheses and biological assays.,Bioorg. Med. Chem.,2016,24,18,"Adhikari N, Halder AK, Mallick S, Saha A, Saha KD, Jha T.",,1589858,DTCT0024091,317166,DTCC00102281,646585,67557
CHEMBL3827615,P50281,,,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,27452283,IC50,=,2407,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP14 by colorimetric analysis,,Robust design of some selective matrix metalloproteinase-2 inhibitors over matrix metalloproteinase-9 through in silico/fragment-based lead identification and de novo lead modification: Syntheses and biological assays.,Bioorg. Med. Chem.,2016,24,18,"Adhikari N, Halder AK, Mallick S, Saha A, Saha KD, Jha T.",,1589858,DTCT0024091,317167,DTCC00102282,1099203,67557
CHEMBL3827640,P50281,,,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,27452283,IC50,=,8805,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP14 by colorimetric analysis,,Robust design of some selective matrix metalloproteinase-2 inhibitors over matrix metalloproteinase-9 through in silico/fragment-based lead identification and de novo lead modification: Syntheses and biological assays.,Bioorg. Med. Chem.,2016,24,18,"Adhikari N, Halder AK, Mallick S, Saha A, Saha KD, Jha T.",,1589858,DTCT0024091,317164,DTCC00102278,160391,67557
CHEMBL3827680,P50281,,,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,27452283,IC50,=,6311,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP14 by colorimetric analysis,,Robust design of some selective matrix metalloproteinase-2 inhibitors over matrix metalloproteinase-9 through in silico/fragment-based lead identification and de novo lead modification: Syntheses and biological assays.,Bioorg. Med. Chem.,2016,24,18,"Adhikari N, Halder AK, Mallick S, Saha A, Saha KD, Jha T.",,1589858,DTCT0024091,317172,DTCC00102292,1454773,67557
CHEMBL3827735,P50281,,,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,27452283,IC50,=,1389,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP14 by colorimetric analysis,,Robust design of some selective matrix metalloproteinase-2 inhibitors over matrix metalloproteinase-9 through in silico/fragment-based lead identification and de novo lead modification: Syntheses and biological assays.,Bioorg. Med. Chem.,2016,24,18,"Adhikari N, Halder AK, Mallick S, Saha A, Saha KD, Jha T.",,1589858,DTCT0024091,317168,DTCC00102283,1227213,67557
CHEMBL382781,P50281,,WAYKDGBJSUBARX-NCRNUEESSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,15837315,IC50,,,,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-14 in MMPi assay; Not tested,Not Determined,A new development of matrix metalloproteinase inhibitors: twin hydroxamic acids as potent inhibitors of MMPs.,Bioorg. Med. Chem. Lett.,2005,15,9,"Rossello A, Nuti E, Catalani MP, Carelli P, Orlandini E, Rapposelli S, Tuccinardi T, Atkinson SJ, Murphy G, Balsamo A",,306077,DTCT0024091,1841409,DTCC00403447,110078,18987
CHEMBL3828051,P50281,,,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,27452283,IC50,=,6875,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP14 by colorimetric analysis,,Robust design of some selective matrix metalloproteinase-2 inhibitors over matrix metalloproteinase-9 through in silico/fragment-based lead identification and de novo lead modification: Syntheses and biological assays.,Bioorg. Med. Chem.,2016,24,18,"Adhikari N, Halder AK, Mallick S, Saha A, Saha KD, Jha T.",,1589858,DTCT0024091,317170,DTCC00102285,840318,67557
CHEMBL3828226,P50281,,,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,27452283,IC50,=,5424,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP14 by colorimetric analysis,,Robust design of some selective matrix metalloproteinase-2 inhibitors over matrix metalloproteinase-9 through in silico/fragment-based lead identification and de novo lead modification: Syntheses and biological assays.,Bioorg. Med. Chem.,2016,24,18,"Adhikari N, Halder AK, Mallick S, Saha A, Saha KD, Jha T.",,1589858,DTCT0024091,317175,DTCC00102295,1805194,67557
CHEMBL387079,P50281,,XIQNNSMTTLQUTR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,16723229,IC50,=,784,NM,,,,,,,,,,,,,,Inhibition of MMP14,,Design and synthesis of butynyloxyphenyl beta-sulfone piperidine hydroxamates as TACE inhibitors.,Bioorg. Med. Chem. Lett.,2006,16,15,"Park K, Aplasca A, Du MT, Sun L, Zhu Y, Zhang Y, Levin JI",,377989,DTCT0024091,1969728,DTCC00428561,1970456,21111
CHEMBL387079,P50281,,XIQNNSMTTLQUTR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,17064892,IC50,=,784,NM,,,,,,,,,,,,,,Inhibition of MMP14,,Identification of potent and selective TACE inhibitors via the S1 pocket.,Bioorg. Med. Chem. Lett.,2007,17,1,"Condon JS, Joseph-McCarthy D, Levin JI, Lombart HG, Lovering FE, Sun L, Wang W, Xu W, Zhang Y",,440767,DTCT0024091,2154035,DTCC00428561,1970726,23077
CHEMBL388453,P50281,,XALJTPOAALNLJP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,19053764,IC50,=,8950,NM,,,,,,,,,,,,,,Inhibition of MMP14,,Dual inhibitors of matrix metalloproteinases and carbonic anhydrases: iminodiacetyl-based hydroxamate-benzenesulfonamide conjugates.,J. Med. Chem.,2008,51,24,"Marques SM, Nuti E, Rossello A, Supuran CT, Tuccinardi T, Martinelli A, Santos MA",,561990,DTCT0024091,2800847,DTCC00463155,425575,31524
CHEMBL388671,P50281,,YTJNSUHDNZWJPI-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,19053764,IC50,=,33900,NM,,,,,,,,,,,,,,Inhibition of MMP14,,Dual inhibitors of matrix metalloproteinases and carbonic anhydrases: iminodiacetyl-based hydroxamate-benzenesulfonamide conjugates.,J. Med. Chem.,2008,51,24,"Marques SM, Nuti E, Rossello A, Supuran CT, Tuccinardi T, Martinelli A, Santos MA",,561990,DTCT0024091,2800841,DTCC00463156,683291,31524
CHEMBL388879,P50281,,UYVVHTPVCDOQRA-IRXDYDNUSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,17127067,INHIBITION,=,47,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP14 at 100 uM,,Methotrexate gamma-hydroxamate derivatives as potential dual target antitumor drugs.,Bioorg. Med. Chem.,2007,15,3,"Santos MA, Enyedy EA, Nuti E, Rossello A, Krupenko NI, Krupenko SA",,441107,DTCT0024091,2148757,DTCC00460189,2015254,23121
CHEMBL389020,P50281,,NEGPFWDWNNSJRQ-CYBMUJFWSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,17591762,IC50,>,100000,NM,,,,,,,,,,,,,,Inhibition of MMP14,,Potent and selective nonpeptidic inhibitors of procollagen C-proteinase.,J. Med. Chem.,2007,50,15,"Fish PV, Allan GA, Bailey S, Blagg J, Butt R, Collis MG, Greiling D, James K, Kendall J, McElroy A, McCleverty D, Reed C, Webster R, Whitlock GA",,440141,DTCT0024091,2113801,DTCC00452712,195826,23023
CHEMBL389020,P50281,,NEGPFWDWNNSJRQ-CYBMUJFWSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,17591762,INHIBITION,<,50,%,,,,,,,,,,,,,,Inhibition of MMP14 at 10 uM,,Potent and selective nonpeptidic inhibitors of procollagen C-proteinase.,J. Med. Chem.,2007,50,15,"Fish PV, Allan GA, Bailey S, Blagg J, Butt R, Collis MG, Greiling D, James K, Kendall J, McElroy A, McCleverty D, Reed C, Webster R, Whitlock GA",,440147,DTCT0024091,2113829,DTCC00452712,195826,23023
CHEMBL389020,P50281,,NEGPFWDWNNSJRQ-CYBMUJFWSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,17591762,INHIBITION,<,50,%,,,,,,,,,,,,,,Inhibition of MMP14 at 100 uM,,Potent and selective nonpeptidic inhibitors of procollagen C-proteinase.,J. Med. Chem.,2007,50,15,"Fish PV, Allan GA, Bailey S, Blagg J, Butt R, Collis MG, Greiling D, James K, Kendall J, McElroy A, McCleverty D, Reed C, Webster R, Whitlock GA",,440153,DTCT0024091,2113858,DTCC00452712,195826,23023
CHEMBL389020,P50281,,NEGPFWDWNNSJRQ-CYBMUJFWSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,17591762,INHIBITION,<,50,%,,,,,,,,,,,,,,Inhibition of MMP14 at 30 uM,,Potent and selective nonpeptidic inhibitors of procollagen C-proteinase.,J. Med. Chem.,2007,50,15,"Fish PV, Allan GA, Bailey S, Blagg J, Butt R, Collis MG, Greiling D, James K, Kendall J, McElroy A, McCleverty D, Reed C, Webster R, Whitlock GA",,440159,DTCT0024091,2113886,DTCC00452712,195826,23023
CHEMBL389020,P50281,,NEGPFWDWNNSJRQ-CYBMUJFWSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,18790648,KI,>,100000,NM,,,,,,,,,,,,,,Inhibition of MMP14,,Specific targeting of metzincin family members with small-molecule inhibitors: progress toward a multifarious challenge.,Bioorg. Med. Chem.,2008,16,19,"Georgiadis D, Yiotakis A",,497410,DTCT0024091,2457532,DTCC00452712,208200,32556
CHEMBL389898,P50281,,HTKNWYDCBWYORK-HXUWFJFHSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,17088065,IC50,,,,,,,,,,,,,,,,,Inhibition of MMP14,Not Determined,alpha-Biphenylsulfonylamino 2-methylpropyl phosphonates: enantioselective synthesis and selective inhibition of MMPs.,Bioorg. Med. Chem.,2007,15,2,"Biasone A, Tortorella P, Campestre C, Agamennone M, Preziuso S, Chiappini M, Nuti E, Carelli P, Rossello A, Mazza F, Gallina C",,432509,DTCT0024091,2061994,DTCC00447846,1555210,22402
CHEMBL391509,P50281,,FNYMWMSAYUTPPB-IJULCPIYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,17512742,IC50,=,2490,NM,,,,,,,,,,,,,,Inhibition of MMP14,,Simultaneous presence of unsaturation and long alkyl chain at P'1 of Ilomastat confers selectivity for gelatinase A (MMP-2) over gelatinase B (MMP-9) inhibition as shown by molecular modelling studies.,Bioorg. Med. Chem.,2007,15,14,"Moroy G, Denhez C, El Mourabit H, Toribio A, Dassonville A, Decarme M, Renault JH, Mirand C, Bellon G, Sapi J, Alix AJ, Hornebeck W, Bourguet E",,447908,DTCT0024091,2176048,DTCC00468628,909116,23716
CHEMBL394003,P50281,,SVFGAFGHEBEAJE-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,17606376,IC50,,,,,,,,,,,,,,,,,Inhibition of human recombinant MMP14,Not Determined,Structure-based design of TACE selective inhibitors: manipulations in the S1'-S3' pocket.,Bioorg. Med. Chem.,2007,15,18,"Huang A, Joseph-McCarthy D, Lovering F, Sun L, Wang W, Xu W, Zhu Y, Cui J, Zhang Y, Levin JI",,448561,DTCT0024091,2180852,DTCC00470414,228329,23780
CHEMBL396294,P50281,FOLATE GAMMA-HYDROXAMIC ACID,TZBJIYPNYFAUQG-LBPRGKRZSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,17127067,INHIBITION,=,42,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP14 at 100 uM,,Methotrexate gamma-hydroxamate derivatives as potential dual target antitumor drugs.,Bioorg. Med. Chem.,2007,15,3,"Santos MA, Enyedy EA, Nuti E, Rossello A, Krupenko NI, Krupenko SA",,441107,DTCT0024091,2148743,DTCC00003030,143060,23121
CHEMBL396296,P50281,METHOTREXATE GAMMA-L-PHENYLALANINEHYDROXAMIC ACID,QHQOEZXEZMHMER-SFTDATJTSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,17127067,IC50,=,70000,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP14,,Methotrexate gamma-hydroxamate derivatives as potential dual target antitumor drugs.,Bioorg. Med. Chem.,2007,15,3,"Santos MA, Enyedy EA, Nuti E, Rossello A, Krupenko NI, Krupenko SA",,441091,DTCT0024091,2143990,DTCC00003033,952076,23121
CHEMBL396296,P50281,METHOTREXATE GAMMA-L-PHENYLALANINEHYDROXAMIC ACID,QHQOEZXEZMHMER-SFTDATJTSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,17127067,RATIO IC50,=,3043,,,,,,,,,,,,,,,Ratio of IC50 of drug to CGS 27023A for human recombinant MMP14,,Methotrexate gamma-hydroxamate derivatives as potential dual target antitumor drugs.,Bioorg. Med. Chem.,2007,15,3,"Santos MA, Enyedy EA, Nuti E, Rossello A, Krupenko NI, Krupenko SA",,441103,DTCT0024091,2144033,DTCC00003033,952076,23121
CHEMBL398271,P50281,,RHOVUJYSXPHHFW-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,17275314,KI,=,25.7,NM,,,,,,,,,,,,,,Inhibition of MMP14,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458934,DTCT0024091,2258287,DTCC00486977,164158,24803
CHEMBL398641,P50281,,XMVZJCLXRBLZHB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,18029177,IC50,=,1710,NM,,,,,,,,,,,,,,Inhibition of MMP14,,A novel series of highly selective inhibitors of MMP-3.,Bioorg. Med. Chem. Lett.,2007,17,24,"Whitlock GA, Dack KN, Dickinson RP, Lewis ML",,459996,DTCT0024091,2266899,DTCC00486121,1523447,24951
CHEMBL399096,P50281,,AGMWQNDXCWDRDZ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,17531482,IC50,=,3410,NM,,,,,,,,,,,,,,Inhibition of MMP14,,"Design and synthesis of 3,3-piperidine hydroxamate analogs as selective TACE inhibitors.",Bioorg. Med. Chem. Lett.,2007,17,15,"Lombart HG, Feyfant E, Joseph-McCarthy D, Huang A, Lovering F, Sun L, Zhu Y, Zeng C, Zhang Y, Levin J",,456211,DTCT0024091,2237296,DTCC00480950,876605,24495
CHEMBL399096,P50281,,AGMWQNDXCWDRDZ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,18790648,IC50,=,3410,NM,,,,,,,,,,,,,,Inhibition of MMP14,,Specific targeting of metzincin family members with small-molecule inhibitors: progress toward a multifarious challenge.,Bioorg. Med. Chem.,2008,16,19,"Georgiadis D, Yiotakis A",,497410,DTCT0024091,2456484,DTCC00480950,888688,32556
CHEMBL399097,P50281,,JQJWNYAMOJOHCE-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,17531482,IC50,=,5650,NM,,,,,,,,,,,,,,Inhibition of MMP14,,"Design and synthesis of 3,3-piperidine hydroxamate analogs as selective TACE inhibitors.",Bioorg. Med. Chem. Lett.,2007,17,15,"Lombart HG, Feyfant E, Joseph-McCarthy D, Huang A, Lovering F, Sun L, Zhu Y, Zeng C, Zhang Y, Levin J",,456211,DTCT0024091,2237292,DTCC00480954,844149,24495
CHEMBL399400,P50281,,HPBWNXRDTAWPAP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,17606376,IC50,,,,,,,,,,,,,,,,,Inhibition of human recombinant MMP14,Not Determined,Structure-based design of TACE selective inhibitors: manipulations in the S1'-S3' pocket.,Bioorg. Med. Chem.,2007,15,18,"Huang A, Joseph-McCarthy D, Lovering F, Sun L, Wang W, Xu W, Zhu Y, Cui J, Zhang Y, Levin JI",,448561,DTCT0024091,2180856,DTCC00470405,876483,23780
CHEMBL399401,P50281,,HGILVKJBXAXGDH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,17606376,IC50,=,3619,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP14,,Structure-based design of TACE selective inhibitors: manipulations in the S1'-S3' pocket.,Bioorg. Med. Chem.,2007,15,18,"Huang A, Joseph-McCarthy D, Lovering F, Sun L, Wang W, Xu W, Zhu Y, Cui J, Zhang Y, Levin JI",,448561,DTCT0024091,2180848,DTCC00470409,2003456,23780
CHEMBL400346,P50281,,PSPSPXCEGQBCDY-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,17275314,KI,=,2041.74,NM,,,,,,,,,,,,,,Inhibition of MMP14,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458934,DTCT0024091,2258293,DTCC00486971,1620398,24803
CHEMBL400430,P50281,,CBEZXYHTYKUDTE-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,17606376,IC50,=,7047,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP14,,Structure-based design of TACE selective inhibitors: manipulations in the S1'-S3' pocket.,Bioorg. Med. Chem.,2007,15,18,"Huang A, Joseph-McCarthy D, Lovering F, Sun L, Wang W, Xu W, Zhu Y, Cui J, Zhang Y, Levin JI",,448561,DTCT0024091,2180846,DTCC00470411,424535,23780
CHEMBL401445,P50281,,RTWRPNRMLWESPM-VLBBBODESA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,17512742,IC50,=,53100,NM,,,,,,,,,,,,,,Inhibition of MMP14,,Simultaneous presence of unsaturation and long alkyl chain at P'1 of Ilomastat confers selectivity for gelatinase A (MMP-2) over gelatinase B (MMP-9) inhibition as shown by molecular modelling studies.,Bioorg. Med. Chem.,2007,15,14,"Moroy G, Denhez C, El Mourabit H, Toribio A, Dassonville A, Decarme M, Renault JH, Mirand C, Bellon G, Sapi J, Alix AJ, Hornebeck W, Bourguet E",,447908,DTCT0024091,2176050,DTCC00468604,1808775,23716
CHEMBL402393,P50281,,SXDMGWZDRWQMPS-DLBZAZTESA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,18282708,KI,>,5290,NM,,,,,,,,,,,,,,Inhibition of MMP14,,"Potent, selective, orally bioavailable inhibitors of tumor necrosis factor-alpha converting enzyme (TACE): discovery of indole, benzofuran, imidazopyridine and pyrazolopyridine P1' substituents.",Bioorg. Med. Chem. Lett.,2008,18,6,"Lu Z, Ott GR, Anand R, Liu RQ, Covington MB, Vaddi K, Qian M, Newton RC, Christ DD, Trzaskos J, Duan JJ",,463869,DTCT0024091,2317290,DTCC00499750,957099,25272
CHEMBL402393,P50281,,SXDMGWZDRWQMPS-DLBZAZTESA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,18790648,KI,>,5290,NM,,,,,,,,,,,,,,Inhibition of MMP14,,Specific targeting of metzincin family members with small-molecule inhibitors: progress toward a multifarious challenge.,Bioorg. Med. Chem.,2008,16,19,"Georgiadis D, Yiotakis A",,497410,DTCT0024091,2456524,DTCC00499750,952985,32556
CHEMBL402436,P50281,,SDNMPMDMJTYOAW-AZUAARDMSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,18242982,KI,>,5290,NM,,,,,,,,,,,,,,Inhibition of MMP14,,"Potent, exceptionally selective, orally bioavailable inhibitors of TNF-alpha Converting Enzyme (TACE): novel 2-substituted-1H-benzo[d]imidazol-1-yl)methyl)benzamide P1' substituents.",Bioorg. Med. Chem. Lett.,2008,18,5,"Ott GR, Asakawa N, Lu Z, Anand R, Liu RQ, Covington MB, Vaddi K, Qian M, Newton RC, Christ DD, Trzaskos JM, Duan JJ",,462371,DTCT0024091,2282337,DTCC00488433,1873486,25163
CHEMBL403186,P50281,,WMWPLQAXVKBJIC-PZJWPPBQSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,18242982,KI,>,5290,NM,,,,,,,,,,,,,,Inhibition of MMP14,,"Potent, exceptionally selective, orally bioavailable inhibitors of TNF-alpha Converting Enzyme (TACE): novel 2-substituted-1H-benzo[d]imidazol-1-yl)methyl)benzamide P1' substituents.",Bioorg. Med. Chem. Lett.,2008,18,5,"Ott GR, Asakawa N, Lu Z, Anand R, Liu RQ, Covington MB, Vaddi K, Qian M, Newton RC, Christ DD, Trzaskos JM, Duan JJ",,462371,DTCT0024091,2282346,DTCC00488436,260773,25163
CHEMBL403647,P50281,,DJWRDXQAJNPSNU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,17275314,IC50,=,512.86,NM,,,,,,,,,,,,,,Inhibition of MMP14,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458934,DTCT0024091,2258800,DTCC00487220,196126,24803
CHEMBL403648,P50281,,RFQHKNUEBCERKP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,17275314,IC50,=,19.05,NM,,,,,,,,,,,,,,Inhibition of MMP14,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458934,DTCT0024091,2258796,DTCC00487224,1523437,24803
CHEMBL403649,P50281,,XXXIDXMAUYIGBL-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,17275314,IC50,=,36.31,NM,,,,,,,,,,,,,,Inhibition of MMP14,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458934,DTCT0024091,2258793,DTCC00487227,326649,24803
CHEMBL404715,P50281,,WBCJYTQOPPAPOU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,17275314,IC50,=,616.6,NM,,,,,,,,,,,,,,Inhibition of MMP14,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458934,DTCT0024091,2258789,DTCC00487231,972941,24803
CHEMBL404716,P50281,,HSGCFPOJGWGLFI-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,17275314,IC50,=,9332.54,NM,,,,,,,,,,,,,,Inhibition of MMP14,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458934,DTCT0024091,2258787,DTCC00487233,1296593,24803
CHEMBL405651,P50281,,WUXSSALNWBMRKU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,10411481,KI,=,63,NM,,,,,,,,,,,,,,Binding affinity against matrix metalloprotease-14 MTI-MMP.,,Phosphinic pseudo-tripeptides as potent inhibitors of matrix metalloproteinases: a structure-activity study.,J. Med. Chem.,1999,42,14,"Vassiliou S, Mucha A, Cuniasse P, Georgiadis D, Lucet-Levannier K, Beau F, Kannan R, Murphy G, Knäuper V, Rio MC, Basset P, Yiotakis A, Dive V",,106782,DTCT0024091,1072669,DTCC00106276,291445,15258
CHEMBL407540,P50281,,AMUGNOPZMAZKFD-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,10411481,KI,=,270,NM,,,,,,,,,,,,,,Binding affinity against matrix metalloprotease-14 MTI-MMP.,,Phosphinic pseudo-tripeptides as potent inhibitors of matrix metalloproteinases: a structure-activity study.,J. Med. Chem.,1999,42,14,"Vassiliou S, Mucha A, Cuniasse P, Georgiadis D, Lucet-Levannier K, Beau F, Kannan R, Murphy G, Knäuper V, Rio MC, Basset P, Yiotakis A, Dive V",,106782,DTCT0024091,1056152,DTCC00249365,356662,15258
CHEMBL408720,P50281,,IXVZBDKTAIRGPK-VWLOTQADSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,16005220,IC50,=,6600,NM,,,,,,,,,,,,,,Inhibitory concentration against MMP-14,,Identification of potent and selective MMP-13 inhibitors.,Bioorg. Med. Chem. Lett.,2005,15,18,"Wu J, Rush TS, Hotchandani R, Du X, Geck M, Collins E, Xu ZB, Skotnicki J, Levin JI, Lovering FE",,304646,DTCT0024091,1796045,DTCC00393966,33080,8231
CHEMBL409536,P50281,,PLBINCOCFGQAJM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,17623656,IC50,>,100000,NM,,,,,,,,,,,,,,Inhibition of MMP14 catalytic domain,,Discovery and characterization of a novel inhibitor of matrix metalloprotease-13 that reduces cartilage damage in vivo without joint fibroplasia side effects.,J. Biol. Chem.,2007,282,38,"Johnson AR, Pavlovsky AG, Ortwine DF, Prior F, Man CF, Bornemeier DA, Banotai CA, Mueller WT, McConnell P, Yan C, Baragi V, Lesch C, Roark WH, Wilson M, Datta K, Guzman R, Han HK, Dyer RD",,507877,DTCT0024091,2388613,DTCC00503784,1950627,29282
CHEMBL409536,P50281,,PLBINCOCFGQAJM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,18251495,IC50,>,100000,NM,,,,,,,,,,,,,,Inhibition of MMP14 catalytic domain,,"Quinazolinones and pyrido[3,4-d]pyrimidin-4-ones as orally active and specific matrix metalloproteinase-13 inhibitors for the treatment of osteoarthritis.",J. Med. Chem.,2008,51,4,"Li JJ, Nahra J, Johnson AR, Bunker A, O'Brien P, Yue WS, Ortwine DF, Man CF, Baragi V, Kilgore K, Dyer RD, Han HK",,465552,DTCT0024091,2311311,DTCC00503784,1954666,25409
CHEMBL409536,P50281,,PLBINCOCFGQAJM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,18790648,ACTIVITY,,,,,,,,,,,,,,,,,Inhibition of MMP14 up to 100 uM,Not Active,Specific targeting of metzincin family members with small-molecule inhibitors: progress toward a multifarious challenge.,Bioorg. Med. Chem.,2008,16,19,"Georgiadis D, Yiotakis A",,497433,DTCT0024091,2457336,DTCC00503784,1950505,32556
CHEMBL409536,P50281,,PLBINCOCFGQAJM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,25265401,IC50,>,30000,NM,,,,,,,,,,,,,,Inhibition of MMP14 (unknown origin),,"Targeting matrix metalloproteinases: exploring the dynamics of the s1' pocket in the design of selective, small molecule inhibitors.",J. Med. Chem.,2014,57,24,"Fabre B, Ramos A, de Pascual-Teresa B",,1433224,DTCT0024091,13993828,DTCC00503784,1943413,60040
CHEMBL418442,P50281,,INVXSBCIDABVMG-INIZCTEOSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,17088065,IC50,,,,,,,,,,,,,,,,,Inhibition of MMP14,Not Determined,alpha-Biphenylsulfonylamino 2-methylpropyl phosphonates: enantioselective synthesis and selective inhibition of MMPs.,Bioorg. Med. Chem.,2007,15,2,"Biasone A, Tortorella P, Campestre C, Agamennone M, Preziuso S, Chiappini M, Nuti E, Carelli P, Rossello A, Mazza F, Gallina C",,432509,DTCT0024091,2061976,DTCC00186442,1037472,22402
CHEMBL419750,P50281,,VTRJTXRAOIMSTL-ZDUSSCGKSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,11563922,KI,=,590,NM,,,,,,,,,,,,,,In vitro inhibitory activity against the catalytic domain of human matrix metalloprotease-14,,"Structure-based design and synthesis of potent matrix metalloproteinase inhibitors derived from a 6H-1,3,4-thiadiazine scaffold.",J. Med. Chem.,2001,44,20,"Schröder J, Henke A, Wenzel H, Brandstetter H, Stammler HG, Stammler A, Pfeiffer WD, Tschesche H",,106783,DTCT0024091,1719490,DTCC00282282,258562,16424
CHEMBL422250,P50281,,IIABJCHWKFZJBK-ZDUSSCGKSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,11563922,KI,=,240,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-14,,"Structure-based design and synthesis of potent matrix metalloproteinase inhibitors derived from a 6H-1,3,4-thiadiazine scaffold.",J. Med. Chem.,2001,44,20,"Schröder J, Henke A, Wenzel H, Brandstetter H, Stammler HG, Stammler A, Pfeiffer WD, Tschesche H",,106786,DTCT0024091,1708546,DTCC00281784,389664,16424
CHEMBL422250,P50281,,IIABJCHWKFZJBK-ZDUSSCGKSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,11563922,KI,=,400,NM,,,,,,,,,,,,,,In vitro inhibitory activity against the ectodomain of the human matrix metalloprotease-14,,"Structure-based design and synthesis of potent matrix metalloproteinase inhibitors derived from a 6H-1,3,4-thiadiazine scaffold.",J. Med. Chem.,2001,44,20,"Schröder J, Henke A, Wenzel H, Brandstetter H, Stammler HG, Stammler A, Pfeiffer WD, Tschesche H",,106784,DTCT0024091,1708547,DTCC00281784,389664,16424
CHEMBL422251,P50281,,JOKZNFFZUNYVMR-GOSISDBHSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,11563922,KI,=,330,NM,,,,,,,,,,,,,,In vitro inhibitory activity against the ectodomain of the human matrix metalloprotease-14,,"Structure-based design and synthesis of potent matrix metalloproteinase inhibitors derived from a 6H-1,3,4-thiadiazine scaffold.",J. Med. Chem.,2001,44,20,"Schröder J, Henke A, Wenzel H, Brandstetter H, Stammler HG, Stammler A, Pfeiffer WD, Tschesche H",,106784,DTCT0024091,1719507,DTCC00282610,906992,16424
CHEMBL422251,P50281,,JOKZNFFZUNYVMR-GOSISDBHSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,11563922,KI,=,590,NM,,,,,,,,,,,,,,In vitro inhibitory activity against the catalytic domain of human matrix metalloprotease-14,,"Structure-based design and synthesis of potent matrix metalloproteinase inhibitors derived from a 6H-1,3,4-thiadiazine scaffold.",J. Med. Chem.,2001,44,20,"Schröder J, Henke A, Wenzel H, Brandstetter H, Stammler HG, Stammler A, Pfeiffer WD, Tschesche H",,106783,DTCT0024091,1719506,DTCC00282610,906992,16424
CHEMBL424130,P50281,,QMIAXILIKVOPKK-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,14684295,IC50,=,4613,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-14 (MMP-14),,Tetrahydroisoquinoline based sulfonamide hydroxamates as potent matrix metalloproteinase inhibitors.,Bioorg. Med. Chem. Lett.,2004,14,1,"Ma D, Wu W, Yang G, Li J, Li J, Ye Q",,106791,DTCT0024091,878647,DTCC00334179,109304,6330
CHEMBL425020,P50281,,PYNQNWZHEDOQHX-VWLOTQADSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,16153831,IC50,=,15000,NM,,,,,,,,,,,,,,Inhibitory concentration against MMP-14,,Synthesis and SAR of highly selective MMP-13 inhibitors.,Bioorg. Med. Chem. Lett.,2005,15,22,"Li J, Rush TS, Li W, DeVincentis D, Du X, Hu Y, Thomason JR, Xiang JS, Skotnicki JS, Tam S, Cunningham KM, Chockalingam PS, Morris EA, Levin JI",,321195,DTCT0024091,1860375,DTCC00407673,1177224,19837
CHEMBL425020,P50281,,PYNQNWZHEDOQHX-VWLOTQADSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,17275314,IC50,=,15135.61,NM,,,,,,,,,,,,,,Inhibition of MMP14,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458934,DTCT0024091,2258809,DTCC00407673,1166451,24803
CHEMBL425525,P50281,,RODBIJLXINIENS-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,15780611,IC50,=,150,NM,,,,,,,,,,,,,,Inhibitory concentration against matrix metalloprotease 14,,Potent pyrimidinetrione-based inhibitors of MMP-13 with enhanced selectivity over MMP-14.,Bioorg. Med. Chem. Lett.,2005,15,7,"Blagg JA, Noe MC, Wolf-Gouveia LA, Reiter LA, Laird ER, Chang SP, Danley DE, Downs JT, Elliott NC, Eskra JD, Griffiths RJ, Hardink JR, Haugeto AI, Jones CS, Liras JL, Lopresti-Morrow LL, Mitchell PG, Pandit J, Robinson RP, Subramanyam C, Vaughn-Bowser ML, Yocum SA",,305128,DTCT0024091,1754263,DTCC00384575,1081004,18917
CHEMBL425783,P50281,,KSOLTKWEALJMDR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,16723229,IC50,=,2740,NM,,,,,,,,,,,,,,Inhibition of MMP14,,Design and synthesis of butynyloxyphenyl beta-sulfone piperidine hydroxamates as TACE inhibitors.,Bioorg. Med. Chem. Lett.,2006,16,15,"Park K, Aplasca A, Du MT, Sun L, Zhu Y, Zhang Y, Levin JI",,377989,DTCT0024091,1969676,DTCC00428619,1296018,21111
CHEMBL426581,P50281,,UHYUCCHEBUTXHO-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,11958997,INHIBITION,=,48,%,,,,,,,,,,,,,,Percent remaining enzyme activity (RA) in catalytic domains of the membrane type MT1-MMP (matrix metalloprotease-14),,Oxal hydroxamic acid derivatives with inhibitory activity against matrix metalloproteinases.,Bioorg. Med. Chem. Lett.,2002,12,6,"Krumme D, Tschesche H",,106778,DTCT0024091,1118074,DTCC00370748,325445,5419
CHEMBL427138,P50281,,YTQZUTBYXGOMDQ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,15780611,IC50,=,1400,NM,,,,,,,,,,,,,,Inhibitory concentration against matrix metalloprotease 14,,Potent pyrimidinetrione-based inhibitors of MMP-13 with enhanced selectivity over MMP-14.,Bioorg. Med. Chem. Lett.,2005,15,7,"Blagg JA, Noe MC, Wolf-Gouveia LA, Reiter LA, Laird ER, Chang SP, Danley DE, Downs JT, Elliott NC, Eskra JD, Griffiths RJ, Hardink JR, Haugeto AI, Jones CS, Liras JL, Lopresti-Morrow LL, Mitchell PG, Pandit J, Robinson RP, Subramanyam C, Vaughn-Bowser ML, Yocum SA",,305128,DTCT0024091,1752655,DTCC00384453,271738,18917
CHEMBL427366,P50281,,USIMDPVZFWUXPH-VWLOTQADSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,16153831,IC50,=,15800,NM,,,,,,,,,,,,,,Inhibitory concentration against MMP-14,,Synthesis and SAR of highly selective MMP-13 inhibitors.,Bioorg. Med. Chem. Lett.,2005,15,22,"Li J, Rush TS, Li W, DeVincentis D, Du X, Hu Y, Thomason JR, Xiang JS, Skotnicki JS, Tam S, Cunningham KM, Chockalingam PS, Morris EA, Levin JI",,321195,DTCT0024091,1860419,DTCC00407677,1113845,19837
CHEMBL427366,P50281,,USIMDPVZFWUXPH-VWLOTQADSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,17275314,IC50,=,15848.93,NM,,,,,,,,,,,,,,Inhibition of MMP14,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458934,DTCT0024091,2258807,DTCC00407677,1103042,24803
CHEMBL428233,P50281,,JUQBJPICEZJIRQ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,17275314,KI,=,549.54,NM,,,,,,,,,,,,,,Inhibition of MMP14,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458934,DTCT0024091,2258294,DTCC00486976,1231162,24803
CHEMBL43147,P50281,,BGKNBDGHNBOSGD-INIZCTEOSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,23453072,INHIBITION,,,,,,,,,,,,,,,,,Inhibition of MMP14 (unknown origin),Not Determined,"Design, synthesis and SAR investigation of thienosultam derivatives as ADAMTS-5 (aggrecanase-2) inhibitors.",Bioorg. Med. Chem. Lett.,2013,23,7,"Atobe M, Maekawara N, Kawanishi M, Suzuki H, Tanaka E, Miyoshi S",,953884,DTCT0024091,11856706,DTCC00186340,783143,54223
CHEMBL43152,P50281,PD-166793,GJOCABIDMCKCEG-INIZCTEOSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,23287054,IC50,=,240,NM,,,,,,,,,,,,,,Inhibition of MMP14 (unknown origin),,Sulphonamides: Deserving class as MMP inhibitors?,Eur. J. Med. Chem.,2013,60,,"Jain P, Saravanan C, Singh SK",,944581,DTCT0024091,11835665,DTCC01739899,2028335,53820
CHEMBL431680,P50281,,DQLDJYJWPVFOFC-REUBFRLUSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,11585440,KI,>,2000,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-14,,"Discovery of macrocyclic hydroxamic acids containing biphenylmethyl derivatives at P1', a series of selective TNF-alpha converting enzyme inhibitors with potent cellular activity in the inhibition of TNF-alpha release.",J. Med. Chem.,2001,44,21,"Xue CB, He X, Corbett RL, Roderick J, Wasserman ZR, Liu RQ, Jaffee BD, Covington MB, Qian M, Trzaskos JM, Newton RC, Magolda RL, Wexler RR, Decicco CP",,106787,DTCT0024091,1294918,DTCC00286954,336147,16439
CHEMBL432770,P50281,,QUIDRRLYQSJQMX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,10411481,KI,=,271,NM,,,,,,,,,,,,,,Binding affinity against matrix metalloprotease-14 MTI-MMP.,,Phosphinic pseudo-tripeptides as potent inhibitors of matrix metalloproteinases: a structure-activity study.,J. Med. Chem.,1999,42,14,"Vassiliou S, Mucha A, Cuniasse P, Georgiadis D, Lucet-Levannier K, Beau F, Kannan R, Murphy G, Knäuper V, Rio MC, Basset P, Yiotakis A, Dive V",,106782,DTCT0024091,1056167,DTCC00249346,161690,15258
CHEMBL432842,P50281,,YPHZFHQBHSELGO-QUCCMNQESA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,9548812,IC50,=,8.5,NM,,,,,,,,,,,,,,Activity against deletion mutant of MT1-MMP lacking the transmembrane domain (deltaMT1),,Inhibition of membrane-type 1 matrix metalloproteinase by hydroxamate inhibitors: an examination of the subsite pocket.,J. Med. Chem.,1998,41,8,"Yamamoto M, Tsujishita H, Hori N, Ohishi Y, Inoue S, Ikeda S, Okada Y",,217867,DTCT0024091,980288,DTCC00151632,1725664,15116
CHEMBL433426,P50281,,GJLVFYXHGPXLCC-QUCCMNQESA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,9548812,IC50,=,17.6,NM,,,,,,,,,,,,,,Activity against deletion mutant of MT1-MMP lacking the transmembrane domain (deltaMT1),,Inhibition of membrane-type 1 matrix metalloproteinase by hydroxamate inhibitors: an examination of the subsite pocket.,J. Med. Chem.,1998,41,8,"Yamamoto M, Tsujishita H, Hori N, Ohishi Y, Inoue S, Ikeda S, Okada Y",,217867,DTCT0024091,998138,DTCC00151649,1081960,15116
CHEMBL433567,P50281,,OFXJMYWLEABUGO-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,15780611,IC50,=,200,NM,,,,,,,,,,,,,,Inhibitory concentration against matrix metalloprotease 14,,Potent pyrimidinetrione-based inhibitors of MMP-13 with enhanced selectivity over MMP-14.,Bioorg. Med. Chem. Lett.,2005,15,7,"Blagg JA, Noe MC, Wolf-Gouveia LA, Reiter LA, Laird ER, Chang SP, Danley DE, Downs JT, Elliott NC, Eskra JD, Griffiths RJ, Hardink JR, Haugeto AI, Jones CS, Liras JL, Lopresti-Morrow LL, Mitchell PG, Pandit J, Robinson RP, Subramanyam C, Vaughn-Bowser ML, Yocum SA",,305128,DTCT0024091,1753731,DTCC00384548,2078781,18917
CHEMBL433816,P50281,,DYKLASPWVUKEIT-QYZOEREBSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,9548812,IC50,=,72,NM,,,,,,,,,,,,,,Activity against deletion mutant of MT1-MMP lacking the transmembrane domain (deltaMT1),,Inhibition of membrane-type 1 matrix metalloproteinase by hydroxamate inhibitors: an examination of the subsite pocket.,J. Med. Chem.,1998,41,8,"Yamamoto M, Tsujishita H, Hori N, Ohishi Y, Inoue S, Ikeda S, Okada Y",,217867,DTCT0024091,990673,DTCC00151405,1725663,15116
CHEMBL434567,P50281,,CKZHFOKQZRZCPF-ROUUACIJSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,18790648,IC50,=,772,NM,,,,,,,,,,,,,,Inhibition of MMP14,,Specific targeting of metzincin family members with small-molecule inhibitors: progress toward a multifarious challenge.,Bioorg. Med. Chem.,2008,16,19,"Georgiadis D, Yiotakis A",,497410,DTCT0024091,2457495,DTCC00438928,36639,32556
CHEMBL434567,P50281,,CKZHFOKQZRZCPF-ROUUACIJSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,26192023,IC50,=,772,NM,,,,,,,,,,,,,,Inhibition of human MT1-MMP,,SAR Studies of Exosite-Binding Substrate-Selective Inhibitors of A Disintegrin And Metalloprotease 17 (ADAM17) and Application as Selective in Vitro Probes.,J. Med. Chem.,2015,58,15,"Knapinska AM, Dreymuller D, Ludwig A, Smith L, Golubkov V, Sohail A, Fridman R, Giulianotti M, LaVoi TM, Houghten RA, Fields GB, Minond D",,1505549,DTCT0024091,14476053,DTCC00438928,26337,63066
CHEMBL435713,P50281,,YEIKCNCZZRBAHT-UGSOOPFHSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,11958997,INHIBITION,=,36,%,,,,,,,,,,,,,,Percent remaining enzyme activity (RA) in catalytic domains of the membrane type MT1-MMP (matrix metalloprotease-14),,Oxal hydroxamic acid derivatives with inhibitory activity against matrix metalloproteinases.,Bioorg. Med. Chem. Lett.,2002,12,6,"Krumme D, Tschesche H",,106778,DTCT0024091,1132635,DTCC00373308,1328008,5419
CHEMBL437793,P50281,,LHXZQNIPVKWAQS-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,17275314,IC50,=,60.26,NM,,,,,,,,,,,,,,Inhibition of MMP14,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458934,DTCT0024091,2258804,DTCC00487216,1744660,24803
CHEMBL438692,P50281,,UYHGJXBEWRNPQI-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,17275314,KI,=,269.15,NM,,,,,,,,,,,,,,Inhibition of MMP14,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458934,DTCT0024091,2258296,DTCC00486972,585407,24803
CHEMBL438810,P50281,"1,3,2'-TRIGUANIDINONEAMINE",ZPDRGOJGQGWHOF-HKEUSBCWSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,16870442,KI,>,300000,NM,,,,,,,,,,,,,,Activity at MMP14,,Selectively guanidinylated derivatives of neamine. Syntheses and inhibition of anthrax lethal factor protease.,Bioorg. Med. Chem. Lett.,2006,16,19,"Jiao GS, Simo O, Nagata M, O'Malley S, Hemscheidt T, Cregar L, Millis SZ, Goldman ME, Tang C",,393602,DTCT0024091,1981421,DTCC00001996,1048918,21299
CHEMBL439012,P50281,,JBPHFUSOSQRLMX-MRXNPFEDSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,17591762,IC50,>,100000,NM,,,,,,,,,,,,,,Inhibition of MMP14,,Potent and selective nonpeptidic inhibitors of procollagen C-proteinase.,J. Med. Chem.,2007,50,15,"Fish PV, Allan GA, Bailey S, Blagg J, Butt R, Collis MG, Greiling D, James K, Kendall J, McElroy A, McCleverty D, Reed C, Webster R, Whitlock GA",,440141,DTCT0024091,2113800,DTCC00452723,1715977,23023
CHEMBL439012,P50281,,JBPHFUSOSQRLMX-MRXNPFEDSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,17591762,INHIBITION,<,50,%,,,,,,,,,,,,,,Inhibition of MMP14 at 10 uM,,Potent and selective nonpeptidic inhibitors of procollagen C-proteinase.,J. Med. Chem.,2007,50,15,"Fish PV, Allan GA, Bailey S, Blagg J, Butt R, Collis MG, Greiling D, James K, Kendall J, McElroy A, McCleverty D, Reed C, Webster R, Whitlock GA",,440147,DTCT0024091,2113828,DTCC00452723,1715977,23023
CHEMBL439012,P50281,,JBPHFUSOSQRLMX-MRXNPFEDSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,17591762,INHIBITION,<,50,%,,,,,,,,,,,,,,Inhibition of MMP14 at 100 uM,,Potent and selective nonpeptidic inhibitors of procollagen C-proteinase.,J. Med. Chem.,2007,50,15,"Fish PV, Allan GA, Bailey S, Blagg J, Butt R, Collis MG, Greiling D, James K, Kendall J, McElroy A, McCleverty D, Reed C, Webster R, Whitlock GA",,440153,DTCT0024091,2113857,DTCC00452723,1715977,23023
CHEMBL439012,P50281,,JBPHFUSOSQRLMX-MRXNPFEDSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,17591762,INHIBITION,<,50,%,,,,,,,,,,,,,,Inhibition of MMP14 at 30 uM,,Potent and selective nonpeptidic inhibitors of procollagen C-proteinase.,J. Med. Chem.,2007,50,15,"Fish PV, Allan GA, Bailey S, Blagg J, Butt R, Collis MG, Greiling D, James K, Kendall J, McElroy A, McCleverty D, Reed C, Webster R, Whitlock GA",,440159,DTCT0024091,2113885,DTCC00452723,1715977,23023
CHEMBL440498,P50281,RS-130830,ROSNVSQTEGHUKU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,19422229,IC50,=,14,NM,,,,,,,,,,,,,,Inhibition of MMP14,,"Discovery of potent, selective, and orally active carboxylic acid based inhibitors of matrix metalloproteinase-13.",J. Med. Chem.,2009,52,11,"Monovich LG, Tommasi RA, Fujimoto RA, Blancuzzi V, Clark K, Cornell WD, Doti R, Doughty J, Fang J, Farley D, Fitt J, Ganu V, Goldberg R, Goldstein R, Lavoie S, Kulathila R, Macchia W, Parker DT, Melton R, O'Byrne E, Pastor G, Pellas T, Quadros E, Reel N, Roland DM, Sakane Y, Singh H, Skiles J, Somers J, Toscano K, Wigg A, Zhou S, Zhu L, Shieh WC, Xue S, McQuire LW",,500586,DTCT0024091,2824189,DTCC01741261,585998,33635
CHEMBL440498,P50281,RS-130830,ROSNVSQTEGHUKU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,25192810,IC50,=,1.1,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP14 using fluorescence peptide Cy3-PLGLK(Cy5Q)AR-NH2 substrate by fluorescence assay,,"Thieno[2,3-d]pyrimidine-2-carboxamides bearing a carboxybenzene group at 5-position: highly potent, selective, and orally available MMP-13 inhibitors interacting with the S1¿ binding site.",Bioorg. Med. Chem.,2014,22,19,"Nara H, Sato K, Naito T, Mototani H, Oki H, Yamamoto Y, Kuno H, Santou T, Kanzaki N, Terauchi J, Uchikawa O, Kori M",,1442068,DTCT0024091,13992260,DTCC01741261,611029,59837
CHEMBL440498,P50281,RS-130830,ROSNVSQTEGHUKU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,25264600,IC50,=,1.1,NM,,,,,,,,,,,,,,Inhibition of human recombinant GST-tagged MMP14 using Cy3-PLGLK(Cy5Q)AR-NH2 as substrate after 40 mins by spectrofluorimetry,,"Discovery of Novel, Highly Potent, and Selective Quinazoline-2-carboxamide-Based Matrix Metalloproteinase (MMP)-13 Inhibitors without a Zinc Binding Group Using a Structure-Based Design Approach.",J. Med. Chem.,2014,57,21,"Nara H, Sato K, Naito T, Mototani H, Oki H, Yamamoto Y, Kuno H, Santou T, Kanzaki N, Terauchi J, Uchikawa O, Kori M",,1431426,DTCT0024091,13989084,DTCC01741261,590804,60036
CHEMBL445456,P50281,HALISTANOL SULFATE,SPEMVTYJKSAHEG-DGLFYPOVSA-K,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,12713420,IC50,=,19,UG.ML-1,,,,,,,,,,,,,,Inhibition of truncated recombinant MT1-MMP expressed in Escherichia coli JM109 after 1 hr by fluorescence assay,,"Callysponginol sulfate A, an MT1-MMP inhibitor isolated from the marine sponge Callyspongia truncata.",J. Nat. Prod.,2003,66,4,"Fujita M, Nakao Y, Matsunaga S, van Soest RW, Itoh Y, Seiki M, Fusetani N",,503789,DTCT0024091,2636562,DTCC00523134,111232,27946
CHEMBL445971,P50281,,PHMPGOJWLISPFK-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,18790648,KI,=,900,NM,,,,,,,,,,,,,,Inhibition of MMP14,,Specific targeting of metzincin family members with small-molecule inhibitors: progress toward a multifarious challenge.,Bioorg. Med. Chem.,2008,16,19,"Georgiadis D, Yiotakis A",,497410,DTCT0024091,2457370,DTCC00115941,371585,32556
CHEMBL447457,P50281,,YDDMVPLLJTZTQL-LAABSITASA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,18790648,KI,=,160,NM,,,,,,,,,,,,,,Inhibition of MMP14,,Specific targeting of metzincin family members with small-molecule inhibitors: progress toward a multifarious challenge.,Bioorg. Med. Chem.,2008,16,19,"Georgiadis D, Yiotakis A",,497410,DTCT0024091,2457429,DTCC00115970,79316,32556
CHEMBL447787,P50281,,HWRTYSUSQVJAGF-RBBKRZOGSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,18242982,KI,>,5290,NM,,,,,,,,,,,,,,Inhibition of MMP14,,"Potent, exceptionally selective, orally bioavailable inhibitors of TNF-alpha Converting Enzyme (TACE): novel 2-substituted-1H-benzo[d]imidazol-1-yl)methyl)benzamide P1' substituents.",Bioorg. Med. Chem. Lett.,2008,18,5,"Ott GR, Asakawa N, Lu Z, Anand R, Liu RQ, Covington MB, Vaddi K, Qian M, Newton RC, Christ DD, Trzaskos JM, Duan JJ",,462371,DTCT0024091,2282355,DTCC00488438,1684915,25163
CHEMBL450479,P50281,,PCUZNOWAYFCVHZ-IRPSRAIASA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,18782669,IC50,=,9700,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP14 catalytic domain by spectrofluorimeter,,Introduction of the 4-(4-bromophenyl)benzenesulfonyl group to hydrazide analogs of Ilomastat leads to potent gelatinase B (MMP-9) inhibitors with improved selectivity.,Bioorg. Med. Chem.,2008,16,18,"Ledour G, Moroy G, Rouffet M, Bourguet E, Guillaume D, Decarme M, Elmourabit H, Augé F, Alix AJ, Laronze JY, Bellon G, Hornebeck W, Sapi J",,557956,DTCT0024091,2791176,DTCC00514877,489273,31586
CHEMBL450721,P50281,,SBTMZMWGVVORIF-CYBMUJFWSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,19053764,IC50,=,353,NM,,,,,,,,,,,,,,Inhibition of MMP14,,Dual inhibitors of matrix metalloproteinases and carbonic anhydrases: iminodiacetyl-based hydroxamate-benzenesulfonamide conjugates.,J. Med. Chem.,2008,51,24,"Marques SM, Nuti E, Rossello A, Supuran CT, Tuccinardi T, Martinelli A, Santos MA",,561990,DTCT0024091,2800819,DTCC00562380,973846,31524
CHEMBL450938,P50281,(3-NITROPHENYLAMINO)METHYLENEDIPHOSPHONIC ACID,VPXZTOOBAWPNGR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,24071448,IC50,>,100000,NM,,,,,,,,,,,,,,Inhibition of MMP14 catalytic domain (unknown origin) using Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 as substrate incubated for 30 mins prior to substrate addition measured after 2 to 4 hrs by fluorometric assay,,Arylamino methylene bisphosphonate derivatives as bone seeking matrix metalloproteinase inhibitors.,Bioorg. Med. Chem.,2013,21,21,"Tauro M, Laghezza A, Loiodice F, Agamennone M, Campestre C, Tortorella P",,990167,DTCT0024091,12628983,DTCC00406538,156505,56259
CHEMBL452947,P50281,,JUTPCQYEVUKCAU-MNNSJKJDSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,18782669,IC50,=,2800,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP14 catalytic domain by spectrofluorimeter,,Introduction of the 4-(4-bromophenyl)benzenesulfonyl group to hydrazide analogs of Ilomastat leads to potent gelatinase B (MMP-9) inhibitors with improved selectivity.,Bioorg. Med. Chem.,2008,16,18,"Ledour G, Moroy G, Rouffet M, Bourguet E, Guillaume D, Decarme M, Elmourabit H, Augé F, Alix AJ, Laronze JY, Bellon G, Hornebeck W, Sapi J",,557956,DTCT0024091,2791188,DTCC00514936,392324,31586
CHEMBL456774,P50281,,LKJAZJMUPQPJNA-GOSISDBHSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,19053764,IC50,=,306,NM,,,,,,,,,,,,,,Inhibition of MMP14,,Dual inhibitors of matrix metalloproteinases and carbonic anhydrases: iminodiacetyl-based hydroxamate-benzenesulfonamide conjugates.,J. Med. Chem.,2008,51,24,"Marques SM, Nuti E, Rossello A, Supuran CT, Tuccinardi T, Martinelli A, Santos MA",,561990,DTCT0024091,2800824,DTCC00562381,1809896,31524
CHEMBL460725,P50281,,QHDIXGPUTSAIJX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,19173605,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP14,,Extra binding region induced by non-zinc chelating inhibitors into the S1' subsite of matrix metalloproteinase 8 (MMP-8).,J. Med. Chem.,2009,52,4,"Pochetti G, Montanari R, Gege C, Chevrier C, Taveras AG, Mazza F",,494624,DTCT0024091,2596041,DTCC00517113,715017,32135
CHEMBL460899,P50281,,ITADELAVAWJACR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,19173605,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP14,,Extra binding region induced by non-zinc chelating inhibitors into the S1' subsite of matrix metalloproteinase 8 (MMP-8).,J. Med. Chem.,2009,52,4,"Pochetti G, Montanari R, Gege C, Chevrier C, Taveras AG, Mazza F",,494624,DTCT0024091,2596050,DTCC00114032,1166828,32135
CHEMBL460899,P50281,,ITADELAVAWJACR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,25265401,IC50,>,2500,NM,,,,,,,,,,,,,,Inhibition of MMP14 (unknown origin),,"Targeting matrix metalloproteinases: exploring the dynamics of the s1' pocket in the design of selective, small molecule inhibitors.",J. Med. Chem.,2014,57,24,"Fabre B, Ramos A, de Pascual-Teresa B",,1433224,DTCT0024091,13993830,DTCC00114032,1171843,60040
CHEMBL461220,P50281,,ZVRPHGZPZLMEPV-PIKZIKFNSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,18835710,KI,=,4072000,NM,,,,,,,,,,,,,,Inhibition of MMP14,,Discovery of novel hydroxamates as highly potent tumor necrosis factor-alpha converting enzyme inhibitors. Part II: optimization of the S3' pocket.,Bioorg. Med. Chem. Lett.,2008,18,21,"Mazzola RD, Zhu Z, Sinning L, McKittrick B, Lavey B, Spitler J, Kozlowski J, Neng-Yang S, Zhou G, Guo Z, Orth P, Madison V, Sun J, Lundell D, Niu X",,496901,DTCT0024091,2456643,DTCC00529493,111525,31825
CHEMBL463395,P50281,,OPSGGAROSGLASJ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,19410464,IC50,=,19700,NM,,,,,,,,,,,,,,Inhibition of MMP14 by FLIPR assay,,Synthesis and activity of tryptophan sulfonamide derivatives as novel non-hydroxamate TNF-alpha converting enzyme (TACE) inhibitors.,Bioorg. Med. Chem.,2009,17,11,"Park K, Gopalsamy A, Aplasca A, Ellingboe JW, Xu W, Zhang Y, Levin JI",,545900,DTCT0024091,2499024,DTCC00571420,1104052,33915
CHEMBL466059,P50281,,GYETWAWIKBOMPE-OAQYLSRUSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,19422229,IC50,=,91,NM,,,,,,,,,,,,,,Inhibition of MMP14,,"Discovery of potent, selective, and orally active carboxylic acid based inhibitors of matrix metalloproteinase-13.",J. Med. Chem.,2009,52,11,"Monovich LG, Tommasi RA, Fujimoto RA, Blancuzzi V, Clark K, Cornell WD, Doti R, Doughty J, Fang J, Farley D, Fitt J, Ganu V, Goldberg R, Goldstein R, Lavoie S, Kulathila R, Macchia W, Parker DT, Melton R, O'Byrne E, Pastor G, Pellas T, Quadros E, Reel N, Roland DM, Sakane Y, Singh H, Skiles J, Somers J, Toscano K, Wigg A, Zhou S, Zhu L, Shieh WC, Xue S, McQuire LW",,500586,DTCT0024091,2824190,DTCC00536373,164710,33635
CHEMBL466118,P50281,,OJALZWLVBUFAQK-HHHXNRCGSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,19329309,IC50,=,1305,NM,,,,,,,,,,,,,,Inhibition of MMP14,,Synthesis and biological evaluation of ((4-keto)-phenoxy)methyl biphenyl-4-sulfonamides: a class of potent aggrecanase-1 inhibitors.,Bioorg. Med. Chem. Lett.,2009,19,9,"Hopper DW, Vera MD, How D, Sabatini J, Xiang JS, Ipek M, Thomason J, Hu Y, Feyfant E, Wang Q, Georgiadis KE, Reifenberg E, Sheldon RT, Keohan CC, Majumdar MK, Morris EA, Skotnicki J, Sum PE",,500228,DTCT0024091,2725240,DTCC00536890,1983077,34185
CHEMBL466360,P50281,,JAHNZBCDKPZQAS-XBKFQHLESA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,12713420,ACTIVITY,,,,,,,,,,,,,,,,,Inhibition of truncated recombinant MT1-MMP expressed in Escherichia coli JM109 after 1 hr by fluorescence assay,Not Active,"Callysponginol sulfate A, an MT1-MMP inhibitor isolated from the marine sponge Callyspongia truncata.",J. Nat. Prod.,2003,66,4,"Fujita M, Nakao Y, Matsunaga S, van Soest RW, Itoh Y, Seiki M, Fusetani N",,503789,DTCT0024091,2636561,DTCC00523309,694314,27946
CHEMBL467891,P50281,,CYVZQRKPMGDNKM-GDLZYMKVSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,19329309,IC50,=,1641,NM,,,,,,,,,,,,,,Inhibition of MMP14,,Synthesis and biological evaluation of ((4-keto)-phenoxy)methyl biphenyl-4-sulfonamides: a class of potent aggrecanase-1 inhibitors.,Bioorg. Med. Chem. Lett.,2009,19,9,"Hopper DW, Vera MD, How D, Sabatini J, Xiang JS, Ipek M, Thomason J, Hu Y, Feyfant E, Wang Q, Georgiadis KE, Reifenberg E, Sheldon RT, Keohan CC, Majumdar MK, Morris EA, Skotnicki J, Sum PE",,500228,DTCT0024091,2725238,DTCC00536758,1950368,34185
CHEMBL468657,P50281,CALLYSPONGINOL SULFATE A,PBGNCXUOHDYVFH-GJUDBQLJSA-M,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,12713420,IC50,=,15,UG.ML-1,,,,,,,,,,,,,,Inhibition of truncated recombinant MT1-MMP expressed in Escherichia coli JM109 after 1 hr by fluorescence assay,,"Callysponginol sulfate A, an MT1-MMP inhibitor isolated from the marine sponge Callyspongia truncata.",J. Nat. Prod.,2003,66,4,"Fujita M, Nakao Y, Matsunaga S, van Soest RW, Itoh Y, Seiki M, Fusetani N",,503789,DTCT0024091,2636560,DTCC00523310,2048039,27946
CHEMBL468722,P50281,,ZHXMXRVBOZWQPF-GDLZYMKVSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,19329309,IC50,=,220,NM,,,,,,,,,,,,,,Inhibition of MMP14,,Synthesis and biological evaluation of ((4-keto)-phenoxy)methyl biphenyl-4-sulfonamides: a class of potent aggrecanase-1 inhibitors.,Bioorg. Med. Chem. Lett.,2009,19,9,"Hopper DW, Vera MD, How D, Sabatini J, Xiang JS, Ipek M, Thomason J, Hu Y, Feyfant E, Wang Q, Georgiadis KE, Reifenberg E, Sheldon RT, Keohan CC, Majumdar MK, Morris EA, Skotnicki J, Sum PE",,500228,DTCT0024091,2725237,DTCC00536694,1243566,34185
CHEMBL468900,P50281,,NHPBWKYFMTXWAA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,18790648,ACTIVITY,,,,,,,,,,,,,,,,,Inhibition of MMP14 up to 100 uM,Not Active,Specific targeting of metzincin family members with small-molecule inhibitors: progress toward a multifarious challenge.,Bioorg. Med. Chem.,2008,16,19,"Georgiadis D, Yiotakis A",,497433,DTCT0024091,2457345,DTCC00530186,2016158,32556
CHEMBL471536,P50281,,WDSISXXPBLTCID-ZHRRBRCNSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,18782669,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP14 catalytic domain by spectrofluorimeter,,Introduction of the 4-(4-bromophenyl)benzenesulfonyl group to hydrazide analogs of Ilomastat leads to potent gelatinase B (MMP-9) inhibitors with improved selectivity.,Bioorg. Med. Chem.,2008,16,18,"Ledour G, Moroy G, Rouffet M, Bourguet E, Guillaume D, Decarme M, Elmourabit H, Augé F, Alix AJ, Laronze JY, Bellon G, Hornebeck W, Sapi J",,557956,DTCT0024091,2791169,DTCC00514801,682698,31586
CHEMBL471537,P50281,,GSWRTFGMHRKLKT-AREMUKBSSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,19053764,IC50,=,0.32,NM,,,,,,,,,,,,,,Inhibition of MMP14,,Dual inhibitors of matrix metalloproteinases and carbonic anhydrases: iminodiacetyl-based hydroxamate-benzenesulfonamide conjugates.,J. Med. Chem.,2008,51,24,"Marques SM, Nuti E, Rossello A, Supuran CT, Tuccinardi T, Martinelli A, Santos MA",,561990,DTCT0024091,2800883,DTCC00514690,489269,31524
CHEMBL472899,P50281,,ZRAUMSIZBNBIFE-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,19053764,IC50,=,14,NM,,,,,,,,,,,,,,Inhibition of MMP14,,Dual inhibitors of matrix metalloproteinases and carbonic anhydrases: iminodiacetyl-based hydroxamate-benzenesulfonamide conjugates.,J. Med. Chem.,2008,51,24,"Marques SM, Nuti E, Rossello A, Supuran CT, Tuccinardi T, Martinelli A, Santos MA",,561990,DTCT0024091,2800901,DTCC00514692,1296946,31524
CHEMBL473326,P50281,,HKDAECHYHSQLRG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,18364257,ACTIVITY,,,,,,,,,,,,,,,,,Inhibition of human recombinant MMP14 at 200 uM by HxBPyne probe-based competitive activity based protein profiling assay in presence of 5 uM HxBpane competitor,Not Active,Ranking the selectivity of PubChem screening hits by activity-based protein profiling: MMP13 as a case study.,Bioorg. Med. Chem.,2009,17,3,"Nakai R, Salisbury CM, Rosen H, Cravatt BF",,518912,DTCT0024091,2709012,DTCC00516458,694221,32218
CHEMBL473326,P50281,,HKDAECHYHSQLRG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,22018790,ACTIVITY,=,106.6,%,,,,,,,,,,,,,,Inhibition of MMP14 assessed as residual activity using Knight SSP as substrate at 100 uM after 1.5 to 4 hrs by spectrofluorometric analysis relative to control,,"Identification of novel, exosite-binding matrix metalloproteinase-13 inhibitor scaffolds.",Bioorg. Med. Chem. Lett.,2011,21,23,"Roth J, Minond D, Darout E, Liu Q, Lauer J, Hodder P, Fields GB, Roush WR",,799335,DTCT0024091,7597020,DTCC00516458,704135,47025
CHEMBL473326,P50281,,HKDAECHYHSQLRG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,22018790,INHIBITION,=,22,%,,,,,,,,,,,,,,Inhibition of MMP14 using triple-helical fTHP-15 as substrate at 40 uM after 4 hrs by FRET assay,,"Identification of novel, exosite-binding matrix metalloproteinase-13 inhibitor scaffolds.",Bioorg. Med. Chem. Lett.,2011,21,23,"Roth J, Minond D, Darout E, Liu Q, Lauer J, Hodder P, Fields GB, Roush WR",,799266,DTCT0024091,7596115,DTCC00516458,704135,47025
CHEMBL474523,P50281,,OUDOQEURKMFZDS-DVECYGJZSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,18782669,IC50,=,2600,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP14 catalytic domain by spectrofluorimeter,,Introduction of the 4-(4-bromophenyl)benzenesulfonyl group to hydrazide analogs of Ilomastat leads to potent gelatinase B (MMP-9) inhibitors with improved selectivity.,Bioorg. Med. Chem.,2008,16,18,"Ledour G, Moroy G, Rouffet M, Bourguet E, Guillaume D, Decarme M, Elmourabit H, Augé F, Alix AJ, Laronze JY, Bellon G, Hornebeck W, Sapi J",,557956,DTCT0024091,2791170,DTCC00514802,844569,31586
CHEMBL474723,P50281,,QJTQSHPLYJZWCK-HXOBKFHXSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,18782669,IC50,=,190,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP14 catalytic domain by spectrofluorimeter,,Introduction of the 4-(4-bromophenyl)benzenesulfonyl group to hydrazide analogs of Ilomastat leads to potent gelatinase B (MMP-9) inhibitors with improved selectivity.,Bioorg. Med. Chem.,2008,16,18,"Ledour G, Moroy G, Rouffet M, Bourguet E, Guillaume D, Decarme M, Elmourabit H, Augé F, Alix AJ, Laronze JY, Bellon G, Hornebeck W, Sapi J",,557956,DTCT0024091,2791171,DTCC00514803,1426981,31586
CHEMBL474924,P50281,,IFXKVYOUWYXBAE-KOSHJBKYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,18782669,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP14 catalytic domain by spectrofluorimeter,,Introduction of the 4-(4-bromophenyl)benzenesulfonyl group to hydrazide analogs of Ilomastat leads to potent gelatinase B (MMP-9) inhibitors with improved selectivity.,Bioorg. Med. Chem.,2008,16,18,"Ledour G, Moroy G, Rouffet M, Bourguet E, Guillaume D, Decarme M, Elmourabit H, Augé F, Alix AJ, Laronze JY, Bellon G, Hornebeck W, Sapi J",,557956,DTCT0024091,2791166,DTCC00514742,682696,31586
CHEMBL474925,P50281,,JEXGMFUVEIZKRF-MWTRTKDXSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,18782669,IC50,=,1000,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP14 catalytic domain by spectrofluorimeter,,Introduction of the 4-(4-bromophenyl)benzenesulfonyl group to hydrazide analogs of Ilomastat leads to potent gelatinase B (MMP-9) inhibitors with improved selectivity.,Bioorg. Med. Chem.,2008,16,18,"Ledour G, Moroy G, Rouffet M, Bourguet E, Guillaume D, Decarme M, Elmourabit H, Augé F, Alix AJ, Laronze JY, Bellon G, Hornebeck W, Sapi J",,557956,DTCT0024091,2791167,DTCC00514743,1103405,31586
CHEMBL474933,P50281,,LJIWTQZYGOAIKX-IERUDJENSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,,IC50,>,80000,NM,,,,,,,,,,,,,,PubChem BioAssay. Dose Response confirmation of uHTS hits for a small molecule inhibitors of MT1-MMP activation in a fluorescence assay set 1. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,954361,DTCT0024091,12209092,DTCC00515686,442925,33038
CHEMBL475540,P50281,,IQGHPUPMOUUHPP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,18364257,ACTIVITY,,,,,,,,,,,,,,,,,Inhibition of human recombinant MMP14 at 200 uM by HxBPyne probe-based competitive activity based protein profiling assay in presence of 5 uM HxBpane competitor,Active,Ranking the selectivity of PubChem screening hits by activity-based protein profiling: MMP13 as a case study.,Bioorg. Med. Chem.,2009,17,3,"Nakai R, Salisbury CM, Rosen H, Cravatt BF",,518912,DTCT0024091,2709014,DTCC00515616,1178199,32218
CHEMBL483857,P50281,2-((4-PHENOXYPHENYLSULFONYL)METHYL)THIIRANE,LSONWRHLFZYHIN-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,,KI,=,37,NM,,,,,,,,,,,,,,Competitive inhibition of human MMP14 using fluorogenic substrate by Dixon plot analysis,,,ACS Med. Chem. Lett.,2012,3,6,,,831080,DTCT0024091,10566544,DTCC00007664,1767161,48923
CHEMBL483857,P50281,2-((4-PHENOXYPHENYLSULFONYL)METHYL)THIIRANE,LSONWRHLFZYHIN-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,,KI,=,110,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP14 catalytic domain by substrate hydrolysis based fluorescence spectrophotometry,,,ACS Med. Chem. Lett.,2011,2,2,,,702136,DTCT0024091,5066089,DTCC00007664,1746732,42713
CHEMBL484261,P50281,,VMOSDDURWLNMNG-GXFFZTMASA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,18790648,IC50,=,582,NM,,,,,,,,,,,,,,Inhibition of MMP14,,Specific targeting of metzincin family members with small-molecule inhibitors: progress toward a multifarious challenge.,Bioorg. Med. Chem.,2008,16,19,"Georgiadis D, Yiotakis A",,497410,DTCT0024091,2456504,DTCC00115945,888681,32556
CHEMBL484262,P50281,,BBCCMNOZBPHYAJ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,18790648,IC50,=,24000,NM,,,,,,,,,,,,,,Inhibition of MMP14,,Specific targeting of metzincin family members with small-molecule inhibitors: progress toward a multifarious challenge.,Bioorg. Med. Chem.,2008,16,19,"Georgiadis D, Yiotakis A",,497410,DTCT0024091,2456494,DTCC00546798,1470988,32556
CHEMBL485492,P50281,,QNKSDDQPRLWOEC-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,18790648,KI,=,680,NM,,,,,,,,,,,,,,Inhibition of MMP14,,Specific targeting of metzincin family members with small-molecule inhibitors: progress toward a multifarious challenge.,Bioorg. Med. Chem.,2008,16,19,"Georgiadis D, Yiotakis A",,497410,DTCT0024091,2457538,DTCC00115942,306350,32556
CHEMBL485492,P50281,,QNKSDDQPRLWOEC-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,21866961,KI,=,680,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP14 assessed as hydrolysis of MOCAcPLGLA2pr(Dnp)AR-NH2 by fluorescence spectrofluorometry ,,Selective water-soluble gelatinase inhibitor prodrugs.,J. Med. Chem.,2011,54,19,"Gooyit M, Lee M, Schroeder VA, Ikejiri M, Suckow MA, Mobashery S, Chang M",,771363,DTCT0024091,6116320,DTCC00115942,296761,46049
CHEMBL488617,P50281,,YQOYDTYUPFCPKG-AMGIVPHBSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,18782669,IC50,=,10000,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP14 catalytic domain by spectrofluorimeter,,Introduction of the 4-(4-bromophenyl)benzenesulfonyl group to hydrazide analogs of Ilomastat leads to potent gelatinase B (MMP-9) inhibitors with improved selectivity.,Bioorg. Med. Chem.,2008,16,18,"Ledour G, Moroy G, Rouffet M, Bourguet E, Guillaume D, Decarme M, Elmourabit H, Augé F, Alix AJ, Laronze JY, Bellon G, Hornebeck W, Sapi J",,557956,DTCT0024091,2791180,DTCC00514928,650740,31586
CHEMBL489100,P50281,BMS-561392,QVNZBDLTUKCPGJ-SHQCIBLASA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,,IC50,=,499,NM,,,,,,,,,,,,,,Inhibition of MMP14 (unknown origin) by fluorescence-based FRET assay,,,MedChemComm,2011,2,10,,,1328288,DTCT0024091,13574323,DTCC00005548,590183,39059
CHEMBL492599,P50281,,ZVFYVGRNAIMTAR-UTKZUKDTSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,18782669,IC50,=,1100,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP14 catalytic domain by spectrofluorimeter,,Introduction of the 4-(4-bromophenyl)benzenesulfonyl group to hydrazide analogs of Ilomastat leads to potent gelatinase B (MMP-9) inhibitors with improved selectivity.,Bioorg. Med. Chem.,2008,16,18,"Ledour G, Moroy G, Rouffet M, Bourguet E, Guillaume D, Decarme M, Elmourabit H, Augé F, Alix AJ, Laronze JY, Bellon G, Hornebeck W, Sapi J",,557956,DTCT0024091,2791175,DTCC00514876,1296949,31586
CHEMBL495502,P50281,,OBBSDCUMPDPHQF-BEEZEEGUSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,18790648,KI,=,163,NM,,,,,,,,,,,,,,Inhibition of MMP14,,Specific targeting of metzincin family members with small-molecule inhibitors: progress toward a multifarious challenge.,Bioorg. Med. Chem.,2008,16,19,"Georgiadis D, Yiotakis A",,497410,DTCT0024091,2457262,DTCC00547246,1983210,32556
CHEMBL495555,P50281,,OKNJOSGDEWUQIH-RNAHPLFWSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,18835710,KI,>,10000000,NM,,,,,,,,,,,,,,Inhibition of MMP14,,Discovery of novel hydroxamates as highly potent tumor necrosis factor-alpha converting enzyme inhibitors. Part II: optimization of the S3' pocket.,Bioorg. Med. Chem. Lett.,2008,18,21,"Mazzola RD, Zhu Z, Sinning L, McKittrick B, Lavey B, Spitler J, Kozlowski J, Neng-Yang S, Zhou G, Guo Z, Orth P, Madison V, Sun J, Lundell D, Niu X",,496901,DTCT0024091,2456645,DTCC00548438,694598,31825
CHEMBL496309,P50281,,QCSQWZYXJSYMSJ-DJUQAAIZSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,18835710,KI,>,10000000,NM,,,,,,,,,,,,,,Inhibition of MMP14,,Discovery of novel hydroxamates as highly potent tumor necrosis factor-alpha converting enzyme inhibitors. Part II: optimization of the S3' pocket.,Bioorg. Med. Chem. Lett.,2008,18,21,"Mazzola RD, Zhu Z, Sinning L, McKittrick B, Lavey B, Spitler J, Kozlowski J, Neng-Yang S, Zhou G, Guo Z, Orth P, Madison V, Sun J, Lundell D, Niu X",,496901,DTCT0024091,2456642,DTCC00547689,111517,31825
CHEMBL496942,P50281,,FLTYDFYSVZBKOB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,17623656,IC50,>,30000,NM,,,,,,,,,,,,,,Inhibition of MMP14 catalytic domain,,Discovery and characterization of a novel inhibitor of matrix metalloprotease-13 that reduces cartilage damage in vivo without joint fibroplasia side effects.,J. Biol. Chem.,2007,282,38,"Johnson AR, Pavlovsky AG, Ortwine DF, Prior F, Man CF, Bornemeier DA, Banotai CA, Mueller WT, McConnell P, Yan C, Baragi V, Lesch C, Roark WH, Wilson M, Datta K, Guzman R, Han HK, Dyer RD",,507877,DTCT0024091,2388634,DTCC00547183,1983321,29282
CHEMBL496942,P50281,,FLTYDFYSVZBKOB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,18790648,ACTIVITY,,,,,,,,,,,,,,,,,Inhibition of MMP14 up to 100 uM,Not Active,Specific targeting of metzincin family members with small-molecule inhibitors: progress toward a multifarious challenge.,Bioorg. Med. Chem.,2008,16,19,"Georgiadis D, Yiotakis A",,497433,DTCT0024091,2457328,DTCC00547183,1983207,32556
CHEMBL496942,P50281,,FLTYDFYSVZBKOB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,25265401,IC50,>,30000,NM,,,,,,,,,,,,,,Inhibition of MMP14 (unknown origin),,"Targeting matrix metalloproteinases: exploring the dynamics of the s1' pocket in the design of selective, small molecule inhibitors.",J. Med. Chem.,2014,57,24,"Fabre B, Ramos A, de Pascual-Teresa B",,1433224,DTCT0024091,13993829,DTCC00547183,1976454,60040
CHEMBL497769,P50281,,PIRLKANLMCDQSE-UFHPHHKVSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,18835710,KI,>,10000000,NM,,,,,,,,,,,,,,Inhibition of MMP14,,Discovery of novel hydroxamates as highly potent tumor necrosis factor-alpha converting enzyme inhibitors. Part II: optimization of the S3' pocket.,Bioorg. Med. Chem. Lett.,2008,18,21,"Mazzola RD, Zhu Z, Sinning L, McKittrick B, Lavey B, Spitler J, Kozlowski J, Neng-Yang S, Zhou G, Guo Z, Orth P, Madison V, Sun J, Lundell D, Niu X",,496901,DTCT0024091,2456640,DTCC00547750,1917719,31825
CHEMBL497772,P50281,,KQIFSUSWYMDFOC-AREMUKBSSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,18790648,IC50,=,5000,NM,,,,,,,,,,,,,,Inhibition of MMP14,,Specific targeting of metzincin family members with small-molecule inhibitors: progress toward a multifarious challenge.,Bioorg. Med. Chem.,2008,16,19,"Georgiadis D, Yiotakis A",,497410,DTCT0024091,2457435,DTCC00547182,823604,32556
CHEMBL497810,P50281,,YOOJSKRBENNWQY-BWKNWUBXSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,18835710,KI,>,10000000,NM,,,,,,,,,,,,,,Inhibition of MMP14,,Discovery of novel hydroxamates as highly potent tumor necrosis factor-alpha converting enzyme inhibitors. Part II: optimization of the S3' pocket.,Bioorg. Med. Chem. Lett.,2008,18,21,"Mazzola RD, Zhu Z, Sinning L, McKittrick B, Lavey B, Spitler J, Kozlowski J, Neng-Yang S, Zhou G, Guo Z, Orth P, Madison V, Sun J, Lundell D, Niu X",,496901,DTCT0024091,2456646,DTCC00548337,1983227,31825
CHEMBL497908,P50281,,QBMRYLHKTSDMJW-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,19410464,IC50,=,20700,NM,,,,,,,,,,,,,,Inhibition of MMP14 by FLIPR assay,,Synthesis and activity of tryptophan sulfonamide derivatives as novel non-hydroxamate TNF-alpha converting enzyme (TACE) inhibitors.,Bioorg. Med. Chem.,2009,17,11,"Park K, Gopalsamy A, Aplasca A, Ellingboe JW, Xu W, Zhang Y, Levin JI",,545900,DTCT0024091,2499025,DTCC00117363,1809997,33915
CHEMBL497985,P50281,,HJNKYGBTSGQBDU-HOCLYGCPSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,18790648,IC50,>,5000,NM,,,,,,,,,,,,,,Inhibition of MMP14,,Specific targeting of metzincin family members with small-molecule inhibitors: progress toward a multifarious challenge.,Bioorg. Med. Chem.,2008,16,19,"Georgiadis D, Yiotakis A",,497410,DTCT0024091,2457486,DTCC00547304,630170,32556
CHEMBL498915,P50281,,NIPJJOWPCLBDGS-CLOONOSVSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,18782669,IC50,=,720,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP14 catalytic domain by spectrofluorimeter,,Introduction of the 4-(4-bromophenyl)benzenesulfonyl group to hydrazide analogs of Ilomastat leads to potent gelatinase B (MMP-9) inhibitors with improved selectivity.,Bioorg. Med. Chem.,2008,16,18,"Ledour G, Moroy G, Rouffet M, Bourguet E, Guillaume D, Decarme M, Elmourabit H, Augé F, Alix AJ, Laronze JY, Bellon G, Hornebeck W, Sapi J",,557956,DTCT0024091,2791181,DTCC00514929,67486,31586
CHEMBL499426,P50281,,XGMBBGDQKHEJGS-NJHZRGNWSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,18782669,IC50,=,3100,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP14 catalytic domain by spectrofluorimeter,,Introduction of the 4-(4-bromophenyl)benzenesulfonyl group to hydrazide analogs of Ilomastat leads to potent gelatinase B (MMP-9) inhibitors with improved selectivity.,Bioorg. Med. Chem.,2008,16,18,"Ledour G, Moroy G, Rouffet M, Bourguet E, Guillaume D, Decarme M, Elmourabit H, Augé F, Alix AJ, Laronze JY, Bellon G, Hornebeck W, Sapi J",,557956,DTCT0024091,2791172,DTCC00514804,1070634,31586
CHEMBL499905,P50281,,JUSNXCIZGYMOPC-HHHXNRCGSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,19410464,IC50,=,13000,NM,,,,,,,,,,,,,,Inhibition of MMP14 by FLIPR assay,,Synthesis and activity of tryptophan sulfonamide derivatives as novel non-hydroxamate TNF-alpha converting enzyme (TACE) inhibitors.,Bioorg. Med. Chem.,2009,17,11,"Park K, Gopalsamy A, Aplasca A, Ellingboe JW, Xu W, Zhang Y, Levin JI",,545900,DTCT0024091,2499022,DTCC00570829,812391,33915
CHEMBL500351,P50281,,XMFWHLZTTUUQHL-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,18364257,ACTIVITY,,,,,,,,,,,,,,,,,Inhibition of human recombinant MMP14 at 200 uM by HxBPyne probe-based competitive activity based protein profiling assay in presence of 5 uM HxBpane competitor,Not Active,Ranking the selectivity of PubChem screening hits by activity-based protein profiling: MMP13 as a case study.,Bioorg. Med. Chem.,2009,17,3,"Nakai R, Salisbury CM, Rosen H, Cravatt BF",,518912,DTCT0024091,2709013,DTCC00516461,984998,32218
CHEMBL502079,P50281,,MQVHPUMPNXPCIB-CPBHLAHYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,18782669,IC50,=,5100,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP14 catalytic domain by spectrofluorimeter,,Introduction of the 4-(4-bromophenyl)benzenesulfonyl group to hydrazide analogs of Ilomastat leads to potent gelatinase B (MMP-9) inhibitors with improved selectivity.,Bioorg. Med. Chem.,2008,16,18,"Ledour G, Moroy G, Rouffet M, Bourguet E, Guillaume D, Decarme M, Elmourabit H, Augé F, Alix AJ, Laronze JY, Bellon G, Hornebeck W, Sapi J",,557956,DTCT0024091,2791177,DTCC00514878,1588157,31586
CHEMBL502412,P50281,,YDMXGNNTWVZROI-PQGRUEKFSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,19109023,KCAT/KM,=,777200,/M/S,,,,,,,,,,,,,,Ratio of kcat/km for human recombinant MMP14 assessed as drug cleavage,,Development of an optimized activatable MMP-14 targeted SPECT imaging probe.,Bioorg. Med. Chem.,2009,17,2,"Watkins GA, Jones EF, Scott Shell M, VanBrocklin HF, Pan MH, Hanrahan SM, Feng JJ, He J, Sounni NE, Dill KA, Contag CH, Coussens LM, Franc BL",,496175,DTCT0024091,2590002,DTCC00516905,2036776,32112
CHEMBL502674,P50281,,MLPPJTCCWGPRTB-MYVCOICNSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,18782669,IC50,=,1237,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP14 catalytic domain by spectrofluorimeter,,Introduction of the 4-(4-bromophenyl)benzenesulfonyl group to hydrazide analogs of Ilomastat leads to potent gelatinase B (MMP-9) inhibitors with improved selectivity.,Bioorg. Med. Chem.,2008,16,18,"Ledour G, Moroy G, Rouffet M, Bourguet E, Guillaume D, Decarme M, Elmourabit H, Augé F, Alix AJ, Laronze JY, Bellon G, Hornebeck W, Sapi J",,557956,DTCT0024091,2791187,DTCC00514935,877015,31586
CHEMBL503231,P50281,,NFPKLGKUZSGXBR-BHYWQNONSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,18790648,IC50,=,930,NM,,,,,,,,,,,,,,Inhibition of MMP14,,Specific targeting of metzincin family members with small-molecule inhibitors: progress toward a multifarious challenge.,Bioorg. Med. Chem.,2008,16,19,"Georgiadis D, Yiotakis A",,497410,DTCT0024091,2457448,DTCC00547118,888687,32556
CHEMBL503651,P50281,,ZBCPKTFDPDVKFC-ABFWBJRFSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,18782669,ACTIVITY,,,,,,,,,,,,,,,,,Inhibition of human recombinant MMP14 catalytic domain by spectrofluorimeter,Not Active,Introduction of the 4-(4-bromophenyl)benzenesulfonyl group to hydrazide analogs of Ilomastat leads to potent gelatinase B (MMP-9) inhibitors with improved selectivity.,Bioorg. Med. Chem.,2008,16,18,"Ledour G, Moroy G, Rouffet M, Bourguet E, Guillaume D, Decarme M, Elmourabit H, Augé F, Alix AJ, Laronze JY, Bellon G, Hornebeck W, Sapi J",,557956,DTCT0024091,2791183,DTCC00514931,714988,31586
CHEMBL506057,P50281,,PHCNKOHEKZYJCZ-OYRZRQNVSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,18835710,KI,>,10000000,NM,,,,,,,,,,,,,,Inhibition of MMP14,,Discovery of novel hydroxamates as highly potent tumor necrosis factor-alpha converting enzyme inhibitors. Part II: optimization of the S3' pocket.,Bioorg. Med. Chem. Lett.,2008,18,21,"Mazzola RD, Zhu Z, Sinning L, McKittrick B, Lavey B, Spitler J, Kozlowski J, Neng-Yang S, Zhou G, Guo Z, Orth P, Madison V, Sun J, Lundell D, Niu X",,496901,DTCT0024091,2456641,DTCC00547690,111518,31825
CHEMBL507420,P50281,,PTUCPHGSAFOJAU-MGONOCMRSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,18790648,KI,=,140,NM,,,,,,,,,,,,,,Inhibition of MMP14,,Specific targeting of metzincin family members with small-molecule inhibitors: progress toward a multifarious challenge.,Bioorg. Med. Chem.,2008,16,19,"Georgiadis D, Yiotakis A",,497410,DTCT0024091,2457420,DTCC00115971,1788790,32556
CHEMBL508335,P50281,,ODFXJYBYTABKHA-BTYSJIOQSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,18782669,IC50,=,17000,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP14 catalytic domain by spectrofluorimeter,,Introduction of the 4-(4-bromophenyl)benzenesulfonyl group to hydrazide analogs of Ilomastat leads to potent gelatinase B (MMP-9) inhibitors with improved selectivity.,Bioorg. Med. Chem.,2008,16,18,"Ledour G, Moroy G, Rouffet M, Bourguet E, Guillaume D, Decarme M, Elmourabit H, Augé F, Alix AJ, Laronze JY, Bellon G, Hornebeck W, Sapi J",,557956,DTCT0024091,2791182,DTCC00514930,877014,31586
CHEMBL508335,P50281,,ODFXJYBYTABKHA-BTYSJIOQSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,18782669,KI,=,1900,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP14 catalytic domain by spectrofluorimeter,,Introduction of the 4-(4-bromophenyl)benzenesulfonyl group to hydrazide analogs of Ilomastat leads to potent gelatinase B (MMP-9) inhibitors with improved selectivity.,Bioorg. Med. Chem.,2008,16,18,"Ledour G, Moroy G, Rouffet M, Bourguet E, Guillaume D, Decarme M, Elmourabit H, Augé F, Alix AJ, Laronze JY, Bellon G, Hornebeck W, Sapi J",,557956,DTCT0024091,2791223,DTCC00514930,877014,31586
CHEMBL509270,P50281,,HDFXAYMYXQRRFT-ATRWTNPRSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,18782669,IC50,=,3784,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP14 catalytic domain by spectrofluorimeter,,Introduction of the 4-(4-bromophenyl)benzenesulfonyl group to hydrazide analogs of Ilomastat leads to potent gelatinase B (MMP-9) inhibitors with improved selectivity.,Bioorg. Med. Chem.,2008,16,18,"Ledour G, Moroy G, Rouffet M, Bourguet E, Guillaume D, Decarme M, Elmourabit H, Augé F, Alix AJ, Laronze JY, Bellon G, Hornebeck W, Sapi J",,557956,DTCT0024091,2791185,DTCC00514933,132052,31586
CHEMBL509346,P50281,,QEEFWEXKMRZIRZ-RTYIMRNCSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,18782669,ACTIVITY,,,,,,,,,,,,,,,,,Inhibition of human recombinant MMP14 catalytic domain by spectrofluorimeter,Not Active,Introduction of the 4-(4-bromophenyl)benzenesulfonyl group to hydrazide analogs of Ilomastat leads to potent gelatinase B (MMP-9) inhibitors with improved selectivity.,Bioorg. Med. Chem.,2008,16,18,"Ledour G, Moroy G, Rouffet M, Bourguet E, Guillaume D, Decarme M, Elmourabit H, Augé F, Alix AJ, Laronze JY, Bellon G, Hornebeck W, Sapi J",,557956,DTCT0024091,2791186,DTCC00514934,1588158,31586
CHEMBL510694,P50281,,LCLWTUJSVDCASO-JLSHBGBKSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,18782669,IC50,=,105,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP14 catalytic domain by spectrofluorimeter,,Introduction of the 4-(4-bromophenyl)benzenesulfonyl group to hydrazide analogs of Ilomastat leads to potent gelatinase B (MMP-9) inhibitors with improved selectivity.,Bioorg. Med. Chem.,2008,16,18,"Ledour G, Moroy G, Rouffet M, Bourguet E, Guillaume D, Decarme M, Elmourabit H, Augé F, Alix AJ, Laronze JY, Bellon G, Hornebeck W, Sapi J",,557956,DTCT0024091,2791184,DTCC00514932,1716557,31586
CHEMBL511203,P50281,,JGTIIKHYSZFICL-AREMUKBSSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,19329309,IC50,=,915,NM,,,,,,,,,,,,,,Inhibition of MMP14,,Synthesis and biological evaluation of ((4-keto)-phenoxy)methyl biphenyl-4-sulfonamides: a class of potent aggrecanase-1 inhibitors.,Bioorg. Med. Chem. Lett.,2009,19,9,"Hopper DW, Vera MD, How D, Sabatini J, Xiang JS, Ipek M, Thomason J, Hu Y, Feyfant E, Wang Q, Georgiadis KE, Reifenberg E, Sheldon RT, Keohan CC, Majumdar MK, Morris EA, Skotnicki J, Sum PE",,500228,DTCT0024091,2725239,DTCC00536888,1115037,34185
CHEMBL514138,P50281,CGS-27023A,ZVYIZSNCEAHMCF-UNTBIKODSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,15713379,IC50,=,8.9,NM,,,,,,,,,,,,,,Inhibition of human matrix metalloprotease-14,,N-i-Propoxy-N-biphenylsulfonylaminobutylhydroxamic acids as potent and selective inhibitors of MMP-2 and MT1-MMP.,Bioorg. Med. Chem. Lett.,2005,15,5,"Rossello A, Nuti E, Carelli P, Orlandini E, Macchia M, Nencetti S, Zandomeneghi M, Balzano F, Uccello Barretta G, Albini A, Benelli R, Cercignani G, Murphy G, Balsamo A",,305766,DTCT0024091,1745885,DTCC00514693,1230128,18841
CHEMBL514138,P50281,CGS-27023A,ZVYIZSNCEAHMCF-UNTBIKODSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,17127067,IC50,=,23,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP14,,Methotrexate gamma-hydroxamate derivatives as potential dual target antitumor drugs.,Bioorg. Med. Chem.,2007,15,3,"Santos MA, Enyedy EA, Nuti E, Rossello A, Krupenko NI, Krupenko SA",,441091,DTCT0024091,2146217,DTCC00514693,1242789,23121
CHEMBL514138,P50281,CGS-27023A,ZVYIZSNCEAHMCF-UNTBIKODSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,19053764,IC50,=,23.2,NM,,,,,,,,,,,,,,Inhibition of MMP14,,Dual inhibitors of matrix metalloproteinases and carbonic anhydrases: iminodiacetyl-based hydroxamate-benzenesulfonamide conjugates.,J. Med. Chem.,2008,51,24,"Marques SM, Nuti E, Rossello A, Supuran CT, Tuccinardi T, Martinelli A, Santos MA",,561990,DTCT0024091,2800908,DTCC00514693,1231512,31524
CHEMBL514138,P50281,CGS-27023A,ZVYIZSNCEAHMCF-UNTBIKODSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,19422229,IC50,=,7.5,NM,,,,,,,,,,,,,,Inhibition of MMP14,,"Discovery of potent, selective, and orally active carboxylic acid based inhibitors of matrix metalloproteinase-13.",J. Med. Chem.,2009,52,11,"Monovich LG, Tommasi RA, Fujimoto RA, Blancuzzi V, Clark K, Cornell WD, Doti R, Doughty J, Fang J, Farley D, Fitt J, Ganu V, Goldberg R, Goldstein R, Lavoie S, Kulathila R, Macchia W, Parker DT, Melton R, O'Byrne E, Pastor G, Pellas T, Quadros E, Reel N, Roland DM, Sakane Y, Singh H, Skiles J, Somers J, Toscano K, Wigg A, Zhou S, Zhu L, Shieh WC, Xue S, McQuire LW",,500586,DTCT0024091,2824187,DTCC00514693,1231748,33635
CHEMBL514138,P50281,CGS-27023A,ZVYIZSNCEAHMCF-UNTBIKODSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,20180536,IC50,=,23,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP14 by fluorometric assay,,Potent arylsulfonamide inhibitors of tumor necrosis factor-alpha converting enzyme able to reduce activated leukocyte cell adhesion molecule shedding in cancer cell models.,J. Med. Chem.,2010,53,6,"Nuti E, Casalini F, Avramova SI, Santamaria S, Fabbi M, Ferrini S, Marinelli L, La Pietra V, Limongelli V, Novellino E, Cercignani G, Orlandini E, Nencetti S, Rossello A",,624095,DTCT0024091,3286043,DTCC00514693,1244871,38228
CHEMBL514138,P50281,CGS-27023A,ZVYIZSNCEAHMCF-UNTBIKODSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,21514700,IC50,=,23,NM,,,,,,,,,,,,,,Inhibition of human MMP14 by fluorometric assay,,Synthesis and biological evaluation in U87MG glioma cells of (ethynylthiophene)sulfonamido-based hydroxamates as matrix metalloproteinase inhibitors.,Eur. J. Med. Chem.,2011,46,7,"Nuti E, Casalini F, Santamaria S, Gabelloni P, Bendinelli S, Da Pozzo E, Costa B, Marinelli L, La Pietra V, Novellino E, Margarida Bernardo M, Fridman R, Da Settimo F, Martini C, Rossello A",,753771,DTCT0024091,6000262,DTCC00514693,1252235,44948
CHEMBL514336,P50281,,MWVPZMFYJCIIFS-KDOFPFPSSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,18782669,IC50,=,3700,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP14 catalytic domain by spectrofluorimeter,,Introduction of the 4-(4-bromophenyl)benzenesulfonyl group to hydrazide analogs of Ilomastat leads to potent gelatinase B (MMP-9) inhibitors with improved selectivity.,Bioorg. Med. Chem.,2008,16,18,"Ledour G, Moroy G, Rouffet M, Bourguet E, Guillaume D, Decarme M, Elmourabit H, Augé F, Alix AJ, Laronze JY, Bellon G, Hornebeck W, Sapi J",,557956,DTCT0024091,2791173,DTCC00514805,1523731,31586
CHEMBL515083,P50281,,QVAVQQVTOJMLHH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,19053764,IC50,=,1690,NM,,,,,,,,,,,,,,Inhibition of MMP14,,Dual inhibitors of matrix metalloproteinases and carbonic anhydrases: iminodiacetyl-based hydroxamate-benzenesulfonamide conjugates.,J. Med. Chem.,2008,51,24,"Marques SM, Nuti E, Rossello A, Supuran CT, Tuccinardi T, Martinelli A, Santos MA",,561990,DTCT0024091,2800894,DTCC00514691,521492,31524
CHEMBL515913,P50281,,VPPUEHXKTJJTPC-HXOBKFHXSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,18782669,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP14 catalytic domain by spectrofluorimeter,,Introduction of the 4-(4-bromophenyl)benzenesulfonyl group to hydrazide analogs of Ilomastat leads to potent gelatinase B (MMP-9) inhibitors with improved selectivity.,Bioorg. Med. Chem.,2008,16,18,"Ledour G, Moroy G, Rouffet M, Bourguet E, Guillaume D, Decarme M, Elmourabit H, Augé F, Alix AJ, Laronze JY, Bellon G, Hornebeck W, Sapi J",,557956,DTCT0024091,2791168,DTCC00514744,1938097,31586
CHEMBL515980,P50281,,KBZNOZAJAJRTII-GOSISDBHSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,19053764,IC50,=,3.9,NM,,,,,,,,,,,,,,Inhibition of MMP14,,Dual inhibitors of matrix metalloproteinases and carbonic anhydrases: iminodiacetyl-based hydroxamate-benzenesulfonamide conjugates.,J. Med. Chem.,2008,51,24,"Marques SM, Nuti E, Rossello A, Supuran CT, Tuccinardi T, Martinelli A, Santos MA",,561990,DTCT0024091,2800830,DTCC00562382,2004561,31524
CHEMBL520785,P50281,,VALKNOMNTXYCBM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,18790648,KI,=,210,NM,,,,,,,,,,,,,,Inhibition of MMP14,,Specific targeting of metzincin family members with small-molecule inhibitors: progress toward a multifarious challenge.,Bioorg. Med. Chem.,2008,16,19,"Georgiadis D, Yiotakis A",,497410,DTCT0024091,2457360,DTCC00115943,1535639,32556
CHEMBL522422,P50281,,JOBBURWSJZOPNT-VGSWGCGISA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,18782669,IC50,=,730,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP14 catalytic domain by spectrofluorimeter,,Introduction of the 4-(4-bromophenyl)benzenesulfonyl group to hydrazide analogs of Ilomastat leads to potent gelatinase B (MMP-9) inhibitors with improved selectivity.,Bioorg. Med. Chem.,2008,16,18,"Ledour G, Moroy G, Rouffet M, Bourguet E, Guillaume D, Decarme M, Elmourabit H, Augé F, Alix AJ, Laronze JY, Bellon G, Hornebeck W, Sapi J",,557956,DTCT0024091,2791179,DTCC00514879,196493,31586
CHEMBL523034,P50281,,MKAIHDAGQJQAHA-KRWDZBQOSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,19278250,IC50,=,1100,NM,,,,,,,,,,,,,,Inhibition of human MMP14,,"A selective matrix metalloprotease 12 inhibitor for potential treatment of chronic obstructive pulmonary disease (COPD): discovery of (S)-2-(8-(methoxycarbonylamino)dibenzo[b,d]furan-3-sulfonamido)-3-methylbutanoic acid (MMP408).",J. Med. Chem.,2009,52,7,"Li W, Li J, Wu Y, Wu J, Hotchandani R, Cunningham K, McFadyen I, Bard J, Morgan P, Schlerman F, Xu X, Tam S, Goldman SJ, Williams C, Sypek J, Mansour TS",,566466,DTCT0024091,2482794,DTCC00534180,682924,33018
CHEMBL523999,P50281,,DPSWSNHGVDSGPZ-HXOBKFHXSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,18782669,IC50,=,1500,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP14 catalytic domain by spectrofluorimeter,,Introduction of the 4-(4-bromophenyl)benzenesulfonyl group to hydrazide analogs of Ilomastat leads to potent gelatinase B (MMP-9) inhibitors with improved selectivity.,Bioorg. Med. Chem.,2008,16,18,"Ledour G, Moroy G, Rouffet M, Bourguet E, Guillaume D, Decarme M, Elmourabit H, Augé F, Alix AJ, Laronze JY, Bellon G, Hornebeck W, Sapi J",,557956,DTCT0024091,2791174,DTCC00514875,9816,31586
CHEMBL527018,P50281,,SFVPXERGVLDWIS-OAQYLSRUSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,19410464,IC50,=,6820,NM,,,,,,,,,,,,,,Inhibition of MMP14 by FLIPR assay,,Synthesis and activity of tryptophan sulfonamide derivatives as novel non-hydroxamate TNF-alpha converting enzyme (TACE) inhibitors.,Bioorg. Med. Chem.,2009,17,11,"Park K, Gopalsamy A, Aplasca A, Ellingboe JW, Xu W, Zhang Y, Levin JI",,545900,DTCT0024091,2499020,DTCC00117362,132799,33915
CHEMBL550038,P50281,,FWPVXLYOKAOERT-SFHVURJKSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,19725580,IC50,=,2250,NM,,,,,,,,,,,,,,Inhibition of human MMP14,,Identification of an orally efficacious matrix metalloprotease 12 inhibitor for potential treatment of asthma.,J. Med. Chem.,2009,52,17,"Li W, Li J, Wu Y, Rancati F, Vallese S, Raveglia L, Wu J, Hotchandani R, Fuller N, Cunningham K, Morgan P, Fish S, Krykbaev R, Xu X, Tam S, Goldman SJ, Abraham W, Williams C, Sypek J, Mansour TS",,579259,DTCT0024091,2894755,DTCC00589403,941987,34869
CHEMBL550081,P50281,,RPWGPXSVYLHGRZ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,19606871,IC50,=,320,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP14,,"N-O-isopropyl sulfonamido-based hydroxamates: design, synthesis and biological evaluation of selective matrix metalloproteinase-13 inhibitors as potential therapeutic agents for osteoarthritis.",J. Med. Chem.,2009,52,15,"Nuti E, Casalini F, Avramova SI, Santamaria S, Cercignani G, Marinelli L, La Pietra V, Novellino E, Orlandini E, Nencetti S, Tuccinardi T, Martinelli A, Lim NH, Visse R, Nagase H, Rossello A",,571087,DTCT0024091,2859506,DTCC00590514,489960,34421
CHEMBL550148,P50281,,NKGRTRASISLCCZ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,19606871,IC50,=,70,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP14,,"N-O-isopropyl sulfonamido-based hydroxamates: design, synthesis and biological evaluation of selective matrix metalloproteinase-13 inhibitors as potential therapeutic agents for osteoarthritis.",J. Med. Chem.,2009,52,15,"Nuti E, Casalini F, Avramova SI, Santamaria S, Cercignani G, Marinelli L, La Pietra V, Novellino E, Orlandini E, Nencetti S, Tuccinardi T, Martinelli A, Lim NH, Visse R, Nagase H, Rossello A",,571087,DTCT0024091,2859505,DTCC00592085,1588878,34421
CHEMBL550148,P50281,,NKGRTRASISLCCZ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,20180536,IC50,=,70,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP14 by fluorometric assay,,Potent arylsulfonamide inhibitors of tumor necrosis factor-alpha converting enzyme able to reduce activated leukocyte cell adhesion molecule shedding in cancer cell models.,J. Med. Chem.,2010,53,6,"Nuti E, Casalini F, Avramova SI, Santamaria S, Fabbi M, Ferrini S, Marinelli L, La Pietra V, Limongelli V, Novellino E, Cercignani G, Orlandini E, Nencetti S, Rossello A",,624095,DTCT0024091,3286000,DTCC00592085,1601175,38228
CHEMBL550350,P50281,,DKTYDWAJILHINP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,19606871,IC50,=,3400,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP14,,"N-O-isopropyl sulfonamido-based hydroxamates: design, synthesis and biological evaluation of selective matrix metalloproteinase-13 inhibitors as potential therapeutic agents for osteoarthritis.",J. Med. Chem.,2009,52,15,"Nuti E, Casalini F, Avramova SI, Santamaria S, Cercignani G, Marinelli L, La Pietra V, Novellino E, Orlandini E, Nencetti S, Tuccinardi T, Martinelli A, Lim NH, Visse R, Nagase H, Rossello A",,571087,DTCT0024091,2859509,DTCC00592090,1653714,34421
CHEMBL550548,P50281,,UTCUOTDVVXFCLJ-AREMUKBSSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,19606871,IC50,=,14000,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP14,,"N-O-isopropyl sulfonamido-based hydroxamates: design, synthesis and biological evaluation of selective matrix metalloproteinase-13 inhibitors as potential therapeutic agents for osteoarthritis.",J. Med. Chem.,2009,52,15,"Nuti E, Casalini F, Avramova SI, Santamaria S, Cercignani G, Marinelli L, La Pietra V, Novellino E, Orlandini E, Nencetti S, Tuccinardi T, Martinelli A, Lim NH, Visse R, Nagase H, Rossello A",,571087,DTCT0024091,2859516,DTCC00592094,327760,34421
CHEMBL550628,P50281,,FRFSAUPOCJTACG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,19606871,IC50,=,11000,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP14,,"N-O-isopropyl sulfonamido-based hydroxamates: design, synthesis and biological evaluation of selective matrix metalloproteinase-13 inhibitors as potential therapeutic agents for osteoarthritis.",J. Med. Chem.,2009,52,15,"Nuti E, Casalini F, Avramova SI, Santamaria S, Cercignani G, Marinelli L, La Pietra V, Novellino E, Orlandini E, Nencetti S, Tuccinardi T, Martinelli A, Lim NH, Visse R, Nagase H, Rossello A",,571087,DTCT0024091,2859512,DTCC00589012,1038878,34421
CHEMBL551312,P50281,,WVRDOLPMKOCJRJ-KNQAVFIVSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,19524436,IC50,=,3100,NM,,,,,,,,,,,,,,Inhibition of human recombinant MT1-MMP expressed in Escherichia coli by fluorogenic peptide cleavage assay,,Regioselective synthesis of methylated epigallocatechin gallate via nitrobenzenesulfonyl (Ns) protecting group.,Bioorg. Med. Chem. Lett.,2009,19,15,"Aihara Y, Yoshida A, Furuta T, Wakimoto T, Akizawa T, Konishi M, Kan T",,579664,DTCT0024091,2894230,DTCC00590911,791478,35073
CHEMBL551313,P50281,,BMJHAAZDURGGSC-CTNGQTDRSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,19524436,IC50,=,10500,NM,,,,,,,,,,,,,,Inhibition of human recombinant MT1-MMP expressed in Escherichia coli by fluorogenic peptide cleavage assay,,Regioselective synthesis of methylated epigallocatechin gallate via nitrobenzenesulfonyl (Ns) protecting group.,Bioorg. Med. Chem. Lett.,2009,19,15,"Aihara Y, Yoshida A, Furuta T, Wakimoto T, Akizawa T, Konishi M, Kan T",,579664,DTCT0024091,2894233,DTCC00590912,1017954,35073
CHEMBL55371,P50281,,IXFMBXNLOHKCPT-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,24071448,IC50,=,40000,NM,,,,,,,,,,,,,,Inhibition of MMP14 catalytic domain (unknown origin) using Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 as substrate incubated for 30 mins prior to substrate addition measured after 2 to 4 hrs by fluorometric assay,,Arylamino methylene bisphosphonate derivatives as bone seeking matrix metalloproteinase inhibitors.,Bioorg. Med. Chem.,2013,21,21,"Tauro M, Laghezza A, Loiodice F, Agamennone M, Campestre C, Tortorella P",,990167,DTCT0024091,12628971,DTCC00200900,383980,56259
CHEMBL556277,P50281,,XGTBMCGGGJLOPS-RBBKRZOGSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,19524436,IC50,=,52000,NM,,,,,,,,,,,,,,Inhibition of human recombinant MT1-MMP expressed in Escherichia coli by fluorogenic peptide cleavage assay,,Regioselective synthesis of methylated epigallocatechin gallate via nitrobenzenesulfonyl (Ns) protecting group.,Bioorg. Med. Chem. Lett.,2009,19,15,"Aihara Y, Yoshida A, Furuta T, Wakimoto T, Akizawa T, Konishi M, Kan T",,579664,DTCT0024091,2894236,DTCC00594139,1148018,35073
CHEMBL556645,P50281,,KNWGEVZOUCQOLE-VWLOTQADSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,19625186,IC50,=,5450,NM,,,,,,,,,,,,,,Inhibition of MMP14,,"3,4-Disubstituted benzofuran P1' MMP-13 inhibitors: optimization of selectivity and reduction of protein binding.",Bioorg. Med. Chem. Lett.,2009,19,16,"Li W, Hu Y, Li J, Thomason JR, DeVincentis D, Du X, Wu J, Hotchandani R, Rush TS, Skotnicki JS, Tam S, Chockalingam PS, Morris EA, Levin JI",,581474,DTCT0024091,2904572,DTCC00593100,651477,35265
CHEMBL556692,P50281,,BXDRTHBTGNNTEW-LEWJYISDSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,19524436,IC50,>,100000,NM,,,,,,,,,,,,,,Inhibition of human recombinant MT1-MMP expressed in Escherichia coli by fluorogenic peptide cleavage assay,,Regioselective synthesis of methylated epigallocatechin gallate via nitrobenzenesulfonyl (Ns) protecting group.,Bioorg. Med. Chem. Lett.,2009,19,15,"Aihara Y, Yoshida A, Furuta T, Wakimoto T, Akizawa T, Konishi M, Kan T",,579664,DTCT0024091,2894239,DTCC00594148,1471297,35073
CHEMBL559294,P50281,,BMJHAAZDURGGSC-TZIWHRDSSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,19524436,IC50,=,12500,NM,,,,,,,,,,,,,,Inhibition of human recombinant MT1-MMP expressed in Escherichia coli by fluorogenic peptide cleavage assay,,Regioselective synthesis of methylated epigallocatechin gallate via nitrobenzenesulfonyl (Ns) protecting group.,Bioorg. Med. Chem. Lett.,2009,19,15,"Aihara Y, Yoshida A, Furuta T, Wakimoto T, Akizawa T, Konishi M, Kan T",,579664,DTCT0024091,2894220,DTCC00594129,1789127,35073
CHEMBL560837,P50281,,LBKCSOUMADYGHM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,19606871,IC50,=,1000,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP14,,"N-O-isopropyl sulfonamido-based hydroxamates: design, synthesis and biological evaluation of selective matrix metalloproteinase-13 inhibitors as potential therapeutic agents for osteoarthritis.",J. Med. Chem.,2009,52,15,"Nuti E, Casalini F, Avramova SI, Santamaria S, Cercignani G, Marinelli L, La Pietra V, Novellino E, Orlandini E, Nencetti S, Tuccinardi T, Martinelli A, Lim NH, Visse R, Nagase H, Rossello A",,571087,DTCT0024091,2859507,DTCC00122971,1717205,34421
CHEMBL561036,P50281,,HZTQDRLCDGHQSA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,19606871,IC50,=,5500,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP14,,"N-O-isopropyl sulfonamido-based hydroxamates: design, synthesis and biological evaluation of selective matrix metalloproteinase-13 inhibitors as potential therapeutic agents for osteoarthritis.",J. Med. Chem.,2009,52,15,"Nuti E, Casalini F, Avramova SI, Santamaria S, Cercignani G, Marinelli L, La Pietra V, Novellino E, Orlandini E, Nencetti S, Tuccinardi T, Martinelli A, Lim NH, Visse R, Nagase H, Rossello A",,571087,DTCT0024091,2859508,DTCC00122972,748051,34421
CHEMBL561038,P50281,,WVAIZSKMOMDPIT-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,19606871,IC50,=,590,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP14,,"N-O-isopropyl sulfonamido-based hydroxamates: design, synthesis and biological evaluation of selective matrix metalloproteinase-13 inhibitors as potential therapeutic agents for osteoarthritis.",J. Med. Chem.,2009,52,15,"Nuti E, Casalini F, Avramova SI, Santamaria S, Cercignani G, Marinelli L, La Pietra V, Novellino E, Orlandini E, Nencetti S, Tuccinardi T, Martinelli A, Lim NH, Visse R, Nagase H, Rossello A",,571087,DTCT0024091,2859511,DTCC00122975,910381,34421
CHEMBL561039,P50281,,KJDPTHLLJDQIMT-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,19606871,IC50,=,2400,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP14,,"N-O-isopropyl sulfonamido-based hydroxamates: design, synthesis and biological evaluation of selective matrix metalloproteinase-13 inhibitors as potential therapeutic agents for osteoarthritis.",J. Med. Chem.,2009,52,15,"Nuti E, Casalini F, Avramova SI, Santamaria S, Cercignani G, Marinelli L, La Pietra V, Novellino E, Orlandini E, Nencetti S, Tuccinardi T, Martinelli A, Lim NH, Visse R, Nagase H, Rossello A",,571087,DTCT0024091,2859514,DTCC00122976,715703,34421
CHEMBL561625,P50281,,PZJJOMPTIHBGHO-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,19606871,IC50,=,530,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP14,,"N-O-isopropyl sulfonamido-based hydroxamates: design, synthesis and biological evaluation of selective matrix metalloproteinase-13 inhibitors as potential therapeutic agents for osteoarthritis.",J. Med. Chem.,2009,52,15,"Nuti E, Casalini F, Avramova SI, Santamaria S, Cercignani G, Marinelli L, La Pietra V, Novellino E, Orlandini E, Nencetti S, Tuccinardi T, Martinelli A, Lim NH, Visse R, Nagase H, Rossello A",,571087,DTCT0024091,2859504,DTCC00587403,1492221,34421
CHEMBL561625,P50281,,PZJJOMPTIHBGHO-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,20180536,IC50,=,530,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP14 by fluorometric assay,,Potent arylsulfonamide inhibitors of tumor necrosis factor-alpha converting enzyme able to reduce activated leukocyte cell adhesion molecule shedding in cancer cell models.,J. Med. Chem.,2010,53,6,"Nuti E, Casalini F, Avramova SI, Santamaria S, Fabbi M, Ferrini S, Marinelli L, La Pietra V, Limongelli V, Novellino E, Cercignani G, Orlandini E, Nencetti S, Rossello A",,624095,DTCT0024091,3285994,DTCC00587403,1504395,38228
CHEMBL561630,P50281,,JSQUVSOHRBZSNW-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,19606871,IC50,>,1000,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP14,,"N-O-isopropyl sulfonamido-based hydroxamates: design, synthesis and biological evaluation of selective matrix metalloproteinase-13 inhibitors as potential therapeutic agents for osteoarthritis.",J. Med. Chem.,2009,52,15,"Nuti E, Casalini F, Avramova SI, Santamaria S, Cercignani G, Marinelli L, La Pietra V, Novellino E, Orlandini E, Nencetti S, Tuccinardi T, Martinelli A, Lim NH, Visse R, Nagase H, Rossello A",,571087,DTCT0024091,2859515,DTCC00587413,489961,34421
CHEMBL562003,P50281,,FSIUHCOQNBURSE-VWLOTQADSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,19625186,IC50,=,11200,NM,,,,,,,,,,,,,,Inhibition of MMP14,,"3,4-Disubstituted benzofuran P1' MMP-13 inhibitors: optimization of selectivity and reduction of protein binding.",Bioorg. Med. Chem. Lett.,2009,19,16,"Li W, Hu Y, Li J, Thomason JR, DeVincentis D, Du X, Wu J, Hotchandani R, Rush TS, Skotnicki JS, Tam S, Chockalingam PS, Morris EA, Levin JI",,581474,DTCT0024091,2904571,DTCC00586782,1071452,35265
CHEMBL562716,P50281,,WVRDOLPMKOCJRJ-DENIHFKCSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,19524436,IC50,=,1700,NM,,,,,,,,,,,,,,Inhibition of human recombinant MT1-MMP expressed in Escherichia coli by fluorogenic peptide cleavage assay,,Regioselective synthesis of methylated epigallocatechin gallate via nitrobenzenesulfonyl (Ns) protecting group.,Bioorg. Med. Chem. Lett.,2009,19,15,"Aihara Y, Yoshida A, Furuta T, Wakimoto T, Akizawa T, Konishi M, Kan T",,579664,DTCT0024091,2894217,DTCC00590907,1789126,35073
CHEMBL563026,P50281,,MRYXWLVKWYVRPC-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,19606871,IC50,=,6500,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP14,,"N-O-isopropyl sulfonamido-based hydroxamates: design, synthesis and biological evaluation of selective matrix metalloproteinase-13 inhibitors as potential therapeutic agents for osteoarthritis.",J. Med. Chem.,2009,52,15,"Nuti E, Casalini F, Avramova SI, Santamaria S, Cercignani G, Marinelli L, La Pietra V, Novellino E, Orlandini E, Nencetti S, Tuccinardi T, Martinelli A, Lim NH, Visse R, Nagase H, Rossello A",,571087,DTCT0024091,2859513,DTCC00584342,327759,34421
CHEMBL563679,P50281,,ZQBRASLBYJYZLM-CMDGGOBGSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,19606871,IC50,=,2800,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP14,,"N-O-isopropyl sulfonamido-based hydroxamates: design, synthesis and biological evaluation of selective matrix metalloproteinase-13 inhibitors as potential therapeutic agents for osteoarthritis.",J. Med. Chem.,2009,52,15,"Nuti E, Casalini F, Avramova SI, Santamaria S, Cercignani G, Marinelli L, La Pietra V, Novellino E, Orlandini E, Nencetti S, Tuccinardi T, Martinelli A, Lim NH, Visse R, Nagase H, Rossello A",,571087,DTCT0024091,2859510,DTCC00587409,425709,34421
CHEMBL567134,P50281,,VLZYXSQGILGQAI-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,19908842,IC50,=,134896.29,NM,,,,,,,,,,,,,,Inhibition of human MMP14,,"Identification and optimization of inhibitors of Trypanosomal cysteine proteases: cruzain, rhodesain, and TbCatB.",J. Med. Chem.,2010,53,1,"Mott BT, Ferreira RS, Simeonov A, Jadhav A, Ang KK, Leister W, Shen M, Silveira JT, Doyle PS, Arkin MR, McKerrow JH, Inglese J, Austin CP, Thomas CJ, Shoichet BK, Maloney DJ",,595905,DTCT0024091,3088551,DTCC00603315,791843,36416
CHEMBL567341,P50281,,SZYYBVWPURUFRR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,19908842,IC50,=,72443.6,NM,,,,,,,,,,,,,,Inhibition of human MMP14,,"Identification and optimization of inhibitors of Trypanosomal cysteine proteases: cruzain, rhodesain, and TbCatB.",J. Med. Chem.,2010,53,1,"Mott BT, Ferreira RS, Simeonov A, Jadhav A, Ang KK, Leister W, Shen M, Silveira JT, Doyle PS, Arkin MR, McKerrow JH, Inglese J, Austin CP, Thomas CJ, Shoichet BK, Maloney DJ",,595905,DTCT0024091,3088549,DTCC00603377,112206,36416
CHEMBL567893,P50281,GRASSYSTATIN A,JZYWSTGTBRHGTL-BIXXXADNSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,19715320,ACTIVITY,=,76,%,,,,,,,,,,,,,,Inhibition of MMP14 assessed as residual activity at 10 uM after 10 to 15 mins by fluorescence assay relative to control,,"Grassystatins A-C from marine cyanobacteria, potent cathepsin E inhibitors that reduce antigen presentation.",J. Med. Chem.,2009,52,18,"Kwan JC, Eksioglu EA, Liu C, Paul VJ, Luesch H",,600023,DTCT0024091,3096291,DTCC00604795,1039098,36236
CHEMBL567893,P50281,GRASSYSTATIN A,JZYWSTGTBRHGTL-BIXXXADNSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,19715320,IC50,=,5000,NM,,,,,,,,,,,,,,Inhibition of MMP14 catalytic domain after 10 to 15 mins by fluorescence assay,,"Grassystatins A-C from marine cyanobacteria, potent cathepsin E inhibitors that reduce antigen presentation.",J. Med. Chem.,2009,52,18,"Kwan JC, Eksioglu EA, Liu C, Paul VJ, Luesch H",,600080,DTCT0024091,3096348,DTCC00604795,1039098,36236
CHEMBL572780,P50281,,ZCRWOWSOWBMWGI-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,19775099,IC50,=,360,NM,,,,,,,,,,,,,,Inhibition of human recombinant pro-MMP14 catalytic domain after 4 hrs by fluorimetry,,"Design, synthesis, biological evaluation, and NMR studies of a new series of arylsulfones as selective and potent matrix metalloproteinase-12 inhibitors.",J. Med. Chem.,2009,52,20,"Nuti E, Panelli L, Casalini F, Avramova SI, Orlandini E, Santamaria S, Nencetti S, Tuccinardi T, Martinelli A, Cercignani G, D'Amelio N, Maiocchi A, Uggeri F, Rossello A",,591605,DTCT0024091,3044437,DTCC00597333,618949,35647
CHEMBL572982,P50281,,ILGSIIFHQGOKKV-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,19703773,IC50,=,36600,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP14,,The identification of beta-hydroxy carboxylic acids as selective MMP-12 inhibitors.,Bioorg. Med. Chem. Lett.,2009,19,19,"Holmes IP, Gaines S, Watson SP, Lorthioir O, Walker A, Baddeley SJ, Herbert S, Egan D, Convery MA, Singh OM, Gross JW, Strelow JM, Smith RH, Amour AJ, Brown D, Martin SL",,592286,DTCT0024091,3044616,DTCC00598166,824314,35947
CHEMBL572982,P50281,,ILGSIIFHQGOKKV-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,19703773,IC50,=,43500,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP14,,The identification of beta-hydroxy carboxylic acids as selective MMP-12 inhibitors.,Bioorg. Med. Chem. Lett.,2009,19,19,"Holmes IP, Gaines S, Watson SP, Lorthioir O, Walker A, Baddeley SJ, Herbert S, Egan D, Convery MA, Singh OM, Gross JW, Strelow JM, Smith RH, Amour AJ, Brown D, Martin SL",,592286,DTCT0024091,3044618,DTCC00598166,824313,35947
CHEMBL572982,P50281,,ILGSIIFHQGOKKV-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,19703773,IC50,>,9000,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP14,,The identification of beta-hydroxy carboxylic acids as selective MMP-12 inhibitors.,Bioorg. Med. Chem. Lett.,2009,19,19,"Holmes IP, Gaines S, Watson SP, Lorthioir O, Walker A, Baddeley SJ, Herbert S, Egan D, Convery MA, Singh OM, Gross JW, Strelow JM, Smith RH, Amour AJ, Brown D, Martin SL",,592286,DTCT0024091,3044617,DTCC00598166,824315,35947
CHEMBL573714,P50281,,ITWGWXCEGHFMHT-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,19775099,IC50,=,200,NM,,,,,,,,,,,,,,Inhibition of human recombinant pro-MMP14 catalytic domain after 4 hrs by fluorimetry,,"Design, synthesis, biological evaluation, and NMR studies of a new series of arylsulfones as selective and potent matrix metalloproteinase-12 inhibitors.",J. Med. Chem.,2009,52,20,"Nuti E, Panelli L, Casalini F, Avramova SI, Orlandini E, Santamaria S, Nencetti S, Tuccinardi T, Martinelli A, Cercignani G, D'Amelio N, Maiocchi A, Uggeri F, Rossello A",,591605,DTCT0024091,3044425,DTCC00597369,1427807,35647
CHEMBL573715,P50281,,YOMXWXIANUYIMH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,19775099,IC50,=,33,NM,,,,,,,,,,,,,,Inhibition of human recombinant pro-MMP14 catalytic domain after 4 hrs by fluorimetry,,"Design, synthesis, biological evaluation, and NMR studies of a new series of arylsulfones as selective and potent matrix metalloproteinase-12 inhibitors.",J. Med. Chem.,2009,52,20,"Nuti E, Panelli L, Casalini F, Avramova SI, Orlandini E, Santamaria S, Nencetti S, Tuccinardi T, Martinelli A, Cercignani G, D'Amelio N, Maiocchi A, Uggeri F, Rossello A",,591605,DTCT0024091,3044402,DTCC00597370,1297783,35647
CHEMBL573934,P50281,,OREDIHYKGISTDR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,19775099,IC50,=,1300,NM,,,,,,,,,,,,,,Inhibition of human recombinant pro-MMP14 catalytic domain after 4 hrs by fluorimetry,,"Design, synthesis, biological evaluation, and NMR studies of a new series of arylsulfones as selective and potent matrix metalloproteinase-12 inhibitors.",J. Med. Chem.,2009,52,20,"Nuti E, Panelli L, Casalini F, Avramova SI, Orlandini E, Santamaria S, Nencetti S, Tuccinardi T, Martinelli A, Cercignani G, D'Amelio N, Maiocchi A, Uggeri F, Rossello A",,591605,DTCT0024091,3044469,DTCC00597353,327896,35647
CHEMBL573935,P50281,,HGICQEUHJFERNR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,19775099,IC50,=,5400,NM,,,,,,,,,,,,,,Inhibition of human recombinant pro-MMP14 catalytic domain after 4 hrs by fluorimetry,,"Design, synthesis, biological evaluation, and NMR studies of a new series of arylsulfones as selective and potent matrix metalloproteinase-12 inhibitors.",J. Med. Chem.,2009,52,20,"Nuti E, Panelli L, Casalini F, Avramova SI, Orlandini E, Santamaria S, Nencetti S, Tuccinardi T, Martinelli A, Cercignani G, D'Amelio N, Maiocchi A, Uggeri F, Rossello A",,591605,DTCT0024091,3044490,DTCC00597354,393223,35647
CHEMBL573936,P50281,,FIPYOKGRSDJCAR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,19775099,IC50,=,740,NM,,,,,,,,,,,,,,Inhibition of human recombinant pro-MMP14 catalytic domain after 4 hrs by fluorimetry,,"Design, synthesis, biological evaluation, and NMR studies of a new series of arylsulfones as selective and potent matrix metalloproteinase-12 inhibitors.",J. Med. Chem.,2009,52,20,"Nuti E, Panelli L, Casalini F, Avramova SI, Orlandini E, Santamaria S, Nencetti S, Tuccinardi T, Martinelli A, Cercignani G, D'Amelio N, Maiocchi A, Uggeri F, Rossello A",,591605,DTCT0024091,3044453,DTCC00597355,1427806,35647
CHEMBL574370,P50281,,YYBFXMXFWMJGLB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,19775099,IC50,=,940,NM,,,,,,,,,,,,,,Inhibition of human recombinant pro-MMP14 catalytic domain after 4 hrs by fluorimetry,,"Design, synthesis, biological evaluation, and NMR studies of a new series of arylsulfones as selective and potent matrix metalloproteinase-12 inhibitors.",J. Med. Chem.,2009,52,20,"Nuti E, Panelli L, Casalini F, Avramova SI, Orlandini E, Santamaria S, Nencetti S, Tuccinardi T, Martinelli A, Cercignani G, D'Amelio N, Maiocchi A, Uggeri F, Rossello A",,591605,DTCT0024091,3044457,DTCC00597263,12430,35647
CHEMBL574589,P50281,,WQRJSSRVHCJAKB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,19775099,IC50,=,8300,NM,,,,,,,,,,,,,,Inhibition of human recombinant pro-MMP14 catalytic domain after 4 hrs by fluorimetry,,"Design, synthesis, biological evaluation, and NMR studies of a new series of arylsulfones as selective and potent matrix metalloproteinase-12 inhibitors.",J. Med. Chem.,2009,52,20,"Nuti E, Panelli L, Casalini F, Avramova SI, Orlandini E, Santamaria S, Nencetti S, Tuccinardi T, Martinelli A, Cercignani G, D'Amelio N, Maiocchi A, Uggeri F, Rossello A",,591605,DTCT0024091,3044501,DTCC00597341,1071501,35647
CHEMBL574605,P50281,,CPUBMGYGVNFLPZ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,19775099,IC50,=,860,NM,,,,,,,,,,,,,,Inhibition of human recombinant pro-MMP14 catalytic domain after 4 hrs by fluorimetry,,"Design, synthesis, biological evaluation, and NMR studies of a new series of arylsulfones as selective and potent matrix metalloproteinase-12 inhibitors.",J. Med. Chem.,2009,52,20,"Nuti E, Panelli L, Casalini F, Avramova SI, Orlandini E, Santamaria S, Nencetti S, Tuccinardi T, Martinelli A, Cercignani G, D'Amelio N, Maiocchi A, Uggeri F, Rossello A",,591605,DTCT0024091,3044454,DTCC00597298,327895,35647
CHEMBL575881,P50281,,ABXUEPSHNXWTBZ-LJQANCHMSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,19775099,IC50,=,10000,NM,,,,,,,,,,,,,,Inhibition of human recombinant pro-MMP14 catalytic domain after 4 hrs by fluorimetry,,"Design, synthesis, biological evaluation, and NMR studies of a new series of arylsulfones as selective and potent matrix metalloproteinase-12 inhibitors.",J. Med. Chem.,2009,52,20,"Nuti E, Panelli L, Casalini F, Avramova SI, Orlandini E, Santamaria S, Nencetti S, Tuccinardi T, Martinelli A, Cercignani G, D'Amelio N, Maiocchi A, Uggeri F, Rossello A",,591605,DTCT0024091,3044918,DTCC00597225,1653861,35647
CHEMBL575895,P50281,,QPFIKHZWPMXTRS-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,19775099,IC50,=,25000,NM,,,,,,,,,,,,,,Inhibition of human recombinant pro-MMP14 catalytic domain after 4 hrs by fluorimetry,,"Design, synthesis, biological evaluation, and NMR studies of a new series of arylsulfones as selective and potent matrix metalloproteinase-12 inhibitors.",J. Med. Chem.,2009,52,20,"Nuti E, Panelli L, Casalini F, Avramova SI, Orlandini E, Santamaria S, Nencetti S, Tuccinardi T, Martinelli A, Cercignani G, D'Amelio N, Maiocchi A, Uggeri F, Rossello A",,591605,DTCT0024091,3044514,DTCC00597330,1427805,35647
CHEMBL575896,P50281,,MYZHQACPXTZCJY-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,19775099,IC50,=,1300,NM,,,,,,,,,,,,,,Inhibition of human recombinant pro-MMP14 catalytic domain after 4 hrs by fluorimetry,,"Design, synthesis, biological evaluation, and NMR studies of a new series of arylsulfones as selective and potent matrix metalloproteinase-12 inhibitors.",J. Med. Chem.,2009,52,20,"Nuti E, Panelli L, Casalini F, Avramova SI, Orlandini E, Santamaria S, Nencetti S, Tuccinardi T, Martinelli A, Cercignani G, D'Amelio N, Maiocchi A, Uggeri F, Rossello A",,591605,DTCT0024091,3044465,DTCC00597331,554423,35647
CHEMBL575945,P50281,,VDQPKRPHLSTBEH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,21413800,IC50,=,2.8,UG.ML-1,,,,,,,,,,,,,,Inhibition of MMP14 using MOCAc-Pro-Leu-Gly-Leu-A2pr(Dnp)-Ala-Arg- NH2 as substrate preincubated for 10 mins measured after 3 hrs by fluorescence assay,,A one-pot synthesis and biological activity of ageladine A and analogues.,J. Med. Chem.,2011,54,7,"Shengule SR, Loa-Kum-Cheung WL, Parish CR, Blairvacq M, Meijer L, Nakao Y, Karuso P",,853831,DTCT0024091,11368675,DTCC00609550,219391,50935
CHEMBL576762,P50281,,RPBGCJQDVJCGSK-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,19775099,IC50,=,120000,NM,,,,,,,,,,,,,,Inhibition of human recombinant pro-MMP14 catalytic domain after 4 hrs by fluorimetry,,"Design, synthesis, biological evaluation, and NMR studies of a new series of arylsulfones as selective and potent matrix metalloproteinase-12 inhibitors.",J. Med. Chem.,2009,52,20,"Nuti E, Panelli L, Casalini F, Avramova SI, Orlandini E, Santamaria S, Nencetti S, Tuccinardi T, Martinelli A, Cercignani G, D'Amelio N, Maiocchi A, Uggeri F, Rossello A",,591605,DTCT0024091,3044535,DTCC00597340,1265255,35647
CHEMBL578159,P50281,,VMJFQUMKCMNFSX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,19908842,IC50,=,426579.52,NM,,,,,,,,,,,,,,Inhibition of human MMP14,,"Identification and optimization of inhibitors of Trypanosomal cysteine proteases: cruzain, rhodesain, and TbCatB.",J. Med. Chem.,2010,53,1,"Mott BT, Ferreira RS, Simeonov A, Jadhav A, Ang KK, Leister W, Shen M, Silveira JT, Doyle PS, Arkin MR, McKerrow JH, Inglese J, Austin CP, Thomas CJ, Shoichet BK, Maloney DJ",,595905,DTCT0024091,3088550,DTCC00603378,1342410,36416
CHEMBL579067,P50281,,YMAXKJGQKQACFZ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,19775099,IC50,=,8100,NM,,,,,,,,,,,,,,Inhibition of human recombinant pro-MMP14 catalytic domain after 4 hrs by fluorimetry,,"Design, synthesis, biological evaluation, and NMR studies of a new series of arylsulfones as selective and potent matrix metalloproteinase-12 inhibitors.",J. Med. Chem.,2009,52,20,"Nuti E, Panelli L, Casalini F, Avramova SI, Orlandini E, Santamaria S, Nencetti S, Tuccinardi T, Martinelli A, Cercignani G, D'Amelio N, Maiocchi A, Uggeri F, Rossello A",,591605,DTCT0024091,3044500,DTCC00597343,812562,35647
CHEMBL579068,P50281,,HSMGGAWDRKACFW-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,19775099,IC50,=,18000,NM,,,,,,,,,,,,,,Inhibition of human recombinant pro-MMP14 catalytic domain after 4 hrs by fluorimetry,,"Design, synthesis, biological evaluation, and NMR studies of a new series of arylsulfones as selective and potent matrix metalloproteinase-12 inhibitors.",J. Med. Chem.,2009,52,20,"Nuti E, Panelli L, Casalini F, Avramova SI, Orlandini E, Santamaria S, Nencetti S, Tuccinardi T, Martinelli A, Cercignani G, D'Amelio N, Maiocchi A, Uggeri F, Rossello A",,591605,DTCT0024091,3044507,DTCC00597380,1842555,35647
CHEMBL584122,P50281,,OAJUMLCSJOEUON-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,19775099,IC50,=,4000,NM,,,,,,,,,,,,,,Inhibition of human recombinant pro-MMP14 catalytic domain after 4 hrs by fluorimetry,,"Design, synthesis, biological evaluation, and NMR studies of a new series of arylsulfones as selective and potent matrix metalloproteinase-12 inhibitors.",J. Med. Chem.,2009,52,20,"Nuti E, Panelli L, Casalini F, Avramova SI, Orlandini E, Santamaria S, Nencetti S, Tuccinardi T, Martinelli A, Cercignani G, D'Amelio N, Maiocchi A, Uggeri F, Rossello A",,591605,DTCT0024091,3044484,DTCC00597332,715843,35647
CHEMBL584147,P50281,,XORCBTCEBZUVES-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,19775099,IC50,=,2100,NM,,,,,,,,,,,,,,Inhibition of human recombinant pro-MMP14 catalytic domain after 4 hrs by fluorimetry,,"Design, synthesis, biological evaluation, and NMR studies of a new series of arylsulfones as selective and potent matrix metalloproteinase-12 inhibitors.",J. Med. Chem.,2009,52,20,"Nuti E, Panelli L, Casalini F, Avramova SI, Orlandini E, Santamaria S, Nencetti S, Tuccinardi T, Martinelli A, Cercignani G, D'Amelio N, Maiocchi A, Uggeri F, Rossello A",,591605,DTCT0024091,3044478,DTCC00597381,2037631,35647
CHEMBL584365,P50281,,DJZNIZCARKSSDE-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,19775099,IC50,=,710,NM,,,,,,,,,,,,,,Inhibition of human recombinant pro-MMP14 catalytic domain after 4 hrs by fluorimetry,,"Design, synthesis, biological evaluation, and NMR studies of a new series of arylsulfones as selective and potent matrix metalloproteinase-12 inhibitors.",J. Med. Chem.,2009,52,20,"Nuti E, Panelli L, Casalini F, Avramova SI, Orlandini E, Santamaria S, Nencetti S, Tuccinardi T, Martinelli A, Cercignani G, D'Amelio N, Maiocchi A, Uggeri F, Rossello A",,591605,DTCT0024091,3044448,DTCC00597271,165336,35647
CHEMBL585376,P50281,,BZWDHUMJSSLVCR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,19775099,IC50,=,77000,NM,,,,,,,,,,,,,,Inhibition of human recombinant pro-MMP14 catalytic domain after 4 hrs by fluorimetry,,"Design, synthesis, biological evaluation, and NMR studies of a new series of arylsulfones as selective and potent matrix metalloproteinase-12 inhibitors.",J. Med. Chem.,2009,52,20,"Nuti E, Panelli L, Casalini F, Avramova SI, Orlandini E, Santamaria S, Nencetti S, Tuccinardi T, Martinelli A, Cercignani G, D'Amelio N, Maiocchi A, Uggeri F, Rossello A",,591605,DTCT0024091,3044531,DTCC00597342,100632,35647
CHEMBL589710,P50281,,FIGGEGWDYUINOK-ULKIPEBDSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,20060717,RATIO,=,69,,,,,,,,,,,,,,,Ratio Kcat to Ki for MMP14,,Discovery of matrix metalloproteases selective and activated peptide-doxorubicin prodrugs as anti-tumor agents.,Bioorg. Med. Chem. Lett.,2010,20,3,"Hu Z, Jiang X, Albright CF, Graciani N, Yue E, Zhang M, Zhang SY, Bruckner R, Diamond M, Dowling R, Rafalski M, Yeleswaram S, Trainor GL, Seitz SP, Han W",,609255,DTCT0024091,3180383,DTCC00620088,1395728,37498
CHEMBL589760,P50281,,QLPKUSVWQWRECK-LLRGJTHUSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,20060717,RATIO,=,4,,,,,,,,,,,,,,,Ratio Kcat to Ki for MMP14,,Discovery of matrix metalloproteases selective and activated peptide-doxorubicin prodrugs as anti-tumor agents.,Bioorg. Med. Chem. Lett.,2010,20,3,"Hu Z, Jiang X, Albright CF, Graciani N, Yue E, Zhang M, Zhang SY, Bruckner R, Diamond M, Dowling R, Rafalski M, Yeleswaram S, Trainor GL, Seitz SP, Han W",,609255,DTCT0024091,3180387,DTCC00620083,1654132,37498
CHEMBL589761,P50281,,YVQBEOXREDVQBP-VTBTYGGHSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,20060717,RATIO,>,120,,,,,,,,,,,,,,,Ratio Kcat to Ki for MMP14,,Discovery of matrix metalloproteases selective and activated peptide-doxorubicin prodrugs as anti-tumor agents.,Bioorg. Med. Chem. Lett.,2010,20,3,"Hu Z, Jiang X, Albright CF, Graciani N, Yue E, Zhang M, Zhang SY, Bruckner R, Diamond M, Dowling R, Rafalski M, Yeleswaram S, Trainor GL, Seitz SP, Han W",,609255,DTCT0024091,3180384,DTCC00620086,1039311,37498
CHEMBL589762,P50281,,WHZAMGQVPGHHBH-HKPJPKSRSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,20060717,RATIO,>,120,,,,,,,,,,,,,,,Ratio Kcat to Ki for MMP14,,Discovery of matrix metalloproteases selective and activated peptide-doxorubicin prodrugs as anti-tumor agents.,Bioorg. Med. Chem. Lett.,2010,20,3,"Hu Z, Jiang X, Albright CF, Graciani N, Yue E, Zhang M, Zhang SY, Bruckner R, Diamond M, Dowling R, Rafalski M, Yeleswaram S, Trainor GL, Seitz SP, Han W",,609255,DTCT0024091,3180380,DTCC00620092,1200301,37498
CHEMBL589763,P50281,,CQUQBNMIEIDWPI-LDNUBHSTSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,20060717,RATIO,=,62,,,,,,,,,,,,,,,Ratio Kcat to Ki for MMP14,,Discovery of matrix metalloproteases selective and activated peptide-doxorubicin prodrugs as anti-tumor agents.,Bioorg. Med. Chem. Lett.,2010,20,3,"Hu Z, Jiang X, Albright CF, Graciani N, Yue E, Zhang M, Zhang SY, Bruckner R, Diamond M, Dowling R, Rafalski M, Yeleswaram S, Trainor GL, Seitz SP, Han W",,609255,DTCT0024091,3180377,DTCC00620095,1136717,37498
CHEMBL589764,P50281,,UEBHASPTCLODRO-FNYWWBFVSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,20060717,RATIO,=,97,,,,,,,,,,,,,,,Ratio Kcat to Ki for MMP14,,Discovery of matrix metalloproteases selective and activated peptide-doxorubicin prodrugs as anti-tumor agents.,Bioorg. Med. Chem. Lett.,2010,20,3,"Hu Z, Jiang X, Albright CF, Graciani N, Yue E, Zhang M, Zhang SY, Bruckner R, Diamond M, Dowling R, Rafalski M, Yeleswaram S, Trainor GL, Seitz SP, Han W",,609255,DTCT0024091,3180371,DTCC00620101,1778015,37498
CHEMBL589886,P50281,,CWUJMCRFVRZWMX-BASHDASISA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,20060717,RATIO,>,120,,,,,,,,,,,,,,,Ratio Kcat to Ki for MMP14,,Discovery of matrix metalloproteases selective and activated peptide-doxorubicin prodrugs as anti-tumor agents.,Bioorg. Med. Chem. Lett.,2010,20,3,"Hu Z, Jiang X, Albright CF, Graciani N, Yue E, Zhang M, Zhang SY, Bruckner R, Diamond M, Dowling R, Rafalski M, Yeleswaram S, Trainor GL, Seitz SP, Han W",,609255,DTCT0024091,3180365,DTCC00620107,1492589,37498
CHEMBL589996,P50281,,QDIKAYSONRRSHM-FXWROETPSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,20060717,RATIO,>,120,,,,,,,,,,,,,,,Ratio Kcat to Ki for MMP14,,Discovery of matrix metalloproteases selective and activated peptide-doxorubicin prodrugs as anti-tumor agents.,Bioorg. Med. Chem. Lett.,2010,20,3,"Hu Z, Jiang X, Albright CF, Graciani N, Yue E, Zhang M, Zhang SY, Bruckner R, Diamond M, Dowling R, Rafalski M, Yeleswaram S, Trainor GL, Seitz SP, Han W",,609255,DTCT0024091,3180370,DTCC00620102,1460098,37498
CHEMBL589997,P50281,,AKDGBIXCKDWCJO-WJCZHFNKSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,20060717,RATIO,=,97,,,,,,,,,,,,,,,Ratio Kcat to Ki for MMP14,,Discovery of matrix metalloproteases selective and activated peptide-doxorubicin prodrugs as anti-tumor agents.,Bioorg. Med. Chem. Lett.,2010,20,3,"Hu Z, Jiang X, Albright CF, Graciani N, Yue E, Zhang M, Zhang SY, Bruckner R, Diamond M, Dowling R, Rafalski M, Yeleswaram S, Trainor GL, Seitz SP, Han W",,609255,DTCT0024091,3180368,DTCC00620104,586915,37498
CHEMBL590343,P50281,,LIKQSFURRNSUMR-UKKPGEIXSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,20022498,KI,=,11000,NM,,,,,,,,,,,,,,Inhibition of MMP14,,The discovery of novel tartrate-based TNF-alpha converting enzyme (TACE) inhibitors.,Bioorg. Med. Chem. Lett.,2010,20,3,"Rosner KE, Guo Z, Orth P, Shipps GW, Belanger DB, Chan TY, Curran PJ, Dai C, Deng Y, Girijavallabhan VM, Hong L, Lavey BJ, Lee JF, Li D, Liu Z, Popovici-Muller J, Ting PC, Vaccaro H, Wang L, Wang T, Yu W, Zhou G, Niu X, Sun J, Kozlowski JA, Lundell DJ, Madison V, McKittrick B, Piwinski JJ, Shih NY, Arshad Siddiqui M, Strickland CO",,608480,DTCT0024091,3182391,DTCC00617046,100864,37349
CHEMBL591774,P50281,,LRRAUDSVXJEODP-VTVVEXCCSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,20022498,KI,=,140,NM,,,,,,,,,,,,,,Inhibition of MMP14,,The discovery of novel tartrate-based TNF-alpha converting enzyme (TACE) inhibitors.,Bioorg. Med. Chem. Lett.,2010,20,3,"Rosner KE, Guo Z, Orth P, Shipps GW, Belanger DB, Chan TY, Curran PJ, Dai C, Deng Y, Girijavallabhan VM, Hong L, Lavey BJ, Lee JF, Li D, Liu Z, Popovici-Muller J, Ting PC, Vaccaro H, Wang L, Wang T, Yu W, Zhou G, Niu X, Sun J, Kozlowski JA, Lundell DJ, Madison V, McKittrick B, Piwinski JJ, Shih NY, Arshad Siddiqui M, Strickland CO",,608480,DTCT0024091,3182392,DTCC00617111,1330626,37349
CHEMBL601266,P50281,,MPPBYRPSQFFWRI-KSEVBTLESA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,20060717,RATIO,>,120,,,,,,,,,,,,,,,Ratio Kcat to Ki for MMP14,,Discovery of matrix metalloproteases selective and activated peptide-doxorubicin prodrugs as anti-tumor agents.,Bioorg. Med. Chem. Lett.,2010,20,3,"Hu Z, Jiang X, Albright CF, Graciani N, Yue E, Zhang M, Zhang SY, Bruckner R, Diamond M, Dowling R, Rafalski M, Yeleswaram S, Trainor GL, Seitz SP, Han W",,609255,DTCT0024091,3180369,DTCC00620103,586914,37498
CHEMBL601474,P50281,,GCPDHEUDCRIVRM-DHLBNNOGSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,20060717,RATIO,=,76,,,,,,,,,,,,,,,Ratio Kcat to Ki for MMP14,,Discovery of matrix metalloproteases selective and activated peptide-doxorubicin prodrugs as anti-tumor agents.,Bioorg. Med. Chem. Lett.,2010,20,3,"Hu Z, Jiang X, Albright CF, Graciani N, Yue E, Zhang M, Zhang SY, Bruckner R, Diamond M, Dowling R, Rafalski M, Yeleswaram S, Trainor GL, Seitz SP, Han W",,609255,DTCT0024091,3180367,DTCC00620105,1039313,37498
CHEMBL601475,P50281,,KETPAISALUWJRR-OAVYBYCVSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,20060717,RATIO,=,111,,,,,,,,,,,,,,,Ratio Kcat to Ki for MMP14,,Discovery of matrix metalloproteases selective and activated peptide-doxorubicin prodrugs as anti-tumor agents.,Bioorg. Med. Chem. Lett.,2010,20,3,"Hu Z, Jiang X, Albright CF, Graciani N, Yue E, Zhang M, Zhang SY, Bruckner R, Diamond M, Dowling R, Rafalski M, Yeleswaram S, Trainor GL, Seitz SP, Han W",,609255,DTCT0024091,3180366,DTCC00620106,554715,37498
CHEMBL602301,P50281,,FHIUBRXIZJRTHF-FBVZUCIOSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,20060717,RATIO,<,1,,,,,,,,,,,,,,,Ratio Kcat to Ki for MMP14,,Discovery of matrix metalloproteases selective and activated peptide-doxorubicin prodrugs as anti-tumor agents.,Bioorg. Med. Chem. Lett.,2010,20,3,"Hu Z, Jiang X, Albright CF, Graciani N, Yue E, Zhang M, Zhang SY, Bruckner R, Diamond M, Dowling R, Rafalski M, Yeleswaram S, Trainor GL, Seitz SP, Han W",,609255,DTCT0024091,3180386,DTCC00620084,1717573,37498
CHEMBL602302,P50281,,KTAORHMSVCAETQ-UUXDBVTOSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,20060717,RATIO,=,24,,,,,,,,,,,,,,,Ratio Kcat to Ki for MMP14,,Discovery of matrix metalloproteases selective and activated peptide-doxorubicin prodrugs as anti-tumor agents.,Bioorg. Med. Chem. Lett.,2010,20,3,"Hu Z, Jiang X, Albright CF, Graciani N, Yue E, Zhang M, Zhang SY, Bruckner R, Diamond M, Dowling R, Rafalski M, Yeleswaram S, Trainor GL, Seitz SP, Han W",,609255,DTCT0024091,3180385,DTCC00620085,910784,37498
CHEMBL602303,P50281,,IUOZLSPXKIQNGM-YGSUAAAGSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,20060717,RATIO,>,120,,,,,,,,,,,,,,,Ratio Kcat to Ki for MMP14,,Discovery of matrix metalloproteases selective and activated peptide-doxorubicin prodrugs as anti-tumor agents.,Bioorg. Med. Chem. Lett.,2010,20,3,"Hu Z, Jiang X, Albright CF, Graciani N, Yue E, Zhang M, Zhang SY, Bruckner R, Diamond M, Dowling R, Rafalski M, Yeleswaram S, Trainor GL, Seitz SP, Han W",,609255,DTCT0024091,3180220,DTCC00620087,1039312,37498
CHEMBL602508,P50281,,YHPSBACDAFARBS-OMYDOWJBSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,20060717,RATIO,=,19,,,,,,,,,,,,,,,Ratio Kcat to Ki for MMP14,,Discovery of matrix metalloproteases selective and activated peptide-doxorubicin prodrugs as anti-tumor agents.,Bioorg. Med. Chem. Lett.,2010,20,3,"Hu Z, Jiang X, Albright CF, Graciani N, Yue E, Zhang M, Zhang SY, Bruckner R, Diamond M, Dowling R, Rafalski M, Yeleswaram S, Trainor GL, Seitz SP, Han W",,609255,DTCT0024091,3180381,DTCC00620090,1746071,37498
CHEMBL602509,P50281,,LPZYDQQHEPEWGM-ZMLVVKDOSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,20060717,RATIO,>,120,,,,,,,,,,,,,,,Ratio Kcat to Ki for MMP14,,Discovery of matrix metalloproteases selective and activated peptide-doxorubicin prodrugs as anti-tumor agents.,Bioorg. Med. Chem. Lett.,2010,20,3,"Hu Z, Jiang X, Albright CF, Graciani N, Yue E, Zhang M, Zhang SY, Bruckner R, Diamond M, Dowling R, Rafalski M, Yeleswaram S, Trainor GL, Seitz SP, Han W",,609255,DTCT0024091,3180316,DTCC00620091,1265490,37498
CHEMBL602510,P50281,,BHGGSEGLXWNHKI-IQVHGFSNSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,20060717,RATIO,=,58,,,,,,,,,,,,,,,Ratio Kcat to Ki for MMP14,,Discovery of matrix metalloproteases selective and activated peptide-doxorubicin prodrugs as anti-tumor agents.,Bioorg. Med. Chem. Lett.,2010,20,3,"Hu Z, Jiang X, Albright CF, Graciani N, Yue E, Zhang M, Zhang SY, Bruckner R, Diamond M, Dowling R, Rafalski M, Yeleswaram S, Trainor GL, Seitz SP, Han W",,609255,DTCT0024091,3180379,DTCC00620093,878120,37498
CHEMBL602511,P50281,,UQIFQWMHIQGZOA-IJGIEEHNSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,20060717,RATIO,>,120,,,,,,,,,,,,,,,Ratio Kcat to Ki for MMP14,,Discovery of matrix metalloproteases selective and activated peptide-doxorubicin prodrugs as anti-tumor agents.,Bioorg. Med. Chem. Lett.,2010,20,3,"Hu Z, Jiang X, Albright CF, Graciani N, Yue E, Zhang M, Zhang SY, Bruckner R, Diamond M, Dowling R, Rafalski M, Yeleswaram S, Trainor GL, Seitz SP, Han W",,609255,DTCT0024091,3180378,DTCC00620094,2037891,37498
CHEMBL602512,P50281,,QUFHCGIQHWBHRW-HFMZJWALSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,20060717,RATIO,=,56,,,,,,,,,,,,,,,Ratio Kcat to Ki for MMP14,,Discovery of matrix metalloproteases selective and activated peptide-doxorubicin prodrugs as anti-tumor agents.,Bioorg. Med. Chem. Lett.,2010,20,3,"Hu Z, Jiang X, Albright CF, Graciani N, Yue E, Zhang M, Zhang SY, Bruckner R, Diamond M, Dowling R, Rafalski M, Yeleswaram S, Trainor GL, Seitz SP, Han W",,609255,DTCT0024091,3180375,DTCC00620097,1460097,37498
CHEMBL602513,P50281,,QLSQTUSZZCKABS-MBEKMZCTSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,20060717,RATIO,=,48,,,,,,,,,,,,,,,Ratio Kcat to Ki for MMP14,,Discovery of matrix metalloproteases selective and activated peptide-doxorubicin prodrugs as anti-tumor agents.,Bioorg. Med. Chem. Lett.,2010,20,3,"Hu Z, Jiang X, Albright CF, Graciani N, Yue E, Zhang M, Zhang SY, Bruckner R, Diamond M, Dowling R, Rafalski M, Yeleswaram S, Trainor GL, Seitz SP, Han W",,609255,DTCT0024091,3180373,DTCC00620099,165568,37498
CHEMBL602708,P50281,,LITXUKDGYSQFSD-FNYWWBFVSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,20060717,RATIO,=,83,,,,,,,,,,,,,,,Ratio Kcat to Ki for MMP14,,Discovery of matrix metalloproteases selective and activated peptide-doxorubicin prodrugs as anti-tumor agents.,Bioorg. Med. Chem. Lett.,2010,20,3,"Hu Z, Jiang X, Albright CF, Graciani N, Yue E, Zhang M, Zhang SY, Bruckner R, Diamond M, Dowling R, Rafalski M, Yeleswaram S, Trainor GL, Seitz SP, Han W",,609255,DTCT0024091,3180372,DTCC00620100,619221,37498
CHEMBL602949,P50281,,YYPITAAWUASTAE-OPWSDZRHSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,20022498,KI,>,30000,NM,,,,,,,,,,,,,,Inhibition of MMP14,,The discovery of novel tartrate-based TNF-alpha converting enzyme (TACE) inhibitors.,Bioorg. Med. Chem. Lett.,2010,20,3,"Rosner KE, Guo Z, Orth P, Shipps GW, Belanger DB, Chan TY, Curran PJ, Dai C, Deng Y, Girijavallabhan VM, Hong L, Lavey BJ, Lee JF, Li D, Liu Z, Popovici-Muller J, Ting PC, Vaccaro H, Wang L, Wang T, Yu W, Zhou G, Niu X, Sun J, Kozlowski JA, Lundell DJ, Madison V, McKittrick B, Piwinski JJ, Shih NY, Arshad Siddiqui M, Strickland CO",,608480,DTCT0024091,3182393,DTCC00617171,683777,37349
CHEMBL603308,P50281,,FEBYOUNMPSRCSF-JZBCIKKISA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,20060717,RATIO,=,25,,,,,,,,,,,,,,,Ratio Kcat to Ki for MMP14,,Discovery of matrix metalloproteases selective and activated peptide-doxorubicin prodrugs as anti-tumor agents.,Bioorg. Med. Chem. Lett.,2010,20,3,"Hu Z, Jiang X, Albright CF, Graciani N, Yue E, Zhang M, Zhang SY, Bruckner R, Diamond M, Dowling R, Rafalski M, Yeleswaram S, Trainor GL, Seitz SP, Han W",,609255,DTCT0024091,3180382,DTCC00620089,1428086,37498
CHEMBL603309,P50281,,OVISQYITSPXJSG-QQJJXHBYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,20060717,RATIO,=,89,,,,,,,,,,,,,,,Ratio Kcat to Ki for MMP14,,Discovery of matrix metalloproteases selective and activated peptide-doxorubicin prodrugs as anti-tumor agents.,Bioorg. Med. Chem. Lett.,2010,20,3,"Hu Z, Jiang X, Albright CF, Graciani N, Yue E, Zhang M, Zhang SY, Bruckner R, Diamond M, Dowling R, Rafalski M, Yeleswaram S, Trainor GL, Seitz SP, Han W",,609255,DTCT0024091,3180376,DTCC00620096,910785,37498
CHEMBL603310,P50281,,PPJQVOJWNQJPRU-SWJJWXSQSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,20060717,RATIO,=,72,,,,,,,,,,,,,,,Ratio Kcat to Ki for MMP14,,Discovery of matrix metalloproteases selective and activated peptide-doxorubicin prodrugs as anti-tumor agents.,Bioorg. Med. Chem. Lett.,2010,20,3,"Hu Z, Jiang X, Albright CF, Graciani N, Yue E, Zhang M, Zhang SY, Bruckner R, Diamond M, Dowling R, Rafalski M, Yeleswaram S, Trainor GL, Seitz SP, Han W",,609255,DTCT0024091,3180374,DTCC00620098,12972,37498
CHEMBL603656,P50281,,KOTGODCEORJYIF-QAQDUYKDSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,20005097,KI,>,25000,NM,,,,,,,,,,,,,,Inhibition of MMP14,,Discovery of (pyridin-4-yl)-2H-tetrazole as a novel scaffold to identify highly selective matrix metalloproteinase-13 inhibitors for the treatment of osteoarthritis.,Bioorg. Med. Chem. Lett.,2010,20,2,"Schnute ME, O'Brien PM, Nahra J, Morris M, Howard Roark W, Hanau CE, Ruminski PG, Scholten JA, Fletcher TR, Hamper BC, Carroll JN, Patt WC, Shieh HS, Collins B, Pavlovsky AG, Palmquist KE, Aston KW, Hitchcock J, Rogers MD, McDonald J, Johnson AR, Munie GE, Wittwer AJ, Man CF, Settle SL, Nemirovskiy O, Vickery LE, Agawal A, Dyer RD, Sunyer T",,605230,DTCT0024091,3176042,DTCC00610540,534004,36915
CHEMBL604365,P50281,,CNPHGGDFYWHAFF-SEBRQYJASA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,20060717,RATIO,>,120,,,,,,,,,,,,,,,Ratio Kcat to Ki for MMP14,,Discovery of matrix metalloproteases selective and activated peptide-doxorubicin prodrugs as anti-tumor agents.,Bioorg. Med. Chem. Lett.,2010,20,3,"Hu Z, Jiang X, Albright CF, Graciani N, Yue E, Zhang M, Zhang SY, Bruckner R, Diamond M, Dowling R, Rafalski M, Yeleswaram S, Trainor GL, Seitz SP, Han W",,609255,DTCT0024091,3180364,DTCC00620108,393496,37498
CHEMBL605201,P50281,,XDBOLPFDJWTESQ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,20005097,IC50,>,100000,NM,,,,,,,,,,,,,,Inhibition of MMP14,,Discovery of (pyridin-4-yl)-2H-tetrazole as a novel scaffold to identify highly selective matrix metalloproteinase-13 inhibitors for the treatment of osteoarthritis.,Bioorg. Med. Chem. Lett.,2010,20,2,"Schnute ME, O'Brien PM, Nahra J, Morris M, Howard Roark W, Hanau CE, Ruminski PG, Scholten JA, Fletcher TR, Hamper BC, Carroll JN, Patt WC, Shieh HS, Collins B, Pavlovsky AG, Palmquist KE, Aston KW, Hitchcock J, Rogers MD, McDonald J, Johnson AR, Munie GE, Wittwer AJ, Man CF, Settle SL, Nemirovskiy O, Vickery LE, Agawal A, Dyer RD, Sunyer T",,605230,DTCT0024091,3176020,DTCC00610415,953811,36915
CHEMBL605764,P50281,,AZEKZZSSVLIPCQ-QZTJIDSGSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,20022498,KI,>,40000,NM,,,,,,,,,,,,,,Inhibition of MMP14,,The discovery of novel tartrate-based TNF-alpha converting enzyme (TACE) inhibitors.,Bioorg. Med. Chem. Lett.,2010,20,3,"Rosner KE, Guo Z, Orth P, Shipps GW, Belanger DB, Chan TY, Curran PJ, Dai C, Deng Y, Girijavallabhan VM, Hong L, Lavey BJ, Lee JF, Li D, Liu Z, Popovici-Muller J, Ting PC, Vaccaro H, Wang L, Wang T, Yu W, Zhou G, Niu X, Sun J, Kozlowski JA, Lundell DJ, Madison V, McKittrick B, Piwinski JJ, Shih NY, Arshad Siddiqui M, Strickland CO",,608480,DTCT0024091,3182390,DTCC00617773,1232601,37349
CHEMBL75094,P50281,PRINOMASTAT,YKPYIPVDTNNYCN-INIZCTEOSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,15713379,IC50,=,0.3,NM,,,,,,,,,,,,,,Inhibition of human matrix metalloprotease-14,,N-i-Propoxy-N-biphenylsulfonylaminobutylhydroxamic acids as potent and selective inhibitors of MMP-2 and MT1-MMP.,Bioorg. Med. Chem. Lett.,2005,15,5,"Rossello A, Nuti E, Carelli P, Orlandini E, Macchia M, Nencetti S, Zandomeneghi M, Balzano F, Uccello Barretta G, Albini A, Benelli R, Cercignani G, Murphy G, Balsamo A",,305766,DTCT0024091,1745887,DTCC00231104,325586,18841
CHEMBL79433,P50281,,IMKDKHQDFFLOKK-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,12773042,IC50,=,7,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-14,,"Synthesis and structure-activity relationship of N-substituted 4-arylsulfonylpiperidine-4-hydroxamic acids as novel, orally active matrix metalloproteinase inhibitors for the treatment of osteoarthritis.",J. Med. Chem.,2003,46,12,"Aranapakam V, Davis JM, Grosu GT, Baker J, Ellingboe J, Zask A, Levin JI, Sandanayaka VP, Du M, Skotnicki JS, DiJoseph JF, Sung A, Sharr MA, Killar LM, Walter T, Jin G, Cowling R, Tillett J, Zhao W, McDevitt J, Xu ZB",,106789,DTCT0024091,494322,DTCC00235743,75938,17340
CHEMBL83508,P50281,,WLZISXXOYYGJNT-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,20180536,IC50,=,210,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP14 by fluorometric assay,,Potent arylsulfonamide inhibitors of tumor necrosis factor-alpha converting enzyme able to reduce activated leukocyte cell adhesion molecule shedding in cancer cell models.,J. Med. Chem.,2010,53,6,"Nuti E, Casalini F, Avramova SI, Santamaria S, Fabbi M, Ferrini S, Marinelli L, La Pietra V, Limongelli V, Novellino E, Cercignani G, Orlandini E, Nencetti S, Rossello A",,624095,DTCT0024091,3286019,DTCC00243572,241678,38228
CHEMBL85744,P50281,,ZGTPJERIIBYCFG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,10411481,KI,=,192,NM,,,,,,,,,,,,,,Binding affinity against matrix metalloprotease-14 MTI-MMP.,,Phosphinic pseudo-tripeptides as potent inhibitors of matrix metalloproteinases: a structure-activity study.,J. Med. Chem.,1999,42,14,"Vassiliou S, Mucha A, Cuniasse P, Georgiadis D, Lucet-Levannier K, Beau F, Kannan R, Murphy G, Knäuper V, Rio MC, Basset P, Yiotakis A, Dive V",,106782,DTCT0024091,1093444,DTCC00248613,1002961,15258
CHEMBL86390,P50281,,HCCYYUWFQWPMDZ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,10411481,KI,=,545,NM,,,,,,,,,,,,,,Binding affinity against matrix metalloprotease-14 MTI-MMP.,,Phosphinic pseudo-tripeptides as potent inhibitors of matrix metalloproteinases: a structure-activity study.,J. Med. Chem.,1999,42,14,"Vassiliou S, Mucha A, Cuniasse P, Georgiadis D, Lucet-Levannier K, Beau F, Kannan R, Murphy G, Knäuper V, Rio MC, Basset P, Yiotakis A, Dive V",,106782,DTCT0024091,1072662,DTCC00248612,452924,15258
CHEMBL87159,P50281,,SFORRVNMTYAPLQ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,10411481,KI,=,40,NM,,,,,,,,,,,,,,Binding affinity against matrix metalloprotease-14 MTI-MMP.,,Phosphinic pseudo-tripeptides as potent inhibitors of matrix metalloproteinases: a structure-activity study.,J. Med. Chem.,1999,42,14,"Vassiliou S, Mucha A, Cuniasse P, Georgiadis D, Lucet-Levannier K, Beau F, Kannan R, Murphy G, Knäuper V, Rio MC, Basset P, Yiotakis A, Dive V",,106782,DTCT0024091,1065672,DTCC00248280,291448,15258
CHEMBL87300,P50281,,BVONHINTCXADCU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,10411481,KI,=,73,NM,,,,,,,,,,,,,,Binding affinity against matrix metalloprotease-14 MTI-MMP.,,Phosphinic pseudo-tripeptides as potent inhibitors of matrix metalloproteinases: a structure-activity study.,J. Med. Chem.,1999,42,14,"Vassiliou S, Mucha A, Cuniasse P, Georgiadis D, Lucet-Levannier K, Beau F, Kannan R, Murphy G, Knäuper V, Rio MC, Basset P, Yiotakis A, Dive V",,106782,DTCT0024091,1056173,DTCC00248279,291447,15258
CHEMBL87786,P50281,,UERCGTJUVRFNRO-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,10411481,KI,=,1282,NM,,,,,,,,,,,,,,Binding affinity against matrix metalloprotease-14 MTI-MMP.,,Phosphinic pseudo-tripeptides as potent inhibitors of matrix metalloproteinases: a structure-activity study.,J. Med. Chem.,1999,42,14,"Vassiliou S, Mucha A, Cuniasse P, Georgiadis D, Lucet-Levannier K, Beau F, Kannan R, Murphy G, Knäuper V, Rio MC, Basset P, Yiotakis A, Dive V",,106782,DTCT0024091,1084529,DTCC00248815,1456037,15258
CHEMBL88187,P50281,,BVNHOVTUHKATJL-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,10411481,KI,=,125,NM,,,,,,,,,,,,,,Binding affinity against matrix metalloprotease-14 MTI-MMP.,,Phosphinic pseudo-tripeptides as potent inhibitors of matrix metalloproteinases: a structure-activity study.,J. Med. Chem.,1999,42,14,"Vassiliou S, Mucha A, Cuniasse P, Georgiadis D, Lucet-Levannier K, Beau F, Kannan R, Murphy G, Knäuper V, Rio MC, Basset P, Yiotakis A, Dive V",,106782,DTCT0024091,1082199,DTCC00249128,323966,15258
CHEMBL88188,P50281,,LWTYDGJEOHWGQD-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,10411481,KI,=,53,NM,,,,,,,,,,,,,,Binding affinity against matrix metalloprotease-14 MTI-MMP.,,Phosphinic pseudo-tripeptides as potent inhibitors of matrix metalloproteinases: a structure-activity study.,J. Med. Chem.,1999,42,14,"Vassiliou S, Mucha A, Cuniasse P, Georgiadis D, Lucet-Levannier K, Beau F, Kannan R, Murphy G, Knäuper V, Rio MC, Basset P, Yiotakis A, Dive V",,106782,DTCT0024091,1092149,DTCC00249129,582755,15258
CHEMBL88520,P50281,,HFAGTNGCAZYYLZ-OTWHNJEPSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,11472217,KI,=,94,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-14,,"Design, synthesis, and structure-activity relationships of macrocyclic hydroxamic acids that inhibit tumor necrosis factor alpha release in vitro and in vivo.",J. Med. Chem.,2001,44,16,"Xue CB, Voss ME, Nelson DJ, Duan JJ, Cherney RJ, Jacobson IC, He X, Roderick J, Chen L, Corbett RL, Wang L, Meyer DT, Kennedy K, DeGradodagger WF, Hardman KD, Teleha CA, Jaffee BD, Liu RQ, Copeland RA, Covington MB, Christ DD, Trzaskos JM, Newton RC, Magolda RL, Wexler RR, Decicco CP",,106785,DTCT0024091,1674086,DTCC00251150,291473,16346
CHEMBL89057,P50281,,RIOJMNDNYHZZFM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,10411481,KI,=,32,NM,,,,,,,,,,,,,,Binding affinity against matrix metalloprotease-14 MTI-MMP.,,Phosphinic pseudo-tripeptides as potent inhibitors of matrix metalloproteinases: a structure-activity study.,J. Med. Chem.,1999,42,14,"Vassiliou S, Mucha A, Cuniasse P, Georgiadis D, Lucet-Levannier K, Beau F, Kannan R, Murphy G, Knäuper V, Rio MC, Basset P, Yiotakis A, Dive V",,106782,DTCT0024091,1082206,DTCC00249245,1838879,15258
CHEMBL90622,P50281,,RZDDQWJXBRPPTM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,10411481,KI,=,26,NM,,,,,,,,,,,,,,Binding affinity against matrix metalloprotease-14 MTI-MMP.,,Phosphinic pseudo-tripeptides as potent inhibitors of matrix metalloproteinases: a structure-activity study.,J. Med. Chem.,1999,42,14,"Vassiliou S, Mucha A, Cuniasse P, Georgiadis D, Lucet-Levannier K, Beau F, Kannan R, Murphy G, Knäuper V, Rio MC, Basset P, Yiotakis A, Dive V",,106782,DTCT0024091,1091000,DTCC00249364,1742142,15258
CHEMBL91636,P50281,,DONMTDNLNMLOIC-OTWHNJEPSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,11472217,KI,=,140,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-14,,"Design, synthesis, and structure-activity relationships of macrocyclic hydroxamic acids that inhibit tumor necrosis factor alpha release in vitro and in vivo.",J. Med. Chem.,2001,44,16,"Xue CB, Voss ME, Nelson DJ, Duan JJ, Cherney RJ, Jacobson IC, He X, Roderick J, Chen L, Corbett RL, Wang L, Meyer DT, Kennedy K, DeGradodagger WF, Hardman KD, Teleha CA, Jaffee BD, Liu RQ, Copeland RA, Covington MB, Christ DD, Trzaskos JM, Newton RC, Magolda RL, Wexler RR, Decicco CP",,106785,DTCT0024091,1647513,DTCC00251443,1261581,16346
CHEMBL924,P50281,ZOLEDRONIC ACID,XRASPMIURGNCCH-UHFFFAOYSA-N,4,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,24071448,IC50,=,12600,NM,,,,,,,,,,,,,,Inhibition of MMP14 catalytic domain (unknown origin) using Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 as substrate incubated for 30 mins prior to substrate addition measured after 2 to 4 hrs by fluorometric assay,,Arylamino methylene bisphosphonate derivatives as bone seeking matrix metalloproteinase inhibitors.,Bioorg. Med. Chem.,2013,21,21,"Tauro M, Laghezza A, Loiodice F, Agamennone M, Campestre C, Tortorella P",,990167,DTCT0024091,12628993,DTCC00200651,1095364,56259
CHEMBL94715,P50281,,XRLMAIWPTHLVKY-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,24044434,IC50,=,2900,NM,,,,,,,,,,,,,,Inhibition of recombinant human MMP-14 catalytic domain using Mca-Lys-Pro-Leu-Gly-Leu-Dap(Dnp)-Ala-Arg-NH2 as substrate incubated for 4 hrs measured every 15 secs for 20 mins by fluorimetric assay,,Selective arylsulfonamide inhibitors of ADAM-17: hit optimization and activity in ovarian cancer cell models.,J. Med. Chem.,2013,56,20,"Nuti E, Casalini F, Santamaria S, Fabbi M, Carbotti G, Ferrini S, Marinelli L, La Pietra V, Novellino E, Camodeca C, Orlandini E, Nencetti S, Rossello A",,984237,DTCT0024091,12586859,DTCC00260052,1612575,55984
CHEMBL95237,P50281,,IHERVMJHCHNTKO-YJJOXIQCSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,17512742,IC50,=,10,NM,,,,,,,,,,,,,,Inhibition of MMP14,,Simultaneous presence of unsaturation and long alkyl chain at P'1 of Ilomastat confers selectivity for gelatinase A (MMP-2) over gelatinase B (MMP-9) inhibition as shown by molecular modelling studies.,Bioorg. Med. Chem.,2007,15,14,"Moroy G, Denhez C, El Mourabit H, Toribio A, Dassonville A, Decarme M, Renault JH, Mirand C, Bellon G, Sapi J, Alix AJ, Hornebeck W, Bourguet E",,447908,DTCT0024091,2176052,DTCC00263307,520985,23716
,P50281,,ABZSPJVXTTUFAA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,-1,IC50,=,3890,NM,,cell_based,binding,,,,,,,,,,,,,,,,,,,,,DTCT0024091,15049207,DTCC01744004,2113367,70044
,P50281,,ABZSPJVXTTUFAA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,-1,IC50,=,7990,NM,,cell_based,binding,,,,,,,,,,,,,,,,,,,,,DTCT0024091,15060569,DTCC01744004,2113367,70044
,P50281,,ABZSPJVXTTUFAA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,-1,IC50,=,14870,NM,,cell_based,binding,,,,,,,,,,,,,,,,,,,,,DTCT0024091,15060567,DTCC01744004,2113367,70044
,P50281,,ABZSPJVXTTUFAA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,-1,IC50,=,50200,NM,,cell_based,binding,,,,,,,,,,,,,,,,,,,,,DTCT0024091,15060566,DTCC01744004,2113367,70044
,P50281,,ABZSPJVXTTUFAA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,-1,IC50,>,100000,NM,,cell_based,binding,,,,,,,,,,,,,,,,,,,,,DTCT0024091,15060568,DTCC01744004,2113367,70044
,P50281,,ABZSPJVXTTUFAA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,27825552,IC50,=,3.8,NM,inhibition,,,,,,,,,,,,,,,,,,,,,,,DTCT0024091,14945302,DTCC01744004,2113725,70170
,P50281,,ABZSPJVXTTUFAA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,27825552,IC50,=,5.4,NM,inhibition,,,,,,,,,,,,,,,,,,,,,,,DTCT0024091,14971468,DTCC01744004,2113725,70170
,P50281,,ABZSPJVXTTUFAA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,27825552,IC50,=,140,NM,inhibition,,,,,,,,,,,,,,,,,,,,,,,DTCT0024091,15020551,DTCC01744004,2113725,70170
,P50281,,ABZSPJVXTTUFAA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,27825552,IC50,=,550,NM,inhibition,,,,,,,,,,,,,,,,,,,,,,,DTCT0024091,15031452,DTCC01744004,2113725,70170
,P50281,,ABZSPJVXTTUFAA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,27825552,IC50,=,3700,NM,inhibition,,,,,,,,,,,,,,,,,,,,,,,DTCT0024091,15055209,DTCC01744004,2113725,70170
,P50281,,ABZSPJVXTTUFAA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,27825552,IC50,=,8900,NM,inhibition,,,,,,,,,,,,,,,,,,,,,,,DTCT0024091,15071408,DTCC01744004,2113725,70170
,P50281,,ABZSPJVXTTUFAA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,27825552,IC50,>,10000,NM,inhibition,,,,,,,,,,,,,,,,,,,,,,,DTCT0024091,15069934,DTCC01744004,2113725,70170
,P50281,,ABZSPJVXTTUFAA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,27825552,IC50,>,10000,NM,inhibition,,,,,,,,,,,,,,,,,,,,,,,DTCT0024091,15069935,DTCC01744004,2113725,70170
,P50281,,ABZSPJVXTTUFAA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,27825552,IC50,>,10000,NM,inhibition,,,,,,,,,,,,,,,,,,,,,,,DTCT0024091,15071406,DTCC01744004,2113725,70170
,P50281,,ABZSPJVXTTUFAA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,27825552,IC50,>,10000,NM,inhibition,,,,,,,,,,,,,,,,,,,,,,,DTCT0024091,15071407,DTCC01744004,2113725,70170
,P50281,,ABZSPJVXTTUFAA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,28337319,IC50,=,23,NM,inhibition,,binding,,,,,,,,,,,,,,,,,,,,,DTCT0024091,14996413,DTCC01744004,2113819,70225
,P50281,,ABZSPJVXTTUFAA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,28337319,IC50,=,116,NM,inhibition,,binding,,,,,,,,,,,,,,,,,,,,,DTCT0024091,15019803,DTCC01744004,2113819,70225
,P50281,,ABZSPJVXTTUFAA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,28337319,IC50,=,250,NM,inhibition,,binding,,,,,,,,,,,,,,,,,,,,,DTCT0024091,15020550,DTCC01744004,2113819,70225
,P50281,,ABZSPJVXTTUFAA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,28337319,IC50,=,850,NM,inhibition,,binding,,,,,,,,,,,,,,,,,,,,,DTCT0024091,15043295,DTCC01744004,2113819,70225
,P50281,,ABZSPJVXTTUFAA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,28337319,IC50,=,900,NM,inhibition,,binding,,,,,,,,,,,,,,,,,,,,,DTCT0024091,15043296,DTCC01744004,2113819,70225
,P50281,,ABZSPJVXTTUFAA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,28337319,IC50,=,1830,NM,inhibition,,binding,,,,,,,,,,,,,,,,,,,,,DTCT0024091,15055207,DTCC01744004,2113819,70225
,P50281,,ABZSPJVXTTUFAA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 14,MMP14,Enzyme,,,28337319,IC50,=,2200,NM,inhibition,,binding,,,,,,,,,,,,,,,,,,,,,DTCT0024091,15055208,DTCC01744004,2113819,70225
